Genworth Financial (GNW) 10-K 28 Feb 22 2021 FY Annual report Financial data

Cover Page

Cover Page - USD ($) $ in Billions	12 Months Ended
	Dec. 31, 2021	Feb. 16, 2022	Jun. 30, 2021
Cover [Abstract]
Document Type	10-K
Amendment Flag	false
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	FY
Entity Central Index Key	0001276520
Current Fiscal Year End Date	--12-31
Document Annual Report	true
Document Transition Report	false
Document Period End Date	Dec. 31, 2021
Entity Registrant Name	GENWORTH FINANCIAL, INC.
Entity File Number	001-32195
Entity Tax Identification Number	80-0873306
Entity Incorporation, State or Country Code	DE
Entity Current Reporting Status	Yes
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Filer Category	Large Accelerated Filer
Entity Shell Company	false
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Address, Address Line One	6620 West Broad Street
Entity Address, State or Province	VA
Entity Address, City or Town	Richmond
Entity Address, Postal Zip Code	23230
Entity Interactive Data Current	Yes
City Area Code	804
Local Phone Number	281-6000
Trading Symbol	GNW
Security Exchange Name	NYSE
Title of 12(b) Security	Class A Common Stock, par value $.001 per share
Entity Common Stock, Shares Outstanding		507,385,834
Entity Public Float			$ 2
ICFR Auditor Attestation Flag	true
Auditor Name	KPMG LLP
Auditor Firm ID	185
Auditor Location	Richmond, VA

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Assets
Fixed maturity securities available-for-sale, at fair value (amortized cost of $52,611 and $53,417 and allowance for credit losses of $— and $4 as of December 31, 2021 and 2020, respectively)	$ 60,480	$ 63,495
Equity securities, at fair value	198	386
Commercial mortgage loans (net of unamortized balance of loan origination fees and costs of $4 as of December 31, 2021 and 2020)	6,856	6,774
Less: Allowance for credit losses	(26)	(31)
Commercial mortgage loans, net	6,830	6,743
Policy loans	2,050	1,978
Limited partnerships	1,900	1,049
Other invested assets	820	1,050
Total investments	72,278	74,701
Cash, cash equivalents and restricted cash	1,571	2,561
Accrued investment income	647	655
Deferred acquisition costs	1,146	1,487
Intangible assets	143	157
Reinsurance recoverable	16,868	16,864
Less: Allowance for credit losses	(55)	(45)
Reinsurance recoverable, net	16,813	16,819
Other assets	388	404
Deferred tax asset	119	65
Separate account assets	6,066	6,081
Assets related to discontinued operations	0	2,817
Total assets	99,171	105,747
Liabilities and equity
Future policy benefits	41,528	42,695
Policyholder account balances	19,354	21,503
Liability for policy and contract claims	11,841	11,486
Unearned premiums	672	775
Other liabilities	1,511	1,614
Long-term borrowings	1,899	3,403
Separate account liabilities	6,066	6,081
Liabilities related to discontinued operations	34	2,370
Total liabilities	82,905	89,927
Commitments and contingencies
Equity:
Class A common stock, $0.001 par value; 1.5 billion shares authorized; 596 million and 594 million shares issued as of December 31, 2021 and 2020, respectively; 508 million and 506 million shares outstanding as of December 31, 2021 and 2020, respectively	1	1
Additional paid-in capital	11,858	12,008
Accumulated other comprehensive income (loss)	3,861	4,425
Retained earnings	2,490	1,584
Treasury stock, at cost (88 million shares as of December 31, 2021 and 2020)	(2,700)	(2,700)
Total Genworth Financial, Inc.'s stockholders' equity	15,510	15,318
Noncontrolling interests	756	502
Total equity	16,266	15,820
Total liabilities and equity	$ 99,171	$ 105,747

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Debt securities amortized costs	$ 52,611	$ 53,417
Debt securities allowance for credit losses	0	4
Unamortized balance of loan origination fees	$ 4	$ 4
Class A common stock, par value	$ 0.001	$ 0.001
Class A common stock, shares authorized	1,500,000,000	1,500,000,000
Class A common stock, shares issued	596,000,000	594,000,000
Class A common stock, shares outstanding	508,000,000	506,000,000
Treasury stock, shares	88,000,000	88,000,000

CONSOLIDATED STATEMENTS OF INCO

CONSOLIDATED STATEMENTS OF INCOME - USD ($) shares in Millions, $ in Millions		12 Months Ended
		Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Revenues:
Premiums		$ 3,435	$ 3,836	$ 3,725
Net investment income		3,370	3,227	3,164
Net investment gains (losses)		323	492	27
Policy fees and other income		704	729	789
Total revenues		7,832	8,284	7,705
Benefits and expenses:
Benefits and other changes in policy reserves		4,383	5,214	5,059
Interest credited		508	549	577
Acquisition and operating expenses, net of deferrals		1,223	935	909
Amortization of deferred acquisition costs and intangibles		377	463	408
Interest expense		160	195	231
Total benefits and expenses		6,651	7,356	7,184
Income from continuing operations before income taxes		1,181	928	521
Provision for income taxes		263	230	139
Income from continuing operations		918	698	382
Income (loss) from discontinued operations, net of taxes		27	(486)	148
Net income		945	212	530
Less: net income from continuing operations attributable to noncontrolling interests		33	0	0
Less: net income from discontinued operations attributable to noncontrolling interests		8	34	187
Net income available to Genworth Financial, Inc.'s common stockholders		904	178	343
Net income (loss) available to Genworth Financial, Inc.'s common stockholders:
Income from continuing operations available to Genworth Financial, Inc.'s common stockholders		885	698	382
Income (loss) from discontinued operations available to Genworth Financial, Inc.'s common stockholders		19	(520)	(39)
Net income available to Genworth Financial, Inc.'s common stockholders		$ 904	$ 178	$ 343
Income from continuing operations available to Genworth Financial, Inc.'s common stockholders per share:
Basic		$ 1.75	$ 1.38	$ 0.76
Diluted		1.72	1.36	0.75
Net income available to Genworth Financial, Inc.'s common stockholders per share:
Basic	[1]	1.78	0.35	0.68
Diluted	[1]	$ 1.76	$ 0.35	$ 0.67
Weighted-average common shares outstanding:
Basic		506.9	505.2	502.9
Diluted		514.7	511.6	509.7
[1]	May not total due to whole number calculation.

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Net income	$ 945	$ 212	$ 530
Other comprehensive income (loss), net of taxes:
Net unrealized gains (losses) on securities without an allowance for credit losses	(370)	764	0
Net unrealized gains (losses) on securities with an allowance for credit losses	6	(6)	0
Net unrealized gains (losses) on securities not other-than-temporarily impaired	0	0	846
Net unrealized gains (losses) on other-than-temporarily impaired securities	0	0	2
Derivatives qualifying as hedges	(186)	209	221
Foreign currency translation and other adjustments	148	55	487
Total other comprehensive income (loss)	(402)	1,022	1,556
Total comprehensive income	543	1,234	2,086
Less: comprehensive income attributable to noncontrolling interests	177	64	354
Total comprehensive income available to Genworth Financial, Inc.'s common stockholders	$ 366	$ 1,170	$ 1,732

CONSOLIDATED STATEMENTS OF CHAN

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($) $ in Millions	Total	Cumulative effect of change in accounting, net of taxes	Common stock	Common stockCumulative effect of change in accounting, net of taxes	Additional paid-in capital	Additional paid-in capitalCumulative effect of change in accounting, net of taxes	Accumulated other comprehensive income (loss)	Accumulated other comprehensive income (loss)Cumulative effect of change in accounting, net of taxes	Retained earnings	Retained earningsCumulative effect of change in accounting, net of taxes	Treasury stock, at cost	Treasury stock, at costCumulative effect of change in accounting, net of taxes	Total Genworth Financial, Inc.‘s stockholders' equity	Total Genworth Financial, Inc.‘s stockholders' equityCumulative effect of change in accounting, net of taxes	Noncontrolling interests	Noncontrolling interestsCumulative effect of change in accounting, net of taxes
Balances, beginning at Dec. 31, 2018	$ 14,189		$ 1		$ 11,987		$ 2,044		$ 1,118		$ (2,700)		$ 12,450		$ 1,739
Repurchase of subsidiary shares	(44)		0		0		0		0		0		0		(44)
Sale of business that included noncontrolling interests	(1,417)		0		0		0		0		0		0		(1,417)
Comprehensive income (loss):
Net income	530		0		0		0		343		0		343		187
Other comprehensive income (loss), net of taxes	1,556		0		0		1,389		0		0		1,389		167
Total comprehensive income	2,086												1,732		354
Dividends to noncontrolling interests	(197)		0		0		0		0		0		0		(197)
Stock-based compensation expense and exercises and other	15		0		3		0		0		0		3		12
Balances, ending at Dec. 31, 2019	14,632	$ (55)	1	$ 0	11,990	$ 0	3,433	$ 0	1,461	$ (55)	(2,700)	$ 0	14,185	$ (55)	447	$ 0
Comprehensive income (loss):
Net income	212		0		0		0		178		0		178		34
Other comprehensive income (loss), net of taxes	1,022		0		0		992		0		0		992		30
Total comprehensive income	1,234												1,170		64
Dividends to noncontrolling interests	(9)		0		0		0		0		0		0		(9)
Stock-based compensation expense and exercises and other	18		0		18		0		0		0		18		0
Balances, ending at Dec. 31, 2020	15,820		1		12,008		4,425		1,584		(2,700)		15,318		502
Initial sale of subsidiary shares to noncontrolling interests	580		0		(167)		(26)		0		0		(193)		773
Sale of business that included noncontrolling interests	(657)		0		0		0		0		0		0		(657)
Comprehensive income (loss):
Net income	945		0		0		0		904		0		904		41
Other comprehensive income (loss), net of taxes	(402)		0		0		(538)		0		0		(538)		136
Total comprehensive income	543												366		177
Dividends to noncontrolling interests	(37)		0		0		0		0		0		0		(37)
Stock-based compensation expense and exercises and other	17		0		17		0		2		0		19		(2)
Balances, ending at Dec. 31, 2021	$ 16,266		$ 1		$ 11,858		$ 3,861		$ 2,490		$ (2,700)		$ 15,510		$ 756

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS $ in Millions	12 Months Ended
	Dec. 31, 2021USD ($)	Dec. 31, 2020USD ($)	Dec. 31, 2019USD ($)
Cash flows from operating activities:
Net income	$ 945	$ 212	$ 530
Less (income) loss from discontinued operations, net of taxes	(27)	486	(148)
Adjustments to reconcile net income to net cash from operating activities:
Amortization of fixed maturity securities discounts and premiums	(176)	(157)	(131)
Net investment (gains) losses	(323)	(492)	(27)
Charges assessed to policyholders	(620)	(646)	(699)
Acquisition costs deferred	(8)	(3)	(17)
Amortization of deferred acquisition costs and intangibles	377	463	408
Deferred income taxes	290	228	119
Derivative instruments, limited partnerships and other	(359)	(112)	(82)
Stock-based compensation expense	40	39	26
Change in certain assets and liabilities:
Accrued investment income and other assets	(129)	(92)	(359)
Insurance reserves	642	1,217	1,259
Current tax liabilities	(34)	6	21
Other liabilities, policy and contract claims and other policy-related balances	310	830	636
Cash from (used by) operating activities—discontinued operations	(491)	(19)	543
Net cash from operating activities	437	1,960	2,079
Cash flows from (used by) investing activities:
Fixed maturity securities	4,162	3,637	3,131
Commercial mortgage loans	874	744	597
Limited partnerships and other invested assets	255	182	153
Proceeds from sales of investments:
Fixed maturity and equity securities	2,273	3,040	3,214
Purchases and originations of investments:
Fixed maturity and equity securities	(5,216)	(7,763)	(5,962)
Commercial mortgage loans	(963)	(547)	(813)
Limited partnerships and other invested assets	(767)	(449)	(476)
Short-term investments, net	18	35	34
Policy loans, net	57	190	62
Proceeds from sale of business, net of cash transferred	270	0	1,398
Cash from (used by) investing activities—discontinued operations	(67)	(222)	(37)
Net cash from (used by) investing activities	896	(1,153)	1,301
Cash flows used by financing activities:
Deposits to universal life and investment contracts	669	862	824
Withdrawals from universal life and investment contracts	(2,071)	(2,282)	(2,319)
Redemption of non-recourse funding obligations	0	(315)	0
Proceeds from issuance of long-term debt	0	738	0
Repayment and repurchase of long-term debt	(1,541)	(490)	(446)
Proceeds from sale of subsidiary shares to noncontrolling interests	529	0	0
Dividends paid to noncontrolling interests	(37)	0	0
Other, net	32	(2)	(35)
Cash used by financing activities—discontinued operations	0	(18)	(241)
Net cash used by financing activities	(2,419)	(1,507)	(2,217)
Effect of exchange rate changes on cash, cash equivalents and restricted cash (includes $(1), $18 and $1 related to discontinued operations)	1	15	1
Net change in cash, cash equivalents and restricted cash	(1,085)	(685)	1,164
Cash, cash equivalents and restricted cash at beginning of period	2,656	3,341	2,177
Cash, cash equivalents and restricted cash at end of period	1,571	2,656	3,341
Less cash, cash equivalents and restricted cash of discontinued operations at end of period	0	95	79
Cash, cash equivalents and restricted cash of continuing operations at end of period	$ 1,571	$ 2,561	$ 3,262

CONSOLIDATED STATEMENTS OF CA_2

CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Statement of Cash Flows [Abstract]
Discontinued operations exchange rate effect	$ (1)	$ 18	$ 1

Nature of Business and Formatio

Nature of Business and Formation of Genworth	12 Months Ended
	Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature of Business and Formation of Genworth	(1) Nature of Business and Formation of Genworth Genworth Holdings, Inc. (“Genworth Holdings”) (formerly known as Genworth Financial, Inc.) was incorporated in Delaware in 2003 in preparation for an initial public offering (“IPO”) of its common stock, which was completed on May 28, 2004. On April 1, 2013, Genworth Holdings completed a holding company reorganization pursuant to which Genworth Holdings became a direct, 100% owned subsidiary of a new public holding company that it had formed. The new public holding company was incorporated in Delaware on December 5, 2012, in connection with the reorganization, and was renamed Genworth Financial, Inc. (“Genworth Financial”) upon the completion of the reorganization. The accompanying financial statements include on a consolidated basis the accounts of Genworth Financial and its affiliate companies in which it holds a majority voting interest or power to direct activities of certain variable interest entities (“VIEs”), which on a consolidated basis is referred to as “Genworth,” the “Company,” “we,” “us” or “our” unless the context otherwise requires. All intercompany accounts and transactions have been eliminated in consolidation. References to “Genworth Financial” refer solely to Genworth Financial, Inc., and not to any of its consolidated subsidiaries. We operate our business through the following three operating segments: • Enact. • U.S. Life Insurance. • Runoff. In addition to our three operating business segments, we also have Corporate and Other activities which include debt financing expenses that are incurred at the Genworth Holdings level, unallocated corporate income and expenses, eliminations of inter-segment transactions and the results of other businesses that are reported outside of our operating segments, including certain international mortgage insurance businesses and discontinued operations. On March 3, 2021, we completed a sale of our entire ownership interest of approximately 52% in Genworth Mortgage Insurance Australia Limited (“Genworth Australia”) through an underwriting agreement. We sold our approximately 214.3 million shares of Genworth Australia for AUD2.28 per share. Our Australian mortgage insurance business, the primary business in our previously reported Australia Mortgage Insurance segment, is reported as discontinued operations and its financial position, results of operations and cash flows are separately reported for all periods presented. All prior periods reflected herein have been re-presented on this basis. See note 23 for additional information related to discontinued operations. Each reporting period, we assess our ability to continue as a going concern for one year from the date the financial statements are issued. As of December 31, 2021, Genworth Holdings has $353 million of unrestricted cash, cash equivalents and liquid assets. For the year ended December 31, 2021, our evaluation of our ability to meet our financial obligations included the following contractual obligations due within one year from the issue date of our audited consolidated financial statements included herein: • Genworth Holdings early redeemed its 7.625% and 4.90% senior notes in July 2021 and December 2021, respectively, originally due in September 2021 and August 2023, respectively. The 7.625% and 4.90% senior notes were redeemed with cash payments of $532 million and $334 million, respectively, comprised of the outstanding principal balances, accrued interest and make-whole premiums. We have no additional debt maturities until February 2024. Interest payments on our remaining senior notes are forecasted to be approximately $65 million due between January 2022 through March 2023. See note 12 for additional details on our long-term borrowings. • As part of the settlement agreement reached in July 2020 regarding the case titled AXA S.A. v. Genworth Financial International Holdings, LLC et al., • Genworth Holdings received intercompany cash tax payments from its subsidiaries during the year ended December 31, 2021 generated from taxable income. Additional intercompany cash tax payments are expected in future periods. Genworth Holdings received net cash proceeds of $370 million and $529 million from the sale of Genworth Australia in March 2021 and the minority IPO of Enact Holdings in September 2021, respectively. See note 22 for additional details related to the minority IPO of Enact Holdings. We believe Genworth Holdings’ current unrestricted cash, cash equivalents and liquid assets provide sufficient liquidity to meet our financial obligations and maintain business operations for one year from the date the audited consolidated financial statements are issued, based on relevant conditions and events that are known and reasonably estimable, including current cash and management actions in the normal course. Accordingly, we no longer need to determine whether our plans alleviate doubt about our ability to meet our financial commitments and obligations within the next year. The impact of the ongoing coronavirus pandemic (“COVID-19”) is very difficult to predict. Its related outcomes and impact on our business and the capital markets, and our ability to raise capital will depend on economic impacts from social, global and political influences as a result of the pandemic, and the shape of the economic recovery, among other factors and uncertainties. While these risks exist, we believe our current liquidity is sufficient to meet our obligations for one year following the issuance of our audited consolidated financial statements.

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2021
Disclosue of Accounting Changes [Abstract]
Summary of Significant Accounting Policies	(2) Summary of Significant Accounting Policies Our consolidated financial statements have been prepared on the basis of U.S. generally accepted accounting principles (“U.S. GAAP”). Preparing financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect reported amounts and related disclosures. Actual results could differ from those estimates. Certain prior year amounts have been reclassified to conform to the current year presentation. The ultimate impact from COVID-19 remains unknown, as we continue to face risks and uncertainties associated with the pandemic. Certain of these risks may include declines in investment valuations and impairments, commercial mortgage loan restructurings, deferred acquisition cost or intangible asset impairments or the acceleration of amortization, inability to recover deferred tax assets and increases to insurance reserves, including higher loss reserves and the resolution of delinquencies subject to a forbearance plan in our Enact segment, among other matters. a) Premiums For traditional long-duration insurance contracts, we report premiums as earned when due. For short-duration insurance contracts, we report premiums as revenue over the terms of the related insurance policies on a pro-rata basis or in proportion to expected claims. For single premium mortgage insurance contracts, we report premiums over the estimated policy life in accordance with the expected pattern of risk emergence as further described in our accounting policy for unearned premiums. In addition, we refund post-delinquent premiums received to the insured party if the delinquent loan goes to claim. We record a liability for premiums received on the delinquent loans consistent with our expectations of the rates at which delinquencies go to claim (“claim rates”). Premiums received under annuity contracts without significant mortality risk and premiums received on investment and universal life insurance products are not reported as revenues but rather as deposits and are included in liabilities for policyholder account balances. b) Net Investment Income and Net Investment Gains and Losses Investment income is recognized when earned. Income or loss upon call or prepayment of available-for-sale fixed maturity securities is recognized in net investment income, except for hybrid securities where the income or loss upon call is recognized in net investment gains and losses. Investment gains and losses are calculated on the basis of specific identification on the trade date. Investment income on mortgage-backed and asset-backed securities is initially based upon yield, cash flow and prepayment assumptions at the date of purchase. Subsequent revisions in those assumptions are recorded using the retrospective or prospective method. Under the retrospective method used for mortgage-backed and asset-backed securities of high credit quality (ratings equal to or greater than “AA” or that are backed by a U.S. agency) which cannot be contractually prepaid in such a manner that we would not recover a substantial portion of the initial investment, amortized cost of the security is adjusted to the amount that would have existed had the revised assumptions been in place at the date of purchase. The adjustments to amortized cost are recorded as a charge or credit to net investment income. Under the prospective method, which is used for all other mortgage-backed and asset-backed securities, future cash flows are estimated and interest income is recognized going forward using the new internal rate of return. c) Policy Fees and Other Income Policy fees and other income consists primarily of insurance charges assessed on universal and term universal life insurance contracts and fees assessed against customer account values. For universal and term universal life insurance contracts, charges to policyholder accounts for cost of insurance are recognized as revenue when due. Variable product fees are charged to variable annuity contractholders and variable life insurance policyholders based upon the daily net assets of the contractholder’s and policyholder’s account values and are recognized as revenue when charged. Policy surrender fees are recognized as income when the policy is surrendered. d) Investment Securities At the time of purchase, we designate our fixed maturity securities as either available-for-sale or trading and report them in our consolidated balance sheets at fair value. Our portfolio of fixed maturity securities comprises primarily investment grade securities. Changes in the fair value of available-for-sale fixed maturity securities, net of the effect on deferred acquisition costs (“DAC”), present value of future profits (“PVFP”), benefit reserves and deferred income taxes, are reflected as unrealized investment gains or losses in a separate component of accumulated other comprehensive income (loss). Equity securities are recorded at fair value in our consolidated balance sheets and changes in the fair value are reflected in net investment gains (losses). Realized and unrealized gains and losses related to trading securities are reflected in net investment gains (losses). Allowance for Credit Losses and Impairments on Available-For-Sale Fixed Maturity Securities On January 1, 2020, we adopted new accounting guidance related to credit losses on financial instruments. Under this new accounting guidance, securities in an unrealized loss position are evaluated to determine whether the decline in fair value is related to credit losses or other factors. In making this assessment, we consider the extent to which fair value is less than amortized cost, any changes to the rating of the security by a rating agency/agencies and adverse conditions specifically related to the security, among other factors. If a credit loss exists, the present value of cash flows expected to be collected from the security is compared to the amortized cost basis of the security. If the present value of cash flows expected to be collected is less than the amortized cost basis and we have either (i) the intent to sell the security, or (ii) it is more likely than not that we will be required to sell the security prior to recovering the amortized cost, we record a reduction to the security’s amortized cost and recognize the loss in net investment gains (losses) for the difference between the security’s amortized cost and estimated fair value. If neither of the two preceding conditions exist, an allowance for credit losses is recorded and a loss is recognized in net investment gains (losses), limited to the amount that the fair value is less than the amortized cost basis. Losses are written off against the allowance when deemed uncollectible or when we intend to sell or expect we will be required to sell a security prior to recovering its amortized cost. When there is an allowance for credit losses, we reassess the credit losses each balance sheet date and subsequent increases or decreases are recorded as an adjustment to the allowance for credit losses, with a corresponding gain or loss recorded in net investment gains (losses). Estimating the cash flows expected to be collected is a quantitative and qualitative process that incorporates information received from third-party sources along with internal assumptions and judgments. When developing the estimate of cash flows expected to be collected at the individual security level, we utilize an analytical model that provides for various loss scenarios and consider the industry sector, current levels of subordination, geographic location and other relevant characteristics of the security or underlying assets, as well as reasonable and supportable forecasts. We regularly monitor our investment portfolio to ensure that securities with a credit loss are identified in a timely manner and any losses are recognized in the proper period. We exclude accrued interest related to available-for-sale fixed maturity securities from the estimate of allowance for credit losses. Accrued interest is included in accrued investment income in our consolidated balance sheet and had a carrying value of $523 million and $532 million as of December 31, 2021 and 2020, respectively. We do not measure an allowance for credit losses related to accrued interest as uncollectible accrued interest related to our available-for-sale fixed maturity securities is written off after 90 days and once collectability is determined to be uncertain and not probable. Amounts written off related to accrued interest are recorded as a credit loss expense included in net investment gains (losses). Prior to the adoption of new accounting guidance related to credit losses on financial instruments on January 1, 2020, we evaluated securities in an unrealized loss position for other-than-temporary impairment as of each balance sheet date. For debt securities, we considered all available information relevant to the collectability of the security, including information about past events, then-current conditions, and reasonable and supportable forecasts, when developing the estimate of cash flows expected to be collected. More specifically for mortgage-backed and asset-backed securities, we also utilized performance indicators of the underlying assets including default or delinquency rates, loan to collateral value ratios, third-party credit enhancements, current levels of subordination, vintage and other relevant characteristics of the security or underlying assets to develop our estimate of cash flows. Estimating the cash flows expected to be collected is a quantitative and qualitative process that incorporates information received from third-party sources along with certain internal assumptions and judgments regarding the future performance of the underlying collateral. Where possible, this data was benchmarked against third-party sources. We recognized other-than-temporary impairments on debt securities in an unrealized loss position when one of the following circumstances exists: • we did not expect full recovery of our amortized cost basis when due, • the present value of cash flows expected to be collected was less than our amortized cost basis, • we intended to sell a security or • it was more likely than not that we would be required to sell a security prior to recovery. For other-than-temporary impairments recognized during the period, we presented the total other-than-temporary impairments, the portion of other-than-temporary impairments included in other comprehensive income (loss) (“OCI”) and the net other-than-temporary impairments as supplemental disclosure presented on the face of our consolidated statements of income. Total other-than-temporary impairments that emerged in the period were calculated as the difference between the amortized cost and fair value. For other-than-temporarily impaired securities where we did not intend to sell the security and it was not more likely than not that we would be required to sell the security prior to recovery, total other-than-temporary impairments were adjusted by the portion of other-than-temporary impairments recognized in OCI (“non-credit”). Net other-than-temporary impairments recorded in net income (loss) represented the credit loss on the other-than-temporarily impaired securities with the offset recognized as an adjustment to the amortized cost to determine the new amortized cost basis of the securities. For securities that were deemed to be other-than-temporarily impaired and a non-credit loss was recorded in OCI, the amount recorded as an unrealized gain (loss) represented the difference between the fair value and the new amortized cost for each period presented. The unrealized gain (loss) on an other-than-temporarily impaired security was recorded as a separate component in OCI until the security was sold or until we recorded an other-than-temporary impairment where we intended to sell the security or were required to sell the security prior to recovery. To estimate the amount of other-than-temporary impairment attributed to credit losses on debt securities where we did not intend to sell the security and it was not more likely than not that we would be required to sell the security prior to recovery, we determined our best estimate of the present value of the cash flows expected to be collected from a security using the effective yield on the security prior to recording any other-than-temporary impairment. If the present value of the discounted cash flows was lower than the amortized cost of the security, the difference between the present value and amortized cost represented the credit loss associated with the security with the remaining difference between fair value and amortized cost recorded as a non-credit other-than-temporary impairment in OCI. While the other-than-temporary impairment model for debt securities generally included fixed maturity securities, there were certain hybrid securities that are classified as fixed maturity securities where the application of a debt impairment model depended on whether there had been any evidence of deterioration in credit of the issuer, such as a downgrade to below investment grade. Under certain circumstances, evidence of deterioration in credit of the issuer may have resulted in the application of the equity securities impairment model where we recognized an impairment charge in the period in which we determined that the security would not recover to book value within a reasonable period of time. We determined what constituted a reasonable period on a security-by-security basis based upon consideration of all the evidence available to us, including the magnitude of an unrealized loss and its duration. In any event, this period did not exceed 15 months. We measured other-than-temporary impairments based upon the difference between the amortized cost of a security and its fair value. e) Fair Value Measurements Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. We have fixed maturity securities, short-term investments, equity securities, limited partnerships, derivatives, embedded derivatives, securities held as collateral, separate account assets and certain other financial instruments, which are carried at fair value. Fair value measurements are based upon observable and unobservable inputs. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our view of market assumptions in the absence of observable market information. We utilize valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs. All assets and liabilities carried at fair value are classified and disclosed in one of the following three categories: • Level 1—Quoted prices for identical instruments in active markets. • Level 2—Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations for which inputs are observable or where those significant value drivers are observable. • Level 3—Instruments for which significant value drivers are unobservable. Level 1 primarily consists of financial instruments whose value is based on quoted market prices such as actively traded equity securities and actively traded mutual fund investments. Level 2 includes those financial instruments that are valued using industry-standard pricing methodologies, models or other valuation methodologies. These models are primarily industry-standard models that consider various inputs, such as interest rate, credit spread and foreign exchange rates for the underlying financial instruments. All significant inputs are observable, or derived from observable information in the marketplace or are supported by observable levels at which transactions are executed in the marketplace. Financial instruments in this category primarily include: certain public and private corporate fixed maturity and equity securities; government or agency securities; certain mortgage-backed and asset-backed securities; securities held as collateral; and certain non-exchange-traded derivatives such as interest rate or cross currency swaps. Level 3 comprises financial instruments whose fair value is estimated based on industry-standard pricing methodologies and internally developed models utilizing significant inputs not based on, nor corroborated by, readily available market information. In certain instances, this category may also utilize non-binding broker quotes. This category primarily consists of certain less liquid fixed maturity, equity and trading securities and certain derivative instruments or embedded derivatives where we cannot corroborate the significant valuation inputs with market observable data. As of each reporting period, all assets and liabilities recorded at fair value are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and considers factors specific to the asset or liability, such as the relative impact on the fair value as a result of including a particular input. We review the fair value hierarchy classifications each reporting period. Changes in the observability of the valuation attributes may result in a reclassification of certain financial assets or liabilities. Such reclassifications are reported as transfers in and out of Level 3 at the beginning fair value for the reporting period in which the changes occur. See note 16 for additional information related to fair value measurements. f) Commercial Mortgage Loans The carrying value of commercial mortgage loans is stated at principal amounts outstanding, net of unamortized premium or discount, deferred expenses and allowance for credit losses. Interest on loans is recognized on an accrual basis at the applicable interest rate on the principal amount outstanding. Loan origination fees and direct costs, as well as premiums and discounts, are amortized as level yield adjustments over the respective loan terms. Unamortized net fees or costs are recognized upon early repayment of the loans. Loan commitment fees are deferred and amortized on an effective yield basis over the term of the loan. Commercial mortgage loans are considered past due when contractual payments have not been received from the borrower by the required payment date. Loans that are considered uncollectible are carried on non-accrual status. Loans are placed on non-accrual status when, in management’s opinion, the collection of principal or interest is not probable, typically when the collection of principal or interest is 90 days or more past due. In determining whether it is probable that we will be unable to collect all amounts due, we consider current payment status, debt service coverage ratios, occupancy levels and current loan-to-value. Income on loans on non-accrual status is not recognized until we believe it is probable that we will collect all future contractual principal and interest. Commercial mortgage loans are written off against the allowance to the extent principal or interest is deemed uncollectible. We determine the adequacy of the allowance for credit losses utilizing an analytical model that provides various loss scenarios based on historical experience adjusted for current events, trends, economic conditions and reasonable and supportable forecasts that result in a loss in the loan portfolio over the estimated life of the loans. We revert to historical credit loss experience for periods beyond forecasts that are reasonable and supportable. The allowance for credit losses is measured on a collective basis with consideration for debt service coverage ratio, debt-to-value, property-type and geographic location. Key inputs into the analytical model include exposure, weighted-average life, return, historical loss rates and forecast scenarios. Actual amounts realized over time could differ from the amounts estimated for the allowance for credit losses reported in the consolidated financial statements. Additions and reductions to the allowance through periodic provisions or benefits are recorded in net investment gains (losses). See note 4 for additional disclosures related to commercial mortgage loans. Accrued interest related to commercial mortgage loans is included in accrued investment income in our consolidated balance sheet and had a carrying value of $23 million as of December 31, 2021 and 2020. We do not measure an allowance for credit losses related to accrued interest as uncollectible accrued interest related to our commercial mortgage loans is written off after 90 days and once collectability is determined to be uncertain and not probable. Amounts written off related to accrued interest are recorded as a credit loss expense included in net investment gains (losses). Prior to the adoption of new accounting guidance related to credit losses on financial instruments on January 1, 2020, we evaluated the impairment of commercial mortgage loans first on an individual loan basis. “Impaired” loans were defined by U.S. GAAP as loans for which it is probable that the lender will be unable to collect all amounts due according to original contractual terms of the loan agreement. For individually impaired loans, we recorded an impairment charge when it was probable that a loss had been incurred. The impairment was recorded as an increase in the allowance for loan losses. If an individual loan was not deemed impaired, then we evaluated the remaining loans collectively to determine whether an impairment should be recorded. The allowance for loan losses for loans that were not considered individually impaired that were evaluated collectively was maintained at a level that we determined was adequate to absorb estimated probable incurred losses in the loan portfolio. Our process to determine the adequacy of the allowance utilized an analytical model based on historical loss experience adjusted for current events, trends and economic conditions that would result in a loss in the loan portfolio over the next 12 months. Key inputs into our evaluation included debt service coverage ratios, debt-to-value, property-type, occupancy levels, geographic region, and probability weighting of the scenarios generated by the model. g) Limited Partnerships Limited partnerships are accounted for at fair value when our partnership interest is considered minor (generally less than 3% ownership in the limited partnerships) and we exercise no influence over operating and financial policies. We utilize the net asset value (“NAV”) from the underlying fund statements as a practical expedient for fair value. Changes in the estimated fair value of these investments are included in net investment gains (losses) and income and expenses are reported in net investment income. Investment distributions are evaluated to determine whether the distribution is a return on investment, such as dividend income, or a return of capital. If our ownership percentage exceeds the minor threshold, limited partnerships are accounted for using the equity method of accounting. Our proportionate share of the earnings or losses for limited partnerships accounted for using the equity method of accounting is included in net investment income. In applying either method, we use financial information provided by the investee generally on a one-to-three month lag. However, for limited partnerships measured at fair value, we consider whether an adjustment to the estimated fair value is necessary when the measurement date is not aligned with our reporting date. h) Securities Lending Activity Prior to the suspension of our securities lending program in the third quarter of 2021, we engaged in certain securities lending transactions for the purpose of enhancing the yield on our investment securities portfolio. We maintained effective control over all loaned securities and, therefore, continued to report such securities as fixed maturity securities on the consolidated balance sheets. We were indemnified against counterparty credit risk by the intermediary. See note 12 for additional information related to our former securities lending activity. i) Cash, Cash Equivalents and Restricted Cash Certificates of deposit, money market funds and other highly liquid investments with original maturities of three months or less are considered cash equivalents in the consolidated balance sheets and consolidated statements of cash flows. Items with maturities greater than three months but less than one year at the time of acquisition are generally considered short-term investments. j) Deferred Acquisition Costs Acquisition costs include costs that are directly related to the successful acquisition of new or renewal insurance contracts. Acquisition costs are deferred and amortized to the extent they are recoverable from future profits. Long-Duration Contracts Amortization for deferred annuity and universal life insurance contracts is based on expected gross profits. Expected gross profits are adjusted quarterly to reflect actual experience to date or for changes in underlying assumptions relating to future gross profits. Estimates of gross profits for DAC amortization are based on assumptions including interest rates, policyholder persistency or lapses, insured life expectancy or longevity and expenses. We are required to analyze the impacts from net unrealized investment gains and losses on our available-for-sale investment securities backing insurance liabilities, as if those unrealized investment gains and losses were realized. These “shadow accounting” adjustments result in the recognition of unrealized gains and losses on related insurance assets and liabilities in a manner consistent with the recognition of the unrealized gains and losses on available-for-sale investment securities within the statement of comprehensive income and changes in equity. Changes to net unrealized investment (gains) losses may increase or decrease the ending DAC balance. Similar to a loss recognition event, when the DAC balance is reduced to zero, additional insurance liabilities are established if necessary. Unlike a loss recognition event, based on changes in net unrealized investment (gains) losses, these shadow adjustments may reverse from period to period. Therefore, DAC amortized based on expected gross profits is adjusted to reflect the effects that would have been recognized had the unrealized investment (gains) losses been actually realized with a corresponding amount recorded in other comprehensive income (loss). DAC associated with traditional long-duration insurance contracts is not adjusted for unrealized investment (gains) or losses unless a premium deficiency would have resulted upon the (gain) or loss being realized. Short-Duration Contracts. We regularly review our assumptions and test DAC for recoverability at least annually. For deferred annuity and universal life insurance contracts, if the present value of expected future gross profits is less than the unamortized DAC for a line of business, a charge to net income (loss) is recorded for additional DAC amortization. For traditional long-duration and short-duration contracts, if the benefit reserve plus anticipated future premiums and interest income for a line of business are less than the current estimate of future benefits and expenses (including any unamortized DAC), a charge to net income (loss) is recorded for additional DAC amortization or for increased benefit reserves. See note 6 for additional information related to DAC including loss recognition and recoverability. k) Intangible Assets Present Value of Future Profits. We regularly review our PVFP assumptions and periodically test PVFP for recoverability similar to our treatment of DAC. See note 7 for additional information related to PVFP including recoverability. Deferred Sales Inducements to Contractholders. Other Intangible Assets l) Reinsurance Premium revenue, benefits and acquisition and operating expenses, net of deferrals, are reported net of the amounts relating to reinsurance ceded to and assumed from other companies. Amounts due from reinsurers for incurred and estimated future claims are reflected in the reinsurance recoverable asset. Amounts received from reinsurers that represent recovery of acquisition costs are netted against DAC so that the net amount is capitalized. The cost of reinsurance is accounted for over the terms of the related treaties using assumptions consistent with those used to account for the underlying reinsured policies. Premium revenue, benefits and acquisition and operating expenses, net of deferrals, for reinsurance contracts that do not qualify for reinsurance accounting are accounted for under the deposit method of accounting. Allowance for Credit Losses on Reinsurance Recoverables On January 1, 2020, we adopted new accounting guidance related to credit losses on financial instruments. Under this new accounting guidance, we record an allowance for credit losses related to reinsurance recoverables. The allowance for credit losses is evaluated based on historical loss experience adjusted for current events and reasonable and supportable forecasts from both internal and external sources. The allowance is measured by reinsurer, taking into consideration the reinsured product type and collateral type, and is calculated based on an externally reported probability of default corresponding to the reinsurer’s credit rating and the expected duration of the reinsurer’s contractual obligation to reimburse us for ceded claims on the underlying policies. Our estimate of the allowance reflects consideration for collateral securing the reinsurance agreements and expected recoveries of amounts previously charged off and expected to be charged off. We also consider other credit risk factors, including, among other factors, the historical frequency and severity of the associated insurance claims, aging of recoverables and regulatory, legal and economic factors, to determine if an additional incremental allowance for credit losses is required. No reversion adjustments are necessary as the starting point for our allowance for credit losses reflects historical loss experience covering the expected duration of the reinsurer’s contractual obligation to reimburse us. If available facts and circumstances indicate the reinsurance recoverable does not reflect expectations consistent with the collective analysis, the reinsurance recoverable is assessed on a separate basis. Write-offs are deducted from the allowance in the period the reinsurance recoverable is determined to be uncollectible. m) Derivatives Derivative instruments are used to manage risk through one of four principal risk management strategies including: (i) liabilities; (ii) invested assets; (iii) portfolios of assets or liabilities; and (iv) forecasted transactions. On the date we enter into a derivative contract, management designates the derivative as a hedge of the identified exposure (cash flow or foreign currency). If a derivative does not qualify for hedge accounting, the changes in its fair value and all scheduled periodic settlement receipts and payments are reported in net income (loss). We formally document all relationships between hedging instruments and hedged items, as well as our risk management objective and strategy for undertaking various hedge transactions. In this documentation, we specifically identify the asset, liability or forecasted transaction that has been designated as a hedged item, state how the hedging instrument is expected to hedge the risks related to the hedged item, and set forth the method that will be used to retrospectively and prospectively assess the hedging instrument’s effectiveness. We generally determine hedge effectiveness based on total changes in fair value of the hedged item attributable to the hedged risk and the total changes in fair value of the derivative instrument. We discontinue hedge accounting prospectively when: (i) it is determined that the derivative is no longer effective in offsetting changes in the cash flows of a hedged item; (ii) the derivative expires or is sold, terminated or exercised; (iii) the derivative is de-designated as a hedge instrument; or (iv) it is no longer probable that the forecasted transaction will occur. For all qualifying and highly effective cash flow

Earnings (Loss) Per Share

Earnings (Loss) Per Share	12 Months Ended
	Dec. 31, 2021
Earnings (Loss) Per Share	(3) Earnings (Loss) Per Share Basic and diluted earnings (loss) per share are calculated by dividing each income (loss) category presented below by the weighted-average basic and diluted common shares outstanding for the years ended December 31: (Amounts in millions, except per share amounts) 2021 2020 2019 Weighted-average common shares used in basic earnings (loss) per share calculations 506.9 505.2 502.9 Potentially dilutive securities: Stock options, restricted stock units and stock appreciation rights 7.8 6.4 6.8 Weighted-average common shares used in diluted earnings (loss) per share calculations 514.7 511.6 509.7 Income from continuing operations: Income from continuing operations $ 918 $ 698 $ 382 Less: net income from continuing operations attributable to noncontrolling interests 33 — — Income from continuing operations available to Genworth Financial, Inc.’s common stockholders $ 885 $ 698 $ 382 Basic per share $ 1.75 $ 1.38 $ 0.76 Diluted per share $ 1.72 $ 1.36 $ 0.75 Income (loss) from discontinued operations: Income (loss) from discontinued operations, net of taxes $ 27 $ (486 ) $ 148 Less: net income from discontinued operations attributable to noncontrolling interests 8 34 187 Income (loss) from discontinued operations available to Genworth Financial, Inc.’s common stockholders $ 19 $ (520 ) $ (39 ) Basic per share $ 0.04 $ (1.03 ) $ (0.08 ) Diluted per share $ 0.04 $ (1.02 ) $ (0.08 ) Net income (loss): Income from continuing operations $ 918 $ 698 $ 382 Income (loss) from discontinued operations, net of taxes 27 (486 ) 148 Net income 945 212 530 Less: net income attributable to noncontrolling interests 41 34 187 Net income available to Genworth Financial, Inc.’s common stockholders $ 904 $ 178 $ 343 Basic per share (1) $ 1.78 $ 0.35 $ 0.68 Diluted per share (1) $ 1.76 $ 0.35 $ 0.67 (1) May not total due to whole number calculation.

Investments

Investments	12 Months Ended
	Dec. 31, 2021
Investments	(4) Investments (a) Net Investment Income Sources of net investment income were as follows for the years ended December 31: (Amounts in millions) 2021 2020 2019 Fixed maturity securities—taxable $ 2,411 $ 2,448 $ 2,444 Fixed maturity securities—non-taxable 7 6 8 Equity securities 9 12 12 Commercial mortgage loans 376 345 348 Policy loans 189 199 180 Limited partnerships 223 72 44 Other invested assets 241 223 190 Cash, cash equivalents, restricted cash and short-term investments 1 15 33 Gross investment income before expenses and fees 3,457 3,320 3,259 Expenses and fees (87 ) (93 ) (95 ) Net investment income $ 3,370 $ 3,227 $ 3,164 (b) Net Investment Gains (Losses) The following table sets forth net investment gains (losses) for the years ended December 31: (Amounts in millions) 2021 2020 2019 Realized investment gains (losses): Available-for-sale fixed maturity securities: Realized gains $ 67 $ 471 $ 90 Realized losses (10 ) (29 ) (38 ) Net realized gains (losses) on available-for-sale fixed maturity securities 57 442 52 Net realized gains (losses) on equity securities sold (7 ) (1 ) — Net realized gains (losses) on limited partnerships 3 — 1 Total net realized investment gains (losses) 53 441 53 Impairments: Total other-than-temporary impairments — — (1 ) Portion of other-than-temporary impairments included in other comprehensive income (loss) — — — Net other-than-temporary impairments — — (1 ) Net change in allowance for credit losses on available-for-sale fixed maturity securities (6 ) (5 ) — Write-down of available-for-sale fixed maturity securities (1) (1 ) (4 ) — Net unrealized gains (losses) on equity securities still held 1 4 14 Net unrealized gains (losses) on limited partnerships 264 112 28 Commercial mortgage loans (3 ) (2 ) (2 ) Derivative instruments (2) 14 (49 ) (70 ) Other 1 (5 ) 5 Net investment gains (losses) $ 323 $ 492 $ 27 (1) Represents write-down of securities deemed uncollectible or that we intend to sell or will be required to sell prior to recovery of the amortized cost basis. (2) See note 5 for additional information on the impact of derivative instruments included in net investment gains (losses). See note 2 for a discussion of our policy for evaluating and measuring the allowance for credit losses related to our available-for-sale fixed maturity securities. The following table represents the allowance for credit losses aggregated by security type for available-for-sale fixed maturity investments as of and for the years ended December 31: 2021 (Amounts in millions) Beginning Increase Increase Securities Decrease Write-offs Recoveries Ending Fixed maturity securities: Non-U.S. corporate $ 1 $ — $ 6 $ (7 ) $ — $ — $ — $ — Commercial mortgage-backed 3 — — — — (3 ) — — Total available-for-sale fixed maturity securities $ 4 $ — $ 6 $ (7 ) $ — $ (3 ) $ — $ — 2020 (Amounts in millions) Beginning Increase Increase Securities Decrease Write-offs Recoveries Ending Fixed maturity securities: Non-U.S. corporate $ — $ 4 $ (2 ) $ (1 ) $ — $ — $ — $ 1 Commercial mortgage-backed — 3 — — — — — 3 Total available-for-sale fixed maturity securities $ — $ 7 $ (2 ) $ (1 ) $ — $ — $ — $ 4 The following represents the activity for credit losses recognized in net income (loss) on debt securities where an other-than-temporary impairment was identified and a portion of other-than-temporary impairments was included in OCI as of and for the year ended December 31, 2019: (Amounts in millions) Beginning balance $ 24 Reductions: Securities sold, paid down or disposed (2 ) Ending balance $ 22 (c) Unrealized Investment Gains and Losses Net unrealized gains and losses on available-for-sale investment securities reflected as a separate component of accumulated other comprehensive income (loss) were as follows as of December 31: (Amounts in millions) 2021 2020 2019 Net unrealized gains (losses) on fixed maturity securities without an allowance for credit losses (1) $ 7,869 $ 10,159 $ 6,676 Net unrealized gains (losses) on fixed maturity securities with an allowance for credit losses (1) — (7 ) — Adjustments to DAC, PVFP, sales inducements, benefit reserves and policyholder contract balances (5,487 ) (7,302 ) (4,789 ) Income taxes, net (507 ) (611 ) (406 ) Net unrealized investment gains (losses) 1,875 2,239 1,481 Less: net unrealized investment gains (losses) attributable to noncontrolling interests 15 25 25 Net unrealized investment gains (losses) attributable to Genworth Financial, Inc. $ 1,860 $ 2,214 $ 1,456 (1) Excludes foreign exchange. The change in net unrealized gains (losses) on available-for-sale investment securities reported in accumulated other comprehensive income (loss) was as follows as of and for the years ended December 31: (Amounts in millions) 2021 2020 2019 Beginning balance $ 2,214 $ 1,456 $ 595 Unrealized gains (losses) arising during the period: Unrealized gains (losses) on fixed maturity securities (2,218 ) 3,950 4,980 Adjustment to DAC (1) 30 122 (956 ) Adjustment to PVFP — (1 ) (49 ) Adjustment to sales inducements 12 (5 ) (32 ) Adjustment to benefit reserves and policyholder contract balances (2) 1,773 (2,629 ) (2,800 ) Provision for income taxes 90 (305 ) (233 ) Change in unrealized gains (losses) on investment securities (313 ) 1,132 910 Reclassification adjustments to net investment (gains) losses, net of taxes of $14, $100 and $17 (51 ) (374 ) (62 ) Change in net unrealized investment gains (losses) (364 ) 758 848 Less: change in net unrealized investment gains (losses) attributable to noncontrolling interests (10 ) — (13 ) Ending balance $ 1,860 $ 2,214 $ 1,456 (1) See note 6 for additional information. (2) See note 9 for additional information. Amounts reclassified out of accumulated other comprehensive income (loss) to net investment gains (losses) include realized gains (losses) on sales of securities, which are determined on a specific identification basis. (d) Fixed Maturity Securities As of December 31, 2021, the amortized cost or cost, gross unrealized gains (losses), allowance for credit losses and fair value of our fixed maturity securities classified as available-for-sale were as follows: (Amounts in millions) Amortized Gross Gross Allowance Fair Fixed maturity securities: U.S. government, agencies and government-sponsored enterprises $ 3,368 $ 1,184 $ — $ — $ 4,552 State and political subdivisions 2,982 474 (6 ) — 3,450 Non-U.S. government 762 86 (13 ) — 835 U.S. corporate: Utilities 4,330 783 (9 ) — 5,104 Energy 2,581 363 (10 ) — 2,934 Finance and insurance 8,003 1,012 (24 ) — 8,991 Consumer—non-cyclical 5,138 1,029 (8 ) — 6,159 Technology and communications 3,345 476 (13 ) — 3,808 Industrial 1,322 175 (3 ) — 1,494 Capital goods 2,334 415 (4 ) — 2,745 Consumer—cyclical 1,703 203 (7 ) — 1,899 Transportation 1,122 249 — — 1,371 Other 379 41 (1 ) — 419 Total U.S. corporate 30,257 4,746 (79 ) — 34,924 Non-U.S. corporate: Utilities 867 63 (2 ) — 928 Energy 1,194 190 (1 ) — 1,383 Finance and insurance 2,171 270 (9 ) — 2,432 Consumer—non-cyclical 664 81 (2 ) — 743 Technology and communications 1,085 166 (1 ) — 1,250 Industrial 933 117 (3 ) — 1,047 Capital goods 640 66 (1 ) — 705 Consumer—cyclical 316 27 (2 ) — 341 Transportation 422 68 (1 ) — 489 Other 1,052 169 (4 ) — 1,217 Total non-U.S. corporate 9,344 1,217 (26 ) — 10,535 Residential mortgage-backed 1,325 116 (1 ) — 1,440 Commercial mortgage-backed 2,435 152 (3 ) — 2,584 Other asset-backed 2,138 29 (7 ) — 2,160 Total available-for-sale fixed maturity securities $ 52,611 $ 8,004 $ (135 ) $ — $ 60,480 As of December 31, 2020, the amortized cost or cost, gross unrealized gains (losses), allowance for credit losses and fair value of our fixed maturity securities classified as available-for-sale were as follows: (Amounts in millions) Amortized Gross Gross Allowance Fair Fixed maturity securities: U.S. government, agencies and government-sponsored enterprises $ 3,401 $ 1,404 $ — $ — $ 4,805 State and political subdivisions 2,622 544 (1 ) — 3,165 Non-U.S. government 728 130 (4 ) — 854 U.S. corporate: Utilities 4,226 970 (2 ) — 5,194 Energy 2,532 367 (16 ) — 2,883 Finance and insurance 7,798 1,306 (2 ) — 9,102 Consumer—non-cyclical 5,115 1,323 (1 ) — 6,437 Technology and communications 3,142 619 — — 3,761 Industrial 1,370 232 — — 1,602 Capital goods 2,456 535 — — 2,991 Consumer—cyclical 1,663 284 — — 1,947 Transportation 1,198 304 (2 ) — 1,500 Other 395 45 — — 440 Total U.S. corporate 29,895 5,985 (23 ) — 35,857 Non-U.S. corporate: Utilities 838 84 — — 922 Energy 1,172 209 (1 ) — 1,380 Finance and insurance 2,130 353 (6 ) (1 ) 2,476 Consumer—non-cyclical 662 112 (1 ) — 773 Technology and communications 1,062 229 — — 1,291 Industrial 969 159 — — 1,128 Capital goods 510 67 (1 ) — 576 Consumer—cyclical 331 41 (1 ) — 371 Transportation 483 88 (1 ) — 570 Other 1,088 236 — — 1,324 Total non-U.S. corporate 9,245 1,578 (11 ) (1 ) 10,811 Residential mortgage-backed 1,698 211 — — 1,909 Commercial mortgage-backed 2,759 231 (13 ) (3 ) 2,974 Other asset-backed 3,069 55 (4 ) — 3,120 Total available-for-sale fixed maturity securities $ 53,417 $ 10,138 $ (56 ) $ (4 ) $ 63,495 The following table presents the gross unrealized losses and fair values of our fixed maturity securities for which an allowance for credit losses has not been recorded, aggregated by investment type and length of time that individual fixed maturity securities have been in a continuous unrealized loss position, as of December 31, 2021: Less than 12 months 12 months or more Total (Dollar amounts in millions) Fair Gross Number of Fair Gross Number of Fair Gross Number of Description of Securities Fixed maturity securities: State and political subdivisions $ 339 $ (6 ) 67 $ — $ — — $ 339 $ (6 ) 67 Non-U.S. government 173 (9 ) 28 19 (4 ) 1 192 (13 ) 29 U.S. corporate 2,593 (64 ) 266 196 (15 ) 22 2,789 (79 ) 288 Non-U.S. corporate 912 (21 ) 124 62 (5 ) 8 974 (26 ) 132 Residential mortgage-backed 97 (1 ) 22 — — — 97 (1 ) 22 Commercial mortgage-backed 113 (2 ) 17 31 (1 ) 4 144 (3 ) 21 Other asset-backed 764 (7 ) 111 — — — 764 (7 ) 111 Total for fixed maturity securities in an unrealized loss position $ 4,991 $ (110 ) 635 $ 308 $ (25 ) 35 $ 5,299 $ (135 ) 670 % Below cost: <20% Below cost $ 4,991 $ (110 ) 635 $ 297 $ (20 ) 33 $ 5,288 $ (130 ) 668 20%-50% Below cost — — — 11 (5 ) 2 11 (5 ) 2 Total for fixed maturity securities in an unrealized loss position $ 4,991 $ (110 ) 635 $ 308 $ (25 ) 35 $ 5,299 $ (135 ) 670 Investment grade $ 4,644 $ (101 ) 587 $ 241 $ (12 ) 25 $ 4,885 $ (113 ) 612 Below investment grade 347 (9 ) 48 67 (13 ) 10 414 (22 ) 58 Total for fixed maturity securities in an unrealized loss position $ 4,991 $ (110 ) 635 $ 308 $ (25 ) 35 $ 5,299 $ (135 ) 670 The following table presents the gross unrealized losses and fair values of our corporate securities for which an allowance for credit losses has not been recorded, aggregated by investment type and length of time that individual investment securities have been in a continuous unrealized loss position, based on industry, as of December 31, 2021: Less than 12 months 12 months or more Total (Dollar amounts in millions) Fair Gross Number of Fair Gross Number of Fair Gross Number of Description of Securities U.S. corporate: Utilities $ 211 $ (7 ) 32 $ 29 $ (2 ) 7 $ 240 $ (9 ) 39 Energy 166 (3 ) 18 25 (7 ) 4 191 (10 ) 22 Finance and insurance 960 (22 ) 89 62 (2 ) 3 1,022 (24 ) 92 Consumer—non-cyclical 296 (7 ) 30 14 (1 ) 2 310 (8 ) 32 Technology and communications 378 (12 ) 37 29 (1 ) 2 407 (13 ) 39 Industrial 143 (3 ) 18 — — — 143 (3 ) 18 Capital goods 171 (3 ) 16 18 (1 ) 2 189 (4 ) 18 Consumer—cyclical 268 (7 ) 26 — — — 268 (7 ) 26 Other — — — 19 (1 ) 2 19 (1 ) 2 Subtotal, U.S. corporate securities 2,593 (64 ) 266 196 (15 ) 22 2,789 (79 ) 288 Non-U.S. corporate: Utilities 69 (2 ) 9 — — — 69 (2 ) 9 Energy 64 (1 ) 10 — — — 64 (1 ) 10 Finance and insurance 366 (8 ) 43 18 (1 ) 2 384 (9 ) 45 Consumer—non-cyclical 67 (1 ) 12 6 (1 ) 1 73 (2 ) 13 Technology and communications 48 (1 ) 8 — — — 48 (1 ) 8 Industrial 122 (3 ) 14 — — — 122 (3 ) 14 Capital goods 78 (1 ) 8 — — — 78 (1 ) 8 Consumer—cyclical 22 (1 ) 8 15 (1 ) 3 37 (2 ) 11 Transportation 37 (1 ) 7 — — — 37 (1 ) 7 Other 39 (2 ) 5 23 (2 ) 2 62 (4 ) 7 Subtotal, non-U.S. corporate securities 912 (21 ) 124 62 (5 ) 8 974 (26 ) 132 Total for corporate securities in an unrealized loss position $ 3,505 $ (85 ) 390 $ 258 $ (20 ) 30 $ 3,763 $ (105 ) 420 We did not recognize an allowance for credit losses on securities in an unrealized loss position included in the tables above. Based on a qualitative and quantitative review of the issuers of the securities, we believe the decline in fair value is largely due to recent market volatility and is not indicative of credit losses. The issuers continue to make timely principal and interest payments. For all securities in an unrealized loss position without an allowance for credit losses, we expect to recover the amortized cost based on our estimate of the amount and timing of cash flows to be collected. We do not intend to sell nor do we expect that we will be required to sell these securities prior to recovering our amortized cost. The following table presents the gross unrealized losses and fair values of our fixed maturity securities for which an allowance for credit losses has not been recorded, aggregated by investment type and length of time that individual fixed maturity securities have been in a continuous unrealized loss position, as of December 31, 2020: Less than 12 months 12 months or more Total (Dollar amounts in millions) Fair Gross Number of Fair Gross Number of Fair Gross Number of Description of Securities Fixed maturity securities: State and political subdivisions $ 28 $ (1 ) 6 $ — $ — — $ 28 $ (1 ) 6 Non-U.S. government 44 (4 ) 5 — — — 44 (4 ) 5 U.S. corporate 345 (20 ) 59 33 (3 ) 4 378 (23 ) 63 Non-U.S. corporate 145 (4 ) 32 6 (1 ) 1 151 (5 ) 33 Commercial mortgage-backed 227 (11 ) 34 1 (1 ) 1 228 (12 ) 35 Other asset-backed 238 (2 ) 60 207 (2 ) 48 445 (4 ) 108 Total for fixed maturity securities in an unrealized loss position $ 1,027 $ (42 ) 196 $ 247 $ (7 ) 54 $ 1,274 $ (49 ) 250 % Below cost: <20% Below cost $ 1,017 $ (35 ) 194 $ 246 $ (6 ) 53 $ 1,263 $ (41 ) 247 20%-50% Below cost 10 (7 ) 2 1 (1 ) 1 11 (8 ) 3 Total for fixed maturity securities in an unrealized loss position $ 1,027 $ (42 ) 196 $ 247 $ (7 ) 54 $ 1,274 $ (49 ) 250 Investment grade $ 852 $ (23 ) 163 $ 207 $ (2 ) 48 $ 1,059 $ (25 ) 211 Below investment grade 175 (19 ) 33 40 (5 ) 6 215 (24 ) 39 Total for fixed maturity securities in an unrealized loss position $ 1,027 $ (42 ) 196 $ 247 $ (7 ) 54 $ 1,274 $ (49 ) 250 The following table presents the gross unrealized losses and fair values of our corporate securities for which an allowance for credit losses has not been recorded, aggregated by investment type and length of time that individual investment securities have been in a continuous unrealized loss position, based on industry, as of December 31, 2020: Less than 12 months 12 months or more Total (Dollar amounts in millions) Fair Gross Number of Fair Gross Number of Fair Gross Number of Description of Securities U.S. corporate: Utilities $ 49 $ (2 ) 9 $ — $ — — $ 49 $ (2 ) 9 Energy 106 (13 ) 19 33 (3 ) 4 139 (16 ) 23 Finance and insurance 128 (2 ) 15 — — — 128 (2 ) 15 Consumer—non-cyclical 16 (1 ) 5 — — — 16 (1 ) 5 Transportation 46 (2 ) 11 — — — 46 (2 ) 11 Subtotal, U.S. corporate securities 345 (20 ) 59 33 (3 ) 4 378 (23 ) 63 Non-U.S. corporate: Energy 66 (1 ) 10 — — — 66 (1 ) 10 Consumer—non-cyclical — — — 6 (1 ) 1 6 (1 ) 1 Capital goods 31 (1 ) 8 — — — 31 (1 ) 8 Consumer—cyclical 15 (1 ) 6 — — — 15 (1 ) 6 Transportation 33 (1 ) 8 — — — 33 (1 ) 8 Subtotal, non-U.S. corporate securities 145 (4 ) 32 6 (1 ) 1 151 (5 ) 33 Total for corporate securities in an unrealized loss position $ 490 $ (24 ) 91 $ 39 $ (4 ) 5 $ 529 $ (28 ) 96 The scheduled maturity distribution of fixed maturity securities as of December 31, 2021 is set forth below. Actual maturities may differ from contractual maturities because issuers of securities may have the right to call or prepay obligations with or without call or prepayment penalties. (Amounts in millions) Amortized Fair Due one year or less $ 1,475 $ 1,499 Due after one year through five years 8,254 8,807 Due after five years through ten years 13,722 15,053 Due after ten years 23,262 28,937 Subtotal 46,713 54,296 Residential mortgage-backed 1,325 1,440 Commercial mortgage-backed 2,435 2,584 Other asset-backed 2,138 2,160 Total $ 52,611 $ 60,480 As of December 31, 2021, securities issued by finance and insurance, consumer—non-cyclical, utilities and technology and communications industry groups represented approximately 25%, 15%, 13% and 11%, respectively, of our domestic and foreign corporate fixed maturity securities portfolio. No other industry group comprised more than 10% of our investment portfolio. As of December 31, 2021, we did not hold any fixed maturity securities in any single issuer, other than securities issued or guaranteed by the U.S. government, which exceeded 10% of stockholders’ equity. As of December 31, 2021 and 2020, securities of $45 million and $46 million, respectively, were on deposit with various state government insurance departments in order to comply with relevant insurance regulations. (e) Commercial Mortgage Loans Our mortgage loans are collateralized by commercial properties, including multi-family residential buildings. The carrying value of commercial mortgage loans is stated at original cost net of principal payments, amortization and allowance for credit losses. We diversify our commercial mortgage loans by both property type and geographic region. The following tables set forth the distribution across property type and geographic region for commercial mortgage loans as of December 31: 2021 2020 (Amounts in millions) Carrying % of Carrying % of Property type: Retail $ 2,774 40 % $ 2,442 36 % Office 1,526 22 1,567 23 Industrial 1,420 21 1,638 24 Apartments 585 9 529 8 Mixed use 330 5 286 4 Other 221 3 312 5 Subtotal 6,856 100 % 6,774 100 % Allowance for credit losses (26 ) (31 ) Total $ 6,830 $ 6,743 2021 2020 (Amounts in millions) Carrying % of Carrying % of Geographic region: South Atlantic $ 1,770 26 % $ 1,711 25 % Pacific 1,360 20 1,510 22 Middle Atlantic 964 14 994 15 Mountain 892 13 781 12 West South Central 483 7 423 6 East North Central 465 7 441 6 West North Central 461 7 467 7 New England 237 3 260 4 East South Central 224 3 187 3 Subtotal 6,856 100 % 6,774 100 % Allowance for credit losses (26 ) (31 ) Total $ 6,830 $ 6,743 As of December 31, 2021, we had one commercial mortgage loan with an amortized cost of $22 million that was past due 31 to 60 days in the office property type. We wrote-off $8 million of this commercial mortgage loan during the year ended December 31, 2021 and it was placed on non-accrual status as of December 31, 2021. The carrying value of this commercial mortgage loan was written down to the fair value of its collateral and this loan did not have an allowance for credit losses as of December 31, 2021. As of December 31, 2020, all of our commercial mortgage loans were current and we had no commercial mortgage loans on non-accrual status. For a discussion of our policy related to placing commercial mortgage loans on non-accrual status, see note 2. During the years ended December 31, 2021 and 2020, we did not have any modifications or extensions that were considered troubled debt restructurings. The following table sets forth the allowance for credit losses related to commercial mortgage loans as of or for the years ended December 31: (Amounts in millions) 2021 2020 2019 Allowance for credit losses: Beginning balance $ 31 $ 13 $ 9 Cumulative effect of change in accounting — 16 — Provision 3 2 4 Write-offs (8 ) — — Recoveries — — — Ending balance $ 26 $ 31 $ 13 In evaluating the credit quality of commercial mortgage loans, we assess the performance of the underlying loans using both quantitative and qualitative criteria. Certain risks associated with commercial mortgage loans can be evaluated by reviewing both the debt-to-value and debt service coverage ratio to understand both the probability of the borrower not being able to make the necessary loan payments as well as the ability to sell the underlying property for an amount that would enable us to recover our unpaid principal balance in the event of default by the borrower. The average debt-to-value ratio is based on our most recent estimate of the fair value for the underlying property which is evaluated at least annually and updated more frequently if necessary to better indicate risk associated with the loan. A lower debt-to-value indicates that our loan value is more likely to be recovered in the event of default by the borrower if the property was sold. The debt service coverage ratio is based on “normalized” annual income of the property compared to the payments required under the terms of the loan. Normalization allows for the removal of annual one-time events such as capital expenditures, prepaid or late real estate tax payments or non-recurring third-party fees (such as legal, consulting or contract fees). This ratio is evaluated at least annually and updated more frequently if necessary to better indicate risk associated with the loan. A higher debt service coverage ratio indicates the borrower is less likely to default on the loan. The debt service coverage ratio is not used without considering other factors associated with the borrower, such as the borrower’s liquidity or access to other resources that may result in our expectation that the borrower will continue to make the future scheduled payments. The following tables set forth commercial mortgage loans by year of origination and credit quality indicator as of December 31, 2021: (Amounts in millions) 2021 2020 2019 2018 2017 2016 and Total Debt-to-value: 0% - 50% $ 20 $ 72 $ 53 $ 158 $ 203 $ 1,974 $ 2,480 51% - 60% 43 25 170 275 257 769 1,539 61% - 75% 889 428 509 449 127 413 2,815 76% - 100% — — — — — — — Greater than 100% — — — — 22 — 22 Total amortized cost $ 952 $ 525 $ 732 $ 882 $ 609 $ 3,156 $ 6,856 Debt service coverage ratio: Less than 1.00 $ — $ 10 $ 19 $ 41 $ 42 $ 111 $ 223 1.00 - 1.25 3 70 73 81 36 296 559 1.26 - 1.50 118 32 168 135 42 296 791 1.51 - 2.00 728 220 273 443 263 1,031 2,958 Greater than 2.00 103 193 199 182 226 1,422 2,325 Total amortized cost $ 952 $ 525 $ 732 $ 882 $ 609 $ 3,156 $ 6,856 Write-offs, gross $ — $ — $ — $ — $ 8 $ — $ 8 Recoveries — — — — — — — Write-offs, net $ — $ — $ — $ — $ 8 $ — $ 8 The following tables set forth the debt-to-value of commercial mortgage loans by property type as of December 31: 2021 (Amounts in millions) 0% - 50% 51% - 60% 61% - 75% 76% - 100% Greater Total Property type: Retail $ 853 $ 611 $ 1,310 $ — $ — $ 2,774 Office 505 395 604 — 22 1,526 Industrial 745 240 435 — — 1,420 Apartments 200 102 283 — — 585 Mixed use 120 70 140 — — 330 Other 57 121 43 — — 221 Total amortized cost $ 2,480 $ 1,539 $ 2,815 $ — $ 22 $ 6,856 % of total 36 % 23 % 41 % — % — % 100 % Weighted-average debt service coverage ratio 2.36 1.83 1.61 — 0.68 1.93 2020 (Amounts in millions) 0% - 50% 51% - 60% 61% - 75% 76% - 100% Greater Total Property type: Retail $ 913 $ 639 $ 859 $ 29 $ 2 $ 2,442 Office 523 431 595 18 — 1,567 Industrial 798 351 456 33 — 1,638 Apartments 199 86 238 6 — 529 Mixed use 112 47 127 — — 286 Other 100 74 121 17 — 312 Total amortized cost $ 2,645 $ 1,628 $ 2,396 $ 103 $ 2 $ 6,774 % of total 39 % 24 % 35 % 2 % — % 100 % Weighted-average debt service coverage ratio 2.40 1.83 1.61 1.49 0.64 1.97 The following tables set forth the debt service coverage ratio for fixed rate commercial mortgage loans by property type as of December 31: 2021 (Amounts in millions) Less 1.00 - 1.25 1.26 - 1.50 1.51 - 2.00 Greater Total Property type: Retail $ 102 $ 166 $ 405 $ 1,375 $ 726 $ 2,774 Office 67 109 167 593 590 1,526 Industrial 9 64 82 599 666 1,420 Apartments 17 62 84 225 197 585 Mixed use 24 32 40 118 116 330 Other 4 126 13 48 30 221 Total amortized cost $ 223 $ 559 $ 791 $ 2,958 $ 2,325 $ 6,856 % of total 3 % 8 % 12 % 43 % 34 % 100 % Weighted-average debt-to-value 68 % 61 % 61 % 60 % 43 % 55 % 2020 (Amounts in millions) Less 1.00 - 1.25 1.26 - 1.50 1.51 - 2.00 Greater Total Property type: Retail $ 55 $ 169 $ 483 $ 969 $ 766 $ 2,442 Office 101 99 170 634 563 1,567 Industrial 21 85 143 616 773 1,638 Apartments 9 24 126 228 142 529 Mixed use 5 24 29 115 113 286 Other 25 125 41 28 93 312 Total amortized cost $ 216 $ 526 $ 992 $ 2,590 $ 2,450 $ 6,774 % of total 3 % 8 % 15 % 38 % 36 % 100 % Weighted-average debt-to-value 57 % 62 % 62 % 57 % 44 % 53 % (f) Limited Partnerships or Similar Entities Investments in limited partnerships or similar entities are generally considered VIEs when the equity group lacks sufficient financial control. Generally, these investments are limited partner or non-managing member equity investments in a widely held fund that is sponsored and managed by a reputable asset manager. We are not the primary beneficiary of any VIE investment in a limited partnership or similar entity. As of December 31, 2021 and 2020, the total carrying value of these investments was $1,829 million and $1,018 million, respectively. Our maximum exposure to loss is equal to the outstanding carrying value and future funding commitments. We have not contributed, and do not plan to contribute, any additional financial or other support outside of what is contractually obligated.

Derivative Instruments

Derivative Instruments	12 Months Ended
	Dec. 31, 2021
Derivative Instruments	(5) Derivative Instruments Our business activities routinely deal with fluctuations in interest rates, equity prices, currency exchange rates and other asset and liability prices. We use derivative instruments to mitigate or reduce some of these risks. We have established policies for managing each of these risks, including prohibitions on derivatives market-making and other speculative derivatives activities. These policies require the use of derivative instruments in concert with other techniques to reduce or mitigate these risks. While we use derivatives to mitigate or reduce risks, certain derivatives do not meet the accounting requirements to be designated as hedging instruments and are denoted as “derivatives not designated as hedges” in the following disclosures. For derivatives that meet the accounting requirements to be designated as hedges, the following disclosures for these derivatives are denoted as “derivatives designated as hedges,” which include cash flow hedges. The following table sets forth our positions in derivative instruments as of December 31: Derivative assets Derivative liabilities Fair value Fair value (Amounts in millions) Balance sheet classification 2021 2020 Balance 2021 2020 Derivatives designated as hedges Cash flow hedges: Interest rate swaps Other invested assets $ 364 $ 468 Other liabilities $ 26 $ 23 Foreign currency swaps Other invested assets 6 1 Other liabilities — 2 Total cash flow hedges 370 469 26 25 Total derivatives designated as hedges 370 469 26 25 Derivatives not designated as hedges Equity index options Other invested assets 42 63 Other liabilities — — Financial futures Other invested assets — — Other liabilities — — Other foreign currency contracts Other invested assets 2 42 Other liabilities — 1 GMWB embedded derivatives Reinsurance recoverable (1) 19 26 Policyholder account balances (2) 271 379 Fixed index annuity embedded derivatives Other assets — — Policyholder account balances (3) 294 399 Indexed universal life embedded derivatives Reinsurance recoverable — — Policyholder account balances (4) 25 26 Total derivatives not designated as hedges 63 131 590 805 Total derivatives $ 433 $ 600 $ 616 $ 830 (1) Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities. (2) Represents the embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. (3) Represents the embedded derivatives associated with our fixed index annuity liabilities. (4) Represents the embedded derivatives associated with our indexed universal life liabilities. The fair value of derivative positions presented above was not offset by the respective collateral amounts received or provided under these agreements. The activity associated with derivative instruments can generally be measured by the change in notional value over the periods presented. However, for GMWB embedded derivatives, fixed index annuity embedded derivatives and indexed universal life embedded derivatives, the change between periods is best illustrated by the number of policies. The following tables represent activity associated with derivative instruments as of the dates indicated: (Notional in millions) Measurement December 31, Additions Maturities/ December 31, Derivatives designated as hedges Cash flow hedges: Interest rate swaps Notional $ 8,178 $ — $ (525 ) $ 7,653 Foreign currency swaps Notional 127 — — 127 Total cash flow hedges 8,305 — (525 ) 7,780 Total derivatives designated as hedges 8,305 — (525 ) 7,780 Derivatives not designated as hedges Interest rate swaps Notional 4,674 — (4,674 ) — Equity index options Notional 2,000 1,438 (1,992 ) 1,446 Financial futures Notional 1,104 3,887 (4,045 ) 946 Other foreign currency contracts Notional 1,186 25 (1,128 ) 83 Total derivatives not designated as hedges 8,964 5,350 (11,839 ) 2,475 Total derivatives $ 17,269 $ 5,350 $ (12,364 ) $ 10,255 (Number of policies) Measurement December 31, Additions Maturities/ December 31, Derivatives not designated as hedges GMWB embedded derivatives Policies 23,713 — (1,909 ) 21,804 Fixed index annuity embedded derivatives Policies 12,778 — (3,434 ) 9,344 Indexed universal life embedded derivatives Policies 842 — (36 ) 806 Cash Flow Hedges Certain derivative instruments are designated as cash flow hedges. The changes in fair value of these instruments are recorded as a component of OCI. We designate and account for the following as cash flow hedges when they have met the effectiveness requirements: (i) various types of interest rate swaps to convert floating rate investments to fixed rate investments; (ii) various types of interest rate swaps to convert floating rate liabilities into fixed rate liabilities; (iii) receive U.S. dollar fixed on foreign currency swaps to hedge the foreign currency cash flow exposure of foreign currency denominated investments; (iv) forward starting interest rate swaps to hedge against changes in interest rates associated with future fixed rate bond purchases and/or interest income; and (v) other instruments to hedge the cash flows of various forecasted transactions. The following table provides information about the pre-tax (Amounts in millions) Gain (loss) Gain (loss) Classification of gain Gain (loss) Classification of gain Interest rate swaps hedging assets $ (100 ) $ 217 Net investment income $ — Net investment gains (losses) Interest rate swaps hedging assets — 1 Net investment gains (losses) — Net investment gains (losses) Interest rate swaps hedging liabilities 36 (1 ) Interest expense — Net investment gains (losses) Foreign currency swaps 7 — Net investment income — Net investment gains (losses) Total $ (57 ) $ 217 $ — The following table provides information about the pre-tax (Amounts in millions) Gain (loss) Gain (loss) Classification of gain (loss) reclassified Gain (loss) Classification of gain Interest rate swaps hedging assets $ 482 $ 196 Net investment income $ — Net investment gains (losses) Interest rate swaps hedging assets — 12 Net investment gains (losses) — Net investment gains (losses) Interest rate swaps hedging liabilities (38 ) — Interest expense — Net investment gains (losses) Foreign currency swaps (5 ) — Net investment income — Net investment gains (losses) Total $ 439 $ 208 $ — The following table provides information about the pre-tax (Amounts in millions) Gain (loss) Gain (loss) Classification of gain Gain (loss) Classification of gain Interest rate swaps hedging assets $ 456 $ 164 Net investment income $ — Net investment gains (losses) Interest rate swaps hedging assets — 6 Net investment gains (losses) — Net investment gains (losses) Interest rate swaps hedging liabilities (36 ) — Interest expense — Net investment gains (losses) Foreign currency swaps (2 ) — Net investment income — Net investment gains (losses) Foreign currency swaps — — Net investment gains (losses) 2 Net investment gains (losses) Total $ 418 $ 170 $ 2 The following table provides a reconciliation of current period changes, net of applicable income taxes, for these designated derivatives presented in the separate component of stockholders’ equity labeled “derivatives qualifying as hedges,” for the years ended December 31: (Amounts in millions) 2021 2020 2019 Derivatives qualifying as effective accounting hedges as of January 1 $ 2,211 $ 2,002 $ 1,781 Current period increases (decreases) in fair value, net of deferred taxes of $12, $(95) and $(87) (45 ) 344 331 Reclassification to net (income), net of deferred taxes of $76, $73 and $60 (141 ) (135 ) (110 ) Derivatives qualifying as effective accounting hedges as of December 31 $ 2,025 $ 2,211 $ 2,002 The total of derivatives designated as cash flow hedges of $2,025 million, net of taxes, recorded in stockholders’ equity as of December 31, 2021 is expected to be reclassified to net income in the future, concurrently with and primarily offsetting changes in interest expense and interest income on floating rate instruments and interest income on future fixed rate bond purchases. Of this amount, $143 million, net of taxes, is expected to be reclassified to net income in the next 12 months. Actual amounts may vary from this amount as a result of market conditions. All forecasted transactions associated with qualifying cash flow hedges are expected to occur by 2057. During the years ended December 31, 2021, 2020 and 2019, we reclassified $10 million, $15 million and $5 million, respectively, to net income in connection with forecasted transactions that were no longer considered probable of occurring. Derivatives Not Designated As Hedges We also enter into certain non-qualifying interest rate swaps and financial futures to mitigate the risks associated with liabilities that have guaranteed minimum benefits, fixed index annuities and indexed universal life; and (iii) foreign currency options and forward contracts to mitigate currency risk associated with dividends, cash payments to AXA reported as discontinued operations and/or other cash flows from certain foreign subsidiaries to our holding company. Additionally, we provide GMWBs on certain variable annuities that are required to be bifurcated as embedded derivatives. We also offer fixed index annuity and indexed universal life insurance products and have reinsurance agreements with certain features that are required to be bifurcated as embedded derivatives. The following table provides the pre-tax (Amounts in millions) 2021 2020 2019 Classification of gain (loss) Interest rate swaps $ 2 $ (11 ) $ (3 ) Net investment gains (losses) Equity index options 18 4 43 Net investment gains (losses) Financial futures (123 ) 2 (64 ) Net investment gains (losses) Other foreign currency contracts — 6 (6 ) Net investment gains (losses) GMWB embedded derivatives 124 (28 ) 38 Net investment gains (losses) Fixed index annuity embedded derivatives (32 ) (51 ) (90 ) Net investment gains (losses) Indexed universal life embedded derivatives 24 17 4 Net investment gains (losses) Total derivatives not designated as hedges $ 13 $ (61 ) $ (78 ) Derivative Counterparty Credit Risk Most of our derivative arrangements with counterparties require the posting of collateral upon meeting certain net exposure thresholds. The following table presents additional information about derivative assets and liabilities subject to an enforceable master netting arrangement as of December 31: 2021 2020 (Amounts in millions) Derivative (1) Derivative (1) Net Derivative (1) Derivative (1) Net Amounts presented in the balance sheet: Gross amounts recognized $ 414 $ 26 $ 388 $ 574 $ 26 $ 548 Gross amounts offset in the balance sheet — — — — — — Net amounts presented in the balance sheet 414 26 388 574 26 548 Gross amounts not offset in the balance sheet: Financial instruments (2) (20 ) (20 ) — (20 ) (20 ) — Collateral received (308 ) — (308 ) (401 ) — (401 ) Collateral pledged — (536 ) 536 — (505 ) 505 Over collateralization 2 530 (528 ) 2 499 (497 ) Net amount $ 88 $ — $ 88 $ 155 $ — $ 155 (1) Does not include amounts related to embedded derivatives as of December 31, 2021 and 2020. (2) Amounts represent derivative assets and/or liabilities that are presented gross within the balance sheet but are held with the same counterparty where we have a master netting arrangement. This adjustment results in presenting the net asset and net liability position for each counterparty.

Deferred Acquisition Costs

Deferred Acquisition Costs	12 Months Ended
	Dec. 31, 2021
Deferred Acquisition Costs	(6) Deferred Acquisition Costs The following table presents the activity impacting DAC as of and for the years ended December 31: (Amounts in millions) 2021 2020 2019 Unamortized balance as of January 1 $ 2,809 $ 3,243 $ 3,591 Costs deferred 8 3 17 Amortization, net of interest accretion (379 ) (437 ) (365 ) Unamortized balance as of December 31 2,438 2,809 3,243 Accumulated effect of net unrealized investment (gains) losses (1,292 ) (1,322 ) (1,444 ) Balance as of December 31 $ 1,146 $ 1,487 $ 1,799 We regularly review DAC to determine if it is recoverable from future income. In 2021 and 2020, we recorded DAC impairments of $117 million and $63 million, respectively, in our universal and term universal life insurance products due principally to lower future estimated gross profits. As of December 31, 2021 and 2020, all of our other products had sufficient future income and therefore the related DAC was recoverable. In 2019, we performed loss recognition testing and determined the related DAC was recoverable. See note 9 for additional information related to loss recognition testing. In the fourth quarter of 2020, as part of our annual review of assumptions, we increased DAC amortization by $48 million in our universal and term universal life insurance products predominantly due to changes in expected gross profits driven mostly by lower projected cost of insurance assessments on our universal life insurance products and a model refinement in our term universal life insurance product related to persistency and grace period timing. In the fourth quarter of 2019, as part of our annual review of assumptions, we increased DAC amortization by $58 million in our universal and term universal life insurance products reflecting updated assumptions primarily related to the lower interest rate environment. As of December 31, 2021, 2020 and 2019, shadow accounting adjustments reduced the DAC balance by $1.3 billion, $1.3 billion and $1.4 billion, respectively, with an offsetting amount recorded in other comprehensive income (loss). The majority of the shadow accounting adjustments as of December 31, 2021, 2020 and 2019 were recorded in our long-term care insurance business, which reduced its DAC balance to zero in each year. As of December 31, 2021, 2020 and 2019, our long-term care insurance business recorded shadow accounting adjustments of $1.0 billion, $1.0 billion and $1.1 billion, respectively, out of the total shadow accounting adjustments recorded of $1.3 billion, $1.3 billion and $1.4 billion, respectively. There was no impact to net income related to our shadow accounting adjustments. See note 2 for further information related to shadow accounting adjustments.

Intangible Assets

Intangible Assets	12 Months Ended
	Dec. 31, 2021
Intangible Assets	(7) Intangible Assets The following table presents our intangible assets as of December 31: 2021 2020 (Amounts in millions) Gross Accumulated Gross Accumulated PVFP $ 2,065 $ (1,994 ) $ 2,065 $ (1,992 ) Capitalized software 465 (403 ) 457 (385 ) Deferred sales inducements to contractholders 295 (288 ) 284 (274 ) Other 159 (156 ) 157 (155 ) Total $ 2,984 $ (2,841 ) $ 2,963 $ (2,806 ) Amortization expense related to PVFP, capitalized software and other intangible assets for the years ended December 31, 2021, 2020 and 2019 was $30 million, $26 million and $44 million, respectively. Amortization expense related to deferred sales inducements of $14 million, $16 million and $15 million, respectively, for the years ended December 31, 2021, 2020 and 2019 was included in benefits and other changes in policy reserves. Present Value of Future Profits The following table presents the activity in PVFP as of and for the years ended December 31: (Amounts in millions) 2021 2020 2019 Unamortized balance as of January 1 $ 154 $ 154 $ 170 Interest accreted at 5.23%, 5.19% and 5.56% 8 8 9 Amortization (10 ) (8 ) (25 ) Unamortized balance as of December 31 152 154 154 Accumulated effect of net unrealized investment (gains) losses (81 ) (81 ) (80 ) Balance as of December 31 $ 71 $ 73 $ 74 We regularly review our assumptions and periodically test PVFP for recoverability in a manner similar to our treatment of DAC. As of December 31, 2021, 2020 and 2019 we believe all of our businesses have sufficient future income and therefore the related PVFP is recoverable. The percentage of the December 31, 2021 PVFP balance net of interest accretion, before the effect of unrealized investment gains or losses, estimated to be amortized over each of the next five years is as follows: 2022 4.2 % 2023 4.2 % 2024 4.2 % 2025 4.0 % 2026 5.0 % Amortization expense for PVFP in future periods will be affected by acquisitions, dispositions, net investment gains (losses) or other factors affecting the ultimate amount of gross profits realized from certain lines of business. Similarly, future amortization expense for other intangibles will depend on future acquisitions, dispositions and other business transactions.

Reinsurance

Reinsurance	12 Months Ended
	Dec. 31, 2021
Reinsurance	(8) Reinsurance We reinsure a portion of our policy risks to other insurance companies in order to reduce our ultimate losses, diversify our exposures and provide capital flexibility. We also assume certain policy risks written by other insurance companies. Reinsurance accounting is followed for assumed and ceded transactions when there is adequate insurance risk transfer. Otherwise, the deposit method of accounting is followed. Reinsurance does not relieve us from our obligations to policyholders. In the event that the reinsurers are unable to meet their obligations, we remain liable for the reinsured claims. We monitor both the financial condition of individual reinsurers and risk concentrations arising from similar geographic regions, activities and economic characteristics of reinsurers to lessen the risk of default by such reinsurers. Other than the relationship discussed below with Union Fidelity Life Insurance Company (“UFLIC”), we do not have significant concentrations of reinsurance with any one reinsurer that could have a material impact on our financial position. U.S. Life Insurance As of December 31, 2021, the maximum amount of individual ordinary life insurance normally retained by us on any one individual life policy was $5 million. We have several significant reinsurance transactions (“Reinsurance Transactions”) with UFLIC, an affiliate of our former parent, General Electric Company (“GE”). In the Reinsurance Transactions, we ceded to UFLIC in-force in-force As of December 31, 2021 and 2020, we had a reinsurance recoverable of $13,095 million and $13,415 million, respectively, with UFLIC. Under the terms of certain reinsurance agreements that our life insurance subsidiaries have with external parties, we pledged assets in either separate portfolios or in trust for the benefit of external reinsurers. These assets support the reserves ceded to those external reinsurers. We have pledged fixed maturity securities and commercial mortgage loans of $13,123 million and $810 million, respectively, as of December 31, 2021 and $13,188 million and $873 million, respectively, as of December 31, 2020 in connection with these reinsurance agreements. However, we maintain the ability to substitute these pledged assets for other qualified collateral, and may use, commingle, encumber or dispose of any portion of the collateral as long as there is no event of default and the remaining qualified collateral is sufficient to satisfy the collateral maintenance level. The following table sets forth net domestic life insurance in-force (Amounts in millions) 2021 2020 2019 Direct life insurance in-force $ 471,147 $ 509,670 $ 555,252 Amounts assumed from other companies 573 624 673 Amounts ceded to other companies (1) (427,464 ) (458,999 ) (500,965 ) Net life insurance in-force $ 44,256 $ 51,295 $ 54,960 Percentage of amount assumed to net 1 % 1 % 1 % (1) Includes amounts accounted for under the deposit method. Enact Enact Holdings reinsures a portion of its U.S. mortgage insurance risk in order to obtain credit towards the financial requirements of the government-sponsored enterprise (“GSE”) private mortgage insurer eligibility requirements (“PMIERs”). The transactions are structured as excess of loss coverage where both the attachment and detachment points of the ceded risk tier are within the PMIERs capital requirements at inception. Each reinsurance treaty has a term of 10 years and grants Enact Holdings a unilateral right to commute the treaty prior to the full term, subject to certain performance triggers. In 2021, Enact Holdings executed an excess of loss reinsurance transaction with a panel of reinsurers that provides approximately $210 million of reinsurance coverage on a portion of new insurance written for its 2021 book year. During 2021 and 2020, Enact Holdings and its U.S. mortgage insurance subsidiaries obtained approximately $1,170 million and $350 million, respectively, of excess of loss reinsurance coverage from certain special purpose insurers that are considered VIEs. The VIEs financed the reinsurance coverage by issuing mortgage insurance-linked notes to unaffiliated investors. The notes are non-recourse pre-established On January 27, 2022, Enact Holdings completed an excess of loss reinsurance transaction that provides approximately $294 million of reinsurance coverage on a portion of new insurance written from January 1, 2022 to December 31, 2022. Premiums Written and Earned The following table sets forth the effects of reinsurance on premiums written and earned for the years ended December 31: Written Earned (Amounts in millions) 2021 2020 2019 2021 2020 2019 Direct: Life insurance $ 774 $ 795 $ 845 $ 775 $ 795 $ 845 Accident and health insurance (1) 2,797 2,836 2,792 2,834 2,860 2,821 Mortgage insurance 990 947 844 1,050 1,023 882 Total direct 4,561 4,578 4,481 4,659 4,678 4,548 Assumed: Life insurance 2 1 1 2 2 1 Accident and health insurance (1) 300 313 321 304 322 326 Mortgage insurance 3 3 4 3 4 4 Total assumed 305 317 326 309 328 331 Ceded: Life insurance (2) (913 ) (558 ) (568 ) (913 ) (559 ) (568 ) Accident and health insurance (1) (541 ) (550 ) (557 ) (548 ) (562 ) (564 ) Mortgage insurance (72 ) (49 ) (22 ) (72 ) (49 ) (22 ) Total ceded (1,526 ) (1,157 ) (1,147 ) (1,533 ) (1,170 ) (1,154 ) Net premiums $ 3,340 $ 3,738 $ 3,660 $ 3,435 $ 3,836 $ 3,725 Percentage of amount assumed to net 9% 9% 9% (1) Accident and health insurance is comprised almost entirely of our long-term care insurance products. (2) Effective December 1, 2021 and included in the year ended December 31, 2021, we entered into a reinsurance agreement with SCOR Global Life USA Reinsurance Company, under which we ceded premiums of $360 million associated with certain term life insurance policies in connection with a life block transaction. Reinsurance recoveries recognized as a reduction of benefits and other changes in policy reserves amounted to $2,850 million, $2,649 million and $2,751 million during 2021, 2020 and 2019, respectively. Allowance for Credit Losses on Reinsurance Recoverables The following table sets forth the changes in the allowance for credit losses related to reinsurance recoverables as of or for the years ended December 31: (Amounts in millions) 2021 2020 Allowance for credit losses: Beginning balance $ 45 $ — Cumulative effect of change in accounting — 40 Provision 10 5 Write-offs — — Recoveries — — Ending balance $ 55 $ 45 Our policy for evaluating and measuring the allowance for credit losses related to reinsurance recoverables utilizes the reinsurer’s credit rating, updated quarterly, to assess the credit quality of reinsurance recoverables. The following tables set forth A.M. Best Company, Inc.’s (“A.M. Best”) credit ratings related to our reinsurance recoverables, gross of the allowance for credit losses, as of December 31: 2021 (Amounts in millions) Collateralized Non-collateralized Total Credit rating: A++ $ — $ 543 $ 543 A+ 1,581 1,510 3,091 A 18 41 59 Not rated 13,099 76 13,175 Total reinsurance recoverable $ 14,698 $ 2,170 $ 16,868 2020 (Amounts in millions) Collateralized Non-collateralized Total Credit rating: A++ $ — $ 519 $ 519 A+ 1,437 1,343 2,780 A 19 45 64 B+ — 1 1 Not rated 13,419 81 13,500 Total reinsurance recoverable $ 14,875 $ 1,989 $ 16,864 In March 2019, upon UFLIC’s request, A.M. Best withdrew UFLIC’s credit rating. There was no impact to us from this action as UFLIC has trust accounts and a guarantee from its parent, as discussed above, and is sufficiently collateralized. Accordingly, the reinsurance recoverable with UFLIC is fully collectible and no allowance for credit losses was recorded as of December 31, 2021 and 2020. Reinsurance recoverables are considered past due when contractual payments have not been received from the reinsurer by the required payment date. Claims submitted for payment are generally due in less than one year. As of December 31, 2021 and 2020, we did not have any reinsurance recoverables past due, except for Scottish Re US Inc. (“Scottish Re”), a reinsurance company domiciled in Delaware. On March 6, 2019, Scottish Re was ordered into receivership for the purposes of rehabilitation by the Court of Chancery of the State of Delaware. The proposed Plan of Rehabilitation of Scottish Re was filed on June 30, 2020. On March 16, 2021, the Receiver filed a draft Amended Plan of Rehabilitation and filed an outline of changes to the amended plan on July 27, 2021. The amended plan has not been approved by the Court nor do we know what deadlines the Court will impose, what standard it will use or whether the receiver will ultimately submit a rehabilitation plan that the Court will approve. As of December 31, 2021 and 2020, amounts past due related to Scottish Re were $40 million and $19 million, respectively, all of which was included in the allowance for credit losses. We will continue to monitor the plan of rehabilitation and expected recovery of the claims balance.

Insurance Reserves

Insurance Reserves	12 Months Ended
	Dec. 31, 2021
Insurance Reserves	(9) Insurance Reserves Future Policy Benefits The following table sets forth our recorded liabilities and the major assumptions underlying our future policy benefits as of December 31: (Amounts in millions) Mortality/ Interest rate 2021 2020 Long-term care insurance contracts (a ) 3.75% - 7.50% $ 28,232 $ 28,770 Structured settlements with life contingencies (b ) 1.00% - 8.00% 8,075 8,240 Annuity contracts with life contingencies (b ) 1.00% - 8.00% 2,934 3,252 Traditional life insurance contracts (c ) 3.00% - 7.50% 1,956 2,101 Supplementary contracts with life contingencies (b ) 1.00% - 8.00% 331 332 Total future policy benefits $ 41,528 $ 42,695 (a) The 1983 Individual Annuitant Mortality Table or the 2000 U.S. Annuity Table, or the 1983 Group Annuitant Mortality Table or the 1994 Group Annuitant Mortality Table and company experience. (b) Assumptions for limited-payment contracts come from either the U.S. Population Table, the 1983 Group Annuitant Mortality Table, the 1983 Individual Annuitant Mortality Table, the Annuity 2000 Mortality Table or the 2012 Individual Annuity Reserving Table. (c) Principally modifications based on company experience of the Society of Actuaries 1965-70 1975-80 We regularly review our assumptions and perform loss recognition testing at least annually. For our fixed immediate annuity products, our 2019 loss recognition testing resulted in a premium deficiency of $39 million primarily driven by the low interest rate environment. The 2021 and 2020 tests did not result in a premium deficiency and therefore our liability for future policy benefits was sufficient. The liability for future policy benefits for our fixed immediate annuity products represents our current best estimate; however, there may be future adjustments to this estimate and related assumptions. Such adjustments, reflecting any variety of new and adverse trends, could result in further increases in the related future policy benefit reserves for these products. Our long-term care insurance products are also among the products tested in connection with our annual loss recognition testing. The 2021, 2020 and 2019 tests did not result in a premium deficiency and therefore our liability for future policy benefits was sufficient. The liability for future policy benefits for our long-term care insurance business represents our current best estimate; however, there may be future adjustments to this estimate and related assumptions. Such adjustments, reflecting any variety of new and adverse trends, could possibly be significant and result in further increases in the related future policy benefit reserves for this business by an amount that could be material to our results of operations and financial condition and liquidity. As of December 31, 2021 and 2020, we accrued future policy benefit reserves of $1,274 million and $625 million, respectively, in our consolidated balance sheets for profits followed by losses in our long-term care insurance business. The present value of expected future losses was approximately $2.5 billion and $2.1 billion as of December 31, 2021 and 2020, respectively. As of December 31, 2021 and 2020, we estimate a factor of approximately 76% of those profits on our long-term care insurance block, excluding the acquired block, will be accrued in the future to offset estimated future losses during later periods. The factor was unchanged compared to December 31, 2020 due mostly to higher actual profits in 2021 resulting in a larger increase in accrued future policy benefits for profits followed by losses, as well as updates to our future in-force Policyholder Account Balances The following table sets forth our recorded liabilities for policyholder account balances as of December 31: (Amounts in millions) 2021 2020 Annuity contracts $ 6,816 $ 8,273 Funding agreements 250 300 Structured settlements without life contingencies 1,027 1,114 Supplementary contracts without life contingencies 550 576 Other 14 13 Total investment contracts 8,657 10,276 Universal and term universal life insurance contracts 10,697 11,227 Total policyholder account balances $ 19,354 $ 21,503 In the fourth quarter of 2021, as part of our annual review of assumptions, we increased our liability for policyholder account balances by $87 million in our term universal and universal life insurance products primarily related to higher pre-COVID-19 Certain of our U.S. life insurance companies are members of the Federal Home Loan Bank (the “FHLB”) system in their respective regions. As of December 31, 2021 and 2020, we held $28 million and $42 million, respectively, of FHLB common stock related to those memberships which was included in equity securities. The FHLBs have been granted a lien on certain of our invested assets to collateralize our obligations; however, we maintain the ability to substitute these pledged assets for other qualified collateral, and may use, commingle, encumber or dispose of any portion of the collateral as long as there is no event of default and the remaining qualified collateral is sufficient to satisfy the collateral maintenance level. Upon any event of default by us, the FHLB’s recovery on the collateral is limited to the amount of our funding agreement liabilities to the FHLB. These funding agreements as of December 31, 2021 and 2020 were collateralized by fixed maturity securities with a fair value of $907 million and $1,309 million, respectively. The amount of funding agreements outstanding with the FHLBs was $250 million and $421 million as of December 31, 2021 and 2020, respectively, which was included in policyholder account balances. Included in the amount of funding agreements outstanding with the FHLBs as of December 31, 2020 are FHLB agreements entered into by our universal life insurance business of $121 million, which were included in universal and term universal life insurance contracts in the table above. Shadow Accounting Adjustments As of December 31, 2021 and 2020, we accrued future policy benefit reserves of $3.2 billion and $4.5 billion, respectively, with an offsetting amount recorded in accumulated other comprehensive income (loss) related to shadow accounting adjustments. The lower amounts accrued for the year ended December 31, 2021 were primarily due to an increase in interest rates decreasing unrealized investment gains. The majority of the shadow accounting adjustments as of December 31, 2021 were recorded in our long-term care insurance business, which comprised $2.6 billion out of the total $3.2 billion accrued. In addition, as of December 31, 2021 and 2020, we accrued policyholder account balances of $0.9 billion and $1.4 billion, respectively, in our universal and term universal life insurance products with an offsetting amount recorded in accumulated other comprehensive income (loss) related to shadow accounting adjustments. There was no impact to net income related to our shadow accounting adjustments. See note 2 for further information related to shadow accounting adjustments. Certain Non-Traditional The following table sets forth information about our variable annuity products with death and living benefit guarantees as of December 31: (Dollar amounts in millions) 2021 2020 Account values with death benefit guarantees (net of reinsurance): Standard death benefits (return of net deposits) account value $ 2,547 $ 2,611 Net amount at risk $ 1 $ 2 Average attained age of contractholders 76 76 Enhanced death benefits (ratchet, rollup) account value $ 1,326 $ 1,350 Net amount at risk $ 94 $ 105 Average attained age of contractholders 76 76 Account values with living benefit guarantees: GMWBs $ 1,893 $ 1,999 Guaranteed annuitization benefits $ 1,002 $ 998 Variable annuity contracts may contain more than one death or living benefit; therefore, the amounts listed above are not mutually exclusive. Substantially all of our variable annuity contracts have some form of GMDB. As of December 31, 2021 and 2020, our total liability associated with variable annuity contracts with minimum guarantees was approximately $4,492 million and $4,668 million, respectively. Account value decreased compared to 2020 principally driven by the continued runoff of these products. The liability, net of reinsurance, for our variable annuity contracts with GMDB and guaranteed annuitization benefits was $135 million and $128 million as of December 31, 2021 and 2020, respectively. The contracts underlying the lifetime benefits such as GMWB and guaranteed annuitization benefits are considered “in the money” if the contractholder’s benefit base, or the protected value, is greater than the account value. As of December 31, 2021 and 2020, our exposure related to GMWB and guaranteed annuitization benefit contracts that were considered “in the money” was $602 million and $669 million, respectively. For GMWBs and guaranteed annuitization benefits, the only way the contractholder can monetize the excess of the benefit base over the account value of the contract is through lifetime withdrawals or lifetime income payments after annuitization. Account balances of variable annuity contracts with death or living benefit guarantees were invested in separate account investment options as follows as of December 31: (Amounts in millions) 2021 2020 Balanced funds $ 2,397 $ 2,343 Equity funds 913 1,016 Bond funds 297 304 Money market funds 189 216 Total $ 3,796 $ 3,879

Liability for Policy and Contra

Liability for Policy and Contract Claims	12 Months Ended
	Dec. 31, 2021
Liability for Policy and Contract Claims	(10) Liability for Policy and Contract Claims The following table sets forth our liability for policy and contract claims as of December 31: (Amounts in millions) 2021 2020 Liability for policy and contract claims for insurance lines other than short-duration contracts: U.S. Life Insurance segment: Long-term care insurance $ 10,861 $ 10,518 Life insurance 308 378 Fixed annuities 14 12 Runoff segment 8 12 Total 11,191 10,920 Liability for policy and contract claims related to short-duration contracts: Enact segment 641 555 Other mortgage insurance businesses 9 11 Total 650 566 Total liability for policy and contract claims $ 11,841 $ 11,486 The liability for policy and contract claims represents our current best estimate; however, there may be future adjustments to this estimate and related assumptions. Such adjustments, reflecting any variety of new and adverse trends, could be significant, and result in increases in reserves by an amount that could be material to our results of operations and financial condition and liquidity. In addition, loss reserves recorded on new delinquencies in our Enact segment have a high degree of estimation, particularly due to the level of uncertainty regarding whether borrowers in forbearance will ultimately cure or result in a claim payment. The liability for policy and contract claims increased $343 million in our long-term care insurance business as discussed further below. The increase in the liability for policy and contract claims of $86 million in our Enact segment was principally attributable to new delinquencies, partially offset by net favorable reserve adjustments related to positive frequency and severity development on pre-COVID-19 Long-term care insurance The following table sets forth changes in the liability for policy and contract claims for our long-term care insurance business for the dates indicated: (Amounts in millions) 2021 2020 2019 Beginning balance as of January 1 $ 10,518 $ 10,239 $ 9,516 Less reinsurance recoverables (2,260 ) (2,283 ) (2,262 ) Net balance as of January 1 8,258 7,956 7,254 Incurred related to insured events of: Current year 2,761 2,595 2,717 Prior years (610 ) (398 ) (219 ) Total incurred 2,151 2,197 2,498 Paid related to insured events of: Current year (203 ) (189 ) (205 ) Prior years (2,011 ) (2,118 ) (1,975 ) Total paid (2,214 ) (2,307 ) (2,180 ) Interest on liability for policy and contract claims 406 412 384 Net balance as of December 31 8,601 8,258 7,956 Add reinsurance recoverables 2,260 2,260 2,283 Ending balance as of December 31 $ 10,861 $ 10,518 $ 10,239 In 2021, the liability for policy and contract claims increased $343 million in our long-term care insurance business primarily attributable to new claims and claim severity as a result of the aging of the in-force COVID-19 pre-pandemic COVID-19. COVID-19 COVID-19 For the year ended 2021, the favorable development of $610 million related to insured events of prior years was primarily attributable to favorable development on prior year incurred but not reported (“IBNR”) claims, favorable claim terminations mostly attributable to higher mortality and favorable experience on pending claims that did not become an active claim. In 2020, the liability for policy and contract claims increased $279 million in our long-term care insurance business. The increase was primarily attributable to new claims and claim severity as a result of the aging of the in-force COVID-19 COVID-19 pre-pandemic For the year ended 2020, the favorable development of $398 million related to insured events of prior years was primarily attributable to favorable claim terminations mostly attributable to higher mortality, favorable development on prior year IBNR claims and favorable experience on pending claims that did not become an active claim. These decreases were partially offset by unfavorable impacts from changes in assumptions and methodologies associated with our annual claim reserve review completed in the fourth quarter of 2020 and from higher reserves associated with changes to incidence and mortality experience driven by COVID-19. In 2019, the liability for policy and contract claims increased $723 million in our long-term care insurance business. The increase was primarily attributable to new claims as a result of the aging of the in-force For the year ended 2019, the favorable development of $219 million related to insured events of prior years was primarily attributable to favorable development on prior year IBNR claims and favorable experience on pending claims that did not become an active claim. Enact segment The following table sets forth information about incurred claims, net of reinsurance, as well as cumulative number of reported delinquencies and the total of IBNR liabilities plus expected development on reported claims included within the net incurred claims amounts for our Enact segment as of December 31, 2021. The information about the incurred claims development for the years ended December 31, 2012 to 2020 and the historical reported delinquencies as of December 31, 2020 and prior are presented as supplementary information. Incurred claims and allocated claim adjustment expenses, net of Total of IBNR Number of (2) (Dollar amounts in millions) For the years ended December 31, Accident year (1) 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 Unaudited 2012 $ 718 $ 675 $ 671 $ 673 $ 671 $ 668 $ 667 $ 666 $ 666 $ 667 $ — 31,126 2013 — 475 407 392 387 384 382 381 381 381 — 22,502 2014 — — 328 288 269 261 259 258 259 259 — 17,809 2015 — — — 235 208 187 181 180 180 179 — 15,400 2016 — — — — 198 160 138 136 137 136 — 13,970 2017 — — — — — 171 121 102 105 104 — 15,097 2018 — — — — — — 117 84 84 78 1 11,269 2019 — — — — — — — 106 111 98 1 11,883 2020 — — — — — — — — 365 362 1 38,863 2021 — — — — — — — — — 141 15 12,585 Total incurred $ 2,405 (1) Represents the year in which first monthly mortgage payments have been missed by the borrower. (2) Represents reported and outstanding delinquencies less actual cures as of December 31 for each respective accident year. The following table sets forth paid claims development, net of reinsurance, for our Enact segment for the year ended December 31, 2021. The information about paid claims development for the years ended December 31, 2012 to 2020 is presented as supplementary information. (Amounts in millions) Cumulative paid claims and allocated claim adjustment expenses, net of reinsurance Accident year (1) 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 Unaudited 2012 $ 92 $ 391 $ 532 $ 602 $ 634 $ 650 $ 658 $ 662 $ 663 $ 663 2013 — 44 202 297 340 362 372 375 376 377 2014 — — 22 127 195 233 247 253 254 255 2015 — — — 12 85 145 167 173 175 176 2016 — — — — 10 64 110 124 127 128 2017 — — — — — 6 46 77 87 90 2018 — — — — — — 3 32 48 55 2019 — — — — — — — 2 18 31 2020 — — — — — — — — 1 8 2021 — — — — — — — — — — Total paid $ 1,783 Total incurred $ 2,405 Total paid 1,783 All outstanding liabilities before 2012 19 Liability for policy and contract claims $ 641 (1) Represents the year in which first monthly mortgage payments have been missed by the borrower. The following table sets forth our average payout of incurred claims by age for our Enact segment as of December 31, 2021: Average annual percentage payout of incurred claims by age Years 1 2 3 4 5 6 7 8 9 10 Unaudited Percentage of payout 6.0 % 33.3 % 25.7 % 11.0 % 4.0 % 1.8 % 0.8 % 0.3 % 0.2 % 0.1 %

Employee Benefit Plans

Employee Benefit Plans	12 Months Ended
	Dec. 31, 2021
Employee Benefit Plans	(11) Employee Benefit Plans (a) Pension and Retiree Health and Life Insurance Benefit Plans Essentially all of our employees are enrolled in a qualified defined contribution pension plan. The plan is 100% funded by Genworth. We make annual contributions to each employee’s pension plan account based on the employee’s age, service and eligible pay. Employees are vested in the plan after three years of service. As of December 31, 2021 and 2020, we recorded a liability related to these benefits of $11 million. In addition, certain employees also participate in non-qualified non-qualified individually or in the aggregate. As of December 31, 2021 and 2020, we recorded a liability related to these plans of $65 million and $69 million, respectively, which we accrued in other liabilities in the consolidated balance sheets. In 2021 and 2020, we recognized an increase of $6 million and a decrease of $8 million, respectively, in OCI. The First Colony Life Insurance Company Pension Plan is one of our defined benefit pension plans available to certain of our employees. The First Colony Life Insurance Pension Plan Committee, as the delegate of Genworth Financial’s Board of Directors, adopted resolutions to terminate the First Colony Life Insurance Company Pension Plan in a standard termination effective December 31, 2021. As of the termination date and to the extent allowed under applicable law, all accrued participant benefits vested and were included in our pension liabilities as of December 31, 2021. In 2022, we intend to undertake all actions necessary to effectuate the termination, including obtaining all required regulatory approvals, among other actions. We provide retiree health benefits to domestic employees hired prior to January 1, 2005 who meet certain service requirements. Under this plan, retirees over 65 years of age receive a subsidy towards the purchase of a Medigap policy, and retirees under 65 years of age receive medical benefits similar to our employees’ medical benefits. In December 2009, we announced that eligibility for retiree medical benefits would be limited to associates who were within 10 years of retirement eligibility as of January 1, 2010. This resulted in a negative plan amendment which will be amortized over the average future service of the participants. We also provide retiree life and long-term care insurance benefits. The plans are funded as claims are incurred. As of December 31, 2021 and 2020, the accumulated postretirement benefit obligation associated with these benefits was $71 million and $77 million, respectively, which we accrued in other liabilities in the consolidated balance sheets. In 2021 and 2020, we recognized an increase of $11 million and a decrease of $6 million, respectively, in OCI. Our cost associated with our pension, retiree health and life insurance benefit plans was $18 million, $18 million and $19 million for the years ended December 31, 2021, 2020 and 2019, respectively. (b) Savings Plans Our domestic employees participate in qualified and non-qualified pre-tax two complete years ® Prior to January 2021, employees also had the option of purchasing a fund which invests primarily in Genworth Fianancial stock as part of the defined contribution savings plan. We had contracted with Newport Trust Company (“Newport”) to act as an independent fiduciary and investment manager with respect to Genworth Financial stock in the defined contribution savings plan. On January 8, 2021, Newport froze the fund and accordingly, future investments or transfers into the fund were suspended indefinitely. Our cost associated with these plans was $13 million for each of the years ended December 31, 2021, 2020 and 2019. (c) Health and Welfare Benefits for Active Employees We provide health and welfare benefits to our employees, including health, life, disability, dental and long-term care insurance, among others. Our long-term care insurance is provided through our group long-term care insurance products. The premiums recorded by this business related to these benefits were insignificant during 2021, 2020 and 2019.

Borrowings and Other Financings

Borrowings and Other Financings	12 Months Ended
	Dec. 31, 2021
Borrowings and Other Financings	(12) Borrowings and Other Financings (a) Long-Term Borrowings The following table sets forth total long-term borrowings as of December 31: (Amounts in millions) 2021 2020 Genworth Holdings 7.20% Senior Notes, due 2021 $ — $ 338 7.625% Senior Notes, due 2021 — 660 4.90% Senior Notes, due 2023 — 400 4.80% Senior Notes, due 2024 282 400 6.50% Senior Notes, due 2034 298 297 Floating Rate Junior Subordinated Notes, due 2066 598 598 Subtotal 1,178 2,693 Bond consent fees (12 ) (19 ) Deferred borrowing charges (7 ) (9 ) Total Genworth Holdings 1,159 2,665 Enact Holdings 6.50% Senior Notes, due 2025 750 750 Deferred borrowing charges (10 ) (12 ) Total Enact Holdings 740 738 Total $1,899 $ 3,403 Genworth Holdings Long-Term Senior Notes Genworth Holdings paid its 7.20% senior notes with a principal balance of $338 million at maturity on February 16, 2021. Genworth Holdings’ 7.20% senior notes were fully redeemed with a cash payment of $350 million, comprised of the outstanding principal balance and accrued interest. In March 2021, Genworth Holdings repurchased $146 million principal amount of its 7.625% senior notes due in September 2021 for a pre-tax In the fourth quarter of 2021, Genworth Holdings repurchased $91 million of its 4.90% senior notes due in 2023 for a pre-tax As of December 31, 2021, Genworth Holdings had outstanding two series of fixed rate senior notes with interest rates of 4.80% and 6.50% and maturity dates of 2024 and 2034, respectively. The senior notes are Genworth Holdings’ direct, unsecured obligations and rank equally in right of payment with all of its existing and future unsecured and unsubordinated obligations. Genworth Financial provides a full and unconditional guarantee to the trustee of Genworth Holdings’ outstanding senior notes and the holders of the senior notes, on an unsecured unsubordinated basis, of the full and punctual payment of the principal of, premium, if any and interest on, and all other amounts payable under, each outstanding series of senior notes, and the full and punctual payment of all other amounts payable by Genworth Holdings under the senior notes indenture in respect of such senior notes. Genworth Holdings has the option to redeem all or a portion of each series of senior notes at any time with notice to the noteholders at a price equal to the greater of 100% of principal or the sum of the present value of the remaining scheduled payments of principal and interest discounted at the then-current treasury rate plus an applicable spread. In the fourth quarter of 2021, Genworth Holdings repurchased $118 million principal amount of its 4.80% senior notes due in 2024 for a pre-tax 33 Long-Term Junior Subordinated Notes As of December 31, 2021, Genworth Holdings had outstanding floating rate junior notes having an aggregate principal amount of $600 million and a discount of $2 million, with an annual interest rate equal to three-month LIBOR plus 2.0025% payable quarterly, until the notes mature in November 2066 (“2066 Notes”). The United Kingdom Financial Conduct Authority announced its intention to eliminate the use of three-month LIBOR effective June 30, 2023. The Alternate Reference Rate Committee, convened by the Board of Governors of the Federal Reserve System and the New York Federal Reserve Bank, is expected to authorize the use of an alternative rate to replace the current contractual three-month LIBOR rate used for the 2066 Notes. As such, we currently have no intention of refinancing the 2066 Notes. Until the elimination of the published rate and transition to an alternate reference rate become effective, we will continue to calculate and record interest payable and expense using three-month LIBOR plus 2.0025%. Subject to certain conditions, Genworth Holdings has the right, on one or more occasions, to defer the payment of interest on the 2066 Notes during any period of up to 10 years without giving rise to an event of default and without permitting acceleration under the terms of the 2066 Notes. Genworth Holdings will not be required to settle deferred interest payments until it has deferred interest for five years or made a payment of current interest. In the event of our bankruptcy, holders will have a limited claim for deferred interest. Genworth Holdings may redeem the 2066 Notes on November 15, 2036, the “scheduled redemption date,” but only to the extent that it has received net proceeds from the sale of certain qualifying capital securities. Genworth Holdings may redeem the 2066 Notes in whole or in part at their principal amount plus accrued and unpaid interest to the date of redemption. The 2066 Notes will be subordinated to all existing and future senior, subordinated and junior subordinated debt of Genworth Holdings, except for any future debt that by its terms is not superior in right of payment, and will be effectively subordinated to all liabilities of our subsidiaries. Genworth Financial provides a full and unconditional guarantee to the trustee of the 2066 Notes and the holders of the 2066 Notes, on an unsecured subordinated basis, of the full and punctual payment of the principal of, premium, if any and interest on, and all other amounts payable under, the outstanding 2066 Notes, and the full and punctual payment of all other amounts payable by Genworth Holdings under the 2066 Notes indenture in respect of the 2066 Notes. In connection with the issuance of the 2066 Notes, we entered into a Replacement Capital Covenant, whereby we agreed, for the benefit of holders of Genworth Holdings’ 6.50% Senior Notes due 2034, that Genworth Holdings will not repay, redeem or repurchase all or any part of the 2066 Notes on or before November 15, 2046, unless such repayment, redemption or repurchase is made from the proceeds of the issuance of certain replacement capital securities and pursuant to the other terms and conditions set forth in the Replacement Capital Covenant. Enact Holdings On August 21, 2020, Enact Holdings, our indirect subsidiary, issued $750 million of its 6.50% senior notes due in 2025 (“2025 Senior Notes”). Interest on the notes is payable semi-annually in arrears on February 15 and August 15 of each year. The notes mature on August 15, 2025. Enact Holdings may redeem the notes, in whole or in part, at any time prior to February 15, 2025 at its option, by paying a make-whole premium, plus accrued and unpaid interest, if any. At any time on or after February 15, 2025, Enact Holdings may redeem the notes, in whole or in part, at its option, at 100% of the principal amount, plus accrued and unpaid interest. The notes contain customary events of default, which subject to certain notice and cure conditions, can result in the acceleration of the principal and accrued interest on the outstanding notes if Enact Holdings breaches the terms of the indenture. (b) Non-Recourse In January 2020, upon receipt of approval from the Director of Insurance of the State of South Carolina, Rivermont Life Insurance Company I (“Rivermont I”), our former wholly-owned special purpose consolidated captive insurance subsidiary, redeemed all of its $315 million of outstanding non-recourse pre-tax write-off (c) Liquidity Principal amounts under our long-term borrowings (including senior notes) by maturity were as follows as of December 31, 2021: (Amounts in millions) 2022 $ — 2023 — 2024 282 2025 750 2026 and thereafter 900 Total $ 1,932 (d) Securities lending activity In 2021, we suspended our securities lending program. Under our previous securities lending program, the borrower was required to provide collateral, which could consist of cash or government securities, on a daily non-cash Risks associated with securities lending programs Our former securities lending program exposed us to liquidity risk if we did not have enough cash or collateral readily available to return to the counterparty when required to do so under the agreement. We managed this risk by regularly monitoring our available sources of cash and collateral to ensure we could meet short-term liquidity demands under normal and stressed scenarios. We were also exposed to credit risk in the event of default of our counterparties or changes in collateral values. This risk was significantly reduced because our program required over collateralization and collateral exposures were trued up on a daily basis. We managed this risk by using multiple counterparties and ensuring that changes in required collateral were monitored and adjusted daily. We also monitored the creditworthiness, including credit ratings, of our counterparties on a regular basis. Contractual maturity The following table presents the remaining contractual maturity of the agreement as of December 31, 2020: (Amounts in millions) Overnight Up to 31 - 90 Greater than Total Securities lending: Fixed maturity securities: Non-U.S. $ 1 $ — $ — $ — $ 1 U.S. corporate 40 — — — 40 Non-U.S. 19 — — — 19 Subtotal, fixed maturity securities 60 — — — 60 Equity securities 7 7 Total securities lending $ 67 $ — $ — $ — $ 67

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2021
Income Taxes	(13) Income Taxes Income from continuing operations before income taxes included the following components for the years ended December 31: (Amounts in millions) 2021 2020 2019 Domestic $ 1,184 $ 931 $ 523 Foreign (3 ) (3 ) (2 ) Income from continuing operations before income taxes $ 1,181 $ 928 $ 521 The total provision for income taxes was as follows for the years ended December 31: (Amounts in millions) 2021 2020 2019 Current federal income taxes $ (32 ) $ — $ 6 Deferred federal income taxes 288 226 114 Total federal income taxes 256 226 120 Current state income taxes 5 3 2 Deferred state income taxes 2 2 5 Total state income taxes 7 5 7 Current foreign income taxes — — 12 Deferred foreign income taxes — (1 ) — Total foreign income taxes — (1 ) 12 Total provision for income taxes $ 263 $ 230 $ 139 Our current income tax payable was $2 million and $32 million as of December 31, 2021 and 2020, respectively. The reconciliation of the federal statutory tax rate to the effective income tax rate was as follows for the years ended December 31: 2021 2020 2019 Statutory U.S. federal income tax rate 21.0 % 21.0 % 21.0 % Increase (reduction) in rate resulting from: Swaps terminated prior to the TCJA 2.5 3.0 4.5 Reduction in uncertain tax positions (1.8 ) — — State income tax, net of federal income tax effect 0.5 0.4 1.1 Other, net 0.1 0.4 0.1 Effective rate 22.3 % 24.8 % 26.7 % The effective tax rate for the year ended December 31, 2021 decreased compared to the year ended December 31, 2020 primarily attributable to changes in uncertain tax positions due to the expiration of certain statutes of limitations in 2021. The effective tax rate for the year ended December 31, 2020 decreased compared to the year ended December 31, 2019 primarily attributable to gains on forward starting swaps settled prior to the enactment of the Tax Cuts and Jobs Act (“TCJA”), which will continue to be tax effected at 35% as they are amortized into net investment income, in relation to higher pre-tax The components of our deferred income taxes were as follows as of December 31: (Amounts in millions) 2021 2020 Assets: Foreign tax credit carryforwards $ 174 $ 136 Net operating loss carryforwards 202 56 Capital loss carryforwards 142 — State income taxes 388 386 Insurance reserves 178 620 Accrued commission and general expenses 118 123 Liabilities associated with discontinued operations 122 126 Investments — 10 Other 18 23 Gross deferred income tax assets 1,342 1,480 Valuation allowance (382 ) (396 ) Total deferred income tax assets 960 1,084 Liabilities: Net unrealized gains on investment securities 506 590 Net unrealized gains on derivatives 73 70 DAC 98 181 PVFP and other intangibles 38 42 Insurance reserves transition adjustment 99 123 Investments 10 — Other 17 13 Total deferred income tax liabilities 841 1,019 Net deferred income tax asset $ 119 $ 65 The above valuation allowances of $382 million and $396 million as of December 31, 2021 and 2020, respectively, are related to state deferred tax assets and foreign net operating losses. The state deferred tax assets related primarily to the future deductions associated with the Section 338 elections and non-insurance U.S federal NOL carryforward amounted to $944 million as of December 31, 2021, and has an indefinite carryforward. The benefits of the NOL carryforwards have been recognized in our consolidated financial statements, except to the extent of the valuation allowances described above relating to state and foreign taxes. The foreign NOL carryforwards, which are included in the net operating loss carryforwards line, are fully offset by a valuation allowance. Foreign tax credit carryforwards amounted to $174 million as of December 31, 2021, and will begin to expire in 2025. Capital loss carryforwards amounted to $675 million as of December 31, 2021, and, if unused, will expire in 2026. Our ability to realize our net deferred tax asset of $119 million, which includes deferred tax assets related to NOL, foreign tax credit and capital loss carryforwards, is primarily dependent upon generating sufficient taxable income and capital gains in future years. Management has concluded that there is sufficient positive evidence to support the expected realization of the net operating losses, foreign tax credit carryforwards and capital loss carryforwards. This positive evidence includes the fact that: (i) we are currently in a cumulative three-year income position; (ii) our U.S. operating forecasts are profitable, which include in-force pre-tax As a consequence of our separation from GE and our joint election with GE to treat that separation as an asset sale under Section 338 of the Internal Revenue Code, we became entitled to additional tax deductions in post IPO periods. We are obligated, pursuant to our Tax Matters Agreement with GE, to make fixed payments to GE on an after-tax IPO-related A reconciliation of the beginning and ending amount of unrecognized tax benefits was as follows: (Amounts in millions) 2021 2020 2019 Balance as of January 1 $ 62 $ 64 $ 79 Tax positions related to the current period: Gross additions — — — Gross reductions (3 ) (3 ) (15 ) Tax positions related to the prior years: Gross additions — 1 — Gross reductions (19 ) — — Balance as of December 31 $ 40 $ 62 $ 64 The total amount of unrecognized tax benefits was $40 million as of December 31, 2021, which if recognized would affect the effective tax rate on continuing operations by $25 million. We believe it is reasonably possible that in 2022, due to the potential resolution of certain potential settlements and other administrative and statutory proceedings and limitations, up to approximately $25 million unrecognized tax benefits will be recognized. We recognize accrued interest and penalties related to unrecognized tax benefits as components of income tax expense. We recorded $2 million of benefit in 2021 and less than $1 million of expense in both 2020 and 2019 related to interest and penalties. Our companies have elected to file a single U.S. consolidated income tax return (the “life/non-life life/non-life

Supplemental Cash Flow Informat

Supplemental Cash Flow Information	12 Months Ended
	Dec. 31, 2021
Supplemental Cash Flow Information	(14) Supplemental Cash Flow Information Net cash (paid) received for taxes was $(7) million, $3 million and $1 million and cash paid for interest was $198 million, $188 million and $287 million for the years ended December 31, 2021, 2020 and 2019, respectively.

Stock-Based Compensation

Stock-Based Compensation	12 Months Ended
	Dec. 31, 2021
Stock-Based Compensation	(15) Stock-Based Compensation Prior to May 2012, we granted share-based awards to employees and directors, including stock options, stock appreciation rights (“SARs”), restricted stock units (“RSUs”) and deferred stock units (“DSUs”) under the 2004 Genworth Financial, Inc. Omnibus Incentive Plan (the “2004 Omnibus Incentive Plan”). In May 2012, the 2012 Genworth Financial, Inc. Omnibus Incentive Plan (the “2012 Omnibus Incentive Plan”) was approved by stockholders. Under the 2012 Omnibus Incentive Plan, we were authorized to grant 16 million equity awards, plus a number of additional shares not to exceed 25 million underlying awards outstanding under the 2004 Omnibus Incentive Plan. In December 2018, the 2018 Genworth Financial, Inc. Omnibus Incentive Plan (the “2018 Omnibus Incentive Plan”) was approved by stockholders. Under the 2018 Omnibus Incentive Plan, we are authorized to grant 25 million equity awards, plus a number of additional shares not to exceed 20 million underlying awards outstanding under the prior Plans. In May 2021, the 2021 Genworth Financial, Inc. Omnibus Incentive Plan (the “2021 Omnibus Incentive Plan”) was approved by stockholders. Under the 2021 Omnibus Incentive Plan, we are authorized to grant 25 million equity awards, plus a number of additional shares not to exceed 20 million underlying awards outstanding under the prior Plans. The 2004 Omnibus Incentive Plan together with the 2012, 2018 and 2021 Omnibus Incentive Plans are referred to collectively as the “Omnibus Incentive Plans.” We recorded stock-based compensation expense under the Omnibus Incentive Plans of $38 million, $39 million and $26 million, respectively, for the years ended December 31, 2021, 2020 and 2019. For awards issued prior to January 1, 2006, stock-based compensation expense was recognized on a graded vesting attribution method over the awards’ respective vesting schedule. For awards issued after January 1, 2006, stock-based compensation expense was recognized evenly on a straight-line attribution method over the awards’ respective vesting period. For purposes of determining the fair value of stock-based payment awards on the date of grant, we have historically used the Black-Scholes Model. However, no SARs or stock options were granted during 2021, 2020 and 2019 and therefore, the Black-Scholes Model was not used in those respective years. The Black-Scholes Model requires the input of certain assumptions that involve judgment. Circumstances may change and additional data may become available over time, which could result in changes to these assumptions and methodologies. During 2021, 2020 and 2019, we issued RSUs with average restriction periods of three years, with a fair value of $3.31, $3.53 and $3.36, respectively, which were measured at the market price of a share of our Class A Common Stock on the grant date. During 2021, 2020 and 2019, we granted performance stock units (“PSUs”) with a weighted-average fair value of $3.45, $3.03 and $4.61, respectively. The PSUs were granted at market price as of the approval date by our Board of Directors. PSUs may be earned over a three-year period based upon the achievement of certain performance goals. The PSUs granted in 2021 have a three-year measurement period starting on January 1, 2021 going through December 31, 2023. The performance metric is based on Genworth’s consolidated adjusted operating income and its total shareholder return relative to certain of its peer companies as of the grant date. See note 18 for our definition of adjusted operating income. The grant-date fair value for the adjusted operating income performance measure was $3.31. The grant-date fair value for the total relative shareholder return performance metric was $4.18, which was calculated using the Monte Carlo simulation with the following valuation assumptions: Valuation assumptions: Valuation-date stock price $ 3.31 Volatility 65.0 % Dividend yield — % Risk-free rate 0.3 % Valuation maximum 800% of grant-date The PSUs granted in 2020 have a three-year measurement period starting on January 1, 2020 going through December 31, 2022. The performance metrics are based on adjusted operating income of our Enact segment and gross incremental annual premiums in our long-term care insurance business, defined as approved weighted-average premium rate increases multiplied by the annualized in-force The PSUs granted in 2019 have a three-year measurement period starting on January 1, 2019 going through December 31, 2021. The performance metric is based on consolidated adjusted operating income. For all PSU awards granted, the compensation committee of our Board of Directors determines and approves no later than March 15, following the end of the three-year performance period for each applicable performance period, the number of units earned and vested for each distinct performance period. For the years ended December 31, 2021, 2020 and 2019, we recorded $16 million, $18 million and $5 million, respectively, of expense associated with our PSUs. In 2021, 2020 and 2019, we granted cash awards with a fair value of $1.00. We have time-based cash awards, which vest over three years, with a third of the payout occurring per year as determined by the vesting period, beginning on the first anniversary of the grant date. We also previously granted performance-based cash awards which vested and were paid out in 2021. The following table summarizes cash award activity as of December 31, 2021 and 2020: (Number of awards, in millions) Time-based Performance-based Balance as of January 1, 2020 26 13 Granted 17 — Performance adjustment — 1 Vested (11 ) (5 ) Forfeited (2 ) (2 ) Balance as of January 1, 2021 30 7 Granted 15 — Performance adjustment — 6 Vested (15 ) (13 ) Forfeited (3 ) — Balance as of December 31, 2021 27 — The following table summarizes stock option activity as of December 31, 2021 and 2020: (Shares in thousands) Shares subject Weighted-average Balance as of January 1, 2020 801 $ 14.17 Granted — $ — Exercised — $ — Expired and forfeited (800 ) $ 14.17 Balance as of January 1, 2021 1 $ 12.75 Granted — $ — Exercised — $ — Expired and forfeited (1 ) $ 12.75 Balance as of December 31, 2021 — $ — Exercisable as of December 31, 2021 — $ — The following tables summarize the status of our other equity-based awards as of December 31, 2021 and 2020: RSUs PSUs DSUs SARs (Awards in thousands) Number Weighted- Number of Weighted- Number Weighted- Number Weighted- Balance as of January 1, 2020 2,675 $ 3.51 5,142 $ 4.28 1,515 $ 4.37 8,151 $ 3.41 Granted 1,683 $ 3.53 2,789 $ 3.03 237 $ 2.00 — $ — Performance adjustment (1) — $ — 443 $ 4.01 — $ — — $ — Exercised (1,336 ) $ 3.62 (1,994 ) $ 4.01 (215 ) $ 4.76 — $ — Terminated (488 ) $ 3.47 (646 ) $ 3.86 — $ — (1,121 ) $ 3.99 Balance as of January 1, 2021 2,534 $ 3.48 5,734 $ 3.79 1,537 $ 3.95 7,030 $ 3.32 Granted 1,391 $ 3.31 2,510 $ 3.45 315 $ 2.52 — $ — Performance adjustment (1) — $ — 626 $ 3.58 — $ — — $ — Exercised (1,474 ) $ 3.47 (1,365 ) $ 3.58 (15 ) $ 7.46 — $ — Terminated (134 ) $ 3.53 — $ — — $ — (835 ) $ 3.04 Balance as of December 31, 2021 2,317 $ 3.38 7,505 $ 3.70 1,837 $ 3.42 6,195 $ 3.36 (1) The performance adjustment relates to additional awards expected to be earned through the achievement of certain performance metrics. As of December 31, 2021 and 2020, total unrecognized stock-based compensation expense related to non-vested The actual tax benefit realized for the tax deductions from the exercise of share-based awards was $4 million for both the years ended December 31, 2021 and 2020. In connection with the minority IPO of Enact Holdings in September 2021, our indirect subsidiary, Enact Holdings granted equity-based awards to its employees, including RSUs and DSUs. Additionally, in 2021, the Enact Holdings, Inc. 2021 Omnibus Incentive Plan was adopted and approved by Enact Holdings’ shareholders. Under the Enact Holdings, Inc. 2021 Omnibus Incentive Plan, Enact Holdings is authorized to issue up to four million equity awards. The following table summarizes the status of Enact Holdings’ equity-based awards as of December 31, 2021: RSUs DSUs (Awards in thousands) Number Weighted- Number Weighted- Balance as of January 1, 2021 — $ — — $ — Granted 628 $ 19.02 17 $ 20.87 Dividend equivalents 36 $ 21.25 — $ — Vested — $ — — $ — Terminated (10 ) $ 19.00 — $ — Balance as of December 31, 2021 654 $ 19.02 17 $ 20.87 As of December 31, 2021, none of the RSUs were vested. For the year ended December 31, 2021, we recorded $2 million of stock-based compensation expense and estimate total unrecognized expense of $11 million related to these awards. This expense is expected to be recognized over a weighted-average period of approximately three years.

Fair Value of Financial Instrum

Fair Value of Financial Instruments	12 Months Ended
	Dec. 31, 2021
Fair Value of Financial Instruments	(16) Fair Value of Financial Instruments Recurring Fair Value Measurements We have fixed maturity securities, short-term investments, equity securities, limited partnerships, derivatives, embedded derivatives, securities held as collateral, separate account assets and certain other financial instruments, which are carried at fair value. Below is a description of the valuation techniques and inputs used to determine fair value by class of instrument. Fixed maturity, short-term investments and equity securities The fair value of fixed maturity securities, short-term investments and equity securities are estimated primarily based on information derived from third-party pricing services (“pricing services”), internal models and/or broker quotes, which use a market approach, income approach or a combination of the market and income approach depending on the type of instrument and availability of information. In general, a market approach is utilized if there is readily available and relevant market activity for an individual security. In certain cases where market information is not available for a specific security but is available for similar securities, that security is valued using market information for similar securities, which is also a market approach. When market information is not available for a specific security (or similar securities) or is available but such information is less relevant or reliable, an income approach or a combination of a market and income approach is utilized. For securities with optionality, such as call or prepayment features (including mortgage-backed or asset-backed securities), an income approach may be used. In addition, a combination of the results from market and income approaches may be used to estimate fair value. These valuation techniques may change from period to period, based on the relevance and availability of market data. Further, while we consider the valuations provided by pricing services and broker quotes to be of high quality, management determines the fair value of our investment securities after considering all relevant and available information. In general, we first obtain valuations from pricing services. If prices are unavailable for public securities, we obtain broker quotes. For all securities, excluding certain private fixed maturity securities, if neither a pricing service nor broker quotes valuation is available, we determine fair value using internal models. For certain private fixed maturity securities where we do not obtain valuations from pricing services, we utilize an internal model to determine fair value since transactions for similar securities are not readily observable and these securities are not typically valued by pricing services. Given our understanding of the pricing methodologies and procedures of pricing services, the securities valued by pricing services are typically classified as Level 2 unless we determine the valuation process for a security or group of securities utilizes significant unobservable inputs, which would result in the valuation being classified as Level 3. Broker quotes are typically based on an income approach given the lack of available market data. As the valuation typically includes significant unobservable inputs, we classify the securities where fair value is based on our consideration of broker quotes as Level 3 measurements. For private fixed maturity securities, we utilize an income approach where we obtain public bond spreads and utilize those in an internal model to determine fair value. Other inputs to the model include rating and weighted-average life, as well as sector which is used to assign the spread. We then add an additional premium, which represents an unobservable input, to the public bond spread to adjust for the liquidity and other features of our private placements. We utilize the estimated market yield to discount the expected cash flows of the security to determine fair value. We utilize price caps for securities where the estimated market yield results in a valuation that may exceed the amount that would be received in a market transaction. When a security does not have an external rating, we assign the security an internal rating to determine the appropriate public bond spread that should be utilized in the valuation. While we generally consider the public bond spreads by sector and maturity to be observable inputs, we evaluate the similarities of our private placement with the public bonds, any price caps utilized, liquidity premiums applied, and whether external ratings are available for our private placements to determine whether the spreads utilized would be considered observable inputs. We classify private securities without an external rating or public bond spread as Level 3. In general, a significant increase (decrease) in credit spreads would have resulted in a significant decrease (increase) in the fair value for our fixed maturity securities as of December 31, 2021. For remaining securities priced using internal models, we determine fair value using an income approach. We maximize the use of observable inputs but typically utilize significant unobservable inputs to determine fair value. Accordingly, the valuations are typically classified as Level 3. Our assessment of whether or not there were significant unobservable inputs related to fixed maturity securities was based on our observations obtained through the course of managing our investment portfolio, including interaction with other market participants, observations related to the availability and consistency of pricing and/or rating, and understanding of general market activity such as new issuance and the level of secondary market trading for a class of securities. Additionally, we considered data obtained from pricing services to determine whether our estimated values incorporate significant unobservable inputs that would result in the valuation being classified as Level 3. A summary of the inputs used for our fixed maturity securities, short-term investments and equity securities based on the level in which instruments are classified is included below. We have combined certain classes of instruments together as the nature of the inputs is similar. Level 1 measurements Equity securities. Separate account assets. Level 2 measurements Fixed maturity securities • Third-party pricing services: The following table presents a summary of the significant inputs used by our pricing services for certain fair value measurements of fixed maturity securities that are classified as Level 2 as of December 31, 2021: (Amounts in millions) Fair value Primary methodologies Significant inputs U.S. government, agencies and government-sponsored enterprises $ 4,552 Price quotes from trading desk, broker feeds Bid side prices, trade prices, Option Adjusted Spread (“OAS”) to swap curve, Bond Market Association OAS, Treasury Curve, Agency Bullet Curve, maturity to issuer spread State and political subdivisions $ 3,368 Multi-dimensional attribute-based modeling systems, third-party pricing vendors Trade prices, material event notices, Municipal Market Data benchmark yields, broker quotes Non-U.S. $ 833 Matrix pricing, spread priced to benchmark curves, price quotes from market makers Benchmark yields, trade prices, broker quotes, comparative transactions, issuer spreads, bid-offer spread, market research publications, third-party pricing sources U.S. corporate $ 30,774 Multi-dimensional attribute-based modeling systems, broker quotes, price quotes from market makers, OAS-based models Bid side prices to Treasury Curve, Issuer Curve, which includes sector, quality, duration, OAS percentage and change for spread matrix, trade prices, comparative transactions, Trade Reporting and Compliance Engine (“TRACE”) reports Non-U.S. $ 8,322 Multi-dimensional attribute-based modeling systems, OAS-based models, price quotes from market makers Benchmark yields, trade prices, broker quotes, comparative transactions, issuer spreads, bid-offer spread, market research publications, third-party pricing sources Residential mortgage-backed $ 1,413 OAS-based models, single factor binomial models, internally priced Prepayment and default assumptions, aggregation of bonds with similar characteristics, including collateral type, vintage, tranche type, weighted-average life, weighted-average loan age, issuer program and delinquency ratio, pay up and pay down factors, TRACE reports Commercial mortgage-backed $ 2,568 Multi-dimensional attribute-based modeling systems, pricing matrix, spread matrix priced to swap curves, Trepp commercial mortgage-backed securities analytics model Credit risk, interest rate risk, prepayment speeds, new issue data, collateral performance, origination year, tranche type, original credit ratings, weighted-average life, cash flows, spreads derived from broker quotes, bid side prices, spreads to daily updated swap curves, TRACE reports Other asset-backed $ 2,022 Multi-dimensional attribute-based modeling systems, spread matrix priced to swap curves, price quotes from market makers Spreads to daily updated swap curves, spreads derived from trade prices and broker quotes, bid side prices, new issue data, collateral performance, analysis of prepayment speeds, cash flows, collateral loss analytics, historical issue analysis, trade data from market makers, TRACE reports • Internal models: non-U.S. Equity securities. Securities lending collateral The fair value of securities held as collateral is primarily based on Level 2 inputs from market information for the collateral that is held on our behalf by the custodian. We determine fair value after considering prices obtained by pricing services. Short-term investments The fair value of short-term investments classified as Level 2 is determined after considering prices obtained by pricing services. Level 3 measurements Fixed maturity securities • Broker quotes: non-U.S. non-U.S. • Internal models: non-U.S. Equity securities. Net asset value Limited partnerships Limited partnerships are valued based on comparable market transactions, discounted future cash flows, quoted market prices and/or estimates using the most recent data available for the underlying instrument. We utilize the NAV from the underlying fund statements as a practical expedient for fair value. Derivatives We consider counterparty collateral arrangements and rights of set-off non-performance non-performance non-performance Interest rate swaps. The valuation of interest rate swaps is determined using an income approach. The primary input into the valuation represents the forward interest rate swap curve, which is generally considered an observable input, and results in the derivative being classified as Level . For certain interest rate swaps, the inputs into the valuation also include the total returns of certain bonds that would primarily be considered an observable input and result in the derivative being classified as Level . Foreign currency swaps. Equity index options. Financial futures. Other foreign currency contracts. forward interest rate, foreign currency exchange rate volatility and time value component associated with the optionality in the derivative, which are generally considered observable inputs and results in the derivative being classified as Level 2. We also have foreign currency forward contracts where the valuation is determined using an income approach. The primary inputs into the valuation represent the forward foreign currency exchange rates, which are generally considered observable inputs and results in the derivative being classified as Level 2. GMWB embedded derivatives We are required to bifurcate an embedded derivative for certain features associated with annuity products and related reinsurance agreements where we provide a GMWB to the policyholder and are required to record the GMWB embedded derivative at fair value. The valuation of our GMWB embedded derivative is based on an income approach that incorporates inputs such as forward interest rates, equity index volatility, equity index and fund correlation, and policyholder assumptions such as utilization, lapse and mortality. We determine fair value using an internal model based on the various inputs noted above. Non-performance non-performance non-performance We classify the GMWB valuation as Level 3 based on having significant unobservable inputs, with equity index volatility and non-performance index volatility increases, the fair value of the GMWB liabilities will increase. Any increase in non-performance risk would increase the discount rate and would decrease the fair value of the GMWB liability. Additionally, we consider lapse and utilization assumptions to be significant unobservable inputs. An increase in our lapse assumption would decrease the fair value of the GMWB liability, whereas an increase in our utilization rate would increase the fair value. As of December 31, 2021, a significant change in the unobservable inputs discussed above would have resulted in a significantly lower or higher fair value measurement. Fixed index annuity embedded derivatives We have fixed indexed annuity products where interest is credited to the policyholder’s account balance based on equity index changes. This feature is required to be bifurcated as an embedded derivative and recorded at fair value. Fair value is determined using an income approach where the present value of the excess cash flows above the guaranteed cash flows is used to determine the value attributed to the equity index feature. The inputs used in determining the fair value include policyholder behavior (lapses and withdrawals), near-term equity index volatility, expected future interest credited, forward interest rates and an adjustment to the discount rate to incorporate non-performance Indexed universal life embedded derivatives We have indexed universal life insurance products where interest is credited to the policyholder’s account balance based on equity index changes. This feature is required to be bifurcated as an embedded derivative and recorded at fair value. Fair value is determined using an income approach where the present value of the excess cash flows above the guaranteed cash flows is used to determine the value attributed to the equity index feature. The inputs used in determining the fair value include policyholder behavior (lapses and withdrawals), near-term equity index volatility, expected future interest credited, forward interest rates and an adjustment to the discount rate to incorporate non-performance The following tables set forth our assets by class of instrument that are measured at fair value on a recurring basis as of December 31: 2021 (Amounts in millions) Total Level 1 Level 2 Level 3 NAV (1) Assets Investments: Fixed maturity securities: U.S. government, agencies and government-sponsored enterprises $ 4,552 $ — $ 4,552 $ — $ — State and political subdivisions 3,450 — 3,368 82 — Non-U.S. 835 — 833 2 — U.S. corporate: Utilities 5,104 — 4,154 950 — Energy 2,934 — 2,858 76 — Finance and insurance 8,991 — 8,306 685 — Consumer—non-cyclical 6,159 — 6,055 104 — Technology and communications 3,808 — 3,779 29 — Industrial 1,494 — 1,457 37 — Capital goods 2,745 — 2,700 45 — Consumer—cyclical 1,899 — 1,762 137 — Transportation 1,371 — 1,307 64 — Other 419 — 165 254 — Total U.S. corporate 34,924 — 32,543 2,381 — Non-U.S. Utilities 928 — 583 345 — Energy 1,383 — 1,238 145 — Finance and insurance 2,432 — 2,272 160 — Consumer—non-cyclical 743 — 680 63 — Technology and communications 1,250 — 1,222 28 — Industrial 1,047 — 954 93 — Capital goods 705 — 532 173 — Consumer—cyclical 341 — 265 76 — Transportation 489 — 436 53 — Other 1,217 — 1,191 26 — Total non-U.S. 10,535 — 9,373 1,162 — Residential mortgage-backed 1,440 — 1,413 27 — Commercial mortgage-backed 2,584 — 2,568 16 — Other asset-backed 2,160 — 2,022 138 — Total fixed maturity securities 60,480 — 56,672 3,808 — Equity securities 198 101 60 37 — Limited partnerships 1,462 — — — 1,462 Other invested assets: Derivative assets: Interest rate swaps 364 — 364 — — Foreign currency swaps 6 — 6 — — Equity index options 42 — — 42 — Other foreign currency contracts 2 — 2 — — Total derivative assets 414 — 372 42 — Short-term investments 26 — 26 — — Total other invested assets 440 — 398 42 — Reinsurance recoverable (2) 19 — — 19 — Separate account assets 6,066 6,066 — — — Total assets $ 68,665 $ 6,167 $ 57,130 $ 3,906 $ 1,462 (1) Limited partnerships that are measured at fair value using the NAV per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy. (2) Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities. 2020 (Amounts in millions) Total Level 1 Level 2 Level 3 NAV (1) Assets Investments: Fixed maturity securities: U.S. government, agencies and government-sponsored enterprises $ 4,805 $ — $ 4,805 $ — $ — State and political subdivisions 3,165 — 3,099 66 — Non-U.S. 854 — 854 — — U.S. corporate: Utilities 5,194 — 4,352 842 — Energy 2,883 — 2,755 128 — Finance and insurance 9,102 — 8,495 607 — Consumer—non-cyclical 6,437 — 6,328 109 — Technology and communications 3,761 — 3,714 47 — Industrial 1,602 — 1,562 40 — Capital goods 2,991 — 2,931 60 — Consumer—cyclical 1,947 — 1,797 150 — Transportation 1,500 — 1,430 70 — Other 440 — 221 219 — Total U.S. corporate 35,857 — 33,585 2,272 — Non-U.S. Utilities 922 — 570 352 — Energy 1,380 — 1,135 245 — Finance and insurance 2,476 — 2,171 305 — Consumer—non-cyclical 773 — 706 67 — Technology and communications 1,291 — 1,263 28 — Industrial 1,128 — 1,033 95 — Capital goods 576 — 398 178 — Consumer—cyclical 371 — 225 146 — Transportation 570 — 461 109 — Other 1,324 — 1,241 83 — Total non-U.S. 10,811 — 9,203 1,608 — Residential mortgage-backed 1,909 — 1,895 14 — Commercial mortgage-backed 2,974 — 2,954 20 — Other asset-backed 3,120 — 3,011 109 — Total fixed maturity securities 63,495 — 59,406 4,089 — Equity securities 386 276 59 51 — Limited partnerships 835 — — — 835 Other invested assets: Derivative assets: Interest rate swaps 468 — 468 — — Foreign currency swaps 1 — 1 — — Equity index options 63 — — 63 — Other foreign currency contracts 42 — 42 — — Total derivative assets 574 — 511 63 — Securities lending collateral 67 — 67 — — Short-term investments 45 25 20 — — Total other invested assets 686 25 598 63 — Reinsurance recoverable (2) 26 — — 26 — Separate account assets 6,081 6,081 — — — Total assets $ 71,509 $ 6,382 $ 60,063 $ 4,229 $ 835 (1) Limited partnerships that are measured at fair value using the NAV per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy. (2) Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities. The following tables present additional information about assets measured at fair value on a recurring basis and for which we have utilized significant unobservable (Level 3) inputs to determine fair value as of or for the dates indicated: Beginning as of Total realized and Purchases Sales Issuances Settlements Transfer (1) Transfer (1) Ending as of Total gains (Amounts in millions) Included Included Included Included Fixed maturity securities: State and political subdivisions $ 66 $ 3 $ 13 $ — $ — $ — $ — $ — $ — $ 82 $ 3 $ 13 Non-U.S. — — — 2 — — — — — 2 — — U.S. corporate: Utilities 842 — 3 118 — — (18 ) 18 (13 ) 950 — 4 Energy 128 — 4 50 — — (10 ) 8 (104 ) 76 — 1 Finance and insurance 607 — (18 ) 233 — — (46 ) 17 (108 ) 685 — (16 ) Consumer—non-cyclical 109 — (2 ) — — — (3 ) 3 (3 ) 104 — (2 ) Technology and communications 47 — (1 ) 12 — — — 4 (33 ) 29 — (1 ) Industrial 40 — — 17 — — (20 ) — — 37 — (1 ) Capital goods 60 — (1 ) — — — (14 ) — — 45 — (2 ) Consumer—cyclical 150 — — — — — (5 ) — (8 ) 137 — — Transportation 70 — (1 ) — — — (5 ) — — 64 — (1 ) Other 219 — (1 ) — — — (32 ) 88 (20 ) 254 — 1 Total U.S. corporate 2,272 — (17 ) 430 — — (153 ) 138 (289 ) 2,381 — (17 ) Non-U.S. Utilities 352 — (5 ) 30 — — (8 ) — (24 ) 345 — (6 ) Energy 245 — 7 — — — (28 ) — (79 ) 145 — 3 Finance and insurance 305 3 (1 ) 1 (2 ) — (62 ) — (84 ) 160 5 (14 ) Consumer—non-cyclical 67 1 (2 ) 8 — — (14 ) 3 — 63 — (2 ) Technology and communications 28 — — — — — — — — 28 — (1 ) Industrial 95 2 (4 ) 14 — — (14 ) — — 93 — (2 ) Capital goods 178 — 1 25 — — — — (31 ) 173 — — Consumer—cyclical 146 — — 17 — — — — (87 ) 76 — — Transportation 109 3 (3 ) — — — (49 ) — (7 ) 53 — — Other 83 6 (3 ) — — — (45 ) — (15 ) 26 — (1 ) Total non-U.S. 1,608 15 (10 ) 95 (2 ) — (220 ) 3 (327 ) 1,162 5 (23 ) Residential mortgage-backed 14 — — 5 — — (2 ) 10 — 27 — — Commercial mortgage-backed 20 — (2 ) 1 — — (3 ) — — 16 1 (2 ) Other asset-backed 109 — — 69 — — (25 ) 35 (50 ) 138 — — Total fixed maturity securities 4,089 18 (16 ) 602 (2 ) — (403 ) 186 (666 ) 3,808 9 (29 ) Equity securities 51 — — — (9 ) — (5 ) — — 37 — — Other invested assets: Derivative assets: Equity index options 63 18 — 31 — — (70 ) — — 42 10 — Total derivative assets 63 18 — 31 — — (70 ) — — 42 10 — Total other invested assets 63 18 — 31 — — (70 ) — — 42 10 — Reinsurance recoverable (2) 26 (9 ) — — — 2 — — — 19 (9 ) — Total Level 3 assets $ 4,229 $ 27 $ (16 ) $ 633 $ (11 ) $ 2 $ (478 ) $ 186 $ (666 ) $ 3,906 $ 10 $ (29 ) (1) The transfers into and out of Level 3 for fixed maturity securities were related to changes in the primary pricing source and changes in the observability of external information used in determining the fair value, such as external ratings or credit spreads, as well as changes in the industry sectors assigned to specific securities. (2) Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities. Beginning as of Total realized and Purchases Sales Issuances Settlements Transfer (1) Transfer (1) Ending as of Total gains (Amounts in millions) Included Included Included Included Fixed maturity securities: State and political subdivisions $ 102 $ 3 $ (11 ) $ — $ — $ — $ (1 ) $ — $ (27 ) $ 66 $ 3 $ (11 ) Non-U.S. — — — — — — (1 ) 1 — — — — U.S. corporate: Utilities 865 9 8 76 (13 ) — (56 ) 42 (89 ) 842 — 14 Energy 129 1 1 30 (21 ) — (21 ) 22 (13 ) 128 — (3 ) Finance and insurance 572 2 16 167 — — (41 ) — (109 ) 607 — 19 Consumer—non-cyclical 94 — 4 8 — — (22 ) 25 — 109 — 4 Technology and communications 50 — 3 82 — — (1 ) 13 (100 ) 47 — 5 Industrial 40 — — — — — — — — 40 — — Capital goods 102 — — — — — (8 ) 11 (45 ) 60 — 1 Consumer—cyclical 173 3 4 15 — — (36 ) 47 (56 ) 150 — 6 Transportation 78 — (1 ) — — — (4 ) 27 (30 ) 70 — 2 Other 136 — 2 25 — — (7 ) 87 (24 ) 219 — 2 Total U.S. corporate 2,239 15 37 403 (34 ) — (196 ) 274 (466 ) 2,272 — 50 Non-U.S. Utilities 374 — 10 13 — — — 28 (73 ) 352 — 9 Energy 247 — (5 ) 7 — — (28 ) 24 — 245 — (5 ) Finance and insurance 234 4 17 15 — — (10 ) 77 (32 ) 305 4 17 Consumer—non-cyclical 59 — 3 20 — — — 1 (16 ) 67 — 2 Technology and communications 28 — — — — — — — — 28 — 1 Industrial 104 — 4 — — — (5 ) — (8 ) 95 — 3 Capital goods 161 1 1 20 — — (39 ) 34 — 178 — 1 Consumer—cyclical 147 — 3 21 — — (26 ) 32 (31 ) 146 — 2 Transportation 191 — 1 7 — — (10 ) 22 (102 ) 109 — 4 Other 140 9 (1 ) 6 — — (72 ) 1 — 83 — 2 Total non-U.S. 1,685 14 33 109 — — (190 ) 219 (262 ) 1,608 4 36 Residential mortgage-backed 27 — (1 ) — — — (1 ) 4 (15 ) 14 — — Commercial mortgage-backed 6 — 1 — — — — 20 (7 ) 20 — 1 Other asset-backed 93 — 1 124 — — (16 ) 10 (103 ) 109 — — Total fixed maturity securities 4,152 32 60 636 (34 ) — (405 ) 528 (880 ) 4,089 7 76 Equity securities 51 — — 6 (7 ) — — 1 — 51 — — Other invested assets: Derivative assets: Equity index options 81 4 — 59 — — (81 ) — — 63 5 — Total derivative assets 81 4 — 59 — — (81 ) — — 63 5 — Total other invested assets 81 4 — 59 — — (81 ) — — 63 5 — Reinsurance recoverable (2) 20 4 — — — 2 — — — 26 4 — Total Level 3 assets $ 4,304 $ 40 $ 60 $ 701 $ (41 ) $ 2 $ (486 ) $ 529 $ (880 ) $ 4,229 $ 16 $ 76 (1) The transfers into and out of Level 3 for fixed maturity securities were related to changes in the primary pricing source and changes in the observability of external information used in determining the fair value, such as external ratings or credit spreads, as well as changes in the industry sectors assigned to specific securities. (2) Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities. Beginning as of Total realized and Purchases Sales Issuances Settlements Transfer (1) Transfer (1) Ending as of Total gains attributable (Amounts in millions) Included Included Fixed maturity securities: State and political subdivisions $ 51 $ 3 $ 20 $ — $ — $ — $ — $ 28 $ — $ 102 $ 3 U.S. corporate: Utilities 643 1 72 156 (14 ) — (49 ) 72 (16 ) 865 — Energy 121 — 9 17 (5 ) — (13 ) — — 129 — Finance and insurance 534 — 51 50 — — (39 ) 35 (59 ) 572 — Consumer—non-cyclical 73 — 5 23 (5 ) — (11 ) 9 — 94 — Technology and communications 50 — 7 — — — (1 ) 5 (11 ) 50 — Industrial 39 — 1 — — — — — — 40 — Capital goods 92 — 10 — — — — — — 102 — Consumer—cyclical 211 — 11 — (13 ) — (18 ) — (18 ) 173 (1 ) Transportation 57 — 3 39 — — (10 ) — (11 ) 78 — Other 178 — 6 23 — — (20 ) 8 (59 ) 136 — Total U.S. corporate 1,998 1 175 308 (37 ) — (161 ) 129 (174 ) 2,239 (1 ) Non-U.S. Utilities 404 — 30 30 (7 ) — (67 ) — (16 ) 374 — Energy 217 (1 ) 19 46 (18 ) — (16 ) — — 247 — Finance and insurance 171 4 23 7 — — (16 ) 54 (9 ) 234 4 Consumer—non-cyclical 106 2 5 1 — — (55 ) — — 59 — Technology and communications 26 — 2 — — — — — — 28 — Industrial 61 — 5 38 — — — — — 104 — Capital goods 173 — 12 10 — — (16 ) 3 (21 ) 161 — Consumer—cyclical 122 — 12 16 — — (3 ) — — 147 — Transportation 171 — 10 27 — — — — (17 ) 191 — Other 81 — 12 43 — — (2 ) 6 — 140 — Total non-U.S. 1,532 5 130 218 (25 ) — (175 ) 63 (63 ) 1,685 4 Residential mortgage-backed 35 — 1 — (2 ) — (1 ) — (6 ) 27 — Commercial mortgage-backed 95 — 17 3 — — — 1 (110 ) 6 — Other asset-backed 81 — 3 122 — — (18 ) 28 (123 ) 93 — Total fixed maturity securities 3,792 9 346 651 (64 ) — (355 ) 249 (476 ) 4,152 6 Equity securities 58 — — 2 (9 ) — — — — 51 — Other invested assets: Derivative assets: Equity index options 39 43 — 63 — — (64 ) — — 81 18 Total derivative assets 39 43 — 63 — — (64 ) — — 81 18 Total other invested assets 39 43 — 63 — — (64 ) — — 81 18 Reinsurance recoverable (2) 20 (1 ) — — — 1 — — — 20 (1 ) Total Level 3 assets $ 3,909 $ 51 $ 346 $ 716 $ (73 ) $ 1 $ (419 ) $ 249 $ (476 ) $ 4,304 $ 23 (1) The transfers into and out of Level 3 for fixed maturity securities were related to changes in the primary pricing source and changes in the observability of external information used in determining the fair value, such as external ratings or credit spreads, as well as changes in the industry sectors assigned to specific securities. (2) Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities. The following table presents the gains and losses included in net income from assets measured at fair value on a recurring basis and for which we have utilized significant unobservable (Level 3) inputs to determine fair value and the related income statement line item in which these gains and losses were presented for the years ended December 31: (Amounts in millions) 2021 2020 2019 Total realized and unrealized gains (losses) included in net income: Net investment income $ 19 $ 32 $ 10 Net investment gains (losses) 8 8 41 Total $ 27 $ 40 $ 51 Total gains (losses) included in net income attributable to assets still held: Net investment income $ 9 $ 7 $ 6 Net investment gains (losses) 1 9 17 Total $ 10 $ 16 $ 23 The amount presented for realized and unrealized gains (losses) included in net income for fixed maturity securities primarily represents amortization and accretion of premiums and discounts on certain fixed maturity securities. The following table presents a summary of the significant unobservable inputs used for certain asset fair value measurements that are based on internal models and classified as Level 3 as of December 31, 2021: (Amounts in millions) Valuation Fair value Unobservable input Range Weighted- (1) Fixed maturity securities: U.S. corporate: Utilities Internal models $ 916 Credit spreads 59bps - 202bps 138bps Energy Internal models 61 Credit spreads 95bps - 217bps 149bps Finance and insurance Internal models 679 Credit spreads 50bps - 184bps 131bps Consumer—non-cyclical Internal models 104 Credit spreads 55bps - 217bps 121bps Technology and communications Internal models 29 Credit spreads 80bps - 158bps 131bps Industrial Internal models 37 Credit spreads 91bps - 171bps 123bps Capital goods Internal models 45 Credit spreads 67bps - 175bps 133bps Consumer—cyclical Internal models 137 Credit spreads 87bps - 165bps 125bps Transportation Internal models 53 Credit spreads 47bps - 139bps 91bps Other Internal models 166 Credit spreads 78bps - 163bps 95bps Total U.S. corporate Internal models $ 2,227 Credit spreads 47bps - 217bps 130bps Non-U.S. Utilities Internal models $ 344 Credit spreads 70bps - 202bps 118bps Energy Internal models 135 Credit spreads 76bps - 171bps 120bps Finance and insurance Internal models 160 Credit spreads 71bps - 128bps 98bps Consumer—non-cyclical Internal models 61 Credit spreads 55bps - 140bps 94bps Technology and communications Internal models 28 Credit spreads 95bps - 114bps 108bps Industrial Internal models 93 Credit spreads 67bps - 161bps 113bps Capital goods Internal models 173 Credit spreads 55bps - 202bps 115bps Consumer—cyclical Internal models 61 Credit spreads 91bps - 171bps 121bps Transportation Internal models 53 Credit spreads 55bps - 171bps 84bps Other Internal models 26 Credit spreads 64bps - 120bps 102bps Total non-U.S. Internal models $ 1,134 Credit spreads 55bps - 202bps 111bps Derivative assets: Discounted cash Equity index Equity index options flows $ 42 volatility 6% - 50% 25 % (1) Unobservable inputs weighted by the relative fair value of the associated instrument for fixed maturity securities and by notional for derivative assets. Certain classes of instruments classified as Level 3 are excluded above as a result of not being material or due to limitations in being able to obtain the underlying inputs used by certain third-party sources, such as broker quotes, used as an input in determining fair value. The following tables set forth our liabilities by class of instrument that are measured at fair value on a recurring basis as of December 31: 2021 (Amounts in millions) Total Level 1 Level 2 Level 3 Liabilities Policyholder account balances: GMWB embedded derivatives (1) $ 271 $ — $ — $ 271 Fixed index annuity embedded derivatives 294 — — 294 Indexed universal life embedded derivatives 25 — — 25 Total policyholder account balances 590 — — 590 Derivative liabilities: Interest rate swaps 26 — 26 — Total derivative liabilities 26 — 26 — Total liabilities $ 616 $ — $ 26 $ 590 (1) Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. 2020 (Amounts in millions) Total Level 1 Level 2 Level 3 Liabilities Policyholder account balances: GMWB embedded derivatives (1) $ 379 $ — $ — $ 379 Fixed index annuity embedded derivatives 399 — — 399 Indexed universal life embedded derivatives 26 — — 26 Total policyholder account balances 804 — — 804 Derivative liabilities: Interest rate swaps 23 — 23 — Foreign currency swaps 2 — 2 — Other foreign currency contracts 1 — 1 — Total derivative liabilities 26 — 26 — Total liabilities $ 830 $ — $ 26 $ 804 (1) Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. The following tables present additional information about liabilities measured at fair value on a recurring basis and for which we have utilized significant unobservable (Level 3) inputs to determine fair value as of or for the dates indicated: Beginning as of Total realized and Ending as of Total (gains) (Amounts in millions) Included Included Purchases Sales Issuances Settlements Transfer Transfer Included Included Policyholder account balances: GMWB embedded derivatives (1) $ 379 $ (133 ) $ — $ — $ — $ 25 $ — $ — $ — $ 271 $ (127 ) $ — Fixed index annuity embedded derivatives 399 32 — — — — (136 ) — (1 ) 294 32 — Indexed universal life embedded derivatives 26 (24 ) — — — 23 — — — 25 (24 ) — Total policyholder account balances 804 (125 ) — — — 48 (136 ) — (1 ) 590 (119 ) — Total Level 3 liabilities $ 804 $ (125 ) $ — $ — $ — $ 48 $ (136 ) $ — $ (1 ) $ 590 $ (119 ) $ — (1) Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. Beginning as of Total realized and Ending as of Total (gains) (Amounts in m

Insurance Subsidiary Financial

Insurance Subsidiary Financial Information and Regulatory Matters	12 Months Ended
	Dec. 31, 2021
Insurance Subsidiary Financial Information and Regulatory Matters	(17) Insurance Subsidiary Financial Information and Regulatory Matters Dividends Our insurance subsidiaries are subject to oversight by applicable insurance laws and regulations as to the amount of dividends they may pay to their parent in any year, the purpose of which is to protect affected insurance policyholders or contractholders, not stockholders. In general, dividends in excess of prescribed limits are deemed “extraordinary” and require insurance regulatory approval. Based on estimated statutory results as of December 31, 2021, in accordance with applicable dividend restrictions, Enact Holdings could pay ordinary dividends of approximately million in 2022. Although the financial results of our U.S. life insurance subsidiaries have improved, they currently have negative unassigned surplus of approximately $1.0 billion under statutory accounting and as a result, could not pay dividends to us in 2022. Even though the approximately $70 million is considered unrestricted, Enact Holdings may not pay dividends at this level during 2022 for a variety of reasons, including the need to preserve capital for regulatory purposes, future growth and capital requirements. Enact Holdings paid dividends during 2021, 2020 and 2019 (none of which were deemed “extraordinary”), of $200 million ($37 million of which was distributed to minority shareholders), $437 million and $250 million, respectively. Dividends paid by Enact Holdings in 2021 included a cash dividend to Genworth Holdings of $163 million and a proportionate dividend distribution to minority shareholders. Dividends paid by Enact Holdings in 2020 were from net proceeds received from the issuance of its 2025 Senior Notes. In the first quarter of 2021, our international subsidiaries paid a dividend of $370 million to Genworth Holdings from the net proceeds of the Genworth Australia sale. Future dividends received by Genworth are highly dependent on the performance of Enact Holdings and its ability to pay dividends to us as anticipated. U.S. domiciled insurance subsidiaries—statutory financial information Our U.S. domiciled insurance subsidiaries file financial statements with state insurance regulatory authorities and the NAIC that are prepared on an accounting basis either prescribed or permitted by such authorities. Statutory accounting practices differ from U.S. GAAP in several respects, causing differences in reported net income (loss) and stockholders’ equity. Permitted statutory accounting practices encompass all accounting practices not so prescribed but that have been specifically allowed by individual state insurance authorities. Our U.S. domiciled insurance subsidiaries have no material permitted accounting practices, except for River Lake Insurance Company VI (“River Lake VI”), River Lake Insurance Company VII (“River Lake VII”), River Lake Insurance Company VIII (“River Lake VIII”) and River Lake Insurance Company X (“River Lake X”), collectively, • In 2021 and 2020, River Lake VI had a permitted accounting practice from the State of Delaware to carry its excess of loss reinsurance agreement with The Canada Life Assurance Company for its universal life insurance business assumed from Genworth Life and Annuity Insurance Company (“GLAIC”) as an admitted asset. Effective December 1, 2021, River Lake VI was granted a permitted accounting practice from the State of Delaware to carry its excess of loss reinsurance agreement with The Canada Life Assurance Company for its term life insurance business assumed from GLAIC as an admitted asset. In 2020, River Lake VI had a permitted accounting practice from the State of Delaware to carry its term life insurance reserves on a basis similar to U.S. GAAP, including an extension of this permitted accounting practice to include additional term life insurance policies assumed from GLAIC since 2019, which was withdrawn in 2021. • Effective December 1, 2021, River Lake X was granted a permitted accounting practice from the State of Vermont to carry its excess of loss reinsurance agreement with Hannover Life Reassurance Company of America for its term life insurance business assumed from GLAIC as an admitted asset. In 2020, River Lake VII, River Lake VIII and River Lake X each had a permitted accounting practice from the State of Vermont to carry their reserves on a basis similar to U.S. GAAP, which was withdrawn by River Lake X in 2021. As of December 31, 2021, there were no remaining statutory reserves in River Lake VII and River Lake VIII as discussed below. In 2020, Genworth Life Insurance Company of New York (“GLICNY”) and GLAIC also had the following permitted practices: • GLICNY was granted a permitted accounting practice from the New York State Department of Financial Services (“NYDFS”) whereby GLICNY is exempt from the requirements of principle-based reserves (“PBR”) as prescribed in the NAIC Valuation Manual under New York Regulation. The permitted practice is limited to term life insurance conversion policies issued in 2020 where existing policyholders exercised their contract options prior to the enactment of PBR requirements. • GLAIC was granted a permitted accounting practice from the Commonwealth of Virginia State Corporation Commission Bureau of Insurance whereby GLAIC is exempt from the requirements of PBR as prescribed in the NAIC Valuation Manual. The permitted practice is limited to ordinary life insurance business issued in 2020 on revised contracts where existing policyholders exercised their contract options prior to the enactment of PBR requirements. The impact of these permitted accounting practices of the SPFCs on our combined U.S. domiciled life insurance subsidiaries’ statutory capital and surplus was zero as of December 31, 2021 and 2020. The impact of these permitted accounting practices of GLICNY and GLAIC on our combined U.S. domiciled life insurance subsidiaries’ statutory capital and surplus was not significant as of December 31, 2020. If these permitted accounting practices had not been used, no regulatory event would have been triggered. For regulatory purposes, our U.S. mortgage insurers are required to establish a special statutory contingency reserve. Annual additions to the statutory contingency reserve must be at least 50% of net earned premiums, as defined by state insurance laws and regulations. These contingency reserves generally are held until the earlier of (i) the time that loss ratios exceed 35% or (ii) 10 years. However, approval by the North Carolina Department of Insurance (“NCDOI”) is required for contingency reserve releases when loss ratios exceed 35%. The statutory contingency reserve for our U.S. mortgage insurers was approximately $3.0 billion and $2.5 billion, respectively, as of December 31, 2021 and 2020 and is included in the table below containing combined statutory capital and surplus balances. The tables below include the combined statutory net income and statutory capital and surplus for our U.S. domiciled insurance subsidiaries for the periods indicated: Years ended December 31, (Amounts in millions) 2021 2020 2019 Combined statutory net income (loss): Life insurance subsidiaries, excluding captive life reinsurance subsidiaries $ 654 $ 197 $ 740 Mortgage insurance subsidiaries 593 404 847 Combined statutory net income, excluding captive reinsurance subsidiaries 1,247 601 1,587 Captive life insurance subsidiaries (1,351 ) 9 (350 ) Combined statutory net income (loss) $ (104 ) $ 610 $ 1,237 As of December 31, (Amounts in millions) 2021 2020 Combined statutory capital and surplus: Life insurance subsidiaries, excluding captive life reinsurance subsidiaries $ 2,945 $ 2,131 Mortgage insurance subsidiaries 4,439 4,073 Combined statutory capital and surplus $ 7,384 $ 6,204 The statutory net income (loss) from our captive life reinsurance subsidiaries relates to the reinsurance of term and universal life insurance statutory reserves assumed from our U.S. domiciled life insurance companies. These reserves are, in turn, secured by excess of loss reinsurance treaties with third parties. Additionally, the life insurance subsidiaries’ combined statutory net income (loss) and distributable income are not affected by the statutory net income (loss) of the captives, except to the extent dividends are received from the captives. The combined statutory capital and surplus of our life insurance subsidiaries does not include the capital and surplus of our captive life reinsurance subsidiaries of $98 million and $106 million as of December 31, 2021 and 2020, respectively. In December 2021, GLAIC recaptured its term life insurance business previously ceded to River Lake VII and River Lake VIII. GLAIC then immediately ceded that recaptured business to SCOR Global Life USA Reinsurance Company. Prior to the GLAIC recapture, River Lake VII and River Lake VIII also recaptured all external reinsurance with third parties and terminated those agreements. As a result, there was no remaining reinsurance (assumed or ceded) in River Lake VII or River Lake VIII. River Lake VII and River Lake VIII also returned capital of $29 million and $37 million, respectively, to GLAIC in December 2021. Effective July 1, 2021, GLAIC recaptured all of the term and universal life insurance business previously ceded to Jamestown Life Insurance Company (“JLIC”), its wholly-owned subsidiary. Additionally, JLIC novated all of its remaining ceded reinsurance agreements to GLAIC. During 2021, JLIC returned $104 million of capital to GLAIC. There was no remaining reinsurance (assumed or ceded) in JLIC as of December 31, 2021. Effective October 14, 2021, Jamestown also withdrew its insurance company license. In December 2019, GLAIC recaptured its term life insurance business previously ceded to River Lake Insurance Company IX (“River Lake IX”) and its universal life insurance business previously ceded to Rivermont I. GLAIC then immediately ceded that recaptured business to River Lake VI. Prior to the GLAIC recapture, River Lake IX also recaptured all external reinsurance with third parties and terminated those agreements. As a result, there was no remaining reinsurance (assumed or ceded) in River Lake IX or Rivermont I. River Lake IX also returned capital of $20 million to GLAIC in December 2019. In 2020, River Lake IX was dissolved and is no longer included as a SPFC. Additionally, in January 2020, Rivermont I redeemed all of its outstanding non-recourse Capital Requirements of U.S. Life Insurers The NAIC has adopted RBC requirements to evaluate the adequacy of statutory capital and surplus in relation to risks associated with: (i) asset risk; (ii) insurance risk; (iii) interest rate and equity market risk; and (iv) business risk. The RBC formula is designated as an early warning tool for the states to identify possible undercapitalized companies for the purpose of initiating regulatory action. In the course of operations, we periodically monitor the RBC level of each of our life insurance subsidiaries. As of December 31, 2021 and 2020, each of our life insurance subsidiaries exceeded the minimum required RBC levels in their respective domiciliary state. The consolidated RBC ratio of our U.S. domiciled life insurance subsidiaries was approximately 289% and 229% as of December 31, 2021 and 2020, respectively. During 2021, 2020 and 2019, we established $231 million, $232 million and $54 million, respectively, of additional statutory reserves resulting from updates to our universal and term universal life insurance products with secondary guarantees in our Virginia and Delaware licensed life insurance subsidiaries. As a part of our cash flow testing process for our life insurance subsidiaries, we consider incremental benefits from expected future in-force mitigate the impact of deteriorating experience. The NYDFS, which regulates GLICNY, generally does not permit in-force in-force We have been monitoring emerging experience with our GLICNY policyholders, as their experience has been adverse as compared to our nationwide experience. With the benefit of additional data and analysis, and based on discussions with the NYDFS, we are using assumptions that reflect GLICNY specific experience in GLICNY’s asset adequacy analysis in 2021 and 2020. After discussions with the NYDFS and through the exercise of professional actuarial judgment, GLICNY also incorporated in its 2021 and 2020 asset adequacy analysis assumptions for future in-force rate actions for long-term care insurance products to offset the emerging adverse experience for these products. With these assumption updates, GLICNY’s 2021 and 2020 asset adequacy analysis produced a negative margin. To address this negative margin, GLICNY recorded an incremental Capital Requirements of U.S. Mortgage Insurers Mortgage insurers are not subject to the NAIC’s RBC requirements but certain states and other regulators impose another form of capital requirement on mortgage insurers requiring maintenance of a risk-to-capital risk-to-capital risk-to-capital Private mortgage insurers must meet the operational and financial requirements under PMIERs as set forth by the GSEs in order to remain eligible to insure loans that are purchased by the GSEs. Each approved mortgage insurer is required to provide the GSEs with an annual certification and a quarterly report evidencing its compliance with PMIERs. On June 29, 2020, the GSEs issued guidance amending PMIERs in light of COVID-19 on December 31, 2020. The GSEs issued another revised and restated version in December 2020 that extended certain defined periods within the PMIERs Amendment. On June 30, 2021, the GSEs issued a revised and restated version of the PMIERs Amendment that replaced the version issued in December 2020. The June 30, 2021 version allows loans that enter a forbearance plan due to a COVID-19 The PMIERs Amendment implemented both permanent and temporary revisions to PMIERs. For loans that became non-performing due to a COVID-19 hardship, PMIERs was temporarily amended with respect to each non-performing loan that (i) had an initial missed monthly payment occurring on or after March 1, 2020 and prior to April 1, 2021 or (ii) is subject to a forbearance plan granted in response to a financial hardship related to COVID-19, the terms of which are materially consistent with terms of forbearance plans offered by the GSEs. The risk-based required asset amount factor for the non-performing loan is the greater of (a) the applicable risk-based required asset amount factor for a performing loan were it not delinquent, and (b) the product of a non-performing non-performing non-performing In September 2020, the GSEs imposed certain restrictions (“GSE Restrictions”) with respect to capital on Enact Holdings. These restrictions will remain in effect until the following collective conditions (“GSE Conditions”) are met: (a) GMICO obtains “BBB+”/“Baa1” (or higher) rating from Standard & Poor’s Financial Services, LLC, Moody’s Investors Service, Inc. or Fitch Ratings, Inc. for two consecutive quarters and ( b • GMICO to maintain 115% of PMIERs Minimum Required Assets through 2021, 120% during 2022 and 125% thereafter; • Enact Holdings to retain $300 million of its holding company cash that can be drawn down exclusively for its debt service or to contribute to GMICO to meet their regulatory capital needs including PMIERs; and • written approval must be received from the GSEs prior to any additional debt issuance by either GMICO or Enact Holdings. Until the GSE Conditions imposed in connection with the GSE Restrictions are met, Enact Holdings’ liquidity must not fall below 13.5% of its outstanding debt. As of December 31, 2021, after taking into account debt service to date, Enact Holdings must maintain holding company cash of approximately $252 million. Enact Holdings has met all PMIERs reporting requirements as required by the GSEs. As of December 31, 2021 and 2020, Enact Holdings has estimated available assets of $5,077 million and $4,588 million, respectively, against $3,074 million and $3,359 million, respectively, net required assets under PMIERs. The sufficiency ratio as of December 31, 2021 and 2020 was 165% and 137%, respectively, or $2,003 million and $1,229 million, respectively, above the published PMIERs requirements. PMIERs sufficiency is based on the published requirements applicable to private mortgage insurers and does not give effect to the GSE Restrictions imposed on Enact Holdings. PMIERs required assets as of December 31, 2021 and 2020 benefited from the application of a 0.30 multiplier applied to the risk-based required asset amount factor for certain non-performing Securities on deposit Certain of our insurance subsidiaries have securities on deposit with various state or foreign government insurance departments in order to comply with relevant insurance regulations. See note 4(d) for additional information related to these deposits. Additionally, under the terms of certain reinsurance agreements that our life insurance subsidiaries have with external parties, we pledged assets in either separate portfolios or in trust for the benefit of external reinsurers. These assets support the reserves ceded to those external reinsurers. See note 8 for additional information related to these pledged assets under reinsurance agreements. Certain of our U.S. life insurance subsidiaries are also members of regional FHLBs and the FHLBs have been granted a lien on certain of our invested assets to collateralize our obligations. See note 9 for additional information related to these pledged assets with the FHLBs. Guarantees of obligations In addition to the commitments discussed in note 20, Genworth Financial and certain of its holding companies provide guarantees to third parties for the performance of certain obligations of their subsidiaries. We estimate that our potential obligations under such guarantees was $10 million and $4 million as of December 31, 2021 and 2020, respectively. Genworth Holdings has provided a limited guarantee of up to $175 million, subject to adjustments, to one of its insurance subsidiaries to support its mortgage insurance business in Mexico. In January 2022, Genworth Holdings terminated this limited guarantee in regard to new business. We believe this insurance subsidiary has adequate reserves to cover its underlying obligations. Genworth Holdings also provided an unlimited guarantee for the benefit of policyholders for the payment of valid claims by our European mortgage insurance subsidiary prior to its sale in May 2016. Following the sale of this United Kingdom subsidiary to AmTrust Financial Services, Inc., the guarantee was limited to the payment of valid claims on policies in-force in-force On March 1, 2021, Genworth Holdings entered into a guarantee agreement with Genworth Financial International Holdings, LLC (“GFIH”) whereby Genworth Holdings agreed to contribute additional capital to GFIH related to certain of its liabilities, or otherwise satisfy or discharge those liabilities. The liabilities include but are not limited to, claims and financial obligations or other liabilities of GFIH that existed immediately prior to the distribution of the net proceeds from the Genworth Australia sale. Pursuant to the agreement, Genworth Holdings paid AXA approximately €15 million ($18 million) in the second quarter of 2021 to settle amounts owed related to underwriting losses on a product sold by a distributor in our former lifestyle protection insurance business.

Segment Information

Segment Information	12 Months Ended
	Dec. 31, 2021
Segment Information	(18) Segment Information (a) Operating Segment Information We have the following three operating business segments: Enact (formerly known as U.S. Mortgage Insurance); U.S. Life Insurance (which includes our long-term care insurance, life insurance and fixed annuities businesses); and Runoff (which includes the results of non-strategic We tax our businesses at the U.S. corporate federal income tax rate of 21%. Each segment is then adjusted to reflect the unique tax attributes of that segment, such as permanent differences between U.S. GAAP and tax law. The difference between the consolidated provision for income taxes and the sum of the provision for income taxes in each segment is reflected in Corporate and Other activities. We use the same accounting policies and procedures to measure segment income (loss) and assets as our consolidated net income and assets. Our chief operating decision maker evaluates segment performance and allocates resources on the basis of “adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders.” We define adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders as income (loss) from continuing operations excluding the after-tax non-operating non-recourse non-operating non-operating While some of these items may be significant components of net income (loss) available to Genworth Financial, Inc.’s common stockholders in accordance with U.S. GAAP, we believe that adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders, and measures that are derived from or incorporate adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders, are appropriate measures that are useful to investors because they identify the income (loss) attributable to the ongoing operations of the business. Management also uses adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders as a basis for determining awards and compensation for senior management and to evaluate performance on a basis comparable to that used by analysts. However, the items excluded from adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders have occurred in the past and could, and in some cases will, recur in the future. Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders is not a substitute for net income (loss) available to Genworth Financial, Inc.’s common stockholders determined in accordance with U.S. GAAP. In addition, our definition of adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders may differ from the definitions used by other companies. Adjustments to reconcile net income (loss) available to Genworth Financial, Inc.’s common stockholders to adjusted operating income (loss) assume a 21% tax rate and are net of the portion attributable to noncontrolling interests. Net investment gains (losses) are also adjusted for DAC and other intangible amortization and certain benefit reserves. In 2021, we paid a pre-tax pre-tax pre-tax pre-tax pre-tax non-recourse pre-tax write-off In the fourth quarter of 2021, we recorded a pre-tax In 2021, 2020 and 2019, we recorded a pre-tax The following is a summary of our segments and Corporate and Other activities as of or for the years ended December 31: 2021 Enact U.S. Life Runoff Corporate Total (Amounts in millions) Premiums $ 975 $ 2,454 $ — $ 6 $ 3,435 Net investment income 141 3,029 194 6 3,370 Net investment gains (losses) (2 ) 329 3 (7 ) 323 Policy fees and other income 4 565 134 1 704 Total revenues 1,118 6,377 331 6 7,832 Benefits and other changes in policy reserves 125 4,230 27 1 4,383 Interest credited — 346 162 — 508 Acquisition and operating expenses, net of deferrals 230 865 53 75 1,223 Amortization of deferred acquisition costs and intangibles 15 340 20 2 377 Interest expense 51 — — 109 160 Total benefits and expenses 421 5,781 262 187 6,651 Income (loss) from continuing operations before income taxes 697 596 69 (181 ) 1,181 Provision (benefit) for income taxes 148 155 13 (53 ) 263 Income (loss) from continuing operations 549 441 56 (128 ) 918 Income from discontinued operations, net of taxes — — — 27 27 Net income (loss) 549 441 56 (101 ) 945 Less: net income from continuing operations attributable to noncontrolling interests 33 — — — 33 Less: net income from discontinued operations attributable to noncontrolling interests — — — 8 8 Net income (loss) available to Genworth Financial, Inc.’s common stockholders $ 516 $ 441 $ 56 $ (109 ) $ 904 Net income (loss) available to Genworth Financial, Inc.’s common stockholders: Income (loss) from continuing operations available to Genworth Financial, Inc.’s common stockholders $ 516 $ 441 $ 56 $ (128 ) $ 885 Income from discontinued operations available to Genworth Financial, Inc.’s common stockholders — — — 19 19 Net income (loss) available to Genworth Financial, Inc.’s common stockholders $ 516 $ 441 $ 56 $ (109 ) $ 904 Segment assets $ 5,850 $ 81,210 $ 9,460 $ 2,651 $ 99,171 Assets held for sale related to discontinued operations — — — — — Total assets $ 5,850 $ 81,210 $ 9,460 $ 2,651 $ 99,171 2020 Enact U.S. Life Runoff Corporate Total (Amounts in millions) Premiums $ 971 $ 2,858 $ — $ 7 $ 3,836 Net investment income 133 2,878 210 6 3,227 Net investment gains (losses) (4 ) 517 (26 ) 5 492 Policy fees and other income 6 595 130 (2 ) 729 Total revenues 1,106 6,848 314 16 8,284 Benefits and other changes in policy reserves 381 4,781 48 4 5,214 Interest credited — 383 166 — 549 Acquisition and operating expenses, net of deferrals 206 620 48 61 935 Amortization of deferred acquisition costs and intangibles 21 418 23 1 463 Interest expense 18 5 — 172 195 Total benefits and expenses 626 6,207 285 238 7,356 Income (loss) from continuing operations before income taxes 480 641 29 (222 ) 928 Provision (benefit) for income taxes 102 163 4 (39 ) 230 Income (loss) from continuing operations 378 478 25 (183 ) 698 Loss from discontinued operations, net of taxes — — — (486 ) (486 ) Net income (loss) 378 478 25 (669 ) 212 Less: net income from continuing operations attributable to noncontrolling interests — — — — — Less: net income from discontinued operations attributable to noncontrolling interests — — — 34 34 Net income (loss) available to Genworth Financial, Inc.’s common stockholders $ 378 $ 478 $ 25 $ (703 ) $ 178 Net income (loss) available to Genworth Financial, Inc.’s common stockholders: Income (loss) from continuing operations available to Genworth Financial, Inc.’s common stockholders $ 378 $ 478 $ 25 $ (183 ) $ 698 Loss from discontinued operations available to Genworth Financial, Inc.’s common stockholders — — — (520 ) (520 ) Net income (loss) available to Genworth Financial, Inc.’s common stockholders $ 378 $ 478 $ 25 $ (703 ) $ 178 Segment assets $ 5,627 $ 84,671 $ 9,735 $ 2,897 $ 102,930 Assets held for sale related to discontinued operations — — — 2,817 2,817 Total assets $ 5,627 $ 84,671 $ 9,735 $ 5,714 $ 105,747 2019 Enact U.S. Life Runoff Corporate Total (Amounts in millions) Premiums $ 856 $ 2,861 $ — $ 8 $ 3,725 Net investment income 117 2,852 187 8 3,164 Net investment gains (losses) 1 82 (25 ) (31 ) 27 Policy fees and other income 4 643 140 2 789 Total revenues 978 6,438 302 (13 ) 7,705 Benefits and other changes in policy reserves 50 4,979 27 3 5,059 Interest credited — 419 158 — 577 Acquisition and operating expenses, net of deferrals 191 604 52 62 909 Amortization of deferred acquisition costs and intangibles 15 372 18 3 408 Interest expense — 17 — 214 231 Total benefits and expenses 256 6,391 255 282 7,184 Income (loss) from continuing operations before income taxes 722 47 47 (295 ) 521 Provision (benefit) for income taxes 153 34 8 (56 ) 139 Income (loss) from continuing operations 569 13 39 (239 ) 382 Income from discontinued operations, net of taxes — — — 148 148 Net income (loss) 569 13 39 (91 ) 530 Less: net income from continuing operations attributable to noncontrolling interests — — — — — Less: net income from discontinued operations attributable to noncontrolling interests — — — 187 187 Net income (loss) available to Genworth Financial, Inc.’s common stockholders $ 569 $ 13 $ 39 $ (278 ) $ 343 Net income (loss) available to Genworth Financial, Inc.’s common stockholders: Income (loss) from continuing operations available to Genworth Financial, Inc.’s common stockholders $ 569 $ 13 $ 39 $ (239 ) $ 382 Loss from discontinued operations available to Genworth Financial, Inc.’s common stockholders — — — (39 ) (39 ) Net income (loss) available to Genworth Financial, Inc.’s common stockholders $ 569 $ 13 $ 39 $ (278 ) $ 343 (b) Revenues of Major Product Groups The following is a summary of revenues of major product groups for our segments and Corporate and Other activities for the years ended December 31: (Amounts in millions) 2021 2020 2019 Revenues: Enact segment $ 1,118 $ 1,106 $ 978 U.S. Life Insurance segment: Long-term care insurance 4,875 4,960 4,385 Life insurance 996 1,357 1,444 Fixed annuities 506 531 609 U.S. Life Insurance segment 6,377 6,848 6,438 Runoff segment 331 314 302 Corporate and Other activities 6 16 (13 ) Total revenues $ 7,832 $ 8,284 $ 7,705 (c) Reconciliations The following tables present the reconciliation of net income available to Genworth Financial, Inc.’s common stockholders to adjusted operating income available to Genworth Financial, Inc.’s common stockholders and a summary of adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders for our segments and Corporate and Other activities for the years ended December 31: (Amounts in millions) 2021 2020 2019 Net income available to Genworth Financial, Inc.’s common stockholders $ 904 $ 178 $ 343 Add: net income from continuing operations attributable to noncontrolling interests 33 — — Add: net income from discontinued operations attributable to noncontrolling interests 8 34 187 Net income 945 212 530 Less: income (loss) from discontinued operations, net of taxes 27 (486 ) 148 Income from continuing operations 918 698 382 Less: net income from continuing operations attributable to noncontrolling interests 33 — — Income from continuing operations available to Genworth Financial, Inc.’s common stockholders 885 698 382 Adjustments to income from continuing operations available to Genworth Financial, Inc.’s common stockholders: Net investment (gains) losses, net (1) (324 ) (503 ) (38 ) (Gains) losses on early extinguishment of debt 45 9 — Initial loss from life block transaction 92 — — Expenses related to restructuring 34 3 4 Taxes on adjustments 33 103 7 Adjusted operating income available to Genworth Financial, Inc.’s common stockholders $ 765 $ 310 $ 355 (1) For the years ended December 31, 2021, 2020 and 2019, net investment (gains) losses were adjusted for DAC and other intangible amortization and certain benefit reserves of $(1) million, $(11) million and $(11) million, respectively. (Amounts in millions) 2021 2020 2019 Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders: Enact segment $ 520 $ 381 $ 568 U.S. Life Insurance segment: Long-term care insurance 445 237 57 Life insurance (269 ) (247 ) (181 ) Fixed annuities 91 78 69 U.S. Life Insurance segment 267 68 (55 ) Runoff segment 54 43 56 Corporate and Other activities (76 ) (182 ) (214 ) Adjusted operating income available to Genworth Financial, Inc.’s common stockholders $ 765 $ 310 $ 355 (d) Geographic Segment Information The following is a summary of geographic region activity as of or for the years ended December 31: 2021 (Amounts in millions) United States International (1) Total Total revenues $ 7,825 $ 7 $ 7,832 Income (loss) from continuing operations $ 921 $ (3 ) $ 918 Net income (loss) $ 948 $ (3 ) $ 945 Segment assets $ 99,117 $ 54 $ 99,171 Assets held for sale related to discontinued operations — — — Total assets $ 99,117 $ 54 $ 99,171 2020 (Amounts in millions) United States International (1) Total Total revenues $ 8,275 $ 9 $ 8,284 Income (loss) from continuing operations $ 700 $ (2 ) $ 698 Net income (loss) $ 214 $ (2 ) $ 212 Segment assets $ 102,871 $ 59 $ 102,930 Assets held for sale related to discontinued operations — 2,817 2,817 Total assets $ 102,871 $ 2,876 $ 105,747 2019 (Amounts in millions) United States International (1) Total Total revenues $ 7,696 $ 9 $ 7,705 Income (loss) from continuing operations $ 384 $ (2 ) $ 382 Net income $ 532 $ (2 ) $ 530 (1) Predominantly comprised of operations in Mexico.

Quarterly Results of Operations

Quarterly Results of Operations (unaudited)	12 Months Ended
	Dec. 31, 2021
Quarterly Results of Operations (unaudited)	(19) Quarterly Results of Operations (unaudited) Our unaudited quarterly results of operations for the year ended December 31, 2021 are summarized in the table below. Three months ended (Amounts in millions, except per share amounts) March 31, June 30, September 30, December 31, Total revenues (1) $ 1,985 $ 2,041 $ 2,070 $ 1,736 Total benefits and expenses (2) $ 1,752 $ 1,721 $ 1,697 $ 1,481 Income from continuing operations (1), (2), (3) $ 174 $ 245 $ 306 $ 193 Income (loss) from discontinued operations, net of taxes $ 21 $ (5 ) $ 12 $ (1 ) Net income (1), (2), (3) $ 195 $ 240 $ 318 $ 192 Net income from continuing operations attributable to noncontrolling interests (4) $ — $ — $ 4 $ 29 Net income from discontinued operations attributable to noncontrolling interests $ 8 $ — $ — $ — Net income available to Genworth Financial, Inc.’s common stockholders (4) $ 187 $ 240 $ 314 $ 163 Net income available to Genworth Financial, Inc.’s common stockholders: Income from continuing operations available to Genworth Financial, Inc.’s common stockholders $ 174 $ 245 $ 302 $ 164 Income (loss) from discontinued operations available to Genworth Financial, Inc.’s common stockholders 13 (5 ) 12 (1 ) Net income available to Genworth Financial, Inc.’s common stockholders $ 187 $ 240 $ 314 $ 163 Income from continuing operations available to Genworth Financial, Inc.’s common stockholders per share: Basic $ 0.35 $ 0.48 $ 0.59 $ 0.32 Diluted $ 0.34 $ 0.47 $ 0.59 $ 0.32 Net income available to Genworth Financial, Inc.’s common stockholders per share: Basic $ 0.37 $ 0.47 $ 0.62 $ 0.32 Diluted $ 0.37 $ 0.47 $ 0.61 $ 0.32 Weighted-average common shares outstanding: Basic 506.0 507.0 507.4 507.4 Diluted 513.8 515.0 514.2 515.6 (1) In the fourth quarter of 2021, our life insurance business initially ceded $360 million of premiums associated with certain term life insurance policies under a new reinsurance treaty as part of a life block transaction. (2) In the fourth quarter of 2021, our life insurance business initially ceded $268 million of certain term life insurance reserves under a new reinsurance treaty as part of a life block transaction. Our life insurance business also completed its annual review of assumptions in the fourth quarter of 2021. This review resulted in higher total benefits and expenses of $87 million from an unfavorable unlocking in our term universal and universal life insurance products largely attributable to higher pre-COVID-19 (3) In the fourth quarter of 2021, our life insurance business recorded a net loss of $131 million predominantly driven by an initial loss of $73 million as a result of ceding certain term life insurance policies as part of a life block transaction, an unfavorable unlocking of $70 million associated with its annual review of assumptions and a DAC impairment of $32 million as a result of recoverability testing. (4) On September 20, 2021, we completed the minority IPO of Enact Holdings, which reduced our ownership percentage to 81.6%, and lowered our available net income by $29 million in the fourth quarter of 2021. Our unaudited quarterly results of operations for the year ended December 31, 2020 are summarized in the table below. Three months ended (Amounts in millions, except per share amounts) March 31, June 30, September 30, December 31, Total revenues (1) $ 1,809 $ 2,003 $ 2,318 $ 2,154 Total benefits and expenses (2) $ 1,874 $ 1,925 $ 1,786 $ 1,771 Income (loss) from continuing operations (1), (2), (3) $ (60 ) $ 55 $ 402 $ 301 Income (loss) from discontinued operations, net of taxes (4) $ (12 ) $ (473 ) $ 34 $ (35 ) Net income (loss) (1), (2), (3), (4) $ (72 ) $ (418 ) $ 436 $ 266 Net income from continuing operations attributable to noncontrolling interests $ — $ — $ — $ — Net income (loss) from discontinued operations attributable to noncontrolling interests $ (6 ) $ 23 $ 18 $ (1 ) Net income (loss) available to Genworth Financial, Inc.’s common stockholders $ (66 ) $ (441 ) $ 418 $ 267 Net income (loss) available to Genworth Financial, Inc.’s common stockholders: Income (loss) from continuing operations available to Genworth Financial, Inc.’s common stockholders $ (60 ) $ 55 $ 402 $ 301 Income (loss) from discontinued operations available to Genworth Financial, Inc.’s common stockholders (6 ) (496 ) 16 (34 ) Net income (loss) available to Genworth Financial, Inc.’s common stockholders $ (66 ) $ (441 ) $ 418 $ 267 Income (loss) from continuing operations available to Genworth Financial, Inc.’s common stockholders per share: Basic $ (0.12 ) $ 0.11 $ 0.79 $ 0.60 Diluted $ (0.12 ) $ 0.11 $ 0.79 $ 0.59 Net income (loss) available to Genworth Financial, Inc.’s common stockholders per share: Basic $ (0.13 ) $ (0.87 ) $ 0.83 $ 0.53 Diluted $ (0.13 ) $ (0.86 ) $ 0.82 $ 0.52 Weighted-average common shares outstanding: Basic 504.3 505.4 505.6 505.6 Diluted (5) 504.3 512.5 511.5 512.5 (1) In the fourth quarter of 2020, we recorded lower net investment gains as compared to the third quarter of 2020. The higher net investment gains recorded in the third quarter of 2020 related to the sale of available-for-sale investment income recorded in the fourth quarter of 2020 largely driven by bond calls and mortgage loan repayments of $40 million and limited partnerships of $38 million. (2) Given our assumption that COVID-19 COVID-19 pre-pandemic (3) In the fourth quarter of 2020, our long-term care insurance business strengthened its reserves by $109 million after-tax. after-tax. (4) In the fourth quarter of 2020, we recorded a loss from discontinued operations, net of taxes, of $35 million principally attributed to expenses associated with the promissory note owed to AXA and from a $5 million net loss in Genworth Australia. The expenses associated with the promissory note mostly consisted of foreign currency remeasurement losses of $26 million, unfavorable tax charges of $17 million and other expenses of $8 million. These expenses were partially offset by derivative hedge gains of $21 million associated with foreign currency forward contracts entered into to mitigate our exposure to the installment payments to be made in British Pounds in 2022. See note 23 for additional details on discontinued operations. (5) Under applicable accounting guidance, companies in a loss position are required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share. Therefore, as a result of our loss from continuing operations available to Genworth Financial, Inc.’s common stockholders for the three months ended March 31, 2020, we were required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share for the three months ended March 31, 2020, as the inclusion of shares for stock options, RSUs and SARs of 5.4 million would have been antidilutive to the calculation. If we had not incurred a loss from continuing operations available to Genworth Financial, Inc.’s common stockholders for the three months ended March 31, 2020, dilutive potential weighted-average common shares outstanding would have been 509.7 million.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2021
Commitments and Contingencies	(20) Commitments and Contingencies (a) Litigation and Regulatory Matters We face the risk of litigation and regulatory investigations and actions in the ordinary course of operating our businesses, including the risk of class action lawsuits. Our pending legal and regulatory actions include proceedings specific to us and others generally applicable to business practices in the industries in which we operate. In our insurance operations, we are, have been, or may become subject to class actions and individual suits alleging, among other things, issues relating to sales or underwriting practices, increases to in- force term care insurance premiums, payment of contingent or other sales commissions, claims payments and procedures, product design, product disclosure, product administration, additional premium charges for premiums paid on a periodic basis, denial or delay of benefits, charging excessive or impermissible fees on products, recommending unsuitable products to customers, our pricing structures and business practices in our mortgage insurance subsidiaries, such as captive reinsurance arrangements with lenders and contract underwriting services, violations of the Real Estate Settlement and Procedures Act of 1974 or related state anti-inducement laws, and mortgage insurance policy rescissions and curtailments, and breaching fiduciary or other duties to customers, including but not limited to breach of customer information. Plaintiffs in class action and other lawsuits against us may seek very large or indeterminate amounts which may remain unknown for substantial periods of time. In our investment-related operations, we are subject to litigation involving commercial disputes with counterparties. We are also subject to litigation arising out of our general business activities such as our contractual and employment relationships, post-closing obligations associated with previous dispositions and securities lawsuits. In addition, we are also subject to various regulatory inquiries, such as information requests, subpoenas, books and record examinations and market conduct and financial examinations from state, federal and international regulators and other authorities. A substantial legal liability or a significant regulatory action against us could have an adverse effect on our business, financial condition and results of operations. Moreover, even if we ultimately prevail in the litigation, regulatory action or investigation, we could suffer significant reputational harm, which could have an adverse effect on our business, financial condition or results of operations. In January 2016, Genworth Financial, certain members of its executive management team, including its former and present chief executive officer, and current and former members of its board of directors were named in a shareholder derivative suit filed by International Union of Operating Engineers Local No. 478 Pension Fund, Richard L. Salberg and David Pinkoski in the Court of Chancery of the State of Delaware. The case was captioned Int’l Union of Operating Engineers Local No. 478 Pension Fund, et al v. McInerney, et al Cohen v. McInerney, et al Genworth Financial, Inc. Consolidated Derivative Litigation In October 2016, Genworth Financial, certain members of its executive management team, including its former and present chief executive officer, and current and former members of its board of directors were named as defendants in a shareholder derivative suit filed by Esther Chopp in the Court of Chancery of the State of Delaware. The case is captioned Chopp v. McInerney, et al directors wrongfully refused plaintiff’s demand to commence litigation on behalf of Genworth and asserts claims for breaches of fiduciary duties, waste, contribution and indemnification, and unjust enrichment concerning Genworth’s long-term care insurance reserves and concerning Genworth’s former Australian mortgage insurance business, including our plans for an IPO of the business, and seeks unspecified damages, costs, attorneys’ fees and such equitable relief as the Court may deem proper. We filed a motion to dismiss on November 14, 2016. The action was stayed pending the outcome of the proposed China Oceanwide transaction. On April 6, 2021, Genworth Financial terminated the proposed China Oceanwide transaction, thereby lifting the stay. We intend to vigorously defend this action. In September 2018, GLAIC, our indirect wholly-owned subsidiary, was named as a defendant in a putative class action lawsuit pending in the United States District Court for the Eastern District of Virginia captioned TVPX ARX INC., as Securities Intermediary for Consolidated Wealth Management, LTD. on behalf of itself and all others similarly situated v. Genworth Life and Annuity Insurance Company non-mortality In September 2018, Genworth Financial, Genworth Holdings, Genworth North America Corporation, GFIH and Genworth Life Insurance Company (“GLIC”) were named as defendants in a putative class action lawsuit pending in the Court of Chancery of the State of Delaware captioned Richard F. Burkhart, William E. Kelly, Richard S. Lavery, Thomas R. Pratt, Gerald Green, individually and on behalf of all other persons similarly situated v. Genworth et al pay-off On April 6, 2020, GLAIC was named as a defendant in a putative class action lawsuit filed in the United States District Court for the Eastern District of Virginia, captioned Brighton Trustees, LLC, on behalf of and as trustee for Diamond LS Trust; and Bank of Utah, solely as securities intermediary for Diamond LS Trust; on behalf of themselves and all others similarly situated v. Genworth Life and Annuity Insurance Company Ronald L. Daubenmier, individually and on behalf of himself and all others similarly situated v. Genworth Life and Annuity Insurance Company In January 2021, GLIC and GLICNY were named as defendants in a putative class action lawsuit pending in the United States District Court for the Eastern District of Virginia captioned Judy Halcom, Hugh Penson, Harold Cherry, and Richard Landino, individually, and on behalf of all others similarly situated v. Genworth Life Insurance Company and Genworth Life Insurance Company of New York In January 2021, GLAIC was named as a defendant in a putative class action lawsuit pending in the United States District Court for the District of Oregon captioned Patsy H. McMillan, Individually and On Behalf Of All Others Similarly Situated, v. Genworth Life and Annuity Insurance Company On August 11, 2021, GLIC and GLICNY received a request for pre-suit pre-suit Fred Haney, Marsha Merrill, Sylvia Swanson, and Alan Wooten, individually, and on behalf of all others similarly situated v. Genworth Life Insurance Company and Genworth Life Insurance Company of New York At this time we cannot determine or predict the ultimate outcome of any of the pending legal and regulatory matters specifically identified above or the likelihood of potential future legal and regulatory matters against us. Except as disclosed above, we are not able to provide an estimate or range of reasonably possible losses related to these matters. Therefore, we cannot ensure that the current investigations and proceedings will not have a material adverse effect on our business, financial condition or results of operations. In addition, it is possible that related investigations and proceedings may be commenced in the future, and we could become subject to additional unrelated investigations and lawsuits. Increased regulatory scrutiny and any resulting investigations or proceedings could result in new legal precedents and industry-wide regulations or practices that could adversely affect our business, financial condition and results of operations. (b) Commitments As of December 31, 2021, we were committed to fund $1,185 million in limited partnership investments, $28 million in U.S. commercial mortgage loan investments and $97 million in private placement investments. As of December 31, 2021, we were also committed to fund $141 million of bank loan investments which had not yet been drawn.

Changes in Accumulated Other Co

Changes in Accumulated Other Comprehensive Income (Loss)	12 Months Ended
	Dec. 31, 2021
Changes In Accumulated Other Comprehensive Income (Loss)	(21) Changes in Accumulated Other Comprehensive Income (Loss) The following tables show the changes in accumulated other comprehensive income (loss), net of taxes, by component as of and for the periods indicated: (Amounts in millions) Net (1) Derivatives (2) Foreign Total Balances as of January 1, 2021 $ 2,214 $ 2,211 $ — $ 4,425 OCI before reclassifications (313 ) (45 ) 148 (210 ) Amounts reclassified from (to) OCI (51 ) (141 ) — (192 ) Current period OCI (364 ) (186 ) 148 (402 ) Balances as of December 31, 2021 before noncontrolling interests 1,850 2,025 148 4,023 Less: change in OCI attributable to noncontrolling interests (10 ) — 172 162 Balances as of December 31, 2021 $ 1,860 $ 2,025 $ (24 ) $ 3,861 (1) Net of adjustments to DAC, PVFP, sales inducements and benefit reserves. See note 4 for additional information. (2) See note 5 for additional information. (Amounts in millions) Net (1) Derivatives (2) Foreign Total Balances as of January 1, 2020 $ 1,456 $ 2,002 $ (25 ) $ 3,433 OCI before reclassifications 1,132 344 55 1,531 Amounts reclassified from (to) OCI (374 ) (135 ) — (509 ) Current period OCI 758 209 55 1,022 Balances as of December 31, 2020 before noncontrolling interests 2,214 2,211 30 4,455 Less: change in OCI attributable to noncontrolling interests — — 30 30 Balances as of December 31, 2020 $ 2,214 $ 2,211 $ — $ 4,425 (1) Net of adjustments to DAC, PVFP, sales inducements and benefit reserves. See note 4 for additional information. (2) See note 5 for additional information. (Amounts in millions) Net (1) Derivatives (2) Foreign Total Balances as of January 1, 2019 $ 595 $ 1,781 $ (332 ) $ 2,044 OCI before reclassifications 910 331 487 1,728 Amounts reclassified from (to) OCI (62 ) (110 ) — (172 ) Current period OCI 848 221 487 1,556 Balances as of December 31, 2019 before noncontrolling interests 1,443 2,002 155 3,600 Less: change in OCI attributable to noncontrolling interests (13 ) — 180 167 Balances as of December 31, 2019 $ 1,456 $ 2,002 $ (25 ) $ 3,433 (1) Net of adjustments to DAC, PVFP, sales inducements and benefit reserves. See note 4 for additional information. (2) See note 5 for additional information. The foreign currency translation and other adjustments balance in the charts above included $(1) million, $(15) million and $(4) million, respectively, net of taxes of $1 million, $4 million and $1 million, respectively, related to a net unrecognized postretirement benefit obligation as of December 31, 2021, 2020 and 2019. The balance also included taxes of $21 and $22 million, respectively, related to foreign currency translation adjustments as of December 31, 2020 and 2019. The following table shows reclassifications out of accumulated other comprehensive income (loss), net of taxes, for the periods presented: Amount reclassified from accumulated Affected line item in the consolidated statements of income Years ended December 31, (Amounts in millions) 2021 2020 2019 Net unrealized investment (gains) losses: Unrealized (gains) losses on investments (1) $ (65 ) $ (474 ) $ (79 ) Net investment (gains) losses Income taxes 14 100 17 Provision for income taxes Total $ (51 ) $ (374 ) $ (62 ) Derivatives designated as hedges: Interest rate swaps hedging assets $ (217 ) $ (196 ) $ (164 ) Net investment income Interest rate swaps hedging assets (1 ) (12 ) (6 ) Net investment (gains) losses Interest rate swaps hedging liabilities 1 — — Interest expense Income taxes 76 73 60 Provision for income taxes Total $ (141 ) $ (135 ) $ (110 ) (1) Amounts exclude adjustments to DAC, PVFP, sales inducements and benefit reserves.

Noncontrolling Interests

Noncontrolling Interests	12 Months Ended
	Dec. 31, 2021
Noncontrolling Interests	(22) Noncontrolling Interests Enact Holdings On September 15, 2021, Enact Holdings, our indirect subsidiary, priced the IPO of its common shares. All of the shares were offered by the selling stockholder, Genworth Holdings, our wholly owned subsidiary, with the net proceeds from the IPO retained by Genworth Holdings. Genworth Holdings sold 13,310,400 of Enact Holdings’ common shares at an IPO price of $19.00 per common share. In addition to the shares sold in the IPO, 14,655,600 common shares were sold in a concurrent private sale (“Private Sale”) at a price per share of $17.86, which is equal to the IPO price less the underwriting discount per share. Genworth Holdings also granted the underwriters a 30-day The gross proceeds of the Offering, before payment of underwriter fees and other expenses, were $553 million. Costs directly related to the Offering, including underwriter fees and other expenses, were $24 million. Consistent with applicable accounting guidance, changes in the ownership of a subsidiary that do not result in a loss of control are accounted for as equity transactions with no gain or loss recognized through earnings. Any difference between the carrying value and the fair value related to the change in ownership is recorded as an adjustment to stockholders’ equity. A summary of these changes in ownership interests and the effect on stockholders’ equity was as follows for the year ended December 31, 2021: (Amounts in millions) Net income available to Genworth Financial, Inc.’s common stockholders $ 904 Transfers to noncontrolling interests: Decrease in Genworth Financial, Inc.’s additional paid-in (167 ) Net transfers to noncontrolling interests (167 ) Change from net income available to Genworth Financial, Inc.’s common stockholders and transfers to noncontrolling interests $ 737 Dividends of $37 million were paid to owners of noncontrolling interests of Enact Holdings in 2021. Genworth Australia Prior to the sale of Genworth Australia on March 3, 2021, we held approximately 52% of its common shares on a consolidated basis through subsidiaries and accounted for the portion attributable to noncontrolling interests as a component of total equity. Upon sale closing, we deconsolidated Genworth Australia, which included the de-recognition

Discontinued Operations

Discontinued Operations	12 Months Ended
	Dec. 31, 2021
Discontinued Operations	(23) Discontinued Operations Australia mortgage insurance business As discussed in note 1, on March 3, 2021, we completed the sale of Genworth Australia through an underwriting agreement and received approximately AUD483 million ($370 million) of net cash proceeds. The following table provides a summary of the gain (loss) on sale associated with the disposition of Genworth Australia for the year ended December 31, 2021: (Amounts in millions) Net cash proceeds $ 370 Add: carrying value of noncontrolling interests (1) 657 Total adjusted consideration (2) 1,027 Carrying value of the disposal group before accumulated other comprehensive (income) loss 1,040 Add: total accumulated other comprehensive (income) loss of disposal group (3) 109 Total adjusted carrying value of the disposal group 1,149 Pre-tax (122 ) Tax benefit on sale 122 After-tax $ — (1) In accordance with accounting guidance on the deconsolidation of a subsidiary or group of assets, the carrying amount of any noncontrolling interests in the subsidiary sold (adjusted to reflect amounts in accumulated other comprehensive income (loss) recognized upon final disposition) is added to the total fair value of the consideration received. (2) Represents the aggregate of the net cash proceeds received upon sale closing plus the adjusted carrying amount of noncontrolling interests in the subsidiary sold. (3) Amount consists of $160 million of cumulative losses on foreign currency translation adjustments, partially offset by cumulative unrealized investment gains of $29 million and deferred tax gains of $22 million. In addition, we recorded an after-tax The assets and liabilities related to Genworth Australia were segregated in our consolidated balance sheet until deconsolidation. The major asset and liability categories of Genworth Australia were as follows as of December 31: (Amounts in millions) 2021 2020 Assets Investments: Fixed maturity securities available-for-sale, $ — $ 2,295 Equity securities, at fair value — 90 Other invested assets — 154 Total investments — 2,539 Cash, cash equivalents and restricted cash — 95 Accrued investment income — 16 Deferred acquisition costs — 42 Intangible assets — 43 Other assets — 40 Deferred tax asset — 42 Assets related to discontinued operations $ — $ 2,817 Liabilities Liability for policy and contract claims $ — $ 331 Unearned premiums — 1,193 Other liabilities — 104 Long-term borrowings — 145 Liabilities related to discontinued operations $ — $ 1,773 Deferred tax assets and liabilities that result in future taxable or deductible amounts to the remaining consolidated group have been reflected in assets or liabilities of continuing operations and not reflected in assets or liabilities related to discontinued operations. A summary of operating results related to Genworth Australia reported as discontinued operations was as follows for the years ended December 31: (Amounts in millions) 2021 2020 2019 Revenues: Premiums $ 51 $ 274 $ 312 Net investment income 4 33 56 Net investment gains (losses) (5 ) 66 23 Policy fees and other income — 1 — Total revenues 50 374 391 Benefits and expenses: Benefits and other changes in policy reserves 11 177 104 Acquisition and operating expenses, net of deferrals 7 53 53 Amortization of deferred acquisition costs and intangibles 6 29 33 Goodwill impairment — 5 — Interest expense 1 7 8 Total benefits and expenses 25 271 198 Income before income taxes and gain (loss) on sale (1) 25 103 193 Provision for income taxes 8 40 56 Income before gain (loss) on sale 17 63 137 Gain (loss) on sale, net of taxes — — — Income from discontinued operations, net of taxes 17 63 137 Less: net income from discontinued operations attributable to noncontrolling interests 8 34 64 Income from discontinued operations available to Genworth Financial, Inc.’s common stockholders $ 9 $ 29 $ 73 (1) The years ended December 31, 2021, 2020 and 2019 include pre-tax Lifestyle protection insurance On December 1, 2015, Genworth Financial, through its subsidiaries, completed the sale of its lifestyle protection insurance business to AXA. In 2017, AXA sued us for damages on an indemnity in the 2015 agreement related to alleged remediation it paid to customers who purchased payment protection insurance (“PPI”). On July 20, 2020, we reached a settlement agreement related to losses incurred from mis-selling complaints on policies sold from 1970 through 2004. As part of the settlement agreement, Genworth Holdings agreed to make payments for certain PPI mis-selling claims, along with a significant portion of future claims that are still being processed. Under the settlement agreement, Genworth Holdings issued a secured promissory note to AXA, in which it agreed to make deferred cash payments in two installments in June 2022 and September 2022. In connection with the Genworth Australia sale, Genworth Holdings made a mandatory principal payment to AXA of approximately £176 million ($245 million) in March 2021. The mandatory payment fully repaid the first installment obligation originally due in June 2022 and partially prepaid the September 2022 installment payment. On September 21, 2021, Genworth Holdings used a portion of the net proceeds from the minority IPO of Enact Holdings to repay the remaining outstanding balance of the secured promissory note of approximately £215 million ($296 million), excluding future claims still being processed. As of December 31, 2021, we accrued approximately £22 million ($30 million) of estimated future claims still in process of being invoiced. In February 2022, Genworth Holdings paid AXA the majority of the remaining unprocessed claims of approximately $30 million. We have established our current best estimates for claims still being processed by AXA, as well as other expenses; however, there may be future adjustments to this estimate. If amounts are different from our estimate, it could result in an adjustment to our liability and an additional amount reflected in income (loss) from discontinued operations. The following table presents the amounts owed to AXA under the settlement agreement reflected as liabilities related to discontinued operations in our consolidated balance sheets as of December 31: (Amounts in millions) British Pounds U.S. Dollar 2021 2020 2021 2020 Installment payments due to AXA: June 2022: Beginning balance £ 159 £ 159 $ 217 $ 217 Prepayments (1) (159 ) — (217 ) — Ending balance — 159 — 217 September 2022: Beginning balance 187 158 256 217 Amounts billed as future losses 45 29 61 39 Prepayments (1) (232 ) — (324 ) — Foreign exchange and other — — 7 — Ending balance — 187 — 256 Total amounts due under the promissory note — 346 — 473 Future claims: Estimated beginning balance 79 107 108 146 Change in estimated future claims (10 ) 1 (14 ) 1 Less: Amounts billed and included as mandatory prepayments (45 ) (29 ) (61 ) (39 ) Less: Amounts paid (2 ) — (3 ) — Estimated future billings 22 79 30 108 Total amounts due to AXA under the settlement agreement £ 22 £ 425 $ 30 $ 581 (1) On March 3, 2021, we completed the sale of Genworth Australia and received net proceeds of approximately AUD483 million ($370 million). The sale of Genworth Australia resulted in a mandatory principal payment of approximately £176 million ($245 million) related to our outstanding secured promissory note issued to AXA, dated as of July 20, 2020, as amended by the parties in connection with the Genworth Australia sale. On September 21, 2021, Genworth Holdings used a portion of the net proceeds from the minority IPO of Enact Holdings to repay the remaining outstanding balance of the secured promissory note of approximately £215 million ($296 million). For the years ended December 31, 2021, 2020 and 2019, we recorded after-tax In the event AXA recovers amounts from third parties related to the mis-selling losses, including from the distributor responsible for the sale of the policies, we have certain rights to share in those recoveries to recoup payments for the underlying mis-selling losses. As of December 31, 2021, we have not recorded any amounts associated with recoveries from third parties. In addition to the future claims still being processed under the settlement agreement, we also have an unrelated liability that is owed to AXA associated with underwriting losses on a product sold by a distributor in our former lifestyle protection insurance business. For the years ended December 31, 2021, 2020 and 2019, we recorded after-tax — Canada mortgage insurance business On December 12, 2019, we completed the sale of Genworth Canada to Brookfield Business Partners L.P. (“Brookfield”) and received approximately $1.7 billion in net cash proceeds. In the fourth quarter of 2019 and prior to sale closing, we also received a special dividend of approximately $54 million from Genworth Canada. This special dividend reduced the sales price on a per purchased share basis by CAD$1.45 per common share. During 2019, we recognized an after-tax The following table provides a summary of the loss on sale recorded in connection with the disposition of Genworth Canada for the year ended December 31, 2019: (Amounts in millions) Net cash proceeds $ 1,736 Add: carrying value of noncontrolling interests (1) 1,417 Total adjusted consideration (2) 3,153 Carrying value of the disposal group before accumulated other comprehensive loss 3,022 Add: total accumulated other comprehensive loss of disposal group (3) 325 Total adjusted carrying value of the disposal group 3,347 Pre-tax (194 ) Tax benefit on sale 73 After-tax $ (121 ) (1) In accordance with accounting guidance on the deconsolidation of a subsidiary or group of assets, the carrying amount of any noncontrolling interests in the subsidiary sold (adjusted to reflect amounts in accumulated other comprehensive income (loss) recognized upon final disposition) is added to the total fair value of the consideration received. (2) Represents the aggregate of the net cash proceeds received upon sale closing plus the adjusted carrying amount of noncontrolling interests in the subsidiary sold. (3) Amount consists of cumulative losses on foreign currency translation adjustments of $369 million and deferred tax losses of $71 million, partially offset by unrealized investment gains of $115 million. A summary of operating results for Genworth Canada reported as discontinued operations was as follows for the year ended December 31, 2019: (Amounts in millions) Revenues: Premiums $ 466 Net investment income 132 Net investment gains (losses) (13 ) Total revenues 585 Benefits and expenses: Benefits and other changes in policy reserves 79 Acquisition and operating expenses, net of deferrals 64 Amortization of deferred acquisition costs and intangibles 39 Interest expense (1) 50 Total benefits and expenses 232 Income before income taxes and loss on sale (2) 353 Provision for income taxes 111 Income before loss on sale 242 Loss on sale, net of taxes (121 ) Income from discontinued operations, net of taxes 121 Less: net income from discontinued operations attributable to noncontrolling interests 123 Loss from discontinued operations available to Genworth Financial, Inc.’s common stockholders $ (2 ) (1) Interest on debt assumed by Brookfield and interest on debt that was repaid as a result of the sale of Genworth Canada was allocated and reported in discontinued operations. The Term Loan, owed by Genworth Holdings and secured by GFIH’s ownership interest in Genworth Canada’s outstanding common shares, was repaid in connection with the close of the Genworth Canada sale. Accordingly, interest expense related to the Term Loan of $ 34 (2) The year ended December 31, 2019 includes pre-tax

Schedule I Genworth Financial,

Schedule I Genworth Financial, Inc. Summary of Investments-Other Than Investments in Related Parties	12 Months Ended
	Dec. 31, 2021
Schedule I Genworth Financial, Inc. Summary of Investments-Other Than Investments in Related Parties	Schedule I Genworth Financial, Inc. Summary of Investments—Other Than Investments in Related Parties (Amounts in millions) As of December 31, 2021, the amortized cost or cost, fair value and carrying value of our invested assets were as follows: Type of investment Amortized Fair Carrying Fixed maturity securities: Bonds: U.S. government, agencies and authorities $ 3,368 $ 4,552 $ 4,552 State and political subdivisions 2,982 3,450 3,450 Non-U.S. 762 835 835 Public utilities 5,197 6,032 6,032 All other corporate bonds 40,302 45,611 45,611 Total fixed maturity securities 52,611 60,480 60,480 Equity securities 186 198 198 Commercial mortgage loans, net 6,830 xxxxx 6,830 Policy loans 2,050 xxxxx 2,050 Limited partnerships 1,314 xxxxx 1,900 Other invested assets (1) 440 xxxxx 820 Total investments $ 63,431 xxxxx $ 72,278 (1) The amount shown in the consolidated balance sheet for other invested assets differs from amortized cost or cost presented, as other invested assets include certain assets with a carrying amount that differs from amortized cost or cost. See Report of Independent Registered Public Accounting Firm

Schedule II Genworth Financial,

Schedule II Genworth Financial, Inc. (Parent Company Only)	12 Months Ended
	Dec. 31, 2021
Schedule II Genworth Financial, Inc. (Parent Company Only)	Schedule II Genworth Financial, Inc. (Parent Company Only) Balance Sheets (Amounts in millions) December 31, 2021 2020 Assets: Investments in subsidiaries $ 15,517 $ 15,358 Deferred tax asset 4 13 Other assets 5 2 Total assets $ 15,526 $ 15,373 Liabilities and stockholders’ equity Liabilities: Other liabilities $ 4 $ 55 Intercompany notes payable 12 — Total liabilities 16 55 Commitments and contingencies Stockholders’ equity: Common stock 1 1 Additional paid-in 11,858 12,008 Accumulated other comprehensive income (loss) 3,861 4,425 Retained earnings 2,490 1,584 Treasury stock, at cost (2,700 ) (2,700 ) Total Genworth Financial, Inc.’s stockholders’ equity 15,510 15,318 Total liabilities and stockholders’ equity $ 15,526 $ 15,373 See Notes to Schedule II See Report of Independent Registered Public Accounting Firm Schedule II Genworth Financial, Inc. (Parent Company Only) Statements of Income (Amounts in millions) Years ended 2021 2020 2019 Revenues: Net investment income $ (3 ) $ (3 ) $ (3 ) Total revenues (3 ) (3 ) (3 ) Expenses: Acquisition and operating expenses, net of deferrals 25 31 20 Interest expense (1 ) 1 3 Total expenses 24 32 23 Loss before income taxes and equity in income of subsidiaries (27 ) (35 ) (26 ) Benefit from income taxes (1 ) (2 ) (3 ) Equity in income of subsidiaries 930 210 366 Income from continuing operations 904 177 343 Income from discontinued operations, net of taxes — 1 — Net income available to Genworth Financial, Inc.’s common stockholders $ 904 $ 178 $ 343 See Notes to Schedule II See Report of Independent Registered Public Accounting Firm Schedule II Genworth Financial, Inc. (Parent Company Only) Statements of Comprehensive Income (Amounts in millions) Years ended December 31, 2021 2020 2019 Net income available to Genworth Financial, Inc.’s common stockholders $ 904 $ 178 $ 343 Other comprehensive income (loss), net of taxes: Net unrealized gains (losses) on securities without an allowance for credit losses (334 ) 764 — Net unrealized gains (losses) on securities with an allowance for credit losses 6 (6 ) — Net unrealized gains (losses) on securities not other-than-temporarily impaired — — 859 Net unrealized gains (losses) on other-than-temporarily impaired securities — — 2 Derivatives qualifying as hedges (186 ) 209 221 Foreign currency translation and other adjustments (24 ) 25 307 Total other comprehensive income (loss) (538 ) 992 1,389 Total comprehensive income available to Genworth Financial, Inc.’s common stockholders $ 366 $ 1,170 $ 1,732 See Notes to Schedule II See Report of Independent Registered Public Accounting Firm Schedule II Genworth Financial, Inc. (Parent Company Only) Statements of Cash Flows (Amounts in millions) Years ended 2021 2020 2019 Cash flows from (used by) operating activities: Net income available to Genworth Financial, Inc.’s common stockholders $ 904 $ 178 $ 343 Less income from discontinued operations, net of taxes — (1 ) — Adjustments to reconcile net income available to Genworth Financial, Inc.’s common stockholders to net cash from (used by) operating activities: Equity in income from subsidiaries (930 ) (210 ) (366 ) Dividends from subsidiaries — — 250 Deferred income taxes — (1 ) 1 Stock-based compensation expense 40 39 26 Change in certain assets and liabilities: Accrued investment income and other assets (1 ) 2 — Current tax liabilities (5 ) (1 ) 16 Other liabilities and other policy-related balances (13 ) 11 (17 ) Net cash from (used by) operating activities (5 ) 17 253 Cash flows used by investing activities: Intercompany notes receivable, net — (10 ) (119 ) Capital contributions paid to subsidiaries (2 ) (2 ) (5 ) Net cash used by investing activities (2 ) (12 ) (124 ) Cash flows from (used by) financing activities: Intercompany notes payable, net 12 — (122 ) Other, net (5 ) (5 ) (7 ) Net cash from (used by) financing activities 7 (5 ) (129 ) Effect of exchange rate changes on cash, cash equivalents and restricted cash — — — Cash, cash equivalents and restricted cash at beginning of year — — — Cash, cash equivalents and restricted cash at end of year $ — $ — $ — See Notes to Schedule II See Report of Independent Registered Public Accounting Firm Schedule II Genworth Financial, Inc. (Parent Company Only) Notes to Schedule II Years Ended December 31, 2021, 2020 and 2019 (1) Organization and Purpose Genworth Holdings (formerly known as Genworth Financial, Inc.) was incorporated in Delaware in 2003 in preparation for an IPO of its common stock, which was completed on May 28, 2004. On April 1, 2013, Genworth Holdings completed a holding company reorganization pursuant to which Genworth Holdings became a direct, 100% owned subsidiary of a new public holding company that it had formed. The new public holding company was incorporated in Delaware on December 5, 2012, in connection with the reorganization, and was renamed Genworth Financial upon the completion of the reorganization. Genworth Financial is a holding company whose subsidiaries offer mortgage and long-term care insurance products and service life insurance, as well as annuities and other investment products. (2) Accounting Changes On January 1, 2021, Genworth Financial adopted new accounting guidance related to simplifying the accounting for income taxes. The guidance eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. Genworth Financial adopted this new accounting guidance using the retrospective method or modified retrospective method for certain changes and prospective method for all other changes, which did not have a significant impact on Genworth Financial’s financial statements and disclosures. (3) Commitments Genworth Financial provides a full and unconditional guarantee to the trustee of Genworth Holdings’ outstanding senior and subordinated notes and the holders of the senior and subordinated notes, on an unsecured unsubordinated and subordinated basis, respectively, of the full and punctual payment of the principal of, premium, if any and interest on, and all other amounts payable under, each outstanding series of senior notes and outstanding subordinated notes, and the full and punctual payment of all other amounts payable by Genworth Holdings under the senior and subordinated notes indentures in respect of such senior and subordinated notes. Genworth Financial and Genworth Holdings have joint and several guarantees associated with the Tax Matters Agreement. (4) Income Taxes As of December 31, 2021 and 2020, Genworth Financial had a deferred tax asset of $4 million and $13 million, respectively, primarily comprised of share-based compensation. Genworth Financial had a current income tax receivable of $2 million as of December 31, 2021 and a current income tax payable of $3 million as of December 31, 2020. Net cash received (paid) for taxes was $(4) million, $ — (5) Supplemental Cash Flow Information In 2020, Genworth Financial forgave an intercompany loan of $129 million due from Genworth Holdings. The extinguishment of the loan between the related parties was treated as a non-cash Schedule II Genworth Financial, Inc. (Parent Company Only) Notes to Schedule II Years Ended December 31, 2021, 2020 and 2019 (6) Sale of Business On December 1, 2015, Genworth Financial completed the sale of its lifestyle protection insurance business to AXA through its subsidiaries. In 2017, AXA sued GFIH, Genworth Financial’s wholly-owned indirect subsidiary, and Genworth Holdings for damages on an indemnity in the 2015 agreement related to alleged remediation it paid to customers who purchased PPI. On July 20, 2020, Genworth Holdings reached a settlement agreement related to losses incurred from mis-selling mis-selling In addition, Genworth Financial completed the sale of Genworth Australia and Genworth Canada on March 3, 2021 and December 12, 2019, respectively, through its subsidiaries. Income from discontinued operations related to the sale of these businesses is also included within equity in income of subsidiaries in the parent company statement of income for the periods presented herein. Income from discontinued operations presented in the parent company statement of income for the year ended December 31, 2020 relates to tax adjustments incurred by Genworth Financial related to previously disposed businesses.

Schedule III Supplemental Insur

Schedule III Supplemental Insurance Information	12 Months Ended
	Dec. 31, 2021
Schedule III Supplemental Insurance Information	Schedule III Genworth Financial, Inc. Supplemental Insurance Information (Amounts in millions) Segment Deferred Future Policyholder Liability for Unearned December 31, 2021 Enact $ 27 $ — $ — $ 641 $ 246 U.S. Life Insurance 1,008 41,526 16,343 11,183 423 Runoff 111 2 3,011 8 3 Corporate and Other — — — 9 — Total $ 1,146 $ 41,528 $ 19,354 $ 11,841 $ 672 December 31, 2020 Enact $ 29 $ — $ — $ 555 $ 307 U.S. Life Insurance 1,319 42,693 18,385 10,908 465 Runoff 139 2 3,118 12 3 Corporate and Other — — — 11 — Total $ 1,487 $ 42,695 $ 21,503 $ 11,486 $ 775 See Report of Independent Registered Public Accounting Firm Schedule III—Continued Genworth Financial, Inc. Supplemental Insurance Information (Amounts in millions) Segment Premium Net Interest Credited Amortization Other Premiums December 31, 2021 Enact $ 975 $ 141 $ 125 $ 9 $ 287 $ 914 U.S. Life Insurance 2,454 3,029 4,576 318 887 2,419 Runoff — 194 189 19 54 — Corporate and Other 6 6 1 — 186 7 Total $ 3,435 $ 3,370 $ 4,891 $ 346 $ 1,414 $ 3,340 December 31, 2020 Enact $ 971 $ 133 $ 381 $ 14 $ 231 $ 894 U.S. Life Insurance 2,858 2,878 5,164 400 643 2,837 Runoff — 210 214 23 48 — Corporate and Other 7 6 4 — 234 7 Total $ 3,836 $ 3,227 $ 5,763 $ 437 $ 1,156 $ 3,738 December 31, 2019 Enact $ 856 $ 117 $ 50 $ 9 $ 197 $ 818 U.S. Life Insurance 2,861 2,852 5,398 340 653 2,834 Runoff — 187 185 16 54 — Corporate and Other 8 8 3 — 279 8 Total $ 3,725 $ 3,164 $ 5,636 $ 365 $ 1,183 $ 3,660 See Report of Independent Registered Public Accounting Firm

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2021
Premiums	a) Premiums For traditional long-duration insurance contracts, we report premiums as earned when due. For short-duration insurance contracts, we report premiums as revenue over the terms of the related insurance policies on a pro-rata basis or in proportion to expected claims. For single premium mortgage insurance contracts, we report premiums over the estimated policy life in accordance with the expected pattern of risk emergence as further described in our accounting policy for unearned premiums. In addition, we refund post-delinquent premiums received to the insured party if the delinquent loan goes to claim. We record a liability for premiums received on the delinquent loans consistent with our expectations of the rates at which delinquencies go to claim (“claim rates”). Premiums received under annuity contracts without significant mortality risk and premiums received on investment and universal life insurance products are not reported as revenues but rather as deposits and are included in liabilities for policyholder account balances.
Net Investment Income and Net Investment Gains and Losses	b) Net Investment Income and Net Investment Gains and Losses Investment income is recognized when earned. Income or loss upon call or prepayment of available-for-sale fixed maturity securities is recognized in net investment income, except for hybrid securities where the income or loss upon call is recognized in net investment gains and losses. Investment gains and losses are calculated on the basis of specific identification on the trade date. Investment income on mortgage-backed and asset-backed securities is initially based upon yield, cash flow and prepayment assumptions at the date of purchase. Subsequent revisions in those assumptions are recorded using the retrospective or prospective method. Under the retrospective method used for mortgage-backed and asset-backed securities of high credit quality (ratings equal to or greater than “AA” or that are backed by a U.S. agency) which cannot be contractually prepaid in such a manner that we would not recover a substantial portion of the initial investment, amortized cost of the security is adjusted to the amount that would have existed had the revised assumptions been in place at the date of purchase. The adjustments to amortized cost are recorded as a charge or credit to net investment income. Under the prospective method, which is used for all other mortgage-backed and asset-backed securities, future cash flows are estimated and interest income is recognized going forward using the new internal rate of return.
Policy Fees and Other Income	c) Policy Fees and Other Income Policy fees and other income consists primarily of insurance charges assessed on universal and term universal life insurance contracts and fees assessed against customer account values. For universal and term universal life insurance contracts, charges to policyholder accounts for cost of insurance are recognized as revenue when due. Variable product fees are charged to variable annuity contractholders and variable life insurance policyholders based upon the daily net assets of the contractholder’s and policyholder’s account values and are recognized as revenue when charged. Policy surrender fees are recognized as income when the policy is surrendered.
Investment Securities	d) Investment Securities At the time of purchase, we designate our fixed maturity securities as either available-for-sale or trading and report them in our consolidated balance sheets at fair value. Our portfolio of fixed maturity securities comprises primarily investment grade securities. Changes in the fair value of available-for-sale fixed maturity securities, net of the effect on deferred acquisition costs (“DAC”), present value of future profits (“PVFP”), benefit reserves and deferred income taxes, are reflected as unrealized investment gains or losses in a separate component of accumulated other comprehensive income (loss). Equity securities are recorded at fair value in our consolidated balance sheets and changes in the fair value are reflected in net investment gains (losses). Realized and unrealized gains and losses related to trading securities are reflected in net investment gains (losses). Allowance for Credit Losses and Impairments on Available-For-Sale Fixed Maturity Securities On January 1, 2020, we adopted new accounting guidance related to credit losses on financial instruments. Under this new accounting guidance, securities in an unrealized loss position are evaluated to determine whether the decline in fair value is related to credit losses or other factors. In making this assessment, we consider the extent to which fair value is less than amortized cost, any changes to the rating of the security by a rating agency/agencies and adverse conditions specifically related to the security, among other factors. If a credit loss exists, the present value of cash flows expected to be collected from the security is compared to the amortized cost basis of the security. If the present value of cash flows expected to be collected is less than the amortized cost basis and we have either (i) the intent to sell the security, or (ii) it is more likely than not that we will be required to sell the security prior to recovering the amortized cost, we record a reduction to the security’s amortized cost and recognize the loss in net investment gains (losses) for the difference between the security’s amortized cost and estimated fair value. If neither of the two preceding conditions exist, an allowance for credit losses is recorded and a loss is recognized in net investment gains (losses), limited to the amount that the fair value is less than the amortized cost basis. Losses are written off against the allowance when deemed uncollectible or when we intend to sell or expect we will be required to sell a security prior to recovering its amortized cost. When there is an allowance for credit losses, we reassess the credit losses each balance sheet date and subsequent increases or decreases are recorded as an adjustment to the allowance for credit losses, with a corresponding gain or loss recorded in net investment gains (losses). Estimating the cash flows expected to be collected is a quantitative and qualitative process that incorporates information received from third-party sources along with internal assumptions and judgments. When developing the estimate of cash flows expected to be collected at the individual security level, we utilize an analytical model that provides for various loss scenarios and consider the industry sector, current levels of subordination, geographic location and other relevant characteristics of the security or underlying assets, as well as reasonable and supportable forecasts. We regularly monitor our investment portfolio to ensure that securities with a credit loss are identified in a timely manner and any losses are recognized in the proper period. We exclude accrued interest related to available-for-sale fixed maturity securities from the estimate of allowance for credit losses. Accrued interest is included in accrued investment income in our consolidated balance sheet and had a carrying value of $523 million and $532 million as of December 31, 2021 and 2020, respectively. We do not measure an allowance for credit losses related to accrued interest as uncollectible accrued interest related to our available-for-sale fixed maturity securities is written off after 90 days and once collectability is determined to be uncertain and not probable. Amounts written off related to accrued interest are recorded as a credit loss expense included in net investment gains (losses). Prior to the adoption of new accounting guidance related to credit losses on financial instruments on January 1, 2020, we evaluated securities in an unrealized loss position for other-than-temporary impairment as of each balance sheet date. For debt securities, we considered all available information relevant to the collectability of the security, including information about past events, then-current conditions, and reasonable and supportable forecasts, when developing the estimate of cash flows expected to be collected. More specifically for mortgage-backed and asset-backed securities, we also utilized performance indicators of the underlying assets including default or delinquency rates, loan to collateral value ratios, third-party credit enhancements, current levels of subordination, vintage and other relevant characteristics of the security or underlying assets to develop our estimate of cash flows. Estimating the cash flows expected to be collected is a quantitative and qualitative process that incorporates information received from third-party sources along with certain internal assumptions and judgments regarding the future performance of the underlying collateral. Where possible, this data was benchmarked against third-party sources. We recognized other-than-temporary impairments on debt securities in an unrealized loss position when one of the following circumstances exists: • we did not expect full recovery of our amortized cost basis when due, • the present value of cash flows expected to be collected was less than our amortized cost basis, • we intended to sell a security or • it was more likely than not that we would be required to sell a security prior to recovery. For other-than-temporary impairments recognized during the period, we presented the total other-than-temporary impairments, the portion of other-than-temporary impairments included in other comprehensive income (loss) (“OCI”) and the net other-than-temporary impairments as supplemental disclosure presented on the face of our consolidated statements of income. Total other-than-temporary impairments that emerged in the period were calculated as the difference between the amortized cost and fair value. For other-than-temporarily impaired securities where we did not intend to sell the security and it was not more likely than not that we would be required to sell the security prior to recovery, total other-than-temporary impairments were adjusted by the portion of other-than-temporary impairments recognized in OCI (“non-credit”). Net other-than-temporary impairments recorded in net income (loss) represented the credit loss on the other-than-temporarily impaired securities with the offset recognized as an adjustment to the amortized cost to determine the new amortized cost basis of the securities. For securities that were deemed to be other-than-temporarily impaired and a non-credit loss was recorded in OCI, the amount recorded as an unrealized gain (loss) represented the difference between the fair value and the new amortized cost for each period presented. The unrealized gain (loss) on an other-than-temporarily impaired security was recorded as a separate component in OCI until the security was sold or until we recorded an other-than-temporary impairment where we intended to sell the security or were required to sell the security prior to recovery. To estimate the amount of other-than-temporary impairment attributed to credit losses on debt securities where we did not intend to sell the security and it was not more likely than not that we would be required to sell the security prior to recovery, we determined our best estimate of the present value of the cash flows expected to be collected from a security using the effective yield on the security prior to recording any other-than-temporary impairment. If the present value of the discounted cash flows was lower than the amortized cost of the security, the difference between the present value and amortized cost represented the credit loss associated with the security with the remaining difference between fair value and amortized cost recorded as a non-credit other-than-temporary impairment in OCI. While the other-than-temporary impairment model for debt securities generally included fixed maturity securities, there were certain hybrid securities that are classified as fixed maturity securities where the application of a debt impairment model depended on whether there had been any evidence of deterioration in credit of the issuer, such as a downgrade to below investment grade. Under certain circumstances, evidence of deterioration in credit of the issuer may have resulted in the application of the equity securities impairment model where we recognized an impairment charge in the period in which we determined that the security would not recover to book value within a reasonable period of time. We determined what constituted a reasonable period on a security-by-security basis based upon consideration of all the evidence available to us, including the magnitude of an unrealized loss and its duration. In any event, this period did not exceed 15 months. We measured other-than-temporary impairments based upon the difference between the amortized cost of a security and its fair value.
Fair Value Measurements	e) Fair Value Measurements Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. We have fixed maturity securities, short-term investments, equity securities, limited partnerships, derivatives, embedded derivatives, securities held as collateral, separate account assets and certain other financial instruments, which are carried at fair value. Fair value measurements are based upon observable and unobservable inputs. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our view of market assumptions in the absence of observable market information. We utilize valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs. All assets and liabilities carried at fair value are classified and disclosed in one of the following three categories: • Level 1—Quoted prices for identical instruments in active markets. • Level 2—Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations for which inputs are observable or where those significant value drivers are observable. • Level 3—Instruments for which significant value drivers are unobservable. Level 1 primarily consists of financial instruments whose value is based on quoted market prices such as actively traded equity securities and actively traded mutual fund investments. Level 2 includes those financial instruments that are valued using industry-standard pricing methodologies, models or other valuation methodologies. These models are primarily industry-standard models that consider various inputs, such as interest rate, credit spread and foreign exchange rates for the underlying financial instruments. All significant inputs are observable, or derived from observable information in the marketplace or are supported by observable levels at which transactions are executed in the marketplace. Financial instruments in this category primarily include: certain public and private corporate fixed maturity and equity securities; government or agency securities; certain mortgage-backed and asset-backed securities; securities held as collateral; and certain non-exchange-traded derivatives such as interest rate or cross currency swaps. Level 3 comprises financial instruments whose fair value is estimated based on industry-standard pricing methodologies and internally developed models utilizing significant inputs not based on, nor corroborated by, readily available market information. In certain instances, this category may also utilize non-binding broker quotes. This category primarily consists of certain less liquid fixed maturity, equity and trading securities and certain derivative instruments or embedded derivatives where we cannot corroborate the significant valuation inputs with market observable data. As of each reporting period, all assets and liabilities recorded at fair value are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and considers factors specific to the asset or liability, such as the relative impact on the fair value as a result of including a particular input. We review the fair value hierarchy classifications each reporting period. Changes in the observability of the valuation attributes may result in a reclassification of certain financial assets or liabilities. Such reclassifications are reported as transfers in and out of Level 3 at the beginning fair value for the reporting period in which the changes occur. See note 16 for additional information related to fair value measurements.
Commercial Mortgage Loans	f) Commercial Mortgage Loans The carrying value of commercial mortgage loans is stated at principal amounts outstanding, net of unamortized premium or discount, deferred expenses and allowance for credit losses. Interest on loans is recognized on an accrual basis at the applicable interest rate on the principal amount outstanding. Loan origination fees and direct costs, as well as premiums and discounts, are amortized as level yield adjustments over the respective loan terms. Unamortized net fees or costs are recognized upon early repayment of the loans. Loan commitment fees are deferred and amortized on an effective yield basis over the term of the loan. Commercial mortgage loans are considered past due when contractual payments have not been received from the borrower by the required payment date. Loans that are considered uncollectible are carried on non-accrual status. Loans are placed on non-accrual status when, in management’s opinion, the collection of principal or interest is not probable, typically when the collection of principal or interest is 90 days or more past due. In determining whether it is probable that we will be unable to collect all amounts due, we consider current payment status, debt service coverage ratios, occupancy levels and current loan-to-value. Income on loans on non-accrual status is not recognized until we believe it is probable that we will collect all future contractual principal and interest. Commercial mortgage loans are written off against the allowance to the extent principal or interest is deemed uncollectible. We determine the adequacy of the allowance for credit losses utilizing an analytical model that provides various loss scenarios based on historical experience adjusted for current events, trends, economic conditions and reasonable and supportable forecasts that result in a loss in the loan portfolio over the estimated life of the loans. We revert to historical credit loss experience for periods beyond forecasts that are reasonable and supportable. The allowance for credit losses is measured on a collective basis with consideration for debt service coverage ratio, debt-to-value, property-type and geographic location. Key inputs into the analytical model include exposure, weighted-average life, return, historical loss rates and forecast scenarios. Actual amounts realized over time could differ from the amounts estimated for the allowance for credit losses reported in the consolidated financial statements. Additions and reductions to the allowance through periodic provisions or benefits are recorded in net investment gains (losses). See note 4 for additional disclosures related to commercial mortgage loans. Accrued interest related to commercial mortgage loans is included in accrued investment income in our consolidated balance sheet and had a carrying value of $23 million as of December 31, 2021 and 2020. We do not measure an allowance for credit losses related to accrued interest as uncollectible accrued interest related to our commercial mortgage loans is written off after 90 days and once collectability is determined to be uncertain and not probable. Amounts written off related to accrued interest are recorded as a credit loss expense included in net investment gains (losses). Prior to the adoption of new accounting guidance related to credit losses on financial instruments on January 1, 2020, we evaluated the impairment of commercial mortgage loans first on an individual loan basis. “Impaired” loans were defined by U.S. GAAP as loans for which it is probable that the lender will be unable to collect all amounts due according to original contractual terms of the loan agreement. For individually impaired loans, we recorded an impairment charge when it was probable that a loss had been incurred. The impairment was recorded as an increase in the allowance for loan losses. If an individual loan was not deemed impaired, then we evaluated the remaining loans collectively to determine whether an impairment should be recorded. The allowance for loan losses for loans that were not considered individually impaired that were evaluated collectively was maintained at a level that we determined was adequate to absorb estimated probable incurred losses in the loan portfolio. Our process to determine the adequacy of the allowance utilized an analytical model based on historical loss experience adjusted for current events, trends and economic conditions that would result in a loss in the loan portfolio over the next 12 months. Key inputs into our evaluation included debt service coverage ratios, debt-to-value, property-type, occupancy levels, geographic region, and probability weighting of the scenarios generated by the model.
Limited Partnerships	g) Limited Partnerships Limited partnerships are accounted for at fair value when our partnership interest is considered minor (generally less than 3% ownership in the limited partnerships) and we exercise no influence over operating and financial policies. We utilize the net asset value (“NAV”) from the underlying fund statements as a practical expedient for fair value. Changes in the estimated fair value of these investments are included in net investment gains (losses) and income and expenses are reported in net investment income. Investment distributions are evaluated to determine whether the distribution is a return on investment, such as dividend income, or a return of capital. If our ownership percentage exceeds the minor threshold, limited partnerships are accounted for using the equity method of accounting. Our proportionate share of the earnings or losses for limited partnerships accounted for using the equity method of accounting is included in net investment income. In applying either method, we use financial information provided by the investee generally on a one-to-three month lag. However, for limited partnerships measured at fair value, we consider whether an adjustment to the estimated fair value is necessary when the measurement date is not aligned with our reporting date.
Securities Lending Activity	h) Securities Lending Activity Prior to the suspension of our securities lending program in the third quarter of 2021, we engaged in certain securities lending transactions for the purpose of enhancing the yield on our investment securities portfolio. We maintained effective control over all loaned securities and, therefore, continued to report such securities as fixed maturity securities on the consolidated balance sheets. We were indemnified against counterparty credit risk by the intermediary. See note 12 for additional information related to our former securities lending activity.
Cash, Cash Equivalents and Restricted Cash	i) Cash, Cash Equivalents and Restricted Cash Certificates of deposit, money market funds and other highly liquid investments with original maturities of three months or less are considered cash equivalents in the consolidated balance sheets and consolidated statements of cash flows. Items with maturities greater than three months but less than one year at the time of acquisition are generally considered short-term investments.
Deferred Acquisition Costs	j) Deferred Acquisition Costs Acquisition costs include costs that are directly related to the successful acquisition of new or renewal insurance contracts. Acquisition costs are deferred and amortized to the extent they are recoverable from future profits. Long-Duration Contracts Amortization for deferred annuity and universal life insurance contracts is based on expected gross profits. Expected gross profits are adjusted quarterly to reflect actual experience to date or for changes in underlying assumptions relating to future gross profits. Estimates of gross profits for DAC amortization are based on assumptions including interest rates, policyholder persistency or lapses, insured life expectancy or longevity and expenses. We are required to analyze the impacts from net unrealized investment gains and losses on our available-for-sale investment securities backing insurance liabilities, as if those unrealized investment gains and losses were realized. These “shadow accounting” adjustments result in the recognition of unrealized gains and losses on related insurance assets and liabilities in a manner consistent with the recognition of the unrealized gains and losses on available-for-sale investment securities within the statement of comprehensive income and changes in equity. Changes to net unrealized investment (gains) losses may increase or decrease the ending DAC balance. Similar to a loss recognition event, when the DAC balance is reduced to zero, additional insurance liabilities are established if necessary. Unlike a loss recognition event, based on changes in net unrealized investment (gains) losses, these shadow adjustments may reverse from period to period. Therefore, DAC amortized based on expected gross profits is adjusted to reflect the effects that would have been recognized had the unrealized investment (gains) losses been actually realized with a corresponding amount recorded in other comprehensive income (loss). DAC associated with traditional long-duration insurance contracts is not adjusted for unrealized investment (gains) or losses unless a premium deficiency would have resulted upon the (gain) or loss being realized. Short-Duration Contracts. We regularly review our assumptions and test DAC for recoverability at least annually. For deferred annuity and universal life insurance contracts, if the present value of expected future gross profits is less than the unamortized DAC for a line of business, a charge to net income (loss) is recorded for additional DAC amortization. For traditional long-duration and short-duration contracts, if the benefit reserve plus anticipated future premiums and interest income for a line of business are less than the current estimate of future benefits and expenses (including any unamortized DAC), a charge to net income (loss) is recorded for additional DAC amortization or for increased benefit reserves. See note 6 for additional information related to DAC including loss recognition and recoverability.
Intangible Assets	k) Intangible Assets Present Value of Future Profits. We regularly review our PVFP assumptions and periodically test PVFP for recoverability similar to our treatment of DAC. See note 7 for additional information related to PVFP including recoverability. Deferred Sales Inducements to Contractholders. Other Intangible Assets
Reinsurance	l) Reinsurance Premium revenue, benefits and acquisition and operating expenses, net of deferrals, are reported net of the amounts relating to reinsurance ceded to and assumed from other companies. Amounts due from reinsurers for incurred and estimated future claims are reflected in the reinsurance recoverable asset. Amounts received from reinsurers that represent recovery of acquisition costs are netted against DAC so that the net amount is capitalized. The cost of reinsurance is accounted for over the terms of the related treaties using assumptions consistent with those used to account for the underlying reinsured policies. Premium revenue, benefits and acquisition and operating expenses, net of deferrals, for reinsurance contracts that do not qualify for reinsurance accounting are accounted for under the deposit method of accounting. Allowance for Credit Losses on Reinsurance Recoverables On January 1, 2020, we adopted new accounting guidance related to credit losses on financial instruments. Under this new accounting guidance, we record an allowance for credit losses related to reinsurance recoverables. The allowance for credit losses is evaluated based on historical loss experience adjusted for current events and reasonable and supportable forecasts from both internal and external sources. The allowance is measured by reinsurer, taking into consideration the reinsured product type and collateral type, and is calculated based on an externally reported probability of default corresponding to the reinsurer’s credit rating and the expected duration of the reinsurer’s contractual obligation to reimburse us for ceded claims on the underlying policies. Our estimate of the allowance reflects consideration for collateral securing the reinsurance agreements and expected recoveries of amounts previously charged off and expected to be charged off. We also consider other credit risk factors, including, among other factors, the historical frequency and severity of the associated insurance claims, aging of recoverables and regulatory, legal and economic factors, to determine if an additional incremental allowance for credit losses is required. No reversion adjustments are necessary as the starting point for our allowance for credit losses reflects historical loss experience covering the expected duration of the reinsurer’s contractual obligation to reimburse us. If available facts and circumstances indicate the reinsurance recoverable does not reflect expectations consistent with the collective analysis, the reinsurance recoverable is assessed on a separate basis. Write-offs are deducted from the allowance in the period the reinsurance recoverable is determined to be uncollectible.
Derivatives	m) Derivatives Derivative instruments are used to manage risk through one of four principal risk management strategies including: (i) liabilities; (ii) invested assets; (iii) portfolios of assets or liabilities; and (iv) forecasted transactions. On the date we enter into a derivative contract, management designates the derivative as a hedge of the identified exposure (cash flow or foreign currency). If a derivative does not qualify for hedge accounting, the changes in its fair value and all scheduled periodic settlement receipts and payments are reported in net income (loss). We formally document all relationships between hedging instruments and hedged items, as well as our risk management objective and strategy for undertaking various hedge transactions. In this documentation, we specifically identify the asset, liability or forecasted transaction that has been designated as a hedged item, state how the hedging instrument is expected to hedge the risks related to the hedged item, and set forth the method that will be used to retrospectively and prospectively assess the hedging instrument’s effectiveness. We generally determine hedge effectiveness based on total changes in fair value of the hedged item attributable to the hedged risk and the total changes in fair value of the derivative instrument. We discontinue hedge accounting prospectively when: (i) it is determined that the derivative is no longer effective in offsetting changes in the cash flows of a hedged item; (ii) the derivative expires or is sold, terminated or exercised; (iii) the derivative is de-designated as a hedge instrument; or (iv) it is no longer probable that the forecasted transaction will occur. For all qualifying and highly effective cash flow hedges, changes in fair value of the derivative instrument are reported as a component of OCI. When hedge accounting is discontinued because it is probable that a forecasted transaction will not occur, the derivative continues to be carried in the consolidated balance sheets at its fair value, and gains and losses that were accumulated in OCI are recognized immediately in net income (loss). When the hedged forecasted transaction is no longer probable, but is reasonably possible, the accumulated gain or loss remains in OCI and is recognized when the transaction affects net income (loss); however, prospective hedge accounting for the transaction is terminated. In all other situations in which hedge accounting is discontinued on a cash flow hedge, amounts previously deferred in OCI are reclassified into net income (loss) when net income (loss) is impacted by the variability of the cash flow of the hedged item. We may enter into contracts that are not themselves derivative instruments but contain embedded derivatives. For each contract, we assess whether the economic characteristics of the embedded derivative are clearly and closely related to those of the host contract and determine whether a separate instrument with the same terms as the embedded instrument would meet the definition of a derivative instrument. If it is determined that the embedded derivative possesses economic characteristics that are not clearly and closely related to the economic characteristics of the host contract, and that a separate instrument with the same terms would qualify as a derivative instrument, the embedded derivative is separated from the host contract and accounted for as a stand-alone derivative. Such embedded derivatives are recorded in the consolidated balance sheets at fair value and are classified consistent with their host contract. Changes in their fair value are recognized in current period net income (loss). If we are unable to properly identify and measure an embedded derivative for separation from its host contract, the entire contract is carried in the consolidated balance sheets at fair value, with changes in fair value recognized in current period net income (loss). Changes in the fair value of non-qualifying derivatives, including embedded derivatives, are reported in net investment gains (losses). The majority of our derivative arrangements require the posting of collateral upon meeting certain net exposure thresholds. The amounts recognized for derivative counterparty collateral received by us are recorded in cash, cash equivalents and restricted cash with a corresponding amount recorded in other liabilities to represent our obligation to return the collateral retained by us. We also receive non-cash collateral that is not recognized in our consolidated balance sheet unless we exercise our right to sell or re-pledge the underlying asset. As of December 31, 2021 and 2020, the fair value of non-cash collateral received was $53 million and $161 million, respectively, and the underlying assets were not sold or re-pledged. We pledged $536 million and $505 million of fixed maturity securities as of December 31, 2021 and 2020, respectively. Additionally, as of December 31, 2020, we pledged $100 million of cash as collateral to derivative counterparties. Fixed maturity securities that we pledge as collateral remain in our consolidated balance sheet within fixed maturity securities available-for-sale. Any cash collateral pledged to a derivative counterparty is derecognized with a receivable recorded in other assets for the right to receive our cash collateral back from the counterparty. Daily changes in the fair value of the derivative contract, commonly referred to as variation margin, for derivatives cleared through a Central Clearing Party, such as the Chicago Mercantile Exchange are treated as daily settlements of the derivative contract.
Separate Accounts and Related Insurance Obligations	n) Separate Accounts and Related Insurance Obligations Separate account assets represent funds for which the investment income and investment gains and losses accrue directly to the contractholders and are reflected in our consolidated balance sheets at fair value, reported as summary total separate account assets with an equivalent summary total reported for liabilities. Amounts assessed against the contractholders for mortality, administrative and other services are included in revenues. Changes in liabilities for minimum guarantees are included in benefits and other changes in policy reserves. Net investment income, net investment gains (losses) and the related liability changes associated with the separate account are offset within the same line item in the consolidated statements of income. There are no gains or losses on transfers of assets from the general account to the separate account. We offer certain minimum guarantees associated with our variable annuity contracts. Our variable annuity contracts usually contain a basic guaranteed minimum death benefit (“GMDB”) which provides a minimum benefit to be paid upon the annuitant’s death equal to the larger of account value or the return of net deposits. Some variable annuity contracts permit contractholders to purchase through riders, at an additional charge, enhanced death benefits such as the highest contract anniversary value (“ratchets”), accumulated net deposits at a stated rate (“rollups”), or combinations thereof. Additionally, some of our variable annuity contracts provide the contractholder with living benefits such as a guaranteed minimum withdrawal benefit (“GMWB”) or certain types of guaranteed annuitization benefits. The GMWB allows contractholders to withdraw a pre-defined percentage of account value or benefit base each year, either for a specified period of time or for life. The guaranteed annuitization benefit generally provides for a guaranteed minimum level of income upon annuitization accompanied by the potential for upside market participation. Most of our reserves for additional insurance and annuitization benefits are calculated by applying a benefit ratio to accumulated contractholder assessments, and then deducting accumulated paid claims. The benefit ratio is equal to the ratio of benefits to assessments, accumulated with interest and considering both past and anticipated future experience. The projections utilize stochastic scenarios of separate account returns incorporating reversion to the mean, as well as assumptions for mortality and lapses. Some of our minimum guarantees, mainly GMWBs, are accounted for as embedded derivatives; see notes 5 and 16 for additional information on these embedded derivatives and related fair value measurement disclosures.
Insurance Reserves	o) Insurance Reserves Future Policy Benefits The liability for future policy benefits is equal to the present value of expected future benefits and expenses, less the present value of expected future net premiums based on assumptions including projected interest rates and investment returns, health care experience (including type of care and cost of care), policyholder persistency or lapses (i.e., the probability that a policy or contract will remain in-force from one period to the next), insured mortality (i.e., life expectancy or longevity), insured morbidity (i.e., frequency and severity of claim, including claim termination rates and benefit utilization rates) and expenses, all of which are locked-in at the time the policies are issued or acquired. Claim termination rates refer to the expected rates at which claims end. Benefit utilization rates estimate how much of the available policy benefits are expected to be used. The liability for future policy benefits is evaluated at least annually to determine if a premium deficiency exists. Loss recognition testing is generally performed at the line of business level, with acquired blocks and certain reinsured blocks tested separately. If the liability for future policy benefits plus the current present value of expected future gross premiums are less than the current present value of expected future benefits and expenses (including any unamortized DAC), a charge to net income (loss) is recorded for accelerated DAC amortization and, if necessary, a premium deficiency reserve is established. If a charge is recorded, DAC amortization and the liability for future policy benefits are measured using updated assumptions, which become the new locked-in assumptions utilized going forward unless another premium deficiency charge is recorded. Our estimates of future in-force rate actions used in loss recognition testing for our long-term care insurance business include assumptions for significant premium rate increases and associated benefit reductions that have been approved or are anticipated to be approved (including premium rate increases and associated benefit reductions not yet filed). These anticipated future increases are based on our best estimate of the rate increases we expect to obtain, considering, among other factors, our historical experience from prior rate increase approvals and based on our best estimate of expected claim costs. We are also required to accrue additional future policy benefit reserves when the overall reserve is adequate, but profits are projected in early periods followed by losses projected in later periods. When this pattern of projected profits followed by projected losses exists, we ratably accrue this additional profits followed by losses liability over time, increasing reserves in the profitable periods to offset estimated losses expected during the periods that follow. We calculate and adjust the additional reserves using our current best estimate of the amount necessary to offset the losses in future periods, based on the pattern of expected income and current best estimate assumptions consistent with our loss recognition testing. We adjust the accrual rate prospectively, over the remaining profit periods, without any catch-up adjustment. For long-term care insurance products, benefit reductions are treated as partial lapse of coverage with the balance of our future policy benefits and DAC both reduced in proportion to the reduced coverage. For level premium term life insurance products, we floor the liability for future policy benefits on each policy at zero. Estimates and actuarial assumptions used for establishing the liability for future policy benefits and in loss recognition testing involve the exercise of significant judgment, and changes in assumptions or deviations of actual experience from assumptions can have material impacts on our liability for future policy benefits and net income (loss). Because these assumptions relate to factors that are not known in advance, change over time, are difficult to accurately predict and are inherently uncertain, we cannot determine with precision the ultimate amounts we will pay for actual claims or the timing of those payments. Small changes in assumptions or small deviations of actual experience from assumptions can have, and in the past have had, material impacts on our reserves, results of operations and financial condition. The risk that our claims experience may differ significantly from our pricing and valuation assumptions is particularly significant for our long-term care insurance products. Long-term care insurance policies provide for long-duration coverage and, therefore, our actual claims experience will emerge over many years after pricing and locked-in valuation assumptions have been established. Policyholder Account Balances The liability for policyholder account balances represents the contract value that has accrued to the benefit of the policyholder as of the balance sheet date for investment-type and universal and term universal life insurance contracts. We are also required to establish additional benefit reserves for guarantees or product features in addition to the contract value where the additional benefit reserves are calculated by applying a benefit ratio to accumulated contractholder assessments, and then deducting accumulated paid claims. The benefit ratio is equal to the ratio of benefits to assessments, accumulated with interest and considering both past and anticipated future claims experience, which includes assumptions for insured mortality (i.e. life expectancy or longevity), interest rates and policyholder persistency or lapses (i.e., the probability that a policy or contract will remain in-force from one period to the next), among other assumptions. Investment-type contracts are broadly defined to include contracts without significant mortality or morbidity risk. Payments received from sales of investment contracts are recognized by providing a liability equal to the current account value of the policyholders’ contracts. Interest rates credited to investment contracts are guaranteed for the initial policy term with renewal rates determined as necessary by management.
Liability for Policy and Contract Claims	p) Liability for Policy and Contract Claims The liability for policy and contract claims, or claim reserves, represents the amount needed to provide for the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the end of the respective reporting period. The estimated liability includes requirements for future payments of: (a) claims that have been reported to the insurer; (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated; and (c) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees and costs to record, process and adjust claims. Our liability for policy and contract claims is reviewed regularly, with changes in our estimates of future claims recorded through net income (loss). Estimates and actuarial assumptions used for establishing the liability for policy and contract claims involve the exercise of significant judgment, and changes in assumptions or deviations of actual experience from assumptions can have material impacts on our liability for policy and contract claims and net income (loss). Because these assumptions relate to factors that are not known in advance, change over time, are difficult to accurately predict and are inherently uncertain, we cannot determine with precision the ultimate amounts we will pay for actual claims or the timing of those payments. Small changes in assumptions or small deviations of actual experience from assumptions can have, and in the past have had, material impacts on our reserves, results of operations and financial condition. The liability for policy and contract claims for our long-term care insurance products represents the present value of the amount needed to provide for the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the end of the respective reporting period. Key assumptions include projected interest rates and investment returns, health care experience (including type of care and cost of care), policyholder persistency or lapses (i.e., the probability that a policy or contract will remain in-force from one period to the next), insured mortality (i.e., life expectancy or longevity), insured morbidity (i.e., frequency and severity of claim, including claim termination rates and benefit utilization rates) and expenses. Claim termination rates refer to the expected rates at which claims end. Benefit utilization rates estimate how much of the available policy benefits are expected to be used. Both claim termination rates and benefit utilization rates are influenced by, among other things, gender, age at claim, diagnosis, type of care needed, benefit period, and daily benefit amount. Because these assumptions relate to factors that are not known in advance, change over time, are difficult to accurately predict and are inherently uncertain, we cannot determine with precision the ultimate amounts we will pay for actual claims or the timing of those payments. Small changes in assumptions or small deviations of actual experience from assumptions can have, and in the past have had, material impacts on our reserves, results of operations and financial condition. The liabilities for our mortgage insurance policies represent our best estimates of the liabilities at the time based on known facts, trends and other external factors, including economic conditions, housing prices, unemployment, government housing policies, state foreclosure timeline, interest rates, tax policy, credit availability and mortgage products. For our mortgage insurance policies, reserves for losses and loss adjustment expenses are based on notices of mortgage loan defaults and estimates of defaults that have been incurred but have not been reported by loan servicers. Reserves for losses are established by estimating the number of loans in our inventory of delinquent loans that will result in a claim payment, which is referred to as the claim rate, and further estimating the amount of the claim payment, which is referred to as claim severity. The estimates are determined using a factor-based approach, in which assumptions of claim rates for loans in default and the average amount paid for loans that result in a claim are calculated using traditional actuarial techniques. As is common accounting practice in the mortgage insurance industry and in accordance with U.S. GAAP, we do not establish loss reserves for future claims on insured loans that are not in default or believed to be in default. Over time, as the status of the underlying delinquent loans moves toward foreclosure and the likelihood of the associated claim loss increases, the amount of the loss reserves associated with the potential claims may also increase. Management considers the liability for policy and contract claims provided to be its best estimate to cover the losses that have occurred. Management monitors actual experience, and where circumstances warrant, will revise its assumptions. The methods of determining such estimates and establishing the reserves are reviewed periodically and any adjustments are reflected in operations in the period in which they become known. Future developments may result in losses and loss expenses greater or less than the liability for policy and contract claims provided.
Unearned Premiums	q) Unearned Premiums For single premium insurance contracts, we recognize premiums over the policy life in accordance with the expected pattern of risk emergence. We recognize a portion of the revenue in premiums earned in the current period, while the remaining portion is deferred as unearned premiums and earned over time in accordance with the expected pattern of risk emergence. If single premium policies are cancelled and the premium is non-refundable, then the remaining unearned premium related to each cancelled policy is recognized to earned premiums upon notification of the cancellation. Expected pattern of risk emergence on which we base premium recognition is inherently judgmental and is based on actuarial analysis of historical experience. We periodically review our premium earnings recognition models with any adjustments to the estimates reflected as a cumulative adjustment in current period net income (loss). Our reviews include the consideration of recent and projected loss experience, policy cancellation experience and refinement of actuarial methods. We did not have any adjustments associated with this review in 2021 and 2020. In 2019, the review resulted in a decrease in unearned premiums of $14 million in our Enact segment.
Stock-Based Compensation	r) Stock-Based Compensation We determine a grant date fair value and recognize the related compensation expense, adjusted for expected forfeitures, through the income statement over the respective vesting period of the awards.
Employee Benefit Plans	s) Employee Benefit Plans We provide employees with a defined contribution pension plan and recognize expense throughout the year based on the employee’s age, service and eligible pay. We make an annual contribution to the plan. We also provide employees with defined contribution savings plans. We recognize expense for our contributions to the savings plans at the time employees make contributions to the plans. Some employees participate in defined benefit pension and postretirement benefit plans. We recognize expense for these plans based upon actuarial valuations performed by external experts. We estimate aggregate benefits by using assumptions for employee turnover, future compensation increases, rates of return on pension plan assets and future health care costs. We recognize an expense for differences between actual experience and estimates over the average future service period of participants. We recognize the overfunded or underfunded status of a defined benefit plan as an asset or liability in our consolidated balance sheets and recognize changes in that funded status in the year in which the changes occur through OCI.
Income Taxes	t) Income Taxes We determine deferred tax assets and/or liabilities by multiplying the differences between the financial reporting and tax reporting bases for assets and liabilities by the enacted tax rates expected to be in effect when such differences are recovered or settled if there is no change in law. The effect on deferred taxes of a change in tax rates is recognized in net income (loss) in the period that includes the enactment date. Valuation allowances on deferred tax assets are estimated based on our assessment of the realizability of such amounts. Under U.S. GAAP, we are generally required to record U.S. deferred taxes on the anticipated repatriation of foreign income as the income is recognized for financial reporting purposes. An exception under certain accounting guidance permits us not to record a U.S. deferred tax liability for foreign income that we expect to reinvest in our foreign operations and for which remittance will be postponed indefinitely. If it becomes apparent that we cannot positively assert that some or all undistributed income will be reinvested indefinitely, the related deferred taxes are recorded in that period based on the expected form of repatriation (i.e. distribution, loan or sale). In determining indefinite reinvestment, we regularly evaluate the capital needs of our domestic and foreign operations considering all available information, including operating and capital plans, regulatory capital requirements, parent company financing and cash flow needs, as well as the applicable tax laws to which our domestic and foreign subsidiaries are subject. Similarly, under another exception to the recognition of deferred taxes under U.S. GAAP, we do not record deferred taxes on U.S. domestic subsidiary entities for the excess of the financial statement carrying amount over the tax basis in the stock of the subsidiary (commonly referred to as “outside basis difference”) if we have the ability under the tax law and intent to recover the basis difference in a tax free manner. Deferred taxes would be recognized in the period of a change to our ability or intent. Our companies have elected to file a single U.S. consolidated income tax return (the “life/non-life consolidated return”). All companies domesticated in the United States are included in the life/non-life consolidated return as allowed by the tax law and regulations. We have a tax sharing agreement in place and all intercompany balances related to this agreement are settled at least annually.
Foreign Currency Translation	u) Foreign Currency Translation The determination of the functional currency is made based on the appropriate economic and management indicators. The assets and liabilities of foreign operations are translated into U.S. dollars at the exchange rates in effect at the balance sheet date. Translation adjustments are included as a separate component of accumulated other comprehensive income (loss). Revenues and expenses of the foreign operations are translated into U.S. dollars at the average rates of exchange during the period of the transaction. Gains and losses from foreign currency transactions are reported in net income and have not been material in any years presented in our consolidated statements of income.
Variable Interest Entities	v) Variable Interest Entities We are involved in certain entities that are considered VIEs as defined under U.S. GAAP, and, accordingly, we evaluate the VIE to determine whether we are the primary beneficiary and are required to consolidate the assets and liabilities of the entity. The primary beneficiary of a VIE is the enterprise that has the power to direct the activities of a VIE that most significantly impacts the VIE’s economic performance and has the obligation to absorb losses or receive benefits that could potentially be significant to the VIE. The determination of the primary beneficiary for a VIE can be complex and requires management judgment regarding the expected results of the entity and how those results are absorbed by variable interest holders, as well as which party has the power to direct activities that most significantly impact the performance of the VIEs. Our primary involvement related to VIEs includes securitization transactions, certain investments, reinsurance transactions and certain mortgage insurance policies. We have a beneficial interest in a VIE where we are the servicer and transferor of certain assets that were sold to the VIE. Our primary economic interest in this VIE represents the excess interest of the commercial mortgage loans. This securitization entity was designed to have significant limitations on the types of assets owned, the types and extent of permitted activities and decision making rights and is comprised of an entity backed by commercial mortgage loans. As a result of our involvement in the entity’s design or having certain decision making ability regarding the assets held by the securitization entity, consolidation of the VIE is required. As of December 31, 2021 and 2020, we had $29 million and $38 million, respectively, of total securitized assets required to be consolidated. The assets held by the securitization entity are restricted and can only be used to fulfill the obligations of the securitization entity. We do not have any additional exposure or guarantees associated with this securitization entity. There was no new asset securitization activity in 2021. We have reinsurance agreements with entities that are considered VIEs. Our involvement with these VIEs represents mortgage insurance claim coverage through excess of loss reinsurance, which includes significant insurance risk and a reasonable possibility of a significant loss but does not result in the unilateral power to direct the activities that most significantly affect the VIEs’ economic performance or result in the obligation to absorb losses or the right to receive benefits. Accordingly, consolidation of the VIEs is not required. The assets of the VIEs are deposited in a reinsurance trust for our benefit that will be the source of reinsurance claim payments. Refer to note 8 for additional information related to our reinsurance agreements with entities that are considered VIEs. We hold investments in certain structures that are considered VIEs. Our investments represent beneficial interests that are primarily in the form of structured securities or limited partnership investments. Our involvement in these structures typically represents a passive investment in the returns generated by the VIE and typically does not result in having significant influence over the economic performance of the VIE. We also provide mortgage insurance on certain residential mortgage loans originated and securitized by third parties using VIEs to issue mortgage-backed securities. While we provide mortgage insurance on the underlying loans, we do not typically have any ongoing involvement with the VIE other than our mortgage insurance coverage and do not act in a servicing capacity for the underlying loans held by the VIE.
Accounting Pronouncements Recently Adopted	w) Accounting Changes Simplification of accounting for income taxes On January 1, 2021, we adopted new accounting guidance related to simplifying the accounting for income taxes. The guidance eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. We adopted this new accounting guidance using the retrospective method or modified retrospective method for certain changes and prospective method for all other changes, which did not have a significant impact on our consolidated financial statements and disclosures. Defined Benefit Plan Disclosures On January 1, 2020, we adopted new accounting guidance related to disclosure requirements for defined benefit plans as part of the Financial Accounting Standards Board’s (the “FASB”) disclosure framework project. The guidance adds, eliminates and modifies certain disclosure requirements for defined benefit pension and other postretirement benefit plans. We adopted this accounting guidance using the retrospective method, which did not have a significant impact on our consolidated financial statements and disclosures. Fair Value Disclosures On January 1, 2020, we adopted new accounting guidance related to fair value disclosure requirements as part of the FASB’s disclosure framework project. The guidance adds, eliminates and modifies certain disclosure requirements for fair value measurements. The guidance includes new disclosure requirements related to changes in unrealized gains and losses included in other comprehensive income (loss) for recurring Level 3 fair value measurements held at the end of the reporting period and the range and weighted-average of significant unobservable inputs used to develop Level 3 fair value measurements. We adopted this accounting guidance using the prospective method for disclosures related to changes in unrealized gains and losses included in other comprehensive income (loss) for recurring Level 3 fair value measurements held at the end of the reporting period, the range and weighted-average of significant unobservable inputs used to develop Level 3 fair value measurements and the narrative description of measurement uncertainty and the retrospective method for all other disclosures. This accounting guidance did not impact our consolidated financial statements but impacted our fair value disclosures. Accounting for Credit Losses on Financial Instruments On January 1, 2020, we adopted new accounting guidance related to accounting for credit losses on financial instruments. The guidance requires entities to recognize an allowance equal to its estimate of lifetime expected credit losses and applies to most financial instruments not measured at fair value, which primarily includes our commercial mortgage loans, bank loan investments and reinsurance recoverables. The guidance also requires the recognition of an allowance for expected credit losses as a liability in our consolidated balance sheet for off-balance sheet credit exposures, including commitments to fund bank loan investments, private placement investments and commercial mortgage loans. The FASB also issued an amendment to the guidance allowing entities to irrevocably elect the fair value option on an instrument-by-instrument basis for eligible instruments, which we did not elect. We adopted the guidance related to our investments carried at amortized cost, reinsurance recoverables and off-balance sheet credit exposures using the modified retrospective method. We recorded an allowance related to lifetime expected credit losses of $23 million, net of deferred taxes of $6 million, for commercial mortgage loans and bank loan investments and $31 million, net of deferred taxes of $9 million, for reinsurance recoverables, with an offset to cumulative effect of change in accounting within retained earnings. See notes 4 and 8 for additional disclosures related to lifetime expected credit losses. In addition, we recorded an allowance related to lifetime expected credit losses for our off-balance sheet credit exposures of $1 million, included in other liabilities in our consolidated balance sheet, with an offset to cumulative effect of change in accounting within retained earnings. We adopted the guidance related to our available-for-sale fixed maturity securities for which a previous other-than-temporary impairment was recognized prior to the date of adoption using the prospective method and the modified retrospective method for all other available-for-sale fixed maturity securities, which did not have any impact upon adoption. The guidance did not have a significant impact on other assets not measured at fair value. Reference Rate Reform In March 2020 and January 2021, the FASB issued new accounting guidance related to reference rate reform, which was effective for us on January 1, 2020. The guidance provides temporary guidance to ease the potential burden in accounting for, or recognizing the effects of, reference rate reform, which includes the transition away from the London Interbank Offered Rate (“LIBOR”) and other interbank offered rates to alternative reference rates, such as the Secured Overnight Financing Rate. This guidance provides optional practical expedients and exceptions for applying generally accepted accounting principles to investments, derivatives or other transactions affected by reference rate reform such as those that impact the assessment of derivative hedge effectiveness and contract modifications, to include continuing hedge accounting when certain critical terms of a hedging relationship change and modifying certain effectiveness assessments to exclude certain potential sources of ineffectiveness. The guidance was updated to clarify that the optional practical expedients and exceptions can be applied to derivatives that use an interest rate for margining, discounting, or contract price alignment. In addition to the optional practical expedients, the guidance includes a general principle that permits an entity to consider contract modifications due to reference rate reform to be an event that does not require contract remeasurement at the modification date or reassessment of a previous accounting determination. We adopted this guidance prospectively and it did not have a significant impact on our consolidated financial statements or disclosures. However, the amendments in this guidance may be elected over time through December 31, 2022 as reference rate reform activities occur and therefore, this guidance may impact our procedures, including our process for assessing the effectiveness of our cash flow hedging relationships, determined on an individual hedge basis, as we implement measures to transition away from LIBOR. Benchmark Interest Rates Used in Derivative Hedge Accounting On January 1, 2019, we adopted new accounting guidance related to benchmark interest rates used in derivative hedge accounting. The guidance adds an additional permissible U.S. benchmark interest rate, the Secured Overnight Financing Rate, for hedge accounting purposes. We adopted this accounting guidance using the prospective method, which did not have any impact on our consolidated financial statements and disclosures. Nonemployee Shared-Based Payments On January 1, 2019, we adopted new accounting guidance related to accounting for nonemployee share-based payments. The guidance aligns the measurement and classification of share-based payments to nonemployees issued in exchange for goods or services with the guidance for share-based payments to employees, with certain exceptions. We adopted this accounting guidance using the modified retrospective method. This guidance is consistent with our previous accounting practices and, accordingly, had no impact on our consolidated financial statements at adoption. Amortization Period of Certain Callable Debt Securities Held at a Premium On January 1, 2019, we adopted new accounting guidance related to shortening the amortization period of certain callable debt securities held at a premium. The guidance requires the premium to be amortized to the earliest call date. This change does not apply to securities held at a discount. We adopted this accounting guidance using the modified retrospective method, which did not have a significant impact on our consolidated financial statements at adoption. Accounting for Leases On January 1, 2019, we adopted new accounting guidance related to the accounting for leases. The guidance generally requires lessees to recognize both a right-of-use asset and a corresponding lease liability on the balance sheet. We adopted this accounting guidance using the effective date transition method, which permits entities to apply the new lease standard using a modified retrospective transition approach at the date of adoption. The package of practical expedients was also elected upon adoption. Upon adoption we recorded a $52 million right-of-use asset lease liability Our leased assets are predominantly classified as operating leases and consist of office space in eight locations in the United States. Lease payments included in the calculation of our lease liability include fixed amounts contained within each rental agreement and variable lease payments that are based upon an index or rate. We have elected to combine lease and non-lease components, as permitted under this new accounting guidance, and as a result, non-lease components are included in the calculation of our lease liability as opposed to being separated and accounted for as consideration under the new revenue recognition standard. Our remaining lease terms ranged from less than 1 year to 17 years and had a weighted-average remaining lease term of ten years as of December 31, 2021. The implicit rate of our lease agreements was not readily determinable; therefore, we utilized our incremental borrowing rate to discount future lease payments. The weighted-average discount rate was 6.6% as of December 31, 2021. The amount of contractual undiscounted lease obligations due in 2022, 2023, 2024, 2025, and 2026 and thereafter is $6 million, $8 million, $8 million, $8 million and $33 million, respectively. As of December 31, 2021, the operating lease liability recorded in our consolidated balance sheet of $45 million was net of imputed interest of $18 million.
Accounting Pronouncements Not Yet Adopted	x) Accounting Pronouncements Not Yet Adopted In August 2018, the FASB issued new accounting guidance that significantly changes the recognition and measurement of long-duration insurance contracts and expands disclosure requirements, which impacts our life insurance DAC and liabilities. In accordance with the guidance, the more significant changes include: • assumptions will no longer be locked-in at contract inception and all cash flow assumptions used to estimate the liability for future policy benefits (except the discount rate) will be reviewed at least annually in the same period each year or more frequently if actual experience indicates a change is required. Changes will be recorded in net income (loss) using a retrospective approach with a cumulative catch-up adjustment by recalculating the net premium ratio (which will be capped at 100%) using actual historical and updated future cash flow assumptions; • the discount rate used to determine the liability for future policy benefits will be a current upper-medium grade (low credit risk) fixed-income instrument yield, which is generally interpreted to mean a single-A rated bond rate for the same duration, and is required to be reviewed quarterly, with changes in the discount rate recorded in other comprehensive income (loss); • the provision for adverse deviation and the premium deficiency test will be eliminated; • market risk benefits associated with deposit-type contracts will be measured at fair value with changes related to instrument-specific credit risk recorded in other comprehensive income (loss) and remaining changes recorded in net income (loss); • the amortization method for DAC will generally be on a straight-line basis over the expected contract term; and • disclosures will be greatly expanded to include significant assumptions and product liability rollforwards. This guidance is effective for us on January 1, 2023 using the modified retrospective method (with transition adjustments as of January 1, 2021) for all topics except for market risk benefits, which is required to be applied using the retrospective method, with early adoption permitted, which we do not intend to elect. We are currently in the process of obtaining necessary data, modifying systems, identifying and developing key inputs and assumptions and establishing policies, systems and internal controls necessary to implement this new accounting guidance. Given the nature and extent of the changes, this guidance is expected to have a significant impact on our consolidated financial statements and significantly reduce our equity at transition primarily due to the change in the discount rate used to determine our liability for future policy benefits.

Earnings (Loss) Per Share (Tabl

Earnings (Loss) Per Share (Tables)	12 Months Ended
	Dec. 31, 2021
Earnings (Loss) Per Share	Basic and diluted earnings (loss) per share are calculated by dividing each income (loss) category presented below by the weighted-average basic and diluted common shares outstanding for the years ended December 31: (Amounts in millions, except per share amounts) 2021 2020 2019 Weighted-average common shares used in basic earnings (loss) per share calculations 506.9 505.2 502.9 Potentially dilutive securities: Stock options, restricted stock units and stock appreciation rights 7.8 6.4 6.8 Weighted-average common shares used in diluted earnings (loss) per share calculations 514.7 511.6 509.7 Income from continuing operations: Income from continuing operations $ 918 $ 698 $ 382 Less: net income from continuing operations attributable to noncontrolling interests 33 — — Income from continuing operations available to Genworth Financial, Inc.’s common stockholders $ 885 $ 698 $ 382 Basic per share $ 1.75 $ 1.38 $ 0.76 Diluted per share $ 1.72 $ 1.36 $ 0.75 Income (loss) from discontinued operations: Income (loss) from discontinued operations, net of taxes $ 27 $ (486 ) $ 148 Less: net income from discontinued operations attributable to noncontrolling interests 8 34 187 Income (loss) from discontinued operations available to Genworth Financial, Inc.’s common stockholders $ 19 $ (520 ) $ (39 ) Basic per share $ 0.04 $ (1.03 ) $ (0.08 ) Diluted per share $ 0.04 $ (1.02 ) $ (0.08 ) Net income (loss): Income from continuing operations $ 918 $ 698 $ 382 Income (loss) from discontinued operations, net of taxes 27 (486 ) 148 Net income 945 212 530 Less: net income attributable to noncontrolling interests 41 34 187 Net income available to Genworth Financial, Inc.’s common stockholders $ 904 $ 178 $ 343 Basic per share (1) $ 1.78 $ 0.35 $ 0.68 Diluted per share (1) $ 1.76 $ 0.35 $ 0.67 (1) May not total due to whole number calculation.

Investments (Tables)

Investments (Tables)	12 Months Ended
	Dec. 31, 2021
Net Investment Income	Sources of net investment income were as follows for the years ended December 31: (Amounts in millions) 2021 2020 2019 Fixed maturity securities—taxable $ 2,411 $ 2,448 $ 2,444 Fixed maturity securities—non-taxable 7 6 8 Equity securities 9 12 12 Commercial mortgage loans 376 345 348 Policy loans 189 199 180 Limited partnerships 223 72 44 Other invested assets 241 223 190 Cash, cash equivalents, restricted cash and short-term investments 1 15 33 Gross investment income before expenses and fees 3,457 3,320 3,259 Expenses and fees (87 ) (93 ) (95 ) Net investment income $ 3,370 $ 3,227 $ 3,164
Net Investment Gains (Losses)	The following table sets forth net investment gains (losses) for the years ended December 31: (Amounts in millions) 2021 2020 2019 Realized investment gains (losses): Available-for-sale fixed maturity securities: Realized gains $ 67 $ 471 $ 90 Realized losses (10 ) (29 ) (38 ) Net realized gains (losses) on available-for-sale fixed maturity securities 57 442 52 Net realized gains (losses) on equity securities sold (7 ) (1 ) — Net realized gains (losses) on limited partnerships 3 — 1 Total net realized investment gains (losses) 53 441 53 Impairments: Total other-than-temporary impairments — — (1 ) Portion of other-than-temporary impairments included in other comprehensive income (loss) — — — Net other-than-temporary impairments — — (1 ) Net change in allowance for credit losses on available-for-sale fixed maturity securities (6 ) (5 ) — Write-down of available-for-sale fixed maturity securities (1) (1 ) (4 ) — Net unrealized gains (losses) on equity securities still held 1 4 14 Net unrealized gains (losses) on limited partnerships 264 112 28 Commercial mortgage loans (3 ) (2 ) (2 ) Derivative instruments (2) 14 (49 ) (70 ) Other 1 (5 ) 5 Net investment gains (losses) $ 323 $ 492 $ 27 (1) Represents write-down of securities deemed uncollectible or that we intend to sell or will be required to sell prior to recovery of the amortized cost basis. (2) See note 5 for additional information on the impact of derivative instruments included in net investment gains (losses).
Allowance for credit losses related to fixed maturity securities	The following table represents the allowance for credit losses aggregated by security type for available-for-sale fixed maturity investments as of and for the years ended December 31: 2021 (Amounts in millions) Beginning Increase Increase Securities Decrease Write-offs Recoveries Ending Fixed maturity securities: Non-U.S. corporate $ 1 $ — $ 6 $ (7 ) $ — $ — $ — $ — Commercial mortgage-backed 3 — — — — (3 ) — — Total available-for-sale fixed maturity securities $ 4 $ — $ 6 $ (7 ) $ — $ (3 ) $ — $ — 2020 (Amounts in millions) Beginning Increase Increase Securities Decrease Write-offs Recoveries Ending Fixed maturity securities: Non-U.S. corporate $ — $ 4 $ (2 ) $ (1 ) $ — $ — $ — $ 1 Commercial mortgage-backed — 3 — — — — — 3 Total available-for-sale fixed maturity securities $ — $ 7 $ (2 ) $ (1 ) $ — $ — $ — $ 4
Credit Losses Recognized in Net Income (Loss)	The following represents the activity for credit losses recognized in net income (loss) on debt securities where an other-than-temporary impairment was identified and a portion of other-than-temporary impairments was included in OCI as of and for the year ended December 31, 2019: (Amounts in millions) Beginning balance $ 24 Reductions: Securities sold, paid down or disposed (2 ) Ending balance $ 22
Unrealized Investment Gains and Losses	Net unrealized gains and losses on available-for-sale investment securities reflected as a separate component of accumulated other comprehensive income (loss) were as follows as of December 31: (Amounts in millions) 2021 2020 2019 Net unrealized gains (losses) on fixed maturity securities without an allowance for credit losses (1) $ 7,869 $ 10,159 $ 6,676 Net unrealized gains (losses) on fixed maturity securities with an allowance for credit losses (1) — (7 ) — Adjustments to DAC, PVFP, sales inducements, benefit reserves and policyholder contract balances (5,487 ) (7,302 ) (4,789 ) Income taxes, net (507 ) (611 ) (406 ) Net unrealized investment gains (losses) 1,875 2,239 1,481 Less: net unrealized investment gains (losses) attributable to noncontrolling interests 15 25 25 Net unrealized investment gains (losses) attributable to Genworth Financial, Inc. $ 1,860 $ 2,214 $ 1,456 (1) Excludes foreign exchange.
Change in Net Unrealized Gains (Losses) on Available-for-Sale Investment Securities Reported in Accumulated Other Comprehensive Income (Loss)	The change in net unrealized gains (losses) on available-for-sale investment securities reported in accumulated other comprehensive income (loss) was as follows as of and for the years ended December 31: (Amounts in millions) 2021 2020 2019 Beginning balance $ 2,214 $ 1,456 $ 595 Unrealized gains (losses) arising during the period: Unrealized gains (losses) on fixed maturity securities (2,218 ) 3,950 4,980 Adjustment to DAC (1) 30 122 (956 ) Adjustment to PVFP — (1 ) (49 ) Adjustment to sales inducements 12 (5 ) (32 ) Adjustment to benefit reserves and policyholder contract balances (2) 1,773 (2,629 ) (2,800 ) Provision for income taxes 90 (305 ) (233 ) Change in unrealized gains (losses) on investment securities (313 ) 1,132 910 Reclassification adjustments to net investment (gains) losses, net of taxes of $14, $100 and $17 (51 ) (374 ) (62 ) Change in net unrealized investment gains (losses) (364 ) 758 848 Less: change in net unrealized investment gains (losses) attributable to noncontrolling interests (10 ) — (13 ) Ending balance $ 1,860 $ 2,214 $ 1,456 (1) See note 6 for additional information. (2) See note 9 for additional information.
Fixed Maturity Securities	As of December 31, 2021, the amortized cost or cost, gross unrealized gains (losses), allowance for credit losses and fair value of our fixed maturity securities classified as available-for-sale were as follows: (Amounts in millions) Amortized Gross Gross Allowance Fair Fixed maturity securities: U.S. government, agencies and government-sponsored enterprises $ 3,368 $ 1,184 $ — $ — $ 4,552 State and political subdivisions 2,982 474 (6 ) — 3,450 Non-U.S. government 762 86 (13 ) — 835 U.S. corporate: Utilities 4,330 783 (9 ) — 5,104 Energy 2,581 363 (10 ) — 2,934 Finance and insurance 8,003 1,012 (24 ) — 8,991 Consumer—non-cyclical 5,138 1,029 (8 ) — 6,159 Technology and communications 3,345 476 (13 ) — 3,808 Industrial 1,322 175 (3 ) — 1,494 Capital goods 2,334 415 (4 ) — 2,745 Consumer—cyclical 1,703 203 (7 ) — 1,899 Transportation 1,122 249 — — 1,371 Other 379 41 (1 ) — 419 Total U.S. corporate 30,257 4,746 (79 ) — 34,924 Non-U.S. corporate: Utilities 867 63 (2 ) — 928 Energy 1,194 190 (1 ) — 1,383 Finance and insurance 2,171 270 (9 ) — 2,432 Consumer—non-cyclical 664 81 (2 ) — 743 Technology and communications 1,085 166 (1 ) — 1,250 Industrial 933 117 (3 ) — 1,047 Capital goods 640 66 (1 ) — 705 Consumer—cyclical 316 27 (2 ) — 341 Transportation 422 68 (1 ) — 489 Other 1,052 169 (4 ) — 1,217 Total non-U.S. corporate 9,344 1,217 (26 ) — 10,535 Residential mortgage-backed 1,325 116 (1 ) — 1,440 Commercial mortgage-backed 2,435 152 (3 ) — 2,584 Other asset-backed 2,138 29 (7 ) — 2,160 Total available-for-sale fixed maturity securities $ 52,611 $ 8,004 $ (135 ) $ — $ 60,480 As of December 31, 2020, the amortized cost or cost, gross unrealized gains (losses), allowance for credit losses and fair value of our fixed maturity securities classified as available-for-sale were as follows: (Amounts in millions) Amortized Gross Gross Allowance Fair Fixed maturity securities: U.S. government, agencies and government-sponsored enterprises $ 3,401 $ 1,404 $ — $ — $ 4,805 State and political subdivisions 2,622 544 (1 ) — 3,165 Non-U.S. government 728 130 (4 ) — 854 U.S. corporate: Utilities 4,226 970 (2 ) — 5,194 Energy 2,532 367 (16 ) — 2,883 Finance and insurance 7,798 1,306 (2 ) — 9,102 Consumer—non-cyclical 5,115 1,323 (1 ) — 6,437 Technology and communications 3,142 619 — — 3,761 Industrial 1,370 232 — — 1,602 Capital goods 2,456 535 — — 2,991 Consumer—cyclical 1,663 284 — — 1,947 Transportation 1,198 304 (2 ) — 1,500 Other 395 45 — — 440 Total U.S. corporate 29,895 5,985 (23 ) — 35,857 Non-U.S. corporate: Utilities 838 84 — — 922 Energy 1,172 209 (1 ) — 1,380 Finance and insurance 2,130 353 (6 ) (1 ) 2,476 Consumer—non-cyclical 662 112 (1 ) — 773 Technology and communications 1,062 229 — — 1,291 Industrial 969 159 — — 1,128 Capital goods 510 67 (1 ) — 576 Consumer—cyclical 331 41 (1 ) — 371 Transportation 483 88 (1 ) — 570 Other 1,088 236 — — 1,324 Total non-U.S. corporate 9,245 1,578 (11 ) (1 ) 10,811 Residential mortgage-backed 1,698 211 — — 1,909 Commercial mortgage-backed 2,759 231 (13 ) (3 ) 2,974 Other asset-backed 3,069 55 (4 ) — 3,120 Total available-for-sale fixed maturity securities $ 53,417 $ 10,138 $ (56 ) $ (4 ) $ 63,495
Gross Unrealized Losses and Fair Values of Securities in a Continuous Unrealized Loss Position	The following table presents the gross unrealized losses and fair values of our fixed maturity securities for which an allowance for credit losses has not been recorded, aggregated by investment type and length of time that individual fixed maturity securities have been in a continuous unrealized loss position, as of December 31, 2021: Less than 12 months 12 months or more Total (Dollar amounts in millions) Fair Gross Number of Fair Gross Number of Fair Gross Number of Description of Securities Fixed maturity securities: State and political subdivisions $ 339 $ (6 ) 67 $ — $ — — $ 339 $ (6 ) 67 Non-U.S. government 173 (9 ) 28 19 (4 ) 1 192 (13 ) 29 U.S. corporate 2,593 (64 ) 266 196 (15 ) 22 2,789 (79 ) 288 Non-U.S. corporate 912 (21 ) 124 62 (5 ) 8 974 (26 ) 132 Residential mortgage-backed 97 (1 ) 22 — — — 97 (1 ) 22 Commercial mortgage-backed 113 (2 ) 17 31 (1 ) 4 144 (3 ) 21 Other asset-backed 764 (7 ) 111 — — — 764 (7 ) 111 Total for fixed maturity securities in an unrealized loss position $ 4,991 $ (110 ) 635 $ 308 $ (25 ) 35 $ 5,299 $ (135 ) 670 % Below cost: <20% Below cost $ 4,991 $ (110 ) 635 $ 297 $ (20 ) 33 $ 5,288 $ (130 ) 668 20%-50% Below cost — — — 11 (5 ) 2 11 (5 ) 2 Total for fixed maturity securities in an unrealized loss position $ 4,991 $ (110 ) 635 $ 308 $ (25 ) 35 $ 5,299 $ (135 ) 670 Investment grade $ 4,644 $ (101 ) 587 $ 241 $ (12 ) 25 $ 4,885 $ (113 ) 612 Below investment grade 347 (9 ) 48 67 (13 ) 10 414 (22 ) 58 Total for fixed maturity securities in an unrealized loss position $ 4,991 $ (110 ) 635 $ 308 $ (25 ) 35 $ 5,299 $ (135 ) 670 The following table presents the gross unrealized losses and fair values of our corporate securities for which an allowance for credit losses has not been recorded, aggregated by investment type and length of time that individual investment securities have been in a continuous unrealized loss position, based on industry, as of December 31, 2021: Less than 12 months 12 months or more Total (Dollar amounts in millions) Fair Gross Number of Fair Gross Number of Fair Gross Number of Description of Securities U.S. corporate: Utilities $ 211 $ (7 ) 32 $ 29 $ (2 ) 7 $ 240 $ (9 ) 39 Energy 166 (3 ) 18 25 (7 ) 4 191 (10 ) 22 Finance and insurance 960 (22 ) 89 62 (2 ) 3 1,022 (24 ) 92 Consumer—non-cyclical 296 (7 ) 30 14 (1 ) 2 310 (8 ) 32 Technology and communications 378 (12 ) 37 29 (1 ) 2 407 (13 ) 39 Industrial 143 (3 ) 18 — — — 143 (3 ) 18 Capital goods 171 (3 ) 16 18 (1 ) 2 189 (4 ) 18 Consumer—cyclical 268 (7 ) 26 — — — 268 (7 ) 26 Other — — — 19 (1 ) 2 19 (1 ) 2 Subtotal, U.S. corporate securities 2,593 (64 ) 266 196 (15 ) 22 2,789 (79 ) 288 Non-U.S. corporate: Utilities 69 (2 ) 9 — — — 69 (2 ) 9 Energy 64 (1 ) 10 — — — 64 (1 ) 10 Finance and insurance 366 (8 ) 43 18 (1 ) 2 384 (9 ) 45 Consumer—non-cyclical 67 (1 ) 12 6 (1 ) 1 73 (2 ) 13 Technology and communications 48 (1 ) 8 — — — 48 (1 ) 8 Industrial 122 (3 ) 14 — — — 122 (3 ) 14 Capital goods 78 (1 ) 8 — — — 78 (1 ) 8 Consumer—cyclical 22 (1 ) 8 15 (1 ) 3 37 (2 ) 11 Transportation 37 (1 ) 7 — — — 37 (1 ) 7 Other 39 (2 ) 5 23 (2 ) 2 62 (4 ) 7 Subtotal, non-U.S. corporate securities 912 (21 ) 124 62 (5 ) 8 974 (26 ) 132 Total for corporate securities in an unrealized loss position $ 3,505 $ (85 ) 390 $ 258 $ (20 ) 30 $ 3,763 $ (105 ) 420 The following table presents the gross unrealized losses and fair values of our fixed maturity securities for which an allowance for credit losses has not been recorded, aggregated by investment type and length of time that individual fixed maturity securities have been in a continuous unrealized loss position, as of December 31, 2020: Less than 12 months 12 months or more Total (Dollar amounts in millions) Fair Gross Number of Fair Gross Number of Fair Gross Number of Description of Securities Fixed maturity securities: State and political subdivisions $ 28 $ (1 ) 6 $ — $ — — $ 28 $ (1 ) 6 Non-U.S. government 44 (4 ) 5 — — — 44 (4 ) 5 U.S. corporate 345 (20 ) 59 33 (3 ) 4 378 (23 ) 63 Non-U.S. corporate 145 (4 ) 32 6 (1 ) 1 151 (5 ) 33 Commercial mortgage-backed 227 (11 ) 34 1 (1 ) 1 228 (12 ) 35 Other asset-backed 238 (2 ) 60 207 (2 ) 48 445 (4 ) 108 Total for fixed maturity securities in an unrealized loss position $ 1,027 $ (42 ) 196 $ 247 $ (7 ) 54 $ 1,274 $ (49 ) 250 % Below cost: <20% Below cost $ 1,017 $ (35 ) 194 $ 246 $ (6 ) 53 $ 1,263 $ (41 ) 247 20%-50% Below cost 10 (7 ) 2 1 (1 ) 1 11 (8 ) 3 Total for fixed maturity securities in an unrealized loss position $ 1,027 $ (42 ) 196 $ 247 $ (7 ) 54 $ 1,274 $ (49 ) 250 Investment grade $ 852 $ (23 ) 163 $ 207 $ (2 ) 48 $ 1,059 $ (25 ) 211 Below investment grade 175 (19 ) 33 40 (5 ) 6 215 (24 ) 39 Total for fixed maturity securities in an unrealized loss position $ 1,027 $ (42 ) 196 $ 247 $ (7 ) 54 $ 1,274 $ (49 ) 250 The following table presents the gross unrealized losses and fair values of our corporate securities for which an allowance for credit losses has not been recorded, aggregated by investment type and length of time that individual investment securities have been in a continuous unrealized loss position, based on industry, as of December 31, 2020: Less than 12 months 12 months or more Total (Dollar amounts in millions) Fair Gross Number of Fair Gross Number of Fair Gross Number of Description of Securities U.S. corporate: Utilities $ 49 $ (2 ) 9 $ — $ — — $ 49 $ (2 ) 9 Energy 106 (13 ) 19 33 (3 ) 4 139 (16 ) 23 Finance and insurance 128 (2 ) 15 — — — 128 (2 ) 15 Consumer—non-cyclical 16 (1 ) 5 — — — 16 (1 ) 5 Transportation 46 (2 ) 11 — — — 46 (2 ) 11 Subtotal, U.S. corporate securities 345 (20 ) 59 33 (3 ) 4 378 (23 ) 63 Non-U.S. corporate: Energy 66 (1 ) 10 — — — 66 (1 ) 10 Consumer—non-cyclical — — — 6 (1 ) 1 6 (1 ) 1 Capital goods 31 (1 ) 8 — — — 31 (1 ) 8 Consumer—cyclical 15 (1 ) 6 — — — 15 (1 ) 6 Transportation 33 (1 ) 8 — — — 33 (1 ) 8 Subtotal, non-U.S. corporate securities 145 (4 ) 32 6 (1 ) 1 151 (5 ) 33 Total for corporate securities in an unrealized loss position $ 490 $ (24 ) 91 $ 39 $ (4 ) 5 $ 529 $ (28 ) 96
Maturity Distribution of Fixed Maturity Securities	Actual maturities may differ from contractual maturities because issuers of securities may have the right to call or prepay obligations with or without call or prepayment penalties. (Amounts in millions) Amortized Fair Due one year or less $ 1,475 $ 1,499 Due after one year through five years 8,254 8,807 Due after five years through ten years 13,722 15,053 Due after ten years 23,262 28,937 Subtotal 46,713 54,296 Residential mortgage-backed 1,325 1,440 Commercial mortgage-backed 2,435 2,584 Other asset-backed 2,138 2,160 Total $ 52,611 $ 60,480
Allowance for Credit Losses and Recorded Investment in Commercial Mortgage Loans	The following table sets forth the allowance for credit losses related to commercial mortgage loans as of or for the years ended December 31: (Amounts in millions) 2021 2020 2019 Allowance for credit losses: Beginning balance $ 31 $ 13 $ 9 Cumulative effect of change in accounting — 16 — Provision 3 2 4 Write-offs (8 ) — — Recoveries — — — Ending balance $ 26 $ 31 $ 13
Commercial Mortgage Loans By Credit Quality Indicator	The following tables set forth commercial mortgage loans by year of origination and credit quality indicator as of December 31, 2021: (Amounts in millions) 2021 2020 2019 2018 2017 2016 and Total Debt-to-value: 0% - 50% $ 20 $ 72 $ 53 $ 158 $ 203 $ 1,974 $ 2,480 51% - 60% 43 25 170 275 257 769 1,539 61% - 75% 889 428 509 449 127 413 2,815 76% - 100% — — — — — — — Greater than 100% — — — — 22 — 22 Total amortized cost $ 952 $ 525 $ 732 $ 882 $ 609 $ 3,156 $ 6,856 Debt service coverage ratio: Less than 1.00 $ — $ 10 $ 19 $ 41 $ 42 $ 111 $ 223 1.00 - 1.25 3 70 73 81 36 296 559 1.26 - 1.50 118 32 168 135 42 296 791 1.51 - 2.00 728 220 273 443 263 1,031 2,958 Greater than 2.00 103 193 199 182 226 1,422 2,325 Total amortized cost $ 952 $ 525 $ 732 $ 882 $ 609 $ 3,156 $ 6,856 Write-offs, gross $ — $ — $ — $ — $ 8 $ — $ 8 Recoveries — — — — — — — Write-offs, net $ — $ — $ — $ — $ 8 $ — $ 8
Loan To Value Ratio
Commercial Mortgage Loans By Credit Quality Indicator	The following tables set forth the debt-to-value of commercial mortgage loans by property type as of December 31: 2021 (Amounts in millions) 0% - 50% 51% - 60% 61% - 75% 76% - 100% Greater Total Property type: Retail $ 853 $ 611 $ 1,310 $ — $ — $ 2,774 Office 505 395 604 — 22 1,526 Industrial 745 240 435 — — 1,420 Apartments 200 102 283 — — 585 Mixed use 120 70 140 — — 330 Other 57 121 43 — — 221 Total amortized cost $ 2,480 $ 1,539 $ 2,815 $ — $ 22 $ 6,856 % of total 36 % 23 % 41 % — % — % 100 % Weighted-average debt service coverage ratio 2.36 1.83 1.61 — 0.68 1.93 2020 (Amounts in millions) 0% - 50% 51% - 60% 61% - 75% 76% - 100% Greater Total Property type: Retail $ 913 $ 639 $ 859 $ 29 $ 2 $ 2,442 Office 523 431 595 18 — 1,567 Industrial 798 351 456 33 — 1,638 Apartments 199 86 238 6 — 529 Mixed use 112 47 127 — — 286 Other 100 74 121 17 — 312 Total amortized cost $ 2,645 $ 1,628 $ 2,396 $ 103 $ 2 $ 6,774 % of total 39 % 24 % 35 % 2 % — % 100 % Weighted-average debt service coverage ratio 2.40 1.83 1.61 1.49 0.64 1.97
Debt Service Coverage Ratio
Commercial Mortgage Loans By Credit Quality Indicator	The following tables set forth the debt service coverage ratio for fixed rate commercial mortgage loans by property type as of December 31: 2021 (Amounts in millions) Less 1.00 - 1.25 1.26 - 1.50 1.51 - 2.00 Greater Total Property type: Retail $ 102 $ 166 $ 405 $ 1,375 $ 726 $ 2,774 Office 67 109 167 593 590 1,526 Industrial 9 64 82 599 666 1,420 Apartments 17 62 84 225 197 585 Mixed use 24 32 40 118 116 330 Other 4 126 13 48 30 221 Total amortized cost $ 223 $ 559 $ 791 $ 2,958 $ 2,325 $ 6,856 % of total 3 % 8 % 12 % 43 % 34 % 100 % Weighted-average debt-to-value 68 % 61 % 61 % 60 % 43 % 55 % 2020 (Amounts in millions) Less 1.00 - 1.25 1.26 - 1.50 1.51 - 2.00 Greater Total Property type: Retail $ 55 $ 169 $ 483 $ 969 $ 766 $ 2,442 Office 101 99 170 634 563 1,567 Industrial 21 85 143 616 773 1,638 Apartments 9 24 126 228 142 529 Mixed use 5 24 29 115 113 286 Other 25 125 41 28 93 312 Total amortized cost $ 216 $ 526 $ 992 $ 2,590 $ 2,450 $ 6,774 % of total 3 % 8 % 15 % 38 % 36 % 100 % Weighted-average debt-to-value 57 % 62 % 62 % 57 % 44 % 53 %
Other Geographic Area | Commercial Mortgage Loan
Distribution Across Property Type and Geographic Region for Commercial Mortgage Loans	The following tables set forth the distribution across property type and geographic region for commercial mortgage loans as of December 31: 2021 2020 (Amounts in millions) Carrying % of Carrying % of Property type: Retail $ 2,774 40 % $ 2,442 36 % Office 1,526 22 1,567 23 Industrial 1,420 21 1,638 24 Apartments 585 9 529 8 Mixed use 330 5 286 4 Other 221 3 312 5 Subtotal 6,856 100 % 6,774 100 % Allowance for credit losses (26 ) (31 ) Total $ 6,830 $ 6,743 2021 2020 (Amounts in millions) Carrying % of Carrying % of Geographic region: South Atlantic $ 1,770 26 % $ 1,711 25 % Pacific 1,360 20 1,510 22 Middle Atlantic 964 14 994 15 Mountain 892 13 781 12 West South Central 483 7 423 6 East North Central 465 7 441 6 West North Central 461 7 467 7 New England 237 3 260 4 East South Central 224 3 187 3 Subtotal 6,856 100 % 6,774 100 % Allowance for credit losses (26 ) (31 ) Total $ 6,830 $ 6,743

Derivative Instruments (Tables)

Derivative Instruments (Tables)	12 Months Ended
	Dec. 31, 2021
Schedule Of Positions in Derivative Instruments	The following table sets forth our positions in derivative instruments as of December 31: Derivative assets Derivative liabilities Fair value Fair value (Amounts in millions) Balance sheet classification 2021 2020 Balance 2021 2020 Derivatives designated as hedges Cash flow hedges: Interest rate swaps Other invested assets $ 364 $ 468 Other liabilities $ 26 $ 23 Foreign currency swaps Other invested assets 6 1 Other liabilities — 2 Total cash flow hedges 370 469 26 25 Total derivatives designated as hedges 370 469 26 25 Derivatives not designated as hedges Equity index options Other invested assets 42 63 Other liabilities — — Financial futures Other invested assets — — Other liabilities — — Other foreign currency contracts Other invested assets 2 42 Other liabilities — 1 GMWB embedded derivatives Reinsurance recoverable (1) 19 26 Policyholder account balances (2) 271 379 Fixed index annuity embedded derivatives Other assets — — Policyholder account balances (3) 294 399 Indexed universal life embedded derivatives Reinsurance recoverable — — Policyholder account balances (4) 25 26 Total derivatives not designated as hedges 63 131 590 805 Total derivatives $ 433 $ 600 $ 616 $ 830 (1) Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities. (2) Represents the embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. (3) Represents the embedded derivatives associated with our fixed index annuity liabilities. (4) Represents the embedded derivatives associated with our indexed universal life liabilities.
Schedule of Notional Amounts Outstanding on Derivative Instruments	The following tables represent activity associated with derivative instruments as of the dates indicated: (Notional in millions) Measurement December 31, Additions Maturities/ December 31, Derivatives designated as hedges Cash flow hedges: Interest rate swaps Notional $ 8,178 $ — $ (525 ) $ 7,653 Foreign currency swaps Notional 127 — — 127 Total cash flow hedges 8,305 — (525 ) 7,780 Total derivatives designated as hedges 8,305 — (525 ) 7,780 Derivatives not designated as hedges Interest rate swaps Notional 4,674 — (4,674 ) — Equity index options Notional 2,000 1,438 (1,992 ) 1,446 Financial futures Notional 1,104 3,887 (4,045 ) 946 Other foreign currency contracts Notional 1,186 25 (1,128 ) 83 Total derivatives not designated as hedges 8,964 5,350 (11,839 ) 2,475 Total derivatives $ 17,269 $ 5,350 $ (12,364 ) $ 10,255 (Number of policies) Measurement December 31, Additions Maturities/ December 31, Derivatives not designated as hedges GMWB embedded derivatives Policies 23,713 — (1,909 ) 21,804 Fixed index annuity embedded derivatives Policies 12,778 — (3,434 ) 9,344 Indexed universal life embedded derivatives Policies 842 — (36 ) 806
Schedule of Pre-Tax Income (Loss) Effects of Cash Flow Hedges	The following table provides information about the pre-tax (Amounts in millions) Gain (loss) Gain (loss) Classification of gain Gain (loss) Classification of gain Interest rate swaps hedging assets $ (100 ) $ 217 Net investment income $ — Net investment gains (losses) Interest rate swaps hedging assets — 1 Net investment gains (losses) — Net investment gains (losses) Interest rate swaps hedging liabilities 36 (1 ) Interest expense — Net investment gains (losses) Foreign currency swaps 7 — Net investment income — Net investment gains (losses) Total $ (57 ) $ 217 $ — The following table provides information about the pre-tax (Amounts in millions) Gain (loss) Gain (loss) Classification of gain (loss) reclassified Gain (loss) Classification of gain Interest rate swaps hedging assets $ 482 $ 196 Net investment income $ — Net investment gains (losses) Interest rate swaps hedging assets — 12 Net investment gains (losses) — Net investment gains (losses) Interest rate swaps hedging liabilities (38 ) — Interest expense — Net investment gains (losses) Foreign currency swaps (5 ) — Net investment income — Net investment gains (losses) Total $ 439 $ 208 $ — pre-tax (Amounts in millions) Gain (loss) Gain (loss) Classification of gain Gain (loss) Classification of gain Interest rate swaps hedging assets $ 456 $ 164 Net investment income $ — Net investment gains (losses) Interest rate swaps hedging assets — 6 Net investment gains (losses) — Net investment gains (losses) Interest rate swaps hedging liabilities (36 ) — Interest expense — Net investment gains (losses) Foreign currency swaps (2 ) — Net investment income — Net investment gains (losses) Foreign currency swaps — — Net investment gains (losses) 2 Net investment gains (losses) Total $ 418 $ 170 $ 2
Reconciliation of Current Period Changes, Net of Applicable Income Taxes, for Derivatives Qualifying as Hedge	The following table provides a reconciliation of current period changes, net of applicable income taxes, for these designated derivatives presented in the separate component of stockholders’ equity labeled “derivatives qualifying as hedges,” for the years ended December 31: (Amounts in millions) 2021 2020 2019 Derivatives qualifying as effective accounting hedges as of January 1 $ 2,211 $ 2,002 $ 1,781 Current period increases (decreases) in fair value, net of deferred taxes of $12, $(95) and $(87) (45 ) 344 331 Reclassification to net (income), net of deferred taxes of $76, $73 and $60 (141 ) (135 ) (110 ) Derivatives qualifying as effective accounting hedges as of December 31 $ 2,025 $ 2,211 $ 2,002
Schedule of Pre-Tax Gain (Loss) Recognized in Net Income (loss) for Effects of Derivatives Not Designated as Hedges	The following table provides the pre-tax (Amounts in millions) 2021 2020 2019 Classification of gain (loss) Interest rate swaps $ 2 $ (11 ) $ (3 ) Net investment gains (losses) Equity index options 18 4 43 Net investment gains (losses) Financial futures (123 ) 2 (64 ) Net investment gains (losses) Other foreign currency contracts — 6 (6 ) Net investment gains (losses) GMWB embedded derivatives 124 (28 ) 38 Net investment gains (losses) Fixed index annuity embedded derivatives (32 ) (51 ) (90 ) Net investment gains (losses) Indexed universal life embedded derivatives 24 17 4 Net investment gains (losses) Total derivatives not designated as hedges $ 13 $ (61 ) $ (78 )
Derivative Assets and Liabilities Subject to Master Netting Arrangement	The following table presents additional information about derivative assets and liabilities subject to an enforceable master netting arrangement as of December 31: 2021 2020 (Amounts in millions) Derivative (1) Derivative (1) Net Derivative (1) Derivative (1) Net Amounts presented in the balance sheet: Gross amounts recognized $ 414 $ 26 $ 388 $ 574 $ 26 $ 548 Gross amounts offset in the balance sheet — — — — — — Net amounts presented in the balance sheet 414 26 388 574 26 548 Gross amounts not offset in the balance sheet: Financial instruments (2) (20 ) (20 ) — (20 ) (20 ) — Collateral received (308 ) — (308 ) (401 ) — (401 ) Collateral pledged — (536 ) 536 — (505 ) 505 Over collateralization 2 530 (528 ) 2 499 (497 ) Net amount $ 88 $ — $ 88 $ 155 $ — $ 155 (1) Does not include amounts related to embedded derivatives as of December 31, 2021 and 2020. (2) Amounts represent derivative assets and/or liabilities that are presented gross within the balance sheet but are held with the same counterparty where we have a master netting arrangement. This adjustment results in presenting the net asset and net liability position for each counterparty.

Deferred Acquisition Costs (Tab

Deferred Acquisition Costs (Tables)	12 Months Ended
	Dec. 31, 2021
Activity Impacting Deferred Acquisition Costs	The following table presents the activity impacting DAC as of and for the years ended December 31: (Amounts in millions) 2021 2020 2019 Unamortized balance as of January 1 $ 2,809 $ 3,243 $ 3,591 Costs deferred 8 3 17 Amortization, net of interest accretion (379 ) (437 ) (365 ) Unamortized balance as of December 31 2,438 2,809 3,243 Accumulated effect of net unrealized investment (gains) losses (1,292 ) (1,322 ) (1,444 ) Balance as of December 31 $ 1,146 $ 1,487 $ 1,799

Intangible Assets (Tables)

Intangible Assets (Tables)	12 Months Ended
	Dec. 31, 2021
Intangible Assets	The following table presents our intangible assets as of December 31: 2021 2020 (Amounts in millions) Gross Accumulated Gross Accumulated PVFP $ 2,065 $ (1,994 ) $ 2,065 $ (1,992 ) Capitalized software 465 (403 ) 457 (385 ) Deferred sales inducements to contractholders 295 (288 ) 284 (274 ) Other 159 (156 ) 157 (155 ) Total $ 2,984 $ (2,841 ) $ 2,963 $ (2,806 )
Activity in Present Value of Future Profits	The following table presents the activity in PVFP as of and for the years ended December 31: (Amounts in millions) 2021 2020 2019 Unamortized balance as of January 1 $ 154 $ 154 $ 170 Interest accreted at 5.23%, 5.19% and 5.56% 8 8 9 Amortization (10 ) (8 ) (25 ) Unamortized balance as of December 31 152 154 154 Accumulated effect of net unrealized investment (gains) losses (81 ) (81 ) (80 ) Balance as of December 31 $ 71 $ 73 $ 74
Percentage of Current PVFP Balance Estimated to be Amortized	The percentage of the December 31, 2021 PVFP balance net of interest accretion, before the effect of unrealized investment gains or losses, estimated to be amortized over each of the next five years is as follows: 2022 4.2 % 2023 4.2 % 2024 4.2 % 2025 4.0 % 2026 5.0 %

Reinsurance (Tables)

Reinsurance (Tables)	12 Months Ended
	Dec. 31, 2021
Net Domestic Life Insurance In-Force	The following table sets forth net domestic life insurance in-force (Amounts in millions) 2021 2020 2019 Direct life insurance in-force $ 471,147 $ 509,670 $ 555,252 Amounts assumed from other companies 573 624 673 Amounts ceded to other companies (1) (427,464 ) (458,999 ) (500,965 ) Net life insurance in-force $ 44,256 $ 51,295 $ 54,960 Percentage of amount assumed to net 1 % 1 % 1 % (1) Includes amounts accounted for under the deposit method.
Schedule of Effects of Reinsurance on Premiums Written and Earned	The following table sets forth the effects of reinsurance on premiums written and earned for the years ended December 31: Written Earned (Amounts in millions) 2021 2020 2019 2021 2020 2019 Direct: Life insurance $ 774 $ 795 $ 845 $ 775 $ 795 $ 845 Accident and health insurance (1) 2,797 2,836 2,792 2,834 2,860 2,821 Mortgage insurance 990 947 844 1,050 1,023 882 Total direct 4,561 4,578 4,481 4,659 4,678 4,548 Assumed: Life insurance 2 1 1 2 2 1 Accident and health insurance (1) 300 313 321 304 322 326 Mortgage insurance 3 3 4 3 4 4 Total assumed 305 317 326 309 328 331 Ceded: Life insurance (2) (913 ) (558 ) (568 ) (913 ) (559 ) (568 ) Accident and health insurance (1) (541 ) (550 ) (557 ) (548 ) (562 ) (564 ) Mortgage insurance (72 ) (49 ) (22 ) (72 ) (49 ) (22 ) Total ceded (1,526 ) (1,157 ) (1,147 ) (1,533 ) (1,170 ) (1,154 ) Net premiums $ 3,340 $ 3,738 $ 3,660 $ 3,435 $ 3,836 $ 3,725 Percentage of amount assumed to net 9% 9% 9% (1) Accident and health insurance is comprised almost entirely of our long-term care insurance products. (2) Effective December 1, 2021 and included in the year ended December 31, 2021, we entered into a reinsurance agreement with SCOR Global Life USA Reinsurance Company, under which we ceded premiums of $360 million associated with certain term life insurance policies in connection with a life block transaction.
Schedule of Reinsurance Recoverable in Allowance for Credit Losses	The following table sets forth the changes in the allowance for credit losses related to reinsurance recoverables as of or for the years ended December 31: (Amounts in millions) 2021 2020 Allowance for credit losses: Beginning balance $ 45 $ — Cumulative effect of change in accounting — 40 Provision 10 5 Write-offs — — Recoveries — — Ending balance $ 55 $ 45
Schedule Of Credit Ratings on Reinsurance Recoverable	The following tables set forth A.M. Best Company, Inc.’s (“A.M. Best”) credit ratings related to our reinsurance recoverables, gross of the allowance for credit losses, as of December 31: 2021 (Amounts in millions) Collateralized Non-collateralized Total Credit rating: A++ $ — $ 543 $ 543 A+ 1,581 1,510 3,091 A 18 41 59 Not rated 13,099 76 13,175 Total reinsurance recoverable $ 14,698 $ 2,170 $ 16,868 2020 (Amounts in millions) Collateralized Non-collateralized Total Credit rating: A++ $ — $ 519 $ 519 A+ 1,437 1,343 2,780 A 19 45 64 B+ — 1 1 Not rated 13,419 81 13,500 Total reinsurance recoverable $ 14,875 $ 1,989 $ 16,864

Insurance Reserves (Tables)

Insurance Reserves (Tables)	12 Months Ended
	Dec. 31, 2021
Recorded Liabilities and Major Assumptions Underlying Future Policy Benefits	The following table sets forth our recorded liabilities and the major assumptions underlying our future policy benefits as of December 31: (Amounts in millions) Mortality/ Interest rate 2021 2020 Long-term care insurance contracts (a ) 3.75% - 7.50% $ 28,232 $ 28,770 Structured settlements with life contingencies (b ) 1.00% - 8.00% 8,075 8,240 Annuity contracts with life contingencies (b ) 1.00% - 8.00% 2,934 3,252 Traditional life insurance contracts (c ) 3.00% - 7.50% 1,956 2,101 Supplementary contracts with life contingencies (b ) 1.00% - 8.00% 331 332 Total future policy benefits $ 41,528 $ 42,695 (a) The 1983 Individual Annuitant Mortality Table or the 2000 U.S. Annuity Table, or the 1983 Group Annuitant Mortality Table or the 1994 Group Annuitant Mortality Table and company experience. (b) Assumptions for limited-payment contracts come from either the U.S. Population Table, the 1983 Group Annuitant Mortality Table, the 1983 Individual Annuitant Mortality Table, the Annuity 2000 Mortality Table or the 2012 Individual Annuity Reserving Table. (c) Principally modifications based on company experience of the Society of Actuaries 1965-70 1975-80
Recorded Liabilities for Policyholder Account Balances	The following table sets forth our recorded liabilities for policyholder account balances as of December 31: (Amounts in millions) 2021 2020 Annuity contracts $ 6,816 $ 8,273 Funding agreements 250 300 Structured settlements without life contingencies 1,027 1,114 Supplementary contracts without life contingencies 550 576 Other 14 13 Total investment contracts 8,657 10,276 Universal and term universal life insurance contracts 10,697 11,227 Total policyholder account balances $ 19,354 $ 21,503
Information about Variable Annuity Products with Death and Living Benefit Guarantees	The following table sets forth information about our variable annuity products with death and living benefit guarantees as of December 31: (Dollar amounts in millions) 2021 2020 Account values with death benefit guarantees (net of reinsurance): Standard death benefits (return of net deposits) account value $ 2,547 $ 2,611 Net amount at risk $ 1 $ 2 Average attained age of contractholders 76 76 Enhanced death benefits (ratchet, rollup) account value $ 1,326 $ 1,350 Net amount at risk $ 94 $ 105 Average attained age of contractholders 76 76 Account values with living benefit guarantees: GMWBs $ 1,893 $ 1,999 Guaranteed annuitization benefits $ 1,002 $ 998
Account Balances of Variable Annuity Contract with Death or Living Benefit Guarantees Invested in Separate Account Investment Options	Account balances of variable annuity contracts with death or living benefit guarantees were invested in separate account investment options as follows as of December 31: (Amounts in millions) 2021 2020 Balanced funds $ 2,397 $ 2,343 Equity funds 913 1,016 Bond funds 297 304 Money market funds 189 216 Total $ 3,796 $ 3,879

Liability for Policy and Cont_2

Liability for Policy and Contract Claims (Tables)	12 Months Ended
	Dec. 31, 2021
Schedule of Liability for Policy and Contract Claims	The following table sets forth our liability for policy and contract claims as of December 31: (Amounts in millions) 2021 2020 Liability for policy and contract claims for insurance lines other than short-duration contracts: U.S. Life Insurance segment: Long-term care insurance $ 10,861 $ 10,518 Life insurance 308 378 Fixed annuities 14 12 Runoff segment 8 12 Total 11,191 10,920 Liability for policy and contract claims related to short-duration contracts: Enact segment 641 555 Other mortgage insurance businesses 9 11 Total 650 566 Total liability for policy and contract claims $ 11,841 $ 11,486
Changes in Liability for Policy and Contract Claims	The following table sets forth changes in the liability for policy and contract claims for our long-term care insurance business for the dates indicated: (Amounts in millions) 2021 2020 2019 Beginning balance as of January 1 $ 10,518 $ 10,239 $ 9,516 Less reinsurance recoverables (2,260 ) (2,283 ) (2,262 ) Net balance as of January 1 8,258 7,956 7,254 Incurred related to insured events of: Current year 2,761 2,595 2,717 Prior years (610 ) (398 ) (219 ) Total incurred 2,151 2,197 2,498 Paid related to insured events of: Current year (203 ) (189 ) (205 ) Prior years (2,011 ) (2,118 ) (1,975 ) Total paid (2,214 ) (2,307 ) (2,180 ) Interest on liability for policy and contract claims 406 412 384 Net balance as of December 31 8,601 8,258 7,956 Add reinsurance recoverables 2,260 2,260 2,283 Ending balance as of December 31 $ 10,861 $ 10,518 $ 10,239
Schedule of Incurred Claims Net of Reinsurance, Cummulative Number of Reported Delinquencies, Total Incurred But Not Reported	The following table sets forth information about incurred claims, net of reinsurance, as well as cumulative number of reported delinquencies and the total of IBNR liabilities plus expected development on reported claims included within the net incurred claims amounts for our Enact segment as of December 31, 2021. The information about the incurred claims development for the years ended December 31, 2012 to 2020 and the historical reported delinquencies as of December 31, 2020 and prior are presented as supplementary information. Incurred claims and allocated claim adjustment expenses, net of Total of IBNR Number of (2) (Dollar amounts in millions) For the years ended December 31, Accident year (1) 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 Unaudited 2012 $ 718 $ 675 $ 671 $ 673 $ 671 $ 668 $ 667 $ 666 $ 666 $ 667 $ — 31,126 2013 — 475 407 392 387 384 382 381 381 381 — 22,502 2014 — — 328 288 269 261 259 258 259 259 — 17,809 2015 — — — 235 208 187 181 180 180 179 — 15,400 2016 — — — — 198 160 138 136 137 136 — 13,970 2017 — — — — — 171 121 102 105 104 — 15,097 2018 — — — — — — 117 84 84 78 1 11,269 2019 — — — — — — — 106 111 98 1 11,883 2020 — — — — — — — — 365 362 1 38,863 2021 — — — — — — — — — 141 15 12,585 Total incurred $ 2,405 (1) Represents the year in which first monthly mortgage payments have been missed by the borrower. (2) Represents reported and outstanding delinquencies less actual cures as of December 31 for each respective accident year.
Schedule of Paid Claims Deveopment, Net of Reinsurance	The following table sets forth paid claims development, net of reinsurance, for our Enact segment for the year ended December 31, 2021. The information about paid claims development for the years ended December 31, 2012 to 2020 is presented as supplementary information. (Amounts in millions) Cumulative paid claims and allocated claim adjustment expenses, net of reinsurance Accident year (1) 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 Unaudited 2012 $ 92 $ 391 $ 532 $ 602 $ 634 $ 650 $ 658 $ 662 $ 663 $ 663 2013 — 44 202 297 340 362 372 375 376 377 2014 — — 22 127 195 233 247 253 254 255 2015 — — — 12 85 145 167 173 175 176 2016 — — — — 10 64 110 124 127 128 2017 — — — — — 6 46 77 87 90 2018 — — — — — — 3 32 48 55 2019 — — — — — — — 2 18 31 2020 — — — — — — — — 1 8 2021 — — — — — — — — — — Total paid $ 1,783 Total incurred $ 2,405 Total paid 1,783 All outstanding liabilities before 2012 19 Liability for policy and contract claims $ 641 (1) Represents the year in which first monthly mortgage payments have been missed by the borrower.
Schedule of Average Payout of Incurred Claims by Age	The following table sets forth our average payout of incurred claims by age for our Enact segment as of December 31, 2021: Average annual percentage payout of incurred claims by age Years 1 2 3 4 5 6 7 8 9 10 Unaudited Percentage of payout 6.0 % 33.3 % 25.7 % 11.0 % 4.0 % 1.8 % 0.8 % 0.3 % 0.2 % 0.1 %

Borrowings and Other Financin_2

Borrowings and Other Financings (Tables)	12 Months Ended
	Dec. 31, 2021
Schedule of Long Term Borrowings	The following table sets forth total long-term borrowings as of December 31: (Amounts in millions) 2021 2020 Genworth Holdings 7.20% Senior Notes, due 2021 $ — $ 338 7.625% Senior Notes, due 2021 — 660 4.90% Senior Notes, due 2023 — 400 4.80% Senior Notes, due 2024 282 400 6.50% Senior Notes, due 2034 298 297 Floating Rate Junior Subordinated Notes, due 2066 598 598 Subtotal 1,178 2,693 Bond consent fees (12 ) (19 ) Deferred borrowing charges (7 ) (9 ) Total Genworth Holdings 1,159 2,665 Enact Holdings 6.50% Senior Notes, due 2025 750 750 Deferred borrowing charges (10 ) (12 ) Total Enact Holdings 740 738 Total $1,899 $ 3,403
Principal Amounts of Long Term Debt Including Senior Notes and Non-Recourse Funding by Maturity	Principal amounts under our long-term borrowings (including senior notes) by maturity were as follows as of December 31, 2021: (Amounts in millions) 2022 $ — 2023 — 2024 282 2025 750 2026 and thereafter 900 Total $ 1,932
Remaining Contractual Maturity of Agreements	The following table presents the remaining contractual maturity of the agreement as of December 31, 2020: (Amounts in millions) Overnight Up to 31 - 90 Greater than Total Securities lending: Fixed maturity securities: Non-U.S. $ 1 $ — $ — $ — $ 1 U.S. corporate 40 — — — 40 Non-U.S. 19 — — — 19 Subtotal, fixed maturity securities 60 — — — 60 Equity securities 7 7 Total securities lending $ 67 $ — $ — $ — $ 67

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2021
Components of Income before Income Taxes	Income from continuing operations before income taxes included the following components for the years ended December 31: (Amounts in millions) 2021 2020 2019 Domestic $ 1,184 $ 931 $ 523 Foreign (3 ) (3 ) (2 ) Income from continuing operations before income taxes $ 1,181 $ 928 $ 521
Components of Income Tax Provision	The total provision for income taxes was as follows for the years ended December 31: (Amounts in millions) 2021 2020 2019 Current federal income taxes $ (32 ) $ — $ 6 Deferred federal income taxes 288 226 114 Total federal income taxes 256 226 120 Current state income taxes 5 3 2 Deferred state income taxes 2 2 5 Total state income taxes 7 5 7 Current foreign income taxes — — 12 Deferred foreign income taxes — (1 ) — Total foreign income taxes — (1 ) 12 Total provision for income taxes $ 263 $ 230 $ 139
Reconciliation of Federal Statutory Tax Rate to Effective Income Tax Rate	The reconciliation of the federal statutory tax rate to the effective income tax rate was as follows for the years ended December 31: 2021 2020 2019 Statutory U.S. federal income tax rate 21.0 % 21.0 % 21.0 % Increase (reduction) in rate resulting from: Swaps terminated prior to the TCJA 2.5 3.0 4.5 Reduction in uncertain tax positions (1.8 ) — — State income tax, net of federal income tax effect 0.5 0.4 1.1 Other, net 0.1 0.4 0.1 Effective rate 22.3 % 24.8 % 26.7 %
Components of Net Deferred Income Tax Liability	The components of our deferred income taxes were as follows as of December 31: (Amounts in millions) 2021 2020 Assets: Foreign tax credit carryforwards $ 174 $ 136 Net operating loss carryforwards 202 56 Capital loss carryforwards 142 — State income taxes 388 386 Insurance reserves 178 620 Accrued commission and general expenses 118 123 Liabilities associated with discontinued operations 122 126 Investments — 10 Other 18 23 Gross deferred income tax assets 1,342 1,480 Valuation allowance (382 ) (396 ) Total deferred income tax assets 960 1,084 Liabilities: Net unrealized gains on investment securities 506 590 Net unrealized gains on derivatives 73 70 DAC 98 181 PVFP and other intangibles 38 42 Insurance reserves transition adjustment 99 123 Investments 10 — Other 17 13 Total deferred income tax liabilities 841 1,019 Net deferred income tax asset $ 119 $ 65
Reconciliation of Unrecognized Tax Benefits	A reconciliation of the beginning and ending amount of unrecognized tax benefits was as follows: (Amounts in millions) 2021 2020 2019 Balance as of January 1 $ 62 $ 64 $ 79 Tax positions related to the current period: Gross additions — — — Gross reductions (3 ) (3 ) (15 ) Tax positions related to the prior years: Gross additions — 1 — Gross reductions (19 ) — — Balance as of December 31 $ 40 $ 62 $ 64

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	12 Months Ended
	Dec. 31, 2021
Summary of Cash Award Activity	The following table summarizes cash award activity as of December 31, 2021 and 2020: (Number of awards, in millions) Time-based Performance-based Balance as of January 1, 2020 26 13 Granted 17 — Performance adjustment — 1 Vested (11 ) (5 ) Forfeited (2 ) (2 ) Balance as of January 1, 2021 30 7 Granted 15 — Performance adjustment — 6 Vested (15 ) (13 ) Forfeited (3 ) — Balance as of December 31, 2021 27 —
Rollforward of Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding	The following table summarizes stock option activity as of December 31, 2021 and 2020: (Shares in thousands) Shares subject Weighted-average Balance as of January 1, 2020 801 $ 14.17 Granted — $ — Exercised — $ — Expired and forfeited (800 ) $ 14.17 Balance as of January 1, 2021 1 $ 12.75 Granted — $ — Exercised — $ — Expired and forfeited (1 ) $ 12.75 Balance as of December 31, 2021 — $ — Exercisable as of December 31, 2021 — $ —
Status of Our Other Equity-Based Awards	The following tables summarize the status of our other equity-based awards as of December 31, 2021 and 2020: RSUs PSUs DSUs SARs (Awards in thousands) Number Weighted- Number of Weighted- Number Weighted- Number Weighted- Balance as of January 1, 2020 2,675 $ 3.51 5,142 $ 4.28 1,515 $ 4.37 8,151 $ 3.41 Granted 1,683 $ 3.53 2,789 $ 3.03 237 $ 2.00 — $ — Performance adjustment (1) — $ — 443 $ 4.01 — $ — — $ — Exercised (1,336 ) $ 3.62 (1,994 ) $ 4.01 (215 ) $ 4.76 — $ — Terminated (488 ) $ 3.47 (646 ) $ 3.86 — $ — (1,121 ) $ 3.99 Balance as of January 1, 2021 2,534 $ 3.48 5,734 $ 3.79 1,537 $ 3.95 7,030 $ 3.32 Granted 1,391 $ 3.31 2,510 $ 3.45 315 $ 2.52 — $ — Performance adjustment (1) — $ — 626 $ 3.58 — $ — — $ — Exercised (1,474 ) $ 3.47 (1,365 ) $ 3.58 (15 ) $ 7.46 — $ — Terminated (134 ) $ 3.53 — $ — — $ — (835 ) $ 3.04 Balance as of December 31, 2021 2,317 $ 3.38 7,505 $ 3.70 1,837 $ 3.42 6,195 $ 3.36 (1) The performance adjustment relates to additional awards expected to be earned through the achievement of certain performance metrics.
Summary of Other Equity Awards Valuation Assumptions	The grant-date fair value for the total relative shareholder return performance metric was $4.18, which was calculated using the Monte Carlo simulation with the following valuation assumptions: Valuation assumptions: Valuation-date stock price $ 3.31 Volatility 65.0 % Dividend yield — % Risk-free rate 0.3 % Valuation maximum 800% of grant-date
summary of Enact Holdings' equity-based awards	The following table summarizes the status of Enact Holdings’ equity-based awards as of December 31, 2021: RSUs DSUs (Awards in thousands) Number Weighted- Number Weighted- Balance as of January 1, 2021 — $ — — $ — Granted 628 $ 19.02 17 $ 20.87 Dividend equivalents 36 $ 21.25 — $ — Vested — $ — — $ — Terminated (10 ) $ 19.00 — $ — Balance as of December 31, 2021 654 $ 19.02 17 $ 20.87

Fair Value of Financial Instr_2

Fair Value of Financial Instruments (Tables)	12 Months Ended
	Dec. 31, 2021
Summary of Significant Inputs Used by Third-Party Pricing Services for Certain Fair Value Measurements of Fixed Maturity Securities that Classified as Level 2	The following table presents a summary of the significant inputs used by our pricing services for certain fair value measurements of fixed maturity securities that are classified as Level 2 as of December 31, 2021: (Amounts in millions) Fair value Primary methodologies Significant inputs U.S. government, agencies and government-sponsored enterprises $ 4,552 Price quotes from trading desk, broker feeds Bid side prices, trade prices, Option Adjusted Spread (“OAS”) to swap curve, Bond Market Association OAS, Treasury Curve, Agency Bullet Curve, maturity to issuer spread State and political subdivisions $ 3,368 Multi-dimensional attribute-based modeling systems, third-party pricing vendors Trade prices, material event notices, Municipal Market Data benchmark yields, broker quotes Non-U.S. $ 833 Matrix pricing, spread priced to benchmark curves, price quotes from market makers Benchmark yields, trade prices, broker quotes, comparative transactions, issuer spreads, bid-offer spread, market research publications, third-party pricing sources U.S. corporate $ 30,774 Multi-dimensional attribute-based modeling systems, broker quotes, price quotes from market makers, OAS-based models Bid side prices to Treasury Curve, Issuer Curve, which includes sector, quality, duration, OAS percentage and change for spread matrix, trade prices, comparative transactions, Trade Reporting and Compliance Engine (“TRACE”) reports Non-U.S. $ 8,322 Multi-dimensional attribute-based modeling systems, OAS-based models, price quotes from market makers Benchmark yields, trade prices, broker quotes, comparative transactions, issuer spreads, bid-offer spread, market research publications, third-party pricing sources Residential mortgage-backed $ 1,413 OAS-based models, single factor binomial models, internally priced Prepayment and default assumptions, aggregation of bonds with similar characteristics, including collateral type, vintage, tranche type, weighted-average life, weighted-average loan age, issuer program and delinquency ratio, pay up and pay down factors, TRACE reports Commercial mortgage-backed $ 2,568 Multi-dimensional attribute-based modeling systems, pricing matrix, spread matrix priced to swap curves, Trepp commercial mortgage-backed securities analytics model Credit risk, interest rate risk, prepayment speeds, new issue data, collateral performance, origination year, tranche type, original credit ratings, weighted-average life, cash flows, spreads derived from broker quotes, bid side prices, spreads to daily updated swap curves, TRACE reports Other asset-backed $ 2,022 Multi-dimensional attribute-based modeling systems, spread matrix priced to swap curves, price quotes from market makers Spreads to daily updated swap curves, spreads derived from trade prices and broker quotes, bid side prices, new issue data, collateral performance, analysis of prepayment speeds, cash flows, collateral loss analytics, historical issue analysis, trade data from market makers, TRACE reports
Assets by Class of Instrument that are Measured at Fair Value on Recurring Basis	The following tables set forth our assets by class of instrument that are measured at fair value on a recurring basis as of December 31: 2021 (Amounts in millions) Total Level 1 Level 2 Level 3 NAV (1) Assets Investments: Fixed maturity securities: U.S. government, agencies and government-sponsored enterprises $ 4,552 $ — $ 4,552 $ — $ — State and political subdivisions 3,450 — 3,368 82 — Non-U.S. 835 — 833 2 — U.S. corporate: Utilities 5,104 — 4,154 950 — Energy 2,934 — 2,858 76 — Finance and insurance 8,991 — 8,306 685 — Consumer—non-cyclical 6,159 — 6,055 104 — Technology and communications 3,808 — 3,779 29 — Industrial 1,494 — 1,457 37 — Capital goods 2,745 — 2,700 45 — Consumer—cyclical 1,899 — 1,762 137 — Transportation 1,371 — 1,307 64 — Other 419 — 165 254 — Total U.S. corporate 34,924 — 32,543 2,381 — Non-U.S. Utilities 928 — 583 345 — Energy 1,383 — 1,238 145 — Finance and insurance 2,432 — 2,272 160 — Consumer—non-cyclical 743 — 680 63 — Technology and communications 1,250 — 1,222 28 — Industrial 1,047 — 954 93 — Capital goods 705 — 532 173 — Consumer—cyclical 341 — 265 76 — Transportation 489 — 436 53 — Other 1,217 — 1,191 26 — Total non-U.S. 10,535 — 9,373 1,162 — Residential mortgage-backed 1,440 — 1,413 27 — Commercial mortgage-backed 2,584 — 2,568 16 — Other asset-backed 2,160 — 2,022 138 — Total fixed maturity securities 60,480 — 56,672 3,808 — Equity securities 198 101 60 37 — Limited partnerships 1,462 — — — 1,462 Other invested assets: Derivative assets: Interest rate swaps 364 — 364 — — Foreign currency swaps 6 — 6 — — Equity index options 42 — — 42 — Other foreign currency contracts 2 — 2 — — Total derivative assets 414 — 372 42 — Short-term investments 26 — 26 — — Total other invested assets 440 — 398 42 — Reinsurance recoverable (2) 19 — — 19 — Separate account assets 6,066 6,066 — — — Total assets $ 68,665 $ 6,167 $ 57,130 $ 3,906 $ 1,462 (1) Limited partnerships that are measured at fair value using the NAV per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy. (2) Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities. 2020 (Amounts in millions) Total Level 1 Level 2 Level 3 NAV (1) Assets Investments: Fixed maturity securities: U.S. government, agencies and government-sponsored enterprises $ 4,805 $ — $ 4,805 $ — $ — State and political subdivisions 3,165 — 3,099 66 — Non-U.S. 854 — 854 — — U.S. corporate: Utilities 5,194 — 4,352 842 — Energy 2,883 — 2,755 128 — Finance and insurance 9,102 — 8,495 607 — Consumer—non-cyclical 6,437 — 6,328 109 — Technology and communications 3,761 — 3,714 47 — Industrial 1,602 — 1,562 40 — Capital goods 2,991 — 2,931 60 — Consumer—cyclical 1,947 — 1,797 150 — Transportation 1,500 — 1,430 70 — Other 440 — 221 219 — Total U.S. corporate 35,857 — 33,585 2,272 — Non-U.S. Utilities 922 — 570 352 — Energy 1,380 — 1,135 245 — Finance and insurance 2,476 — 2,171 305 — Consumer—non-cyclical 773 — 706 67 — Technology and communications 1,291 — 1,263 28 — Industrial 1,128 — 1,033 95 — Capital goods 576 — 398 178 — Consumer—cyclical 371 — 225 146 — Transportation 570 — 461 109 — Other 1,324 — 1,241 83 — Total non-U.S. 10,811 — 9,203 1,608 — Residential mortgage-backed 1,909 — 1,895 14 — Commercial mortgage-backed 2,974 — 2,954 20 — Other asset-backed 3,120 — 3,011 109 — Total fixed maturity securities 63,495 — 59,406 4,089 — Equity securities 386 276 59 51 — Limited partnerships 835 — — — 835 Other invested assets: Derivative assets: Interest rate swaps 468 — 468 — — Foreign currency swaps 1 — 1 — — Equity index options 63 — — 63 — Other foreign currency contracts 42 — 42 — — Total derivative assets 574 — 511 63 — Securities lending collateral 67 — 67 — — Short-term investments 45 25 20 — — Total other invested assets 686 25 598 63 — Reinsurance recoverable (2) 26 — — 26 — Separate account assets 6,081 6,081 — — — Total assets $ 71,509 $ 6,382 $ 60,063 $ 4,229 $ 835 (1) Limited partnerships that are measured at fair value using the NAV per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy. (2) Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities.
Assets Measured at Fair Value on Recurring Basis and Utilized Significant Unobservable (Level 3) Inputs to Determine Fair Value	The following tables present additional information about assets measured at fair value on a recurring basis and for which we have utilized significant unobservable (Level 3) inputs to determine fair value as of or for the dates indicated: Beginning as of Total realized and Purchases Sales Issuances Settlements Transfer (1) Transfer (1) Ending as of Total gains (Amounts in millions) Included Included Included Included Fixed maturity securities: State and political subdivisions $ 66 $ 3 $ 13 $ — $ — $ — $ — $ — $ — $ 82 $ 3 $ 13 Non-U.S. — — — 2 — — — — — 2 — — U.S. corporate: Utilities 842 — 3 118 — — (18 ) 18 (13 ) 950 — 4 Energy 128 — 4 50 — — (10 ) 8 (104 ) 76 — 1 Finance and insurance 607 — (18 ) 233 — — (46 ) 17 (108 ) 685 — (16 ) Consumer—non-cyclical 109 — (2 ) — — — (3 ) 3 (3 ) 104 — (2 ) Technology and communications 47 — (1 ) 12 — — — 4 (33 ) 29 — (1 ) Industrial 40 — — 17 — — (20 ) — — 37 — (1 ) Capital goods 60 — (1 ) — — — (14 ) — — 45 — (2 ) Consumer—cyclical 150 — — — — — (5 ) — (8 ) 137 — — Transportation 70 — (1 ) — — — (5 ) — — 64 — (1 ) Other 219 — (1 ) — — — (32 ) 88 (20 ) 254 — 1 Total U.S. corporate 2,272 — (17 ) 430 — — (153 ) 138 (289 ) 2,381 — (17 ) Non-U.S. Utilities 352 — (5 ) 30 — — (8 ) — (24 ) 345 — (6 ) Energy 245 — 7 — — — (28 ) — (79 ) 145 — 3 Finance and insurance 305 3 (1 ) 1 (2 ) — (62 ) — (84 ) 160 5 (14 ) Consumer—non-cyclical 67 1 (2 ) 8 — — (14 ) 3 — 63 — (2 ) Technology and communications 28 — — — — — — — — 28 — (1 ) Industrial 95 2 (4 ) 14 — — (14 ) — — 93 — (2 ) Capital goods 178 — 1 25 — — — — (31 ) 173 — — Consumer—cyclical 146 — — 17 — — — — (87 ) 76 — — Transportation 109 3 (3 ) — — — (49 ) — (7 ) 53 — — Other 83 6 (3 ) — — — (45 ) — (15 ) 26 — (1 ) Total non-U.S. 1,608 15 (10 ) 95 (2 ) — (220 ) 3 (327 ) 1,162 5 (23 ) Residential mortgage-backed 14 — — 5 — — (2 ) 10 — 27 — — Commercial mortgage-backed 20 — (2 ) 1 — — (3 ) — — 16 1 (2 ) Other asset-backed 109 — — 69 — — (25 ) 35 (50 ) 138 — — Total fixed maturity securities 4,089 18 (16 ) 602 (2 ) — (403 ) 186 (666 ) 3,808 9 (29 ) Equity securities 51 — — — (9 ) — (5 ) — — 37 — — Other invested assets: Derivative assets: Equity index options 63 18 — 31 — — (70 ) — — 42 10 — Total derivative assets 63 18 — 31 — — (70 ) — — 42 10 — Total other invested assets 63 18 — 31 — — (70 ) — — 42 10 — Reinsurance recoverable (2) 26 (9 ) — — — 2 — — — 19 (9 ) — Total Level 3 assets $ 4,229 $ 27 $ (16 ) $ 633 $ (11 ) $ 2 $ (478 ) $ 186 $ (666 ) $ 3,906 $ 10 $ (29 ) (1) The transfers into and out of Level 3 for fixed maturity securities were related to changes in the primary pricing source and changes in the observability of external information used in determining the fair value, such as external ratings or credit spreads, as well as changes in the industry sectors assigned to specific securities. (2) Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities. Beginning as of Total realized and Purchases Sales Issuances Settlements Transfer (1) Transfer (1) Ending as of Total gains (Amounts in millions) Included Included Included Included Fixed maturity securities: State and political subdivisions $ 102 $ 3 $ (11 ) $ — $ — $ — $ (1 ) $ — $ (27 ) $ 66 $ 3 $ (11 ) Non-U.S. — — — — — — (1 ) 1 — — — — U.S. corporate: Utilities 865 9 8 76 (13 ) — (56 ) 42 (89 ) 842 — 14 Energy 129 1 1 30 (21 ) — (21 ) 22 (13 ) 128 — (3 ) Finance and insurance 572 2 16 167 — — (41 ) — (109 ) 607 — 19 Consumer—non-cyclical 94 — 4 8 — — (22 ) 25 — 109 — 4 Technology and communications 50 — 3 82 — — (1 ) 13 (100 ) 47 — 5 Industrial 40 — — — — — — — — 40 — — Capital goods 102 — — — — — (8 ) 11 (45 ) 60 — 1 Consumer—cyclical 173 3 4 15 — — (36 ) 47 (56 ) 150 — 6 Transportation 78 — (1 ) — — — (4 ) 27 (30 ) 70 — 2 Other 136 — 2 25 — — (7 ) 87 (24 ) 219 — 2 Total U.S. corporate 2,239 15 37 403 (34 ) — (196 ) 274 (466 ) 2,272 — 50 Non-U.S. Utilities 374 — 10 13 — — — 28 (73 ) 352 — 9 Energy 247 — (5 ) 7 — — (28 ) 24 — 245 — (5 ) Finance and insurance 234 4 17 15 — — (10 ) 77 (32 ) 305 4 17 Consumer—non-cyclical 59 — 3 20 — — — 1 (16 ) 67 — 2 Technology and communications 28 — — — — — — — — 28 — 1 Industrial 104 — 4 — — — (5 ) — (8 ) 95 — 3 Capital goods 161 1 1 20 — — (39 ) 34 — 178 — 1 Consumer—cyclical 147 — 3 21 — — (26 ) 32 (31 ) 146 — 2 Transportation 191 — 1 7 — — (10 ) 22 (102 ) 109 — 4 Other 140 9 (1 ) 6 — — (72 ) 1 — 83 — 2 Total non-U.S. 1,685 14 33 109 — — (190 ) 219 (262 ) 1,608 4 36 Residential mortgage-backed 27 — (1 ) — — — (1 ) 4 (15 ) 14 — — Commercial mortgage-backed 6 — 1 — — — — 20 (7 ) 20 — 1 Other asset-backed 93 — 1 124 — — (16 ) 10 (103 ) 109 — — Total fixed maturity securities 4,152 32 60 636 (34 ) — (405 ) 528 (880 ) 4,089 7 76 Equity securities 51 — — 6 (7 ) — — 1 — 51 — — Other invested assets: Derivative assets: Equity index options 81 4 — 59 — — (81 ) — — 63 5 — Total derivative assets 81 4 — 59 — — (81 ) — — 63 5 — Total other invested assets 81 4 — 59 — — (81 ) — — 63 5 — Reinsurance recoverable (2) 20 4 — — — 2 — — — 26 4 — Total Level 3 assets $ 4,304 $ 40 $ 60 $ 701 $ (41 ) $ 2 $ (486 ) $ 529 $ (880 ) $ 4,229 $ 16 $ 76 (1) The transfers into and out of Level 3 for fixed maturity securities were related to changes in the primary pricing source and changes in the observability of external information used in determining the fair value, such as external ratings or credit spreads, as well as changes in the industry sectors assigned to specific securities. (2) Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities. Beginning as of Total realized and Purchases Sales Issuances Settlements Transfer (1) Transfer (1) Ending as of Total gains attributable (Amounts in millions) Included Included Fixed maturity securities: State and political subdivisions $ 51 $ 3 $ 20 $ — $ — $ — $ — $ 28 $ — $ 102 $ 3 U.S. corporate: Utilities 643 1 72 156 (14 ) — (49 ) 72 (16 ) 865 — Energy 121 — 9 17 (5 ) — (13 ) — — 129 — Finance and insurance 534 — 51 50 — — (39 ) 35 (59 ) 572 — Consumer—non-cyclical 73 — 5 23 (5 ) — (11 ) 9 — 94 — Technology and communications 50 — 7 — — — (1 ) 5 (11 ) 50 — Industrial 39 — 1 — — — — — — 40 — Capital goods 92 — 10 — — — — — — 102 — Consumer—cyclical 211 — 11 — (13 ) — (18 ) — (18 ) 173 (1 ) Transportation 57 — 3 39 — — (10 ) — (11 ) 78 — Other 178 — 6 23 — — (20 ) 8 (59 ) 136 — Total U.S. corporate 1,998 1 175 308 (37 ) — (161 ) 129 (174 ) 2,239 (1 ) Non-U.S. Utilities 404 — 30 30 (7 ) — (67 ) — (16 ) 374 — Energy 217 (1 ) 19 46 (18 ) — (16 ) — — 247 — Finance and insurance 171 4 23 7 — — (16 ) 54 (9 ) 234 4 Consumer—non-cyclical 106 2 5 1 — — (55 ) — — 59 — Technology and communications 26 — 2 — — — — — — 28 — Industrial 61 — 5 38 — — — — — 104 — Capital goods 173 — 12 10 — — (16 ) 3 (21 ) 161 — Consumer—cyclical 122 — 12 16 — — (3 ) — — 147 — Transportation 171 — 10 27 — — — — (17 ) 191 — Other 81 — 12 43 — — (2 ) 6 — 140 — Total non-U.S. 1,532 5 130 218 (25 ) — (175 ) 63 (63 ) 1,685 4 Residential mortgage-backed 35 — 1 — (2 ) — (1 ) — (6 ) 27 — Commercial mortgage-backed 95 — 17 3 — — — 1 (110 ) 6 — Other asset-backed 81 — 3 122 — — (18 ) 28 (123 ) 93 — Total fixed maturity securities 3,792 9 346 651 (64 ) — (355 ) 249 (476 ) 4,152 6 Equity securities 58 — — 2 (9 ) — — — — 51 — Other invested assets: Derivative assets: Equity index options 39 43 — 63 — — (64 ) — — 81 18 Total derivative assets 39 43 — 63 — — (64 ) — — 81 18 Total other invested assets 39 43 — 63 — — (64 ) — — 81 18 Reinsurance recoverable (2) 20 (1 ) — — — 1 — — — 20 (1 ) Total Level 3 assets $ 3,909 $ 51 $ 346 $ 716 $ (73 ) $ 1 $ (419 ) $ 249 $ (476 ) $ 4,304 $ 23 (1) The transfers into and out of Level 3 for fixed maturity securities were related to changes in the primary pricing source and changes in the observability of external information used in determining the fair value, such as external ratings or credit spreads, as well as changes in the industry sectors assigned to specific securities. (2) Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities.
Gains and Losses Included in Net Income (Loss) from Assets Measured at Fair Value	The following table presents the gains and losses included in net income from assets measured at fair value on a recurring basis and for which we have utilized significant unobservable (Level 3) inputs to determine fair value and the related income statement line item in which these gains and losses were presented for the years ended December 31: (Amounts in millions) 2021 2020 2019 Total realized and unrealized gains (losses) included in net income: Net investment income $ 19 $ 32 $ 10 Net investment gains (losses) 8 8 41 Total $ 27 $ 40 $ 51 Total gains (losses) included in net income attributable to assets still held: Net investment income $ 9 $ 7 $ 6 Net investment gains (losses) 1 9 17 Total $ 10 $ 16 $ 23
Summary of Significant Unobservable Inputs Used for Certain Asset Fair Value Measurements	The following table presents a summary of the significant unobservable inputs used for certain asset fair value measurements that are based on internal models and classified as Level 3 as of December 31, 2021: (Amounts in millions) Valuation Fair value Unobservable input Range Weighted- (1) Fixed maturity securities: U.S. corporate: Utilities Internal models $ 916 Credit spreads 59bps - 202bps 138bps Energy Internal models 61 Credit spreads 95bps - 217bps 149bps Finance and insurance Internal models 679 Credit spreads 50bps - 184bps 131bps Consumer—non-cyclical Internal models 104 Credit spreads 55bps - 217bps 121bps Technology and communications Internal models 29 Credit spreads 80bps - 158bps 131bps Industrial Internal models 37 Credit spreads 91bps - 171bps 123bps Capital goods Internal models 45 Credit spreads 67bps - 175bps 133bps Consumer—cyclical Internal models 137 Credit spreads 87bps - 165bps 125bps Transportation Internal models 53 Credit spreads 47bps - 139bps 91bps Other Internal models 166 Credit spreads 78bps - 163bps 95bps Total U.S. corporate Internal models $ 2,227 Credit spreads 47bps - 217bps 130bps Non-U.S. Utilities Internal models $ 344 Credit spreads 70bps - 202bps 118bps Energy Internal models 135 Credit spreads 76bps - 171bps 120bps Finance and insurance Internal models 160 Credit spreads 71bps - 128bps 98bps Consumer—non-cyclical Internal models 61 Credit spreads 55bps - 140bps 94bps Technology and communications Internal models 28 Credit spreads 95bps - 114bps 108bps Industrial Internal models 93 Credit spreads 67bps - 161bps 113bps Capital goods Internal models 173 Credit spreads 55bps - 202bps 115bps Consumer—cyclical Internal models 61 Credit spreads 91bps - 171bps 121bps Transportation Internal models 53 Credit spreads 55bps - 171bps 84bps Other Internal models 26 Credit spreads 64bps - 120bps 102bps Total non-U.S. Internal models $ 1,134 Credit spreads 55bps - 202bps 111bps Derivative assets: Discounted cash Equity index Equity index options flows $ 42 volatility 6% - 50% 25 % (1) Unobservable inputs weighted by the relative fair value of the associated instrument for fixed maturity securities and by notional for derivative assets.
Liabilities by Class of Instrument that are Measured at Fair Value on Recurring Basis	The following tables set forth our liabilities by class of instrument that are measured at fair value on a recurring basis as of December 31: 2021 (Amounts in millions) Total Level 1 Level 2 Level 3 Liabilities Policyholder account balances: GMWB embedded derivatives (1) $ 271 $ — $ — $ 271 Fixed index annuity embedded derivatives 294 — — 294 Indexed universal life embedded derivatives 25 — — 25 Total policyholder account balances 590 — — 590 Derivative liabilities: Interest rate swaps 26 — 26 — Total derivative liabilities 26 — 26 — Total liabilities $ 616 $ — $ 26 $ 590 (1) Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. 2020 (Amounts in millions) Total Level 1 Level 2 Level 3 Liabilities Policyholder account balances: GMWB embedded derivatives (1) $ 379 $ — $ — $ 379 Fixed index annuity embedded derivatives 399 — — 399 Indexed universal life embedded derivatives 26 — — 26 Total policyholder account balances 804 — — 804 Derivative liabilities: Interest rate swaps 23 — 23 — Foreign currency swaps 2 — 2 — Other foreign currency contracts 1 — 1 — Total derivative liabilities 26 — 26 — Total liabilities $ 830 $ — $ 26 $ 804 (1) Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance.
Liabilities Measured at Fair Value on Recurring Basis and Utilized Significant Unobservable (Level 3) Inputs to Determine Fair Value	The following tables present additional information about liabilities measured at fair value on a recurring basis and for which we have utilized significant unobservable (Level 3) inputs to determine fair value as of or for the dates indicated: Beginning as of Total realized and Ending as of Total (gains) (Amounts in millions) Included Included Purchases Sales Issuances Settlements Transfer Transfer Included Included Policyholder account balances: GMWB embedded derivatives (1) $ 379 $ (133 ) $ — $ — $ — $ 25 $ — $ — $ — $ 271 $ (127 ) $ — Fixed index annuity embedded derivatives 399 32 — — — — (136 ) — (1 ) 294 32 — Indexed universal life embedded derivatives 26 (24 ) — — — 23 — — — 25 (24 ) — Total policyholder account balances 804 (125 ) — — — 48 (136 ) — (1 ) 590 (119 ) — Total Level 3 liabilities $ 804 $ (125 ) $ — $ — $ — $ 48 $ (136 ) $ — $ (1 ) $ 590 $ (119 ) $ — (1) Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. Beginning as of Total realized and Ending as of Total (gains) (Amounts in millions) Included Included Purchases Sales Issuances Settlements Transfer Transfer Included Included Policyholder account balances: GMWB embedded derivatives (1) $ 323 $ 32 $ — $ — $ — $ 24 $ — $ — $ — $ 379 $ 38 $ — Fixed index annuity embedded derivatives 452 51 — — — — (104 ) — — 399 51 — Indexed universal life embedded derivatives 19 (17 ) — — — 24 — — — 26 (17 ) — Total policyholder account balances 794 66 — — — 48 (104 ) — — 804 72 — Total Level 3 liabilities $ 794 $ 66 $ — $ — $ — $ 48 $ (104 ) $ — $ — $ 804 $ 72 $ — (1) Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. Beginning as of Total realized and Ending as of Total attributable (Amounts in millions) Included in Included Purchases Sales Issuances Settlements Transfer Transfer Policyholder account balances: GMWB embedded derivatives (1) $ 337 $ (39 ) $ — $ — $ — $ 25 $ — $ — $ — $ 323 $ (34 ) Fixed index annuity embedded derivatives 389 90 — — — — (27 ) — — 452 90 Indexed universal life embedded derivatives 12 (4 ) — — — 11 — — — 19 (4 ) Total policyholder account balances 738 47 — — — 36 (27 ) — — 794 52 Total Level 3 liabilities $ 738 $ 47 $ — $ — $ — $ 36 $ (27 ) $ — $ — $ 794 $ 52 (1) Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance.
Gains and Losses Included in Net (Income) from Liabilities Measured at Fair Value	The following table presents the gains and losses included in net (income) from liabilities measured at fair value on a recurring basis and for which we have utilized significant unobservable (Level 3) inputs to determine fair value and the related income statement line item in which these gains and losses were presented for the years ended December 31: (Amounts in millions) 2021 2020 2019 Total realized and unrealized (gains) losses included in net (income): Net investment income $ — $ — $ — Net investment (gains) losses (125 ) 66 47 Total $ (125 ) $ 66 $ 47 Total (gains) losses included in net (income) attributable to liabilities still held: Net investment income $ — $ — $ — Net investment (gains) losses (119 ) 72 52 Total $ (119 ) $ 72 $ 52
Summary of Significant Unobservable Inputs Used for Certain Liability Fair Value Measurements	The following table presents a summary of the significant unobservable inputs used for certain liability fair value measurements that are based on internal models and classified as Level 3 as of December 31, 2021: (Amounts in millions) Valuation Fair Unobservable input Range Weighted- (1) Policyholder account balances: Withdrawal utilization rate 60% - 89% 76% Lapse rate 2% - 9% 4% Non-performance (credit spreads) 20bps - 83bps 66bps GMWB embedded derivatives (2) Stochastic $271 Equity index 15% - 27% 22% Fixed index annuity embedded derivatives Option budget method $294 Expected future —% - 3% 1% Indexed universal life embedded derivatives Option budget method $25 Expected future 3% - 11% 5% (1) Unobservable inputs weighted by the policyholder account balances associated with the instrument. (2) Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. The unobservable inputs associated with GMWB embedded derivatives are not interrelated and therefore, a directional change in one input will not affect the other inputs.
Fair Value Financial Instruments Not Required to be Carried at Fair Value	The following represents our estimated fair value of financial assets and liabilities that are not required to be carried at fair value as of December 31: 2021 Notional amount Carrying amount Fair value (Amounts in millions) Total Level 1 Level 2 Level 3 Assets: Commercial mortgage loans, net (1 ) $ 6,830 $ 7,224 $ — $ — $ 7,224 Bank loan investments (1 ) 363 370 — — 370 Liabilities: Long-term borrowings (2) (1 ) 1,899 1,767 — 1,767 — Investment contracts (1 ) 8,657 9,352 — — 9,352 Other firm commitments: Commitments to fund limited partnerships 1,185 — — — — — Commitments to fund bank loan investments 141 — — — — — Ordinary course of business lending commitments 125 — — — — — (1) These financial instruments do not have notional amounts. (2) See note 12 for additional information related to borrowings. 2020 Notional amount Carrying amount Fair value (Amounts in millions) Total Level 1 Level 2 Level 3 Assets: Commercial mortgage loans, net (1 ) $ 6,743 $ 7,145 $ — $ — $ 7,145 Bank loan investments (1 ) 344 354 — — 354 Liabilities: Long-term borrowings (2) (1 ) 3,403 3,090 — 3,090 — Investment contracts (1 ) 10,276 11,353 — — 11,353 Other firm commitments: Commitments to fund limited partnerships 1,090 — — — — — Commitments to fund bank loan investments 32 — — — — — Ordinary course of business lending commitments 117 — — — — — (1) These financial instruments do not have notional amounts. (2) See note 12 for additional information related to borrowings.
Summary of carrying value of limited partnerships and commitments to fund	The following table presents the carrying value of limited partnerships and commitments to fund as of December 31: 2021 2020 Carrying Commitments Carrying Commitments (Amounts in millions) value to fund value to fund Limited partnerships accounted for at NAV: Private equity funds (1) $ 1,338 $ 951 $ 749 $ 859 Real estate funds (2) 67 101 39 66 Infrastructure funds (3) 57 13 47 22 Total limited partnerships accounted for at NAV 1,462 1,065 835 947 Limited partnerships accounted for under equity method of accounting 437 120 213 143 Low-income (4) 1 — 1 — Total $ 1,900 $ 1,185 $ 1,049 $ 1,090 (1) This class employs various investment strategies such as leveraged buyout, growth equity, venture capital and mezzanine financing, generally investing in debt or equity positions directly in companies or assets of various sizes across diverse industries globally, primarily concentrated in North America. (2) This class invests in real estate in North America, Europe and Asia via direct property ownership, joint ventures, mortgages and investments in debt and equity instruments. (3) This class invests in the debt or equity of cash flow generating assets diversified across a variety of industries, including transportation, energy infrastructure, renewable power, social infrastructure, power generation, water, telecommunications and other regulated entities globally. (4) Relates to limited partnership investments that invest in affordable housing projects that qualify for the Low-Income

Insurance Subsidiary Financia_2

Insurance Subsidiary Financial Information and Regulatory Matters (Tables)	12 Months Ended
	Dec. 31, 2021
Schedule of Combined Statutory Net Income (Loss) and Statutory Capital and Surplus	The tables below include the combined statutory net income and statutory capital and surplus for our U.S. domiciled insurance subsidiaries for the periods indicated: Years ended December 31, (Amounts in millions) 2021 2020 2019 Combined statutory net income (loss): Life insurance subsidiaries, excluding captive life reinsurance subsidiaries $ 654 $ 197 $ 740 Mortgage insurance subsidiaries 593 404 847 Combined statutory net income, excluding captive reinsurance subsidiaries 1,247 601 1,587 Captive life insurance subsidiaries (1,351 ) 9 (350 ) Combined statutory net income (loss) $ (104 ) $ 610 $ 1,237 As of December 31, (Amounts in millions) 2021 2020 Combined statutory capital and surplus: Life insurance subsidiaries, excluding captive life reinsurance subsidiaries $ 2,945 $ 2,131 Mortgage insurance subsidiaries 4,439 4,073 Combined statutory capital and surplus $ 7,384 $ 6,204

Segment Information (Tables)

Segment Information (Tables)	12 Months Ended
	Dec. 31, 2021
Summary of Segments and Corporate and Other Activities	The following is a summary of our segments and Corporate and Other activities as of or for the years ended December 31: 2021 Enact U.S. Life Runoff Corporate Total (Amounts in millions) Premiums $ 975 $ 2,454 $ — $ 6 $ 3,435 Net investment income 141 3,029 194 6 3,370 Net investment gains (losses) (2 ) 329 3 (7 ) 323 Policy fees and other income 4 565 134 1 704 Total revenues 1,118 6,377 331 6 7,832 Benefits and other changes in policy reserves 125 4,230 27 1 4,383 Interest credited — 346 162 — 508 Acquisition and operating expenses, net of deferrals 230 865 53 75 1,223 Amortization of deferred acquisition costs and intangibles 15 340 20 2 377 Interest expense 51 — — 109 160 Total benefits and expenses 421 5,781 262 187 6,651 Income (loss) from continuing operations before income taxes 697 596 69 (181 ) 1,181 Provision (benefit) for income taxes 148 155 13 (53 ) 263 Income (loss) from continuing operations 549 441 56 (128 ) 918 Income from discontinued operations, net of taxes — — — 27 27 Net income (loss) 549 441 56 (101 ) 945 Less: net income from continuing operations attributable to noncontrolling interests 33 — — — 33 Less: net income from discontinued operations attributable to noncontrolling interests — — — 8 8 Net income (loss) available to Genworth Financial, Inc.’s common stockholders $ 516 $ 441 $ 56 $ (109 ) $ 904 Net income (loss) available to Genworth Financial, Inc.’s common stockholders: Income (loss) from continuing operations available to Genworth Financial, Inc.’s common stockholders $ 516 $ 441 $ 56 $ (128 ) $ 885 Income from discontinued operations available to Genworth Financial, Inc.’s common stockholders — — — 19 19 Net income (loss) available to Genworth Financial, Inc.’s common stockholders $ 516 $ 441 $ 56 $ (109 ) $ 904 Segment assets $ 5,850 $ 81,210 $ 9,460 $ 2,651 $ 99,171 Assets held for sale related to discontinued operations — — — — — Total assets $ 5,850 $ 81,210 $ 9,460 $ 2,651 $ 99,171 2020 Enact U.S. Life Runoff Corporate Total (Amounts in millions) Premiums $ 971 $ 2,858 $ — $ 7 $ 3,836 Net investment income 133 2,878 210 6 3,227 Net investment gains (losses) (4 ) 517 (26 ) 5 492 Policy fees and other income 6 595 130 (2 ) 729 Total revenues 1,106 6,848 314 16 8,284 Benefits and other changes in policy reserves 381 4,781 48 4 5,214 Interest credited — 383 166 — 549 Acquisition and operating expenses, net of deferrals 206 620 48 61 935 Amortization of deferred acquisition costs and intangibles 21 418 23 1 463 Interest expense 18 5 — 172 195 Total benefits and expenses 626 6,207 285 238 7,356 Income (loss) from continuing operations before income taxes 480 641 29 (222 ) 928 Provision (benefit) for income taxes 102 163 4 (39 ) 230 Income (loss) from continuing operations 378 478 25 (183 ) 698 Loss from discontinued operations, net of taxes — — — (486 ) (486 ) Net income (loss) 378 478 25 (669 ) 212 Less: net income from continuing operations attributable to noncontrolling interests — — — — — Less: net income from discontinued operations attributable to noncontrolling interests — — — 34 34 Net income (loss) available to Genworth Financial, Inc.’s common stockholders $ 378 $ 478 $ 25 $ (703 ) $ 178 Net income (loss) available to Genworth Financial, Inc.’s common stockholders: Income (loss) from continuing operations available to Genworth Financial, Inc.’s common stockholders $ 378 $ 478 $ 25 $ (183 ) $ 698 Loss from discontinued operations available to Genworth Financial, Inc.’s common stockholders — — — (520 ) (520 ) Net income (loss) available to Genworth Financial, Inc.’s common stockholders $ 378 $ 478 $ 25 $ (703 ) $ 178 Segment assets $ 5,627 $ 84,671 $ 9,735 $ 2,897 $ 102,930 Assets held for sale related to discontinued operations — — — 2,817 2,817 Total assets $ 5,627 $ 84,671 $ 9,735 $ 5,714 $ 105,747 2019 Enact U.S. Life Runoff Corporate Total (Amounts in millions) Premiums $ 856 $ 2,861 $ — $ 8 $ 3,725 Net investment income 117 2,852 187 8 3,164 Net investment gains (losses) 1 82 (25 ) (31 ) 27 Policy fees and other income 4 643 140 2 789 Total revenues 978 6,438 302 (13 ) 7,705 Benefits and other changes in policy reserves 50 4,979 27 3 5,059 Interest credited — 419 158 — 577 Acquisition and operating expenses, net of deferrals 191 604 52 62 909 Amortization of deferred acquisition costs and intangibles 15 372 18 3 408 Interest expense — 17 — 214 231 Total benefits and expenses 256 6,391 255 282 7,184 Income (loss) from continuing operations before income taxes 722 47 47 (295 ) 521 Provision (benefit) for income taxes 153 34 8 (56 ) 139 Income (loss) from continuing operations 569 13 39 (239 ) 382 Income from discontinued operations, net of taxes — — — 148 148 Net income (loss) 569 13 39 (91 ) 530 Less: net income from continuing operations attributable to noncontrolling interests — — — — — Less: net income from discontinued operations attributable to noncontrolling interests — — — 187 187 Net income (loss) available to Genworth Financial, Inc.’s common stockholders $ 569 $ 13 $ 39 $ (278 ) $ 343 Net income (loss) available to Genworth Financial, Inc.’s common stockholders: Income (loss) from continuing operations available to Genworth Financial, Inc.’s common stockholders $ 569 $ 13 $ 39 $ (239 ) $ 382 Loss from discontinued operations available to Genworth Financial, Inc.’s common stockholders — — — (39 ) (39 ) Net income (loss) available to Genworth Financial, Inc.’s common stockholders $ 569 $ 13 $ 39 $ (278 ) $ 343
Summary of Revenues of Major Product Groups for Segments and Corporate and Other Activities	The following is a summary of revenues of major product groups for our segments and Corporate and Other activities for the years ended December 31: (Amounts in millions) 2021 2020 2019 Revenues: Enact segment $ 1,118 $ 1,106 $ 978 U.S. Life Insurance segment: Long-term care insurance 4,875 4,960 4,385 Life insurance 996 1,357 1,444 Fixed annuities 506 531 609 U.S. Life Insurance segment 6,377 6,848 6,438 Runoff segment 331 314 302 Corporate and Other activities 6 16 (13 ) Total revenues $ 7,832 $ 8,284 $ 7,705
Summary of Net Operating Income (Loss) for Segments and Corporate and Other Activities	The following tables present the reconciliation of net income available to Genworth Financial, Inc.’s common stockholders to adjusted operating income available to Genworth Financial, Inc.’s common stockholders and a summary of adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders for our segments and Corporate and Other activities for the years ended December 31: (Amounts in millions) 2021 2020 2019 Net income available to Genworth Financial, Inc.’s common stockholders $ 904 $ 178 $ 343 Add: net income from continuing operations attributable to noncontrolling interests 33 — — Add: net income from discontinued operations attributable to noncontrolling interests 8 34 187 Net income 945 212 530 Less: income (loss) from discontinued operations, net of taxes 27 (486 ) 148 Income from continuing operations 918 698 382 Less: net income from continuing operations attributable to noncontrolling interests 33 — — Income from continuing operations available to Genworth Financial, Inc.’s common stockholders 885 698 382 Adjustments to income from continuing operations available to Genworth Financial, Inc.’s common stockholders: Net investment (gains) losses, net (1) (324 ) (503 ) (38 ) (Gains) losses on early extinguishment of debt 45 9 — Initial loss from life block transaction 92 — — Expenses related to restructuring 34 3 4 Taxes on adjustments 33 103 7 Adjusted operating income available to Genworth Financial, Inc.’s common stockholders $ 765 $ 310 $ 355 (1) For the years ended December 31, 2021, 2020 and 2019, net investment (gains) losses were adjusted for DAC and other intangible amortization and certain benefit reserves of $(1) million, $(11) million and $(11) million, respectively. (Amounts in millions) 2021 2020 2019 Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders: Enact segment $ 520 $ 381 $ 568 U.S. Life Insurance segment: Long-term care insurance 445 237 57 Life insurance (269 ) (247 ) (181 ) Fixed annuities 91 78 69 U.S. Life Insurance segment 267 68 (55 ) Runoff segment 54 43 56 Corporate and Other activities (76 ) (182 ) (214 ) Adjusted operating income available to Genworth Financial, Inc.’s common stockholders $ 765 $ 310 $ 355
Schedule of Revenue, Net Income and Assets by Geographic Location	The following is a summary of geographic region activity as of or for the years ended December 31: 2021 (Amounts in millions) United States International (1) Total Total revenues $ 7,825 $ 7 $ 7,832 Income (loss) from continuing operations $ 921 $ (3 ) $ 918 Net income (loss) $ 948 $ (3 ) $ 945 Segment assets $ 99,117 $ 54 $ 99,171 Assets held for sale related to discontinued operations — — — Total assets $ 99,117 $ 54 $ 99,171 2020 (Amounts in millions) United States International (1) Total Total revenues $ 8,275 $ 9 $ 8,284 Income (loss) from continuing operations $ 700 $ (2 ) $ 698 Net income (loss) $ 214 $ (2 ) $ 212 Segment assets $ 102,871 $ 59 $ 102,930 Assets held for sale related to discontinued operations — 2,817 2,817 Total assets $ 102,871 $ 2,876 $ 105,747 2019 (Amounts in millions) United States International (1) Total Total revenues $ 7,696 $ 9 $ 7,705 Income (loss) from continuing operations $ 384 $ (2 ) $ 382 Net income $ 532 $ (2 ) $ 530 (1) Predominantly comprised of operations in Mexico.

Quarterly Results of Operatio_2

Quarterly Results of Operations (unaudited) (Tables)	12 Months Ended
	Dec. 31, 2021
Quarterly Results of Operations	Our unaudited quarterly results of operations for the year ended December 31, 2021 are summarized in the table below. Three months ended (Amounts in millions, except per share amounts) March 31, June 30, September 30, December 31, Total revenues (1) $ 1,985 $ 2,041 $ 2,070 $ 1,736 Total benefits and expenses (2) $ 1,752 $ 1,721 $ 1,697 $ 1,481 Income from continuing operations (1), (2), (3) $ 174 $ 245 $ 306 $ 193 Income (loss) from discontinued operations, net of taxes $ 21 $ (5 ) $ 12 $ (1 ) Net income (1), (2), (3) $ 195 $ 240 $ 318 $ 192 Net income from continuing operations attributable to noncontrolling interests (4) $ — $ — $ 4 $ 29 Net income from discontinued operations attributable to noncontrolling interests $ 8 $ — $ — $ — Net income available to Genworth Financial, Inc.’s common stockholders (4) $ 187 $ 240 $ 314 $ 163 Net income available to Genworth Financial, Inc.’s common stockholders: Income from continuing operations available to Genworth Financial, Inc.’s common stockholders $ 174 $ 245 $ 302 $ 164 Income (loss) from discontinued operations available to Genworth Financial, Inc.’s common stockholders 13 (5 ) 12 (1 ) Net income available to Genworth Financial, Inc.’s common stockholders $ 187 $ 240 $ 314 $ 163 Income from continuing operations available to Genworth Financial, Inc.’s common stockholders per share: Basic $ 0.35 $ 0.48 $ 0.59 $ 0.32 Diluted $ 0.34 $ 0.47 $ 0.59 $ 0.32 Net income available to Genworth Financial, Inc.’s common stockholders per share: Basic $ 0.37 $ 0.47 $ 0.62 $ 0.32 Diluted $ 0.37 $ 0.47 $ 0.61 $ 0.32 Weighted-average common shares outstanding: Basic 506.0 507.0 507.4 507.4 Diluted 513.8 515.0 514.2 515.6 (1) In the fourth quarter of 2021, our life insurance business initially ceded $360 million of premiums associated with certain term life insurance policies under a new reinsurance treaty as part of a life block transaction. (2) In the fourth quarter of 2021, our life insurance business initially ceded $268 million of certain term life insurance reserves under a new reinsurance treaty as part of a life block transaction. Our life insurance business also completed its annual review of assumptions in the fourth quarter of 2021. This review resulted in higher total benefits and expenses of $87 million from an unfavorable unlocking in our term universal and universal life insurance products largely attributable to higher pre-COVID-19 (3) In the fourth quarter of 2021, our life insurance business recorded a net loss of $131 million predominantly driven by an initial loss of $73 million as a result of ceding certain term life insurance policies as part of a life block transaction, an unfavorable unlocking of $70 million associated with its annual review of assumptions and a DAC impairment of $32 million as a result of recoverability testing. (4) On September 20, 2021, we completed the minority IPO of Enact Holdings, which reduced our ownership percentage to 81.6%, and lowered our available net income by $29 million in the fourth quarter of 2021. Our unaudited quarterly results of operations for the year ended December 31, 2020 are summarized in the table below. Three months ended (Amounts in millions, except per share amounts) March 31, June 30, September 30, December 31, Total revenues (1) $ 1,809 $ 2,003 $ 2,318 $ 2,154 Total benefits and expenses (2) $ 1,874 $ 1,925 $ 1,786 $ 1,771 Income (loss) from continuing operations (1), (2), (3) $ (60 ) $ 55 $ 402 $ 301 Income (loss) from discontinued operations, net of taxes (4) $ (12 ) $ (473 ) $ 34 $ (35 ) Net income (loss) (1), (2), (3), (4) $ (72 ) $ (418 ) $ 436 $ 266 Net income from continuing operations attributable to noncontrolling interests $ — $ — $ — $ — Net income (loss) from discontinued operations attributable to noncontrolling interests $ (6 ) $ 23 $ 18 $ (1 ) Net income (loss) available to Genworth Financial, Inc.’s common stockholders $ (66 ) $ (441 ) $ 418 $ 267 Net income (loss) available to Genworth Financial, Inc.’s common stockholders: Income (loss) from continuing operations available to Genworth Financial, Inc.’s common stockholders $ (60 ) $ 55 $ 402 $ 301 Income (loss) from discontinued operations available to Genworth Financial, Inc.’s common stockholders (6 ) (496 ) 16 (34 ) Net income (loss) available to Genworth Financial, Inc.’s common stockholders $ (66 ) $ (441 ) $ 418 $ 267 Income (loss) from continuing operations available to Genworth Financial, Inc.’s common stockholders per share: Basic $ (0.12 ) $ 0.11 $ 0.79 $ 0.60 Diluted $ (0.12 ) $ 0.11 $ 0.79 $ 0.59 Net income (loss) available to Genworth Financial, Inc.’s common stockholders per share: Basic $ (0.13 ) $ (0.87 ) $ 0.83 $ 0.53 Diluted $ (0.13 ) $ (0.86 ) $ 0.82 $ 0.52 Weighted-average common shares outstanding: Basic 504.3 505.4 505.6 505.6 Diluted (5) 504.3 512.5 511.5 512.5 (1) In the fourth quarter of 2020, we recorded lower net investment gains as compared to the third quarter of 2020. The higher net investment gains recorded in the third quarter of 2020 related to the sale of available-for-sale investment income recorded in the fourth quarter of 2020 largely driven by bond calls and mortgage loan repayments of $40 million and limited partnerships of $38 million. (2) Given our assumption that COVID-19 COVID-19 pre-pandemic (3) In the fourth quarter of 2020, our long-term care insurance business strengthened its reserves by $109 million after-tax. after-tax. (4) In the fourth quarter of 2020, we recorded a loss from discontinued operations, net of taxes, of $35 million principally attributed to expenses associated with the promissory note owed to AXA and from a $5 million net loss in Genworth Australia. The expenses associated with the promissory note mostly consisted of foreign currency remeasurement losses of $26 million, unfavorable tax charges of $17 million and other expenses of $8 million. These expenses were partially offset by derivative hedge gains of $21 million associated with foreign currency forward contracts entered into to mitigate our exposure to the installment payments to be made in British Pounds in 2022. See note 23 for additional details on discontinued operations. (5) Under applicable accounting guidance, companies in a loss position are required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share. Therefore, as a result of our loss from continuing operations available to Genworth Financial, Inc.’s common stockholders for the three months ended March 31, 2020, we were required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share for the three months ended March 31, 2020, as the inclusion of shares for stock options, RSUs and SARs of 5.4 million would have been antidilutive to the calculation. If we had not incurred a loss from continuing operations available to Genworth Financial, Inc.’s common stockholders for the three months ended March 31, 2020, dilutive potential weighted-average common shares outstanding would have been 509.7 million.

Changes in Accumulated Other _2

Changes in Accumulated Other Comprehensive Income (Loss) (Tables)	12 Months Ended
	Dec. 31, 2021
Component of Changes in Accumulated Other Comprehensive Income (Loss), Net of Taxes	The following tables show the changes in accumulated other comprehensive income (loss), net of taxes, by component as of and for the periods indicated: (Amounts in millions) Net (1) Derivatives (2) Foreign Total Balances as of January 1, 2021 $ 2,214 $ 2,211 $ — $ 4,425 OCI before reclassifications (313 ) (45 ) 148 (210 ) Amounts reclassified from (to) OCI (51 ) (141 ) — (192 ) Current period OCI (364 ) (186 ) 148 (402 ) Balances as of December 31, 2021 before noncontrolling interests 1,850 2,025 148 4,023 Less: change in OCI attributable to noncontrolling interests (10 ) — 172 162 Balances as of December 31, 2021 $ 1,860 $ 2,025 $ (24 ) $ 3,861 (1) Net of adjustments to DAC, PVFP, sales inducements and benefit reserves. See note 4 for additional information. (2) See note 5 for additional information. (Amounts in millions) Net (1) Derivatives (2) Foreign Total Balances as of January 1, 2020 $ 1,456 $ 2,002 $ (25 ) $ 3,433 OCI before reclassifications 1,132 344 55 1,531 Amounts reclassified from (to) OCI (374 ) (135 ) — (509 ) Current period OCI 758 209 55 1,022 Balances as of December 31, 2020 before noncontrolling interests 2,214 2,211 30 4,455 Less: change in OCI attributable to noncontrolling interests — — 30 30 Balances as of December 31, 2020 $ 2,214 $ 2,211 $ — $ 4,425 (1) Net of adjustments to DAC, PVFP, sales inducements and benefit reserves. See note 4 for additional information. (2) See note 5 for additional information. (Amounts in millions) Net (1) Derivatives (2) Foreign Total Balances as of January 1, 2019 $ 595 $ 1,781 $ (332 ) $ 2,044 OCI before reclassifications 910 331 487 1,728 Amounts reclassified from (to) OCI (62 ) (110 ) — (172 ) Current period OCI 848 221 487 1,556 Balances as of December 31, 2019 before noncontrolling interests 1,443 2,002 155 3,600 Less: change in OCI attributable to noncontrolling interests (13 ) — 180 167 Balances as of December 31, 2019 $ 1,456 $ 2,002 $ (25 ) $ 3,433 (1) Net of adjustments to DAC, PVFP, sales inducements and benefit reserves. See note 4 for additional information. (2) See note 5 for additional information.
Reclassifications in (out) of Accumulated Other Comprehensive Income (Loss), Net of Taxes	The following table shows reclassifications out of accumulated other comprehensive income (loss), net of taxes, for the periods presented: Amount reclassified from accumulated Affected line item in the consolidated statements of income Years ended December 31, (Amounts in millions) 2021 2020 2019 Net unrealized investment (gains) losses: Unrealized (gains) losses on investments (1) $ (65 ) $ (474 ) $ (79 ) Net investment (gains) losses Income taxes 14 100 17 Provision for income taxes Total $ (51 ) $ (374 ) $ (62 ) Derivatives designated as hedges: Interest rate swaps hedging assets $ (217 ) $ (196 ) $ (164 ) Net investment income Interest rate swaps hedging assets (1 ) (12 ) (6 ) Net investment (gains) losses Interest rate swaps hedging liabilities 1 — — Interest expense Income taxes 76 73 60 Provision for income taxes Total $ (141 ) $ (135 ) $ (110 ) (1) Amounts exclude adjustments to DAC, PVFP, sales inducements and benefit reserves.

Noncontrolling Interests (Table

Noncontrolling Interests (Tables)	12 Months Ended
	Dec. 31, 2021
Noncontrolling Interest [Abstract]
Summary of Changes in Ownership Interests	A summary of these changes in ownership interests and the effect on stockholders’ equity was as follows for the year ended December 31, 2021: (Amounts in millions) Net income available to Genworth Financial, Inc.’s common stockholders $ 904 Transfers to noncontrolling interests: Decrease in Genworth Financial, Inc.’s additional paid-in (167 ) Net transfers to noncontrolling interests (167 ) Change from net income available to Genworth Financial, Inc.’s common stockholders and transfers to noncontrolling interests $ 737

Discontinued Operations (Tables

Discontinued Operations (Tables)	12 Months Ended
	Dec. 31, 2021
Schedule Of Income Loss On Sale Recorded In Our Disposition Group	The following table provides a summary of the gain (loss) on sale associated with the disposition of Genworth Australia for the year ended December 31, 2021: (Amounts in millions) Net cash proceeds $ 370 Add: carrying value of noncontrolling interests (1) 657 Total adjusted consideration (2) 1,027 Carrying value of the disposal group before accumulated other comprehensive (income) loss 1,040 Add: total accumulated other comprehensive (income) loss of disposal group (3) 109 Total adjusted carrying value of the disposal group 1,149 Pre-tax (122 ) Tax benefit on sale 122 After-tax $ — (1) In accordance with accounting guidance on the deconsolidation of a subsidiary or group of assets, the carrying amount of any noncontrolling interests in the subsidiary sold (adjusted to reflect amounts in accumulated other comprehensive income (loss) recognized upon final disposition) is added to the total fair value of the consideration received. (2) Represents the aggregate of the net cash proceeds received upon sale closing plus the adjusted carrying amount of noncontrolling interests in the subsidiary sold. (3) Amount consists of $160 million of cumulative losses on foreign currency translation adjustments, partially offset by cumulative unrealized investment gains of $29 million and deferred tax gains of $22 million. The following table provides a summary of the loss on sale recorded in connection with the disposition of Genworth Canada for the year ended December 31, 2019: (Amounts in millions) Net cash proceeds $ 1,736 Add: carrying value of noncontrolling interests (1) 1,417 Total adjusted consideration (2) 3,153 Carrying value of the disposal group before accumulated other comprehensive loss 3,022 Add: total accumulated other comprehensive loss of disposal group (3) 325 Total adjusted carrying value of the disposal group 3,347 Pre-tax (194 ) Tax benefit on sale 73 After-tax $ (121 ) (1) In accordance with accounting guidance on the deconsolidation of a subsidiary or group of assets, the carrying amount of any noncontrolling interests in the subsidiary sold (adjusted to reflect amounts in accumulated other comprehensive income (loss) recognized upon final disposition) is added to the total fair value of the consideration received. (2) Represents the aggregate of the net cash proceeds received upon sale closing plus the adjusted carrying amount of noncontrolling interests in the subsidiary sold. (3) Amount consists of cumulative losses on foreign currency translation adjustments of $369 million and deferred tax losses of $71 million, partially offset by unrealized investment gains of $115 million.
Summary Of Balance Sheet Disclosures Relating To Disposal Group	The assets and liabilities related to Genworth Australia were segregated in our consolidated balance sheet until deconsolidation. The major asset and liability categories of Genworth Australia were as follows as of December 31: (Amounts in millions) 2021 2020 Assets Investments: Fixed maturity securities available-for-sale, $ — $ 2,295 Equity securities, at fair value — 90 Other invested assets — 154 Total investments — 2,539 Cash, cash equivalents and restricted cash — 95 Accrued investment income — 16 Deferred acquisition costs — 42 Intangible assets — 43 Other assets — 40 Deferred tax asset — 42 Assets related to discontinued operations $ — $ 2,817 Liabilities Liability for policy and contract claims $ — $ 331 Unearned premiums — 1,193 Other liabilities — 104 Long-term borrowings — 145 Liabilities related to discontinued operations $ — $ 1,773
Summary of Operating Results Related to Discontinued Operations	A summary of operating results related to Genworth Australia reported as discontinued operations was as follows for the years ended December 31: (Amounts in millions) 2021 2020 2019 Revenues: Premiums $ 51 $ 274 $ 312 Net investment income 4 33 56 Net investment gains (losses) (5 ) 66 23 Policy fees and other income — 1 — Total revenues 50 374 391 Benefits and expenses: Benefits and other changes in policy reserves 11 177 104 Acquisition and operating expenses, net of deferrals 7 53 53 Amortization of deferred acquisition costs and intangibles 6 29 33 Goodwill impairment — 5 — Interest expense 1 7 8 Total benefits and expenses 25 271 198 Income before income taxes and gain (loss) on sale (1) 25 103 193 Provision for income taxes 8 40 56 Income before gain (loss) on sale 17 63 137 Gain (loss) on sale, net of taxes — — — Income from discontinued operations, net of taxes 17 63 137 Less: net income from discontinued operations attributable to noncontrolling interests 8 34 64 Income from discontinued operations available to Genworth Financial, Inc.’s common stockholders $ 9 $ 29 $ 73 (1) The years ended December 31, 2021, 2020 and 2019 include pre-tax A summary of operating results for Genworth Canada reported as discontinued operations was as follows for the year ended December 31, 2019: (Amounts in millions) Revenues: Premiums $ 466 Net investment income 132 Net investment gains (losses) (13 ) Total revenues 585 Benefits and expenses: Benefits and other changes in policy reserves 79 Acquisition and operating expenses, net of deferrals 64 Amortization of deferred acquisition costs and intangibles 39 Interest expense (1) 50 Total benefits and expenses 232 Income before income taxes and loss on sale (2) 353 Provision for income taxes 111 Income before loss on sale 242 Loss on sale, net of taxes (121 ) Income from discontinued operations, net of taxes 121 Less: net income from discontinued operations attributable to noncontrolling interests 123 Loss from discontinued operations available to Genworth Financial, Inc.’s common stockholders $ (2 ) (1) Interest on debt assumed by Brookfield and interest on debt that was repaid as a result of the sale of Genworth Canada was allocated and reported in discontinued operations. The Term Loan, owed by Genworth Holdings and secured by GFIH’s ownership interest in Genworth Canada’s outstanding common shares, was repaid in connection with the close of the Genworth Canada sale. Accordingly, interest expense related to the Term Loan of $ 34 (2) The year ended December 31, 2019 includes pre-tax
Assets and liabilities held for sale and operating results related to discontinued operations	The following table presents the amounts owed to AXA under the settlement agreement reflected as liabilities related to discontinued operations in our consolidated balance sheets as of December 31: (Amounts in millions) British Pounds U.S. Dollar 2021 2020 2021 2020 Installment payments due to AXA: June 2022: Beginning balance £ 159 £ 159 $ 217 $ 217 Prepayments (1) (159 ) — (217 ) — Ending balance — 159 — 217 September 2022: Beginning balance 187 158 256 217 Amounts billed as future losses 45 29 61 39 Prepayments (1) (232 ) — (324 ) — Foreign exchange and other — — 7 — Ending balance — 187 — 256 Total amounts due under the promissory note — 346 — 473 Future claims: Estimated beginning balance 79 107 108 146 Change in estimated future claims (10 ) 1 (14 ) 1 Less: Amounts billed and included as mandatory prepayments (45 ) (29 ) (61 ) (39 ) Less: Amounts paid (2 ) — (3 ) — Estimated future billings 22 79 30 108 Total amounts due to AXA under the settlement agreement £ 22 £ 425 $ 30 $ 581 (1) On March 3, 2021, we completed the sale of Genworth Australia and received net proceeds of approximately AUD483 million ($370 million). The sale of Genworth Australia resulted in a mandatory principal payment of approximately £176 million ($245 million) related to our outstanding secured promissory note issued to AXA, dated as of July 20, 2020, as amended by the parties in connection with the Genworth Australia sale. On September 21, 2021, Genworth Holdings used a portion of the net proceeds from the minority IPO of Enact Holdings to repay the remaining outstanding balance of the secured promissory note of approximately £215 million ($296 million).

Nature of Business and Format_2

Nature of Business and Formation of Genworth - Additional Information (Detail) $ in Millions	3 Months Ended	9 Months Ended	12 Months Ended
	Mar. 31, 2021USD ($)	Sep. 30, 2021USD ($)	Dec. 31, 2021USD ($)Segmentshares	Dec. 31, 2021$ / shares	Dec. 31, 2021USD ($)	Jul. 31, 2021USD ($)	Apr. 01, 2013
Number of operating segments | Segment			3
AXA Settlement Agreement
Litigation Settlement, Expense			$ 30
Genworth Mortgage Insurance Australia Limited [Member]
Proceeds from Divestiture of Businesses and Interests in Affiliates	$ 370
Genworth Holdings
Percentage of subsidiary equity ownership							100.00%
Unrestricted cash and cash equivalents					$ 353
Debt instrument interest payment on outstanding debt					65
Genworth Holdings | 7.625% Senior Notes, Due 2021
Debt instrument face amount						$ 532
Debt instrument interest rate						7.625%
Genworth Holdings | 4.90% Senior Notes, Due 2021
Debt instrument face amount					$ 334
Debt instrument interest rate					4.90%
Enact Holdings [Member] | Minority IPO [Member]
Sale of Stock, Consideration Received on Transaction		$ 529
Genworth Australia
Percentage of subsidiary equity ownership					52.00%
Sale of Stock, Price Per Share | $ / shares				$ 2.28
Sale of Stock, Number of Shares Issued in Transaction | shares			214.3

Summary of Significant Accoun_3

Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($) $ in Millions		Dec. 31, 2019	Dec. 31, 2021	Dec. 31, 2019	Dec. 31, 2020	Jan. 01, 2020	Jan. 01, 2019
Accounting Policies [Abstract]
Equity securities, impairment charge recognition within number of months		15 months
Non-accrual status of loans after number of days past due			90 days
Cash equivalents determination for original maturities of investments, maximum number of months			90 days
Unearned premiums, increase (decrease) in earned premiums due to updated premium recognition factors for international mortgage insurance business				$ 14
Retained earnings			$ 2,490		$ 1,584
Operating Lease, Liability			$ 45
Operating Lease, Liability, Statement of Financial Position [Extensible Enumeration]							Operating Lease, Liability
Operating Lease, Weighted Average Remaining Lease Term			10 years
Operating lease weighted average discount rate			6.60%
Restricted commercial mortgage loans related to securitization entities			$ 29		38
2022			6
2023			8
2024			8
2025			8
2026			33
Imputed interest			$ 18
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]							Right of use asset related to operating leases included in other assets
Short-term investments, minimum number of months			3 months
Short-term investments, maximum number of months			12 months
Commercial mortgage loans
Accounting Policies [Abstract]
Accrued interest carrying value in Accrued investment income			$ 23		23
Maximum [Member]
Accounting Policies [Abstract]
Operating lease term			17 years
Minimum [Member]
Accounting Policies [Abstract]
Operating lease term			1 year
Subject to enforceable master netting arrangement
Accounting Policies [Abstract]
Collateral received			$ (308)		(401)
Collateral pledged			536		505
Subject to enforceable master netting arrangement | Derivative liabilities
Accounting Policies [Abstract]
Collateral received	[1]		0		0
Collateral pledged	[1]		(536)		(505)
Subject to enforceable master netting arrangement | Derivative assets
Accounting Policies [Abstract]
Collateral received	[1]		(308)		(401)
Collateral pledged	[1]		0		0
Subject to enforceable master netting arrangement | Non Cash Collateral | Derivative liabilities
Accounting Policies [Abstract]
Collateral pledged			536		505
Subject to enforceable master netting arrangement | Non Cash Collateral | Derivative assets
Accounting Policies [Abstract]
Collateral received			53		161
Subject to enforceable master netting arrangement | Cash Collateral | Derivative liabilities
Accounting Policies [Abstract]
Collateral pledged					100
Fixed maturity securities
Accounting Policies [Abstract]
Accrued interest carrying value in Accrued investment income			$ 523		$ 532
Limited Partnerships
Accounting Policies [Abstract]
Minimum threshold ownership percentage of limited partnership interest, equity method			3.00%
Accounting standards update 2016-02
Accounting Policies [Abstract]
Right of use asset related to operating leases included in other assets							$ 52
Operating Lease, Liability							55
Accrued rent expense, derecognized							$ 3
Accounting Standards Update 2016-13 | Off-balance sheet credit exposures | Cumulative effect of change in accounting
Accounting Policies [Abstract]
Retained earnings						$ 1
Accounting Standards Update 2016-13 | Reinsurance recoverables | Cumulative effect of change in accounting
Accounting Policies [Abstract]
Retained earnings						31
Adoption of new accounting guidance, deferred tax impact						9
Accounting Standards Update 2016-13 | Investments carried at amortized cost | Cumulative effect of change in accounting
Accounting Policies [Abstract]
Retained earnings						23
Adoption of new accounting guidance, deferred tax impact						$ 6
[1]	Does not include amounts related to embedded derivatives as of December 31, 2021 and 2020.

Earning (Loss) Per Share (Detai

Earning (Loss) Per Share (Detail) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended																12 Months Ended
	Dec. 31, 2021		Sep. 30, 2021		Jun. 30, 2021		Mar. 31, 2021		Dec. 31, 2020		Sep. 30, 2020		Jun. 30, 2020		Mar. 31, 2020		Dec. 31, 2021		Dec. 31, 2020		Dec. 31, 2019
Earnings Per Share [Abstract]
Weighted-average common shares used in basic earnings (loss) per share calculations	507.4		507.4		507		506		505.6		505.6		505.4		504.3		506.9		505.2		502.9
Stock options, restricted stock units and stock appreciation rights																	7.8		6.4		6.8
Weighted-average common shares used in diluted earnings (loss) per share calculations	515.6		514.2		515		513.8		512.5	[1]	511.5	[1]	512.5	[1]	504.3	[1]	514.7		511.6		509.7
Income from continuing operations:
Income from continuing operations	$ 193	[2],[3],[4]	$ 306	[2],[3],[4]	$ 245	[2],[3],[4]	$ 174	[2],[3],[4]	$ 301	[5],[6],[7]	$ 402	[5],[6],[7]	$ 55	[5],[6],[7]	$ (60)	[5],[6],[7]	$ 918		$ 698		$ 382
Less: net income from continuing operations attributable to noncontrolling interests	29	[8]	4	[8]	0	[8]	0	[8]	0		0		0		0		33		0		0
Income from continuing operations available to Genworth Financial, Inc.'s common stockholders	$ 164		$ 302		$ 245		$ 174		$ 301		$ 402		$ 55		$ (60)		$ 885		$ 698		$ 382
Basic per share	$ 0.32		$ 0.59		$ 0.48		$ 0.35		$ 0.60		$ 0.79		$ 0.11		$ (0.12)		$ 1.75		$ 1.38		$ 0.76
Diluted per share	$ 0.32		$ 0.59		$ 0.47		$ 0.34		$ 0.59		$ 0.79		$ 0.11		$ (0.12)		$ 1.72		$ 1.36		$ 0.75
Income (loss) from discontinued operations:
Income (loss) from discontinued operations, net of taxes	$ (1)		$ 12		$ (5)		$ 21		$ (35)	[9]	$ 34	[9]	$ (473)	[9]	$ (12)	[9]	$ 27		$ (486)		$ 148
Less: net income from discontinued operations attributable to noncontrolling interests	0		0		0		8		(1)		18		23		(6)		8		34		187
Income (loss) from discontinued operations available to Genworth Financial, Inc.'s common stockholders	(1)		12		(5)		13		(34)		16		(496)		(6)		$ 19		$ (520)		$ (39)
Basic per share																	$ 0.04		$ (1.03)		$ (0.08)
Diluted per share																	$ 0.04		$ (1.02)		$ (0.08)
Net income (loss):
Income from continuing operations	193	[2],[3],[4]	306	[2],[3],[4]	245	[2],[3],[4]	174	[2],[3],[4]	301	[5],[6],[7]	402	[5],[6],[7]	55	[5],[6],[7]	(60)	[5],[6],[7]	$ 918		$ 698		$ 382
Income (loss) from discontinued operations, net of taxes	(1)		12		(5)		21		(35)	[9]	34	[9]	(473)	[9]	(12)	[9]	27		(486)		148
Net income	192	[2],[3],[4]	318	[2],[3],[4]	240	[2],[3],[4]	195	[2],[3],[4]	266	[5],[6],[7],[9]	436	[5],[6],[7],[9]	(418)	[5],[6],[7],[9]	(72)	[5],[6],[7],[9]	945		212		530
Less: net income attributable to noncontrolling interests																	41		34		187
Net income available to Genworth Financial, Inc.'s common stockholders	$ 163	[8]	$ 314	[8]	$ 240	[8]	$ 187	[8]	$ 267		$ 418		$ (441)		$ (66)		$ 904		$ 178		$ 343
Basic per share	$ 0.32		$ 0.62		$ 0.47		$ 0.37		$ 0.53		$ 0.83		$ (0.87)		$ (0.13)		$ 1.78	[10]	$ 0.35	[10]	$ 0.68	[10]
Diluted per share	$ 0.32		$ 0.61		$ 0.47		$ 0.37		$ 0.52		$ 0.82		$ (0.86)		$ (0.13)		$ 1.76	[10]	$ 0.35	[10]	$ 0.67	[10]
[1]	Under applicable accounting guidance, companies in a loss position are required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share. Therefore, as a result of our loss from continuing operations available to Genworth Financial, Inc.’s common stockholders for the three months ended March 31, 2020, we were required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share for the three months ended March 31, 2020, as the inclusion of shares for stock options, RSUs and SARs of 5.4 million would have been antidilutive to the calculation. If we had not incurred a loss from continuing operations available to Genworth Financial, Inc.’s common stockholders for the three months ended March 31, 2020, dilutive potential weighted-average common shares outstanding would have been 509.7 million.
[2]	In the fourth quarter of 2021, our life insurance business initially ceded $268 million of certain term life insurance reserves under a new reinsurance treaty as part of a life block transaction. Our life insurance business also completed its annual review of assumptions in the fourth quarter of 2021. This review resulted in higher total benefits and expenses of $87 million from an unfavorable unlocking in our term universal and universal life insurance products largely attributable to higher pre-COVID-19 mortality. In our term universal life insurance products, we also recorded a DAC impairment of $41 million in the fourth quarter of 2021 principally due to lower future estimated gross profits.
[3]	In the fourth quarter of 2021, our life insurance business initially ceded $360 million of premiums associated with certain term life insurance policies under a new reinsurance treaty as part of a life block transaction.
[4]	In the fourth quarter of 2021, our life insurance business recorded a net loss of $131 million predominantly driven by an initial loss of $73 million as a result of ceding certain term life insurance policies as part of a life block transaction, an unfavorable unlocking of $70 million associated with its annual review of assumptions and a DAC impairment of $32 million as a result of recoverability testing.
[5]	Given our assumption that COVID-19 has temporarily decreased the number of new claims submitted, our long-term care insurance business strengthened IBNR reserves in the fourth quarter of 2020 by $47 million. Additionally, our long-term care insurance business recorded a $91 million increase to claim reserves reflecting our assumption that COVID-19 accelerated mortality experience on the most vulnerable claimants, leaving the remaining claim population less likely to terminate compared to the pre-pandemic average population. Our Enact segment recorded an unfavorable reserve adjustment of $37 million primarily due to slowing cure emergence patterns impacting the frequency of claim. Our life insurance business completed its annual review of assumptions in the fourth quarter of 2020. This review resulted in lower total benefits and expenses of $82 million from a net favorable unlocking in our term universal and universal life insurance products largely attributable to a model refinement in our term universal life insurance product related to persistency and grace period timing and lower projected cost of insurance assessments on our universal life insurance products. In addition, we recorded a DAC impairment of $63 million in our universal life insurance products due principally to lower future estimated gross profits.
[6]	In the fourth quarter of 2020, our long-term care insurance business strengthened its reserves by $109 million after-tax. Our Enact segment strengthened loss reserves by $29 million after-tax. Our life insurance business recorded a $60 million net favorable unlocking, net of taxes, related to its annual review of assumptions. This favorable unlocking in our life insurance business was partially offset by a DAC impairment of $50 million, net of taxes, as a result of recoverability testing. For all of the aforementioned transactions, see above under superscript (2) for additional details.
[7]	In the fourth quarter of 2020, we recorded lower net investment gains as compared to the third quarter of 2020. The higher net investment gains recorded in the third quarter of 2020 related to the sale of available-for-sale fixed maturity securities of $330 million driven primarily from the sale of U.S. government securities due to portfolio rebalancing and asset exposure management as a result of the prolonged low interest rate environment. This decrease to total revenues was partially offset by higher net investment income recorded in the fourth quarter of 2020 largely driven by bond calls and mortgage loan repayments of $40 million and limited partnerships of $38 million.
[8]	On September 20, 2021, we completed the minority IPO of Enact Holdings, which reduced our ownership percentage to 81.6%, and lowered our available net income by $29 million in the fourth quarter of 2021.
[9]	In the fourth quarter of 2020, we recorded a loss from discontinued operations, net of taxes, of $35 million principally attributed to expenses associated with the promissory note owed to AXA and from a $5 million net loss in Genworth Australia. The expenses associated with the promissory note mostly consisted of foreign currency remeasurement losses of $26 million, unfavorable tax charges of $17 million and other expenses of $8 million. These expenses were partially offset by derivative hedge gains of $21 million associated with foreign currency forward contracts entered into to mitigate our exposure to the installment payments to be made in British Pounds in 2022. See note 23 for additional details on discontinued operations.
[10]	May not total due to whole number calculation.

Net Investment Income (Detail)

Net Investment Income (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Net Investment Income [Line Items]
Gross investment income before expenses and fees	$ 3,457	$ 3,320	$ 3,259
Expenses and fees	(87)	(93)	(95)
Net investment income	3,370	3,227	3,164
Fixed maturity securities—taxable
Net Investment Income [Line Items]
Gross investment income before expenses and fees	2,411	2,448	2,444
Fixed maturity securities—non-taxable
Net Investment Income [Line Items]
Gross investment income before expenses and fees	7	6	8
Equity Securities
Net Investment Income [Line Items]
Gross investment income before expenses and fees	9	12	12
Commercial mortgage loans
Net Investment Income [Line Items]
Gross investment income before expenses and fees	376	345	348
Policy Loans
Net Investment Income [Line Items]
Gross investment income before expenses and fees	189	199	180
Limited Partnerships
Net Investment Income [Line Items]
Gross investment income before expenses and fees	223	72	44
Other invested assets
Net Investment Income [Line Items]
Gross investment income before expenses and fees	241	223	190
Cash, cash equivalents, restricted cash and short-term investments
Net Investment Income [Line Items]
Gross investment income before expenses and fees	$ 1	$ 15	$ 33

Net Investment Gains (Losses) (

Net Investment Gains (Losses) (Detail) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Available-for-sale fixed maturity securities
Realized gains		$ 67	$ 471	$ 90
Realized losses		(10)	(29)	(38)
Net realized gains (losses) on available-for-sale fixed maturity securities		57	442	52
Net realized gains (losses) on equity securities sold		(7)	(1)	0
Net realized gains (losses) on limited partnerships		3	0	1
Total net realized investment gains (losses)		53	441	53
Impairments:
Total other-than-temporary impairments		0	0	(1)
Portion of other-than-temporary impairments included in other comprehensive income (loss)		0	0	0
Net other-than-temporary impairments		0	0	(1)
Net change in allowance for credit losses on available-for-sale fixed maturity securities		(6)	(5)	0
Write-down of available-for-sale fixed maturity securities	[1]	(1)	(4)	0
Net unrealized gains (losses) on equity securities still held		1	4	14
Net unrealized gains (losses) on limited partnerships		264	112	28
Commercial mortgage loans		(3)	(2)	(2)
Derivative instruments	[2]	14	(49)	(70)
Other		1	(5)	5
Total net investment gains (losses)		$ 323	$ 492	$ 27
[1]	Represents write-down of securities deemed uncollectible or that we intend to sell or will be required to sell prior to recovery of the amortized cost basis.
[2]	See note 5 for additional information on the impact of derivative instruments included in net investment gains (losses).

Net Investment Allowance for Cr

Net Investment Allowance for Credit Losses (Detail) - Fixed maturity securities - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Debt Securities, Available-for-sale, Allowance for Credit Loss [Line Items]
Beginning Balance	$ 4	$ 0
Increase from securities without allowance in previous periods	0	7
Increase (decrease) from securities with allowance in previous periods	6	(2)
Securities Sold	(7)	(1)
Decrease due to change in intent or requirement to sell	0	0
Write-offs	(3)	0
Recoveries	0	0
Ending Balance	0	4
Non-U.S. corporate
Debt Securities, Available-for-sale, Allowance for Credit Loss [Line Items]
Beginning Balance	1	0
Increase from securities without allowance in previous periods	0	4
Increase (decrease) from securities with allowance in previous periods	6	(2)
Securities Sold	(7)	(1)
Decrease due to change in intent or requirement to sell	0	0
Write-offs	0	0
Recoveries	0	0
Ending Balance	0	1
Commercial mortgage-backed
Debt Securities, Available-for-sale, Allowance for Credit Loss [Line Items]
Beginning Balance	3	0
Increase from securities without allowance in previous periods	0	3
Increase (decrease) from securities with allowance in previous periods	0	0
Securities Sold	0	0
Decrease due to change in intent or requirement to sell	0	0
Write-offs	(3)	0
Recoveries	0	0
Ending Balance	$ 0	$ 3

Investments - Additional Inform

Investments - Additional Information (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Schedule of Investments [Line Items]
Percentage of investment portfolio by which no other industry group exceeded	10.00%
Percentage of stockholders' equity by which no single issuer of fixed maturity securities exceeded	10
Commercial mortgage loans on nonaccrual status	$ 0
Total Assets	99,171	$ 105,747
Commercial mortgage loans, amortized cost	6,856	6,774
Commercial mortgage-backed
Schedule of Investments [Line Items]
Commercial mortgage loans,Allowance for credit losses	0
Limited Partnerships | Variable interest Entity, not primary beneficiary
Schedule of Investments [Line Items]
Total Assets	$ 1,829	1,018
Finance and insurance | Fixed maturity securities
Schedule of Investments [Line Items]
Percent of investment portfolio, greater than 10%	25.00%
Utilities | Fixed maturity securities
Schedule of Investments [Line Items]
Percent of investment portfolio, greater than 10%	13.00%
Consumer-non-cyclical | Fixed maturity securities
Schedule of Investments [Line Items]
Percent of investment portfolio, greater than 10%	15.00%
Insurance [Member]
Schedule of Investments [Line Items]
Securities on deposit with various state government insurance departments	$ 45	46
Technology and Communications [Member] | Fixed maturity securities
Schedule of Investments [Line Items]
Percent of investment portfolio, greater than 10%	11.00%
Office
Schedule of Investments [Line Items]
Commercial mortgage loans, amortized cost	$ 1,526	$ 1,567
Write-offs	8
Office | 31 to 60 Past due
Schedule of Investments [Line Items]
Commercial mortgage loans, amortized cost	$ 22

Credit Losses Recognized in Net

Credit Losses Recognized in Net Income (Loss) on Debt Securities (Detail) - Debt Securities $ in Millions	12 Months Ended
	Dec. 31, 2019USD ($)
Other than Temporary Impairment, Credit Losses Recognized in Earnings [Line Items]
Cumulative credit losses, beginning balance	$ 24
Securities sold, paid down or disposed	(2)
Cumulative credit losses, ending balance	$ 22

Net Unrealized Gains and Losses

Net Unrealized Gains and Losses on Available-for-Sale Investment Securities Reflected as Separate Component of Accumulated Other Comprehensive Income (Loss) (Detail) - USD ($) $ in Millions		Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Components of Net Unrealized Investment Gains Losses Included in Accumulated Other Comprehensive Income Loss [Line Items]
Net unrealized gains (losses) on fixed maturity securities without an allowance for credit losses	[1]	$ 7,869	$ 10,159	$ 6,676
Net unrealized gains (losses) on fixed maturity securities with an allowance for credit losses	[1]	0	(7)	0
Adjustments to DAC, PVFP, sales inducements, benefit reserves and policyholder contract balances		(5,487)	(7,302)	(4,789)
Income taxes, net		(507)	(611)	(406)
Net unrealized investment gains (losses)		1,875	2,239	1,481
Less: net unrealized investment gains (losses) attributable to noncontrolling interests		15	25	25
Net unrealized investment gains (losses)		$ 1,860	$ 2,214	$ 1,456	$ 595
[1]	Excludes foreign exchange.

Change in Net Unrealized Gains

Change in Net Unrealized Gains (Losses) on Available-for-Sale Securities Reported in Accumulated Other Comprehensive Income (Loss) (Detail) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Investments [Abstract]
Net unrealized investment gains (losses), beginning of period		$ 2,214	$ 1,456	$ 595
Unrealized gains (losses) on fixed maturity securities		(2,218)	3,950	4,980
Adjustment to DAC	[1]	30	122	(956)
Adjustment to PVFP		0	(1)	(49)
Adjustment to sales inducements		12	(5)	(32)
Adjustment to benefit reserves and policyholder contract balances	[2]	1,773	(2,629)	(2,800)
Provision for income taxes		90	(305)	(233)
Change in unrealized gains (losses) on investment securities		(313)	1,132	910
Reclassification adjustments to net investment (gains) losses, net of taxes of $17, $5 and $55		(51)	(374)	(62)
Change in net unrealized investment gains (losses)		(364)	758	848
Less: change in net unrealized investment gains (losses) attributable to noncontrolling interests		(10)	0	(13)
Net unrealized investment gains (losses), end of period		$ 1,860	$ 2,214	$ 1,456
[1]	See note 6 for additional information.
[2]	See note 9 for additional information.

Change in Net Unrealized Gain_2

Change in Net Unrealized Gains (Losses) on Available-for-Sale Securities Reported in Accumulated Other Comprehensive Income (Loss) (Parenthetical) (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Components of Net Unrealized Investment Gains Losses Included in Accumulated Other Comprehensive Income Loss [Line Items]
Reclassification adjustments to net investment (gains) losses, taxes	$ 14	$ 100	$ 17

Amortized Cost or Cost, Gross U

Amortized Cost or Cost, Gross Unrealized Gains (Losses), Allowance for Credit Losses and Fair Value of Fixed Maturity Securities Classified as Available-for-Sale (Detail) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	$ 52,611	$ 53,417
Fair value, fixed maturity securities	60,480	63,495
Fixed maturity securities
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	52,611	53,417
Gross unrealized gains, fixed maturity securities	8,004	10,138
Gross unrealized losses, fixed maturity securities	(135)	(56)
Allowance for credit losses	0	(4)	$ 0
Fair value, fixed maturity securities	60,480	63,495
Fixed maturity securities | U.S. government, agencies and government-sponsored enterprises
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	3,368	3,401
Gross unrealized gains, fixed maturity securities	1,184	1,404
Gross unrealized losses, fixed maturity securities	0	0
Allowance for credit losses	0	0
Fair value, fixed maturity securities	4,552	4,805
Fixed maturity securities | State and Political Subdivisions
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	2,982	2,622
Gross unrealized gains, fixed maturity securities	474	544
Gross unrealized losses, fixed maturity securities	(6)	(1)
Allowance for credit losses	0	0
Fair value, fixed maturity securities	3,450	3,165
Fixed maturity securities | Non-U.S. government
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	762	728
Gross unrealized gains, fixed maturity securities	86	130
Gross unrealized losses, fixed maturity securities	(13)	(4)
Allowance for credit losses	0	0
Fair value, fixed maturity securities	835	854
Fixed maturity securities | U.S. corporate
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	30,257	29,895
Gross unrealized gains, fixed maturity securities	4,746	5,985
Gross unrealized losses, fixed maturity securities	(79)	(23)
Allowance for credit losses	0	0
Fair value, fixed maturity securities	34,924	35,857
Fixed maturity securities | U.S. corporate | Utilities
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	4,330	4,226
Gross unrealized gains, fixed maturity securities	783	970
Gross unrealized losses, fixed maturity securities	(9)	(2)
Allowance for credit losses	0	0
Fair value, fixed maturity securities	5,104	5,194
Fixed maturity securities | U.S. corporate | Energy
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	2,581	2,532
Gross unrealized gains, fixed maturity securities	363	367
Gross unrealized losses, fixed maturity securities	(10)	(16)
Allowance for credit losses	0	0
Fair value, fixed maturity securities	2,934	2,883
Fixed maturity securities | U.S. corporate | Finance and insurance
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	8,003	7,798
Gross unrealized gains, fixed maturity securities	1,012	1,306
Gross unrealized losses, fixed maturity securities	(24)	(2)
Allowance for credit losses	0	0
Fair value, fixed maturity securities	8,991	9,102
Fixed maturity securities | U.S. corporate | Consumer-non-cyclical
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	5,138	5,115
Gross unrealized gains, fixed maturity securities	1,029	1,323
Gross unrealized losses, fixed maturity securities	(8)	(1)
Allowance for credit losses	0	0
Fair value, fixed maturity securities	6,159	6,437
Fixed maturity securities | U.S. corporate | Technology and communications
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	3,345	3,142
Gross unrealized gains, fixed maturity securities	476	619
Gross unrealized losses, fixed maturity securities	(13)	0
Allowance for credit losses	0	0
Fair value, fixed maturity securities	3,808	3,761
Fixed maturity securities | U.S. corporate | Industrial
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	1,322	1,370
Gross unrealized gains, fixed maturity securities	175	232
Gross unrealized losses, fixed maturity securities	(3)	0
Allowance for credit losses	0	0
Fair value, fixed maturity securities	1,494	1,602
Fixed maturity securities | U.S. corporate | Capital goods
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	2,334	2,456
Gross unrealized gains, fixed maturity securities	415	535
Gross unrealized losses, fixed maturity securities	(4)	0
Allowance for credit losses	0	0
Fair value, fixed maturity securities	2,745	2,991
Fixed maturity securities | U.S. corporate | Consumer-cyclical
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	1,703	1,663
Gross unrealized gains, fixed maturity securities	203	284
Gross unrealized losses, fixed maturity securities	(7)	0
Allowance for credit losses	0	0
Fair value, fixed maturity securities	1,899	1,947
Fixed maturity securities | U.S. corporate | Transportation
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	1,122	1,198
Gross unrealized gains, fixed maturity securities	249	304
Gross unrealized losses, fixed maturity securities	0	(2)
Allowance for credit losses	0	0
Fair value, fixed maturity securities	1,371	1,500
Fixed maturity securities | U.S. corporate | Other
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	379	395
Gross unrealized gains, fixed maturity securities	41	45
Gross unrealized losses, fixed maturity securities	(1)	0
Allowance for credit losses	0	0
Fair value, fixed maturity securities	419	440
Fixed maturity securities | Non-U.S. corporate
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	9,344	9,245
Gross unrealized gains, fixed maturity securities	1,217	1,578
Gross unrealized losses, fixed maturity securities	(26)	(11)
Allowance for credit losses	0	(1)	0
Fair value, fixed maturity securities	10,535	10,811
Fixed maturity securities | Non-U.S. corporate | Utilities
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	867	838
Gross unrealized gains, fixed maturity securities	63	84
Gross unrealized losses, fixed maturity securities	(2)	0
Allowance for credit losses	0	0
Fair value, fixed maturity securities	928	922
Fixed maturity securities | Non-U.S. corporate | Energy
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	1,194	1,172
Gross unrealized gains, fixed maturity securities	190	209
Gross unrealized losses, fixed maturity securities	(1)	(1)
Allowance for credit losses	0	0
Fair value, fixed maturity securities	1,383	1,380
Fixed maturity securities | Non-U.S. corporate | Finance and insurance
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	2,171	2,130
Gross unrealized gains, fixed maturity securities	270	353
Gross unrealized losses, fixed maturity securities	(9)	(6)
Allowance for credit losses	0	(1)
Fair value, fixed maturity securities	2,432	2,476
Fixed maturity securities | Non-U.S. corporate | Consumer-non-cyclical
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	664	662
Gross unrealized gains, fixed maturity securities	81	112
Gross unrealized losses, fixed maturity securities	(2)	(1)
Allowance for credit losses	0	0
Fair value, fixed maturity securities	743	773
Fixed maturity securities | Non-U.S. corporate | Technology and communications
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	1,085	1,062
Gross unrealized gains, fixed maturity securities	166	229
Gross unrealized losses, fixed maturity securities	(1)	0
Allowance for credit losses	0	0
Fair value, fixed maturity securities	1,250	1,291
Fixed maturity securities | Non-U.S. corporate | Industrial
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	933	969
Gross unrealized gains, fixed maturity securities	117	159
Gross unrealized losses, fixed maturity securities	(3)	0
Allowance for credit losses	0	0
Fair value, fixed maturity securities	1,047	1,128
Fixed maturity securities | Non-U.S. corporate | Capital goods
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	640	510
Gross unrealized gains, fixed maturity securities	66	67
Gross unrealized losses, fixed maturity securities	(1)	(1)
Allowance for credit losses	0	0
Fair value, fixed maturity securities	705	576
Fixed maturity securities | Non-U.S. corporate | Consumer-cyclical
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	316	331
Gross unrealized gains, fixed maturity securities	27	41
Gross unrealized losses, fixed maturity securities	(2)	(1)
Allowance for credit losses	0	0
Fair value, fixed maturity securities	341	371
Fixed maturity securities | Non-U.S. corporate | Transportation
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	422	483
Gross unrealized gains, fixed maturity securities	68	88
Gross unrealized losses, fixed maturity securities	(1)	(1)
Allowance for credit losses	0	0
Fair value, fixed maturity securities	489	570
Fixed maturity securities | Non-U.S. corporate | Other
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	1,052	1,088
Gross unrealized gains, fixed maturity securities	169	236
Gross unrealized losses, fixed maturity securities	(4)	0
Allowance for credit losses	0	0
Fair value, fixed maturity securities	1,217	1,324
Fixed maturity securities | Residential mortgage-backed
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	1,325	1,698
Gross unrealized gains, fixed maturity securities	116	211
Gross unrealized losses, fixed maturity securities	(1)	0
Allowance for credit losses	0	0
Fair value, fixed maturity securities	1,440	1,909
Fixed maturity securities | Commercial mortgage-backed
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	2,435	2,759
Gross unrealized gains, fixed maturity securities	152	231
Gross unrealized losses, fixed maturity securities	(3)	(13)
Allowance for credit losses	0	(3)	$ 0
Fair value, fixed maturity securities	2,584	2,974
Fixed maturity securities | Other asset-backed
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	2,138	3,069
Gross unrealized gains, fixed maturity securities	29	55
Gross unrealized losses, fixed maturity securities	(7)	(4)
Allowance for credit losses	0	0
Fair value, fixed maturity securities	$ 2,160	$ 3,120

Gross Unrealized Losses and Fai

Gross Unrealized Losses and Fair Value of Investment Securities (Detail) $ in Millions	Dec. 31, 2021USD ($)Securities	Dec. 31, 2020USD ($)Securities
Schedule of Investments [Line Items]
Less than 12 months, Fair value	$ 4,991	$ 1,027
Less than 12 months, Gross unrealized losses	$ (110)	$ (42)
Less than 12 months, Number of securities | Securities	635	196
12 months or more, Fair value	$ 308	$ 247
12 months or more, Gross unrealized losses	$ (25)	$ (7)
12 months or more, Number of securities | Securities	35	54
Total, Fair value	$ 5,299	$ 1,274
Total, Gross unrealized losses	$ (135)	$ (49)
Total, Number of securities | Securities	670	250
Investment grade
Schedule of Investments [Line Items]
Less than 12 months, Fair value	$ 4,644	$ 852
Less than 12 months, Gross unrealized losses	$ (101)	$ (23)
Less than 12 months, Number of securities | Securities	587	163
12 months or more, Fair value	$ 241	$ 207
12 months or more, Gross unrealized losses	$ (12)	$ (2)
12 months or more, Number of securities | Securities	25	48
Total, Fair value	$ 4,885	$ 1,059
Total, Gross unrealized losses	$ (113)	$ (25)
Total, Number of securities | Securities	612	211
Below investment grade
Schedule of Investments [Line Items]
Less than 12 months, Fair value	$ 347	$ 175
Less than 12 months, Gross unrealized losses	$ (9)	$ (19)
Less than 12 months, Number of securities | Securities	48	33
12 months or more, Fair value	$ 67	$ 40
12 months or more, Gross unrealized losses	$ (13)	$ (5)
12 months or more, Number of securities | Securities	10	6
Total, Fair value	$ 414	$ 215
Total, Gross unrealized losses	$ (22)	$ (24)
Total, Number of securities | Securities	58	39
Fixed maturity securities
Schedule of Investments [Line Items]
Less than 12 months, Fair value	$ 4,991	$ 1,027
Less than 12 months, Gross unrealized losses	$ (110)	$ (42)
Less than 12 months, Number of securities | Securities	635	196
12 months or more, Fair value	$ 308	$ 247
12 months or more, Gross unrealized losses	$ (25)	$ (7)
12 months or more, Number of securities | Securities	35	54
Total, Fair value	$ 5,299	$ 1,274
Total, Gross unrealized losses	$ (135)	$ (49)
Total, Number of securities | Securities	670	250
Fixed maturity securities | Less Than 20 Percent Below Cost
Schedule of Investments [Line Items]
Less than 12 months, Fair value	$ 4,991	$ 1,017
Less than 12 months, Gross unrealized losses	$ (110)	$ (35)
Less than 12 months, Number of securities | Securities	635	194
12 months or more, Fair value	$ 297	$ 246
12 months or more, Gross unrealized losses	$ (20)	$ (6)
12 months or more, Number of securities | Securities	33	53
Total, Fair value	$ 5,288	$ 1,263
Total, Gross unrealized losses	$ (130)	$ (41)
Total, Number of securities | Securities	668	247
Fixed maturity securities | 20 To 50 percent below cost
Schedule of Investments [Line Items]
Less than 12 months, Fair value	$ 0	$ 10
Less than 12 months, Gross unrealized losses	$ 0	$ (7)
Less than 12 months, Number of securities | Securities	0	2
12 months or more, Fair value	$ 11	$ 1
12 months or more, Gross unrealized losses	$ (5)	$ (1)
12 months or more, Number of securities | Securities	2	1
Total, Fair value	$ 11	$ 11
Total, Gross unrealized losses	$ (5)	$ (8)
Total, Number of securities | Securities	2	3
Fixed maturity securities | State and Political Subdivisions
Schedule of Investments [Line Items]
Less than 12 months, Fair value	$ 339	$ 28
Less than 12 months, Gross unrealized losses	$ (6)	$ (1)
Less than 12 months, Number of securities | Securities	67	6
12 months or more, Fair value	$ 0	$ 0
12 months or more, Gross unrealized losses	$ 0	$ 0
12 months or more, Number of securities | Securities	0	0
Total, Fair value	$ 339	$ 28
Total, Gross unrealized losses	$ (6)	$ (1)
Total, Number of securities | Securities	67	6
Fixed maturity securities | Non-U.S. government
Schedule of Investments [Line Items]
Less than 12 months, Fair value	$ 173	$ 44
Less than 12 months, Gross unrealized losses	$ (9)	$ (4)
Less than 12 months, Number of securities | Securities	28	5
12 months or more, Fair value	$ 19	$ 0
12 months or more, Gross unrealized losses	$ (4)	$ 0
12 months or more, Number of securities | Securities	1	0
Total, Fair value	$ 192	$ 44
Total, Gross unrealized losses	$ (13)	$ (4)
Total, Number of securities | Securities	29	5
Fixed maturity securities | U.S. corporate
Schedule of Investments [Line Items]
Less than 12 months, Fair value	$ 2,593	$ 345
Less than 12 months, Gross unrealized losses	$ (64)	$ (20)
Less than 12 months, Number of securities | Securities	266	59
12 months or more, Fair value	$ 196	$ 33
12 months or more, Gross unrealized losses	$ (15)	$ (3)
12 months or more, Number of securities | Securities	22	4
Total, Fair value	$ 2,789	$ 378
Total, Gross unrealized losses	$ (79)	$ (23)
Total, Number of securities | Securities	288	63
Fixed maturity securities | Non-U.S. corporate
Schedule of Investments [Line Items]
Less than 12 months, Fair value	$ 912	$ 145
Less than 12 months, Gross unrealized losses	$ (21)	$ (4)
Less than 12 months, Number of securities | Securities	124	32
12 months or more, Fair value	$ 62	$ 6
12 months or more, Gross unrealized losses	$ (5)	$ (1)
12 months or more, Number of securities | Securities	8	1
Total, Fair value	$ 974	$ 151
Total, Gross unrealized losses	$ (26)	$ (5)
Total, Number of securities | Securities	132	33
Fixed maturity securities | Residential mortgage-backed
Schedule of Investments [Line Items]
Less than 12 months, Fair value	$ 97
Less than 12 months, Gross unrealized losses	$ (1)
Less than 12 months, Number of securities | Securities	22
12 months or more, Fair value	$ 0
12 months or more, Gross unrealized losses	$ 0
12 months or more, Number of securities | Securities	0
Total, Fair value	$ 97
Total, Gross unrealized losses	$ (1)
Total, Number of securities | Securities	22
Fixed maturity securities | Commercial mortgage-backed
Schedule of Investments [Line Items]
Less than 12 months, Fair value	$ 113	$ 227
Less than 12 months, Gross unrealized losses	$ (2)	$ (11)
Less than 12 months, Number of securities | Securities	17	34
12 months or more, Fair value	$ 31	$ 1
12 months or more, Gross unrealized losses	$ (1)	$ (1)
12 months or more, Number of securities | Securities	4	1
Total, Fair value	$ 144	$ 228
Total, Gross unrealized losses	$ (3)	$ (12)
Total, Number of securities | Securities	21	35
Fixed maturity securities | Other asset-backed
Schedule of Investments [Line Items]
Less than 12 months, Fair value	$ 764	$ 238
Less than 12 months, Gross unrealized losses	$ (7)	$ (2)
Less than 12 months, Number of securities | Securities	111	60
12 months or more, Fair value	$ 0	$ 207
12 months or more, Gross unrealized losses	$ 0	$ (2)
12 months or more, Number of securities | Securities	0	48
Total, Fair value	$ 764	$ 445
Total, Gross unrealized losses	$ (7)	$ (4)
Total, Number of securities | Securities	111	108

Gross Unrealized Losses and F_2

Gross Unrealized Losses and Fair Value of Corporate Securities Based on Industries (Detail) $ in Millions	Dec. 31, 2021USD ($)Securities	Dec. 31, 2020USD ($)Securities
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 4,991	$ 1,027
Less than 12 months, Gross unrealized losses	$ (110)	$ (42)
Less than 12 months, Number of securities | Securities	635	196
12 months or more, Fair value	$ 308	$ 247
12 months or more, Gross unrealized losses	$ (25)	$ (7)
12 months or more, Number of securities | Securities	35	54
Fair value	$ 5,299	$ 1,274
Gross unrealized losses	$ (135)	$ (49)
Number of securities | Securities	670	250
Fixed maturity securities
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 4,991	$ 1,027
Less than 12 months, Gross unrealized losses	$ (110)	$ (42)
Less than 12 months, Number of securities | Securities	635	196
12 months or more, Fair value	$ 308	$ 247
12 months or more, Gross unrealized losses	$ (25)	$ (7)
12 months or more, Number of securities | Securities	35	54
Fair value	$ 5,299	$ 1,274
Gross unrealized losses	$ (135)	$ (49)
Number of securities | Securities	670	250
Fixed maturity securities | U.S. corporate
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 2,593	$ 345
Less than 12 months, Gross unrealized losses	$ (64)	$ (20)
Less than 12 months, Number of securities | Securities	266	59
12 months or more, Fair value	$ 196	$ 33
12 months or more, Gross unrealized losses	$ (15)	$ (3)
12 months or more, Number of securities | Securities	22	4
Fair value	$ 2,789	$ 378
Gross unrealized losses	$ (79)	$ (23)
Number of securities | Securities	288	63
Fixed maturity securities | U.S. corporate | Utilities
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 211	$ 49
Less than 12 months, Gross unrealized losses	$ (7)	$ (2)
Less than 12 months, Number of securities | Securities	32	9
12 months or more, Fair value	$ 29	$ 0
12 months or more, Gross unrealized losses	$ (2)	$ 0
12 months or more, Number of securities | Securities	7	0
Fair value	$ 240	$ 49
Gross unrealized losses	$ (9)	$ (2)
Number of securities | Securities	39	9
Fixed maturity securities | U.S. corporate | Energy
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 166	$ 106
Less than 12 months, Gross unrealized losses	$ (3)	$ (13)
Less than 12 months, Number of securities | Securities	18	19
12 months or more, Fair value	$ 25	$ 33
12 months or more, Gross unrealized losses	$ (7)	$ (3)
12 months or more, Number of securities | Securities	4	4
Fair value	$ 191	$ 139
Gross unrealized losses	$ (10)	$ (16)
Number of securities | Securities	22	23
Fixed maturity securities | U.S. corporate | Finance and insurance
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 960	$ 128
Less than 12 months, Gross unrealized losses	$ (22)	$ (2)
Less than 12 months, Number of securities | Securities	89	15
12 months or more, Fair value	$ 62	$ 0
12 months or more, Gross unrealized losses	$ (2)	$ 0
12 months or more, Number of securities | Securities	3	0
Fair value	$ 1,022	$ 128
Gross unrealized losses	$ (24)	$ (2)
Number of securities | Securities	92	15
Fixed maturity securities | U.S. corporate | Consumer-non-cyclical
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 296	$ 16
Less than 12 months, Gross unrealized losses	$ (7)	$ (1)
Less than 12 months, Number of securities | Securities	30	5
12 months or more, Fair value	$ 14	$ 0
12 months or more, Gross unrealized losses	$ (1)	$ 0
12 months or more, Number of securities | Securities	2	0
Fair value	$ 310	$ 16
Gross unrealized losses	$ (8)	$ (1)
Number of securities | Securities	32	5
Fixed maturity securities | U.S. corporate | Technology and communications
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 378
Less than 12 months, Gross unrealized losses	$ (12)
Less than 12 months, Number of securities | Securities	37
12 months or more, Fair value	$ 29
12 months or more, Gross unrealized losses	$ (1)
12 months or more, Number of securities | Securities	2
Fair value	$ 407
Gross unrealized losses	$ (13)
Number of securities | Securities	39
Fixed maturity securities | U.S. corporate | Industrial
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 143
Less than 12 months, Gross unrealized losses	$ (3)
Less than 12 months, Number of securities | Securities	18
12 months or more, Fair value	$ 0
12 months or more, Gross unrealized losses	$ 0
12 months or more, Number of securities | Securities	0
Fair value	$ 143
Gross unrealized losses	$ (3)
Number of securities | Securities	18
Fixed maturity securities | U.S. corporate | Capital goods
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 171
Less than 12 months, Gross unrealized losses	$ (3)
Less than 12 months, Number of securities | Securities	16
12 months or more, Fair value	$ 18
12 months or more, Gross unrealized losses	$ (1)
12 months or more, Number of securities | Securities	2
Fair value	$ 189
Gross unrealized losses	$ (4)
Number of securities | Securities	18
Fixed maturity securities | U.S. corporate | Consumer-cyclical
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 268
Less than 12 months, Gross unrealized losses	$ (7)
Less than 12 months, Number of securities | Securities	26
12 months or more, Fair value	$ 0
12 months or more, Gross unrealized losses	$ 0
12 months or more, Number of securities | Securities	0
Fair value	$ 268
Gross unrealized losses	$ (7)
Number of securities | Securities	26
Fixed maturity securities | U.S. corporate | Transportation
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value		$ 46
Less than 12 months, Gross unrealized losses		$ (2)
Less than 12 months, Number of securities | Securities		11
12 months or more, Fair value		$ 0
12 months or more, Gross unrealized losses		$ 0
12 months or more, Number of securities | Securities		0
Fair value		$ 46
Gross unrealized losses		$ (2)
Number of securities | Securities		11
Fixed maturity securities | U.S. corporate | Other
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 0
Less than 12 months, Gross unrealized losses	$ 0
Less than 12 months, Number of securities | Securities	0
12 months or more, Fair value	$ 19
12 months or more, Gross unrealized losses	$ (1)
12 months or more, Number of securities | Securities	2
Fair value	$ 19
Gross unrealized losses	$ (1)
Number of securities | Securities	2
Fixed maturity securities | Non-U.S. corporate
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 912	$ 145
Less than 12 months, Gross unrealized losses	$ (21)	$ (4)
Less than 12 months, Number of securities | Securities	124	32
12 months or more, Fair value	$ 62	$ 6
12 months or more, Gross unrealized losses	$ (5)	$ (1)
12 months or more, Number of securities | Securities	8	1
Fair value	$ 974	$ 151
Gross unrealized losses	$ (26)	$ (5)
Number of securities | Securities	132	33
Fixed maturity securities | Non-U.S. corporate | Utilities
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 69
Less than 12 months, Gross unrealized losses	$ (2)
Less than 12 months, Number of securities | Securities	9
12 months or more, Fair value	$ 0
12 months or more, Gross unrealized losses	$ 0
12 months or more, Number of securities | Securities	0
Fair value	$ 69
Gross unrealized losses	$ (2)
Number of securities | Securities	9
Fixed maturity securities | Non-U.S. corporate | Energy
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 64	$ 66
Less than 12 months, Gross unrealized losses	$ (1)	$ (1)
Less than 12 months, Number of securities | Securities	10	10
12 months or more, Fair value	$ 0	$ 0
12 months or more, Gross unrealized losses	$ 0	$ 0
12 months or more, Number of securities | Securities	0	0
Fair value	$ 64	$ 66
Gross unrealized losses	$ (1)	$ (1)
Number of securities | Securities	10	10
Fixed maturity securities | Non-U.S. corporate | Finance and insurance
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 366
Less than 12 months, Gross unrealized losses	$ (8)
Less than 12 months, Number of securities | Securities	43
12 months or more, Fair value	$ 18
12 months or more, Gross unrealized losses	$ (1)
12 months or more, Number of securities | Securities	2
Fair value	$ 384
Gross unrealized losses	$ (9)
Number of securities | Securities	45
Fixed maturity securities | Non-U.S. corporate | Consumer-non-cyclical
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 67	$ 0
Less than 12 months, Gross unrealized losses	$ (1)	$ 0
Less than 12 months, Number of securities | Securities	12	0
12 months or more, Fair value	$ 6	$ 6
12 months or more, Gross unrealized losses	$ (1)	$ (1)
12 months or more, Number of securities | Securities	1	1
Fair value	$ 73	$ 6
Gross unrealized losses	$ (2)	$ (1)
Number of securities | Securities	13	1
Fixed maturity securities | Non-U.S. corporate | Technology and communications
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 48
Less than 12 months, Gross unrealized losses	$ (1)
Less than 12 months, Number of securities | Securities	8
12 months or more, Fair value	$ 0
12 months or more, Gross unrealized losses	$ 0
12 months or more, Number of securities | Securities	0
Fair value	$ 48
Gross unrealized losses	$ (1)
Number of securities | Securities	8
Fixed maturity securities | Non-U.S. corporate | Industrial
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 122
Less than 12 months, Gross unrealized losses	$ (3)
Less than 12 months, Number of securities | Securities	14
12 months or more, Fair value	$ 0
12 months or more, Gross unrealized losses	$ 0
12 months or more, Number of securities | Securities	0
Fair value	$ 122
Gross unrealized losses	$ (3)
Number of securities | Securities	14
Fixed maturity securities | Non-U.S. corporate | Capital goods
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 78	$ 31
Less than 12 months, Gross unrealized losses	$ (1)	$ (1)
Less than 12 months, Number of securities | Securities	8	8
12 months or more, Fair value	$ 0	$ 0
12 months or more, Gross unrealized losses	$ 0	$ 0
12 months or more, Number of securities | Securities	0	0
Fair value	$ 78	$ 31
Gross unrealized losses	$ (1)	$ (1)
Number of securities | Securities	8	8
Fixed maturity securities | Non-U.S. corporate | Consumer-cyclical
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 22	$ 15
Less than 12 months, Gross unrealized losses	$ (1)	$ (1)
Less than 12 months, Number of securities | Securities	8	6
12 months or more, Fair value	$ 15	$ 0
12 months or more, Gross unrealized losses	$ (1)	$ 0
12 months or more, Number of securities | Securities	3	0
Fair value	$ 37	$ 15
Gross unrealized losses	$ (2)	$ (1)
Number of securities | Securities	11	6
Fixed maturity securities | Non-U.S. corporate | Transportation
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 37	$ 33
Less than 12 months, Gross unrealized losses	$ (1)	$ (1)
Less than 12 months, Number of securities | Securities	7	8
12 months or more, Fair value	$ 0	$ 0
12 months or more, Gross unrealized losses	$ 0	$ 0
12 months or more, Number of securities | Securities	0	0
Fair value	$ 37	$ 33
Gross unrealized losses	$ (1)	$ (1)
Number of securities | Securities	7	8
Fixed maturity securities | Non-U.S. corporate | Other
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 39
Less than 12 months, Gross unrealized losses	$ (2)
Less than 12 months, Number of securities | Securities	5
12 months or more, Fair value	$ 23
12 months or more, Gross unrealized losses	$ (2)
12 months or more, Number of securities | Securities	2
Fair value	$ 62
Gross unrealized losses	$ (4)
Number of securities | Securities	7
Fixed maturity securities | Corporate Debt Securities
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 3,505	$ 490
Less than 12 months, Gross unrealized losses	$ (85)	$ (24)
Less than 12 months, Number of securities | Securities	390	91
12 months or more, Fair value	$ 258	$ 39
12 months or more, Gross unrealized losses	$ (20)	$ (4)
12 months or more, Number of securities | Securities	30	5
Fair value	$ 3,763	$ 529
Gross unrealized losses	$ (105)	$ (28)
Number of securities | Securities	420	96

Scheduled Maturity Distribution

Scheduled Maturity Distribution of Fixed Maturity Securities (Detail) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Amortized cost or cost
Due one year or less	$ 1,475
Due after one year through five years	8,254
Due after five years through ten years	13,722
Due after ten years	23,262
Subtotal	46,713
Amortized cost or cost, fixed maturity securities	52,611	$ 53,417
Fair value
Due one year or less	1,499
Due after one year through five years	8,807
Due after five years through ten years	15,053
Due after ten years	28,937
Subtotal	54,296
Fair value, fixed maturity securities	60,480	$ 63,495
Residential mortgage-backed
Amortized cost or cost
Fixed maturity securities	1,325
Fair value
Fixed maturity securities	1,440
Commercial mortgage-backed
Amortized cost or cost
Fixed maturity securities	2,435
Fair value
Fixed maturity securities	2,584
Other asset-backed
Amortized cost or cost
Fixed maturity securities	2,138
Fair value
Fixed maturity securities	$ 2,160

Distribution Across Property Ty

Distribution Across Property Type and Geographic Region for Commercial Mortgage Loans (Detail) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 6,856	$ 6,774
% of total	100.00%	100.00%
Allowance for credit losses	$ (26)	$ (31)
Commercial mortgage loans, net	6,830	6,743
Commercial Mortgage Loan
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 6,856	$ 6,774
% of total	100.00%	100.00%
Allowance for credit losses	$ (26)	$ (31)
Commercial mortgage loans, net	6,830	6,743
South Atlantic | Commercial Mortgage Loan
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 1,770	$ 1,711
% of total	26.00%	25.00%
Pacific | Commercial Mortgage Loan
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 1,360	$ 1,510
% of total	20.00%	22.00%
Middle Atlantic | Commercial Mortgage Loan
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 964	$ 994
% of total	14.00%	15.00%
Mountain | Commercial Mortgage Loan
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 892	$ 781
% of total	13.00%	12.00%
West North Central | Commercial Mortgage Loan
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 461	$ 467
% of total	7.00%	7.00%
East North Central | Commercial Mortgage Loan
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 465	$ 441
% of total	7.00%	6.00%
West South Central | Commercial Mortgage Loan
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 483	$ 423
% of total	7.00%	6.00%
New England | Commercial Mortgage Loan
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 237	$ 260
% of total	3.00%	4.00%
East South Central | Commercial Mortgage Loan
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 224	$ 187
% of total	3.00%	3.00%
Retail
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 2,774	$ 2,442
% of total	40.00%	36.00%
Industrial
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 1,420	$ 1,638
% of total	21.00%	24.00%
Office
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 1,526	$ 1,567
% of total	22.00%	23.00%
Apartments
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 585	$ 529
% of total	9.00%	8.00%
Mixed Use
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 330	$ 286
% of total	5.00%	4.00%
Other
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 221	$ 312
% of total	3.00%	5.00%

Allowance for Credit Losses and

Allowance for Credit Losses and Recorded Investment in Commercial Mortgage Loans (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Financing Receivable, Allowance for Credit Losses [Line Items]
Beginning balance	$ 31
Ending balance	26	$ 31
Allowance for Credit Losses
Financing Receivable, Allowance for Credit Losses [Line Items]
Beginning balance	31	13	$ 9
Cumulative effect of change in accounting	0	16	0
Provision	3	2	4
Write-offs	(8)	0	0
Recoveries	0	0	0
Ending balance	$ 26	$ 31	$ 13

Commercial Mortgage Loans By Ye

Commercial Mortgage Loans By Year of Origination and Credit Quality Indicator (Detail) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	$ 6,856	$ 6,774
Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	6,856	6,774
Write-offs	8
Recoveries	0
Write-offs, net	8
0% - 50%
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	2,480	2,645
0% - 50% | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	2,480
51% - 60%
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	1,539	1,628
51% - 60% | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	1,539
61% - 75%
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	2,815	2,396
61% - 75% | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	2,815
76% - 100%
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	0	103
76% - 100% | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	0
Greater than 100%
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	22	2
Greater than 100% | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	22
Less than 1.00 | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	223	216
1.00 - 1.25 | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	559	526
1.26 - 1.50 | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	791	992
1.51 - 2.00 | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	2,958	2,590
Greater than 2.00 | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	2,325	$ 2,450
2021 | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	952
Write-offs	0
Recoveries	0
Write-offs, net	0
2021 | 0% - 50% | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	20
2021 | 51% - 60% | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	43
2021 | 61% - 75% | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	889
2021 | 76% - 100% | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	0
2021 | Greater than 100% | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	0
2021 | Less than 1.00 | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	0
2021 | 1.00 - 1.25 | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	3
2021 | 1.26 - 1.50 | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	118
2021 | 1.51 - 2.00 | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	728
2021 | Greater than 2.00 | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	103
2020 | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	525
Write-offs	0
Recoveries	0
Write-offs, net	0
2020 | 0% - 50% | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	72
2020 | 51% - 60% | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	25
2020 | 61% - 75% | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	428
2020 | 76% - 100% | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	0
2020 | Greater than 100% | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	0
2020 | Less than 1.00 | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	10
2020 | 1.00 - 1.25 | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	70
2020 | 1.26 - 1.50 | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	32
2020 | 1.51 - 2.00 | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	220
2020 | Greater than 2.00 | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	193
2019 | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	732
Write-offs	0
Recoveries	0
Write-offs, net	0
2019 | 0% - 50% | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	53
2019 | 51% - 60% | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	170
2019 | 61% - 75% | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	509
2019 | 76% - 100% | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	0
2019 | Greater than 100% | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	0
2019 | Less than 1.00 | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	19
2019 | 1.00 - 1.25 | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	73
2019 | 1.26 - 1.50 | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	168
2019 | 1.51 - 2.00 | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	273
2019 | Greater than 2.00 | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	199
2018 | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	882
Write-offs	0
Recoveries	0
Write-offs, net	0
2018 | 0% - 50% | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	158
2018 | 51% - 60% | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	275
2018 | 61% - 75% | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	449
2018 | 76% - 100% | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	0
2018 | Greater than 100% | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	0
2018 | Less than 1.00 | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	41
2018 | 1.00 - 1.25 | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	81
2018 | 1.26 - 1.50 | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	135
2018 | 1.51 - 2.00 | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	443
2018 | Greater than 2.00 | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	182
2017 | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	609
Write-offs	8
Recoveries	0
Write-offs, net	8
2017 | 0% - 50% | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	203
2017 | 51% - 60% | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	257
2017 | 61% - 75% | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	127
2017 | 76% - 100% | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	0
2017 | Greater than 100% | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	22
2017 | Less than 1.00 | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	42
2017 | 1.00 - 1.25 | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	36
2017 | 1.26 - 1.50 | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	42
2017 | 1.51 - 2.00 | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	263
2017 | Greater than 2.00 | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	226
2016 and prior | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	3,156
Write-offs	0
Recoveries	0
Write-offs, net	0
2016 and prior | 0% - 50% | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	1,974
2016 and prior | 51% - 60% | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	769
2016 and prior | 61% - 75% | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	413
2016 and prior | 76% - 100% | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	0
2016 and prior | Greater than 100% | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	0
2016 and prior | Less than 1.00 | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	111
2016 and prior | 1.00 - 1.25 | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	296
2016 and prior | 1.26 - 1.50 | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	296
2016 and prior | 1.51 - 2.00 | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	1,031
2016 and prior | Greater than 2.00 | Fixed Rate Commercial Mortgage Loans
Disclosure Of Commercial Mortgage Loans By Year Of Origination And Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	$ 1,422

Debt-to-Value of Commercial Mor

Debt-to-Value of Commercial Mortgage Loans by Property Type (Detail) $ in Millions	12 Months Ended
	Dec. 31, 2021USD ($)	Dec. 31, 2020USD ($)
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 6,856	$ 6,774
Commercial mortgage loans, amortized cost	$ 6,856	$ 6,774
% of total	100.00%	100.00%
Weighted-average debt service coverage ratio	1.93	1.97
Retail
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 2,774	$ 2,442
% of total	40.00%	36.00%
Industrial
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 1,420	$ 1,638
% of total	21.00%	24.00%
Office
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 1,526	$ 1,567
% of total	22.00%	23.00%
Apartments
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 585	$ 529
% of total	9.00%	8.00%
Mixed Use
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 330	$ 286
% of total	5.00%	4.00%
Other
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 221	$ 312
% of total	3.00%	5.00%
0% - 50%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 2,480	$ 2,645
% of total	36.00%	39.00%
Weighted-average debt service coverage ratio	2.36	2.40
0% - 50% | Retail
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 853	$ 913
0% - 50% | Industrial
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	745	798
0% - 50% | Office
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	505	523
0% - 50% | Apartments
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	200	199
0% - 50% | Mixed Use
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	120	112
0% - 50% | Other
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	57	100
51% - 60%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 1,539	$ 1,628
% of total	23.00%	24.00%
Weighted-average debt service coverage ratio	1.83	1.83
51% - 60% | Retail
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 611	$ 639
51% - 60% | Industrial
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	240	351
51% - 60% | Office
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	395	431
51% - 60% | Apartments
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	102	86
51% - 60% | Mixed Use
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	70	47
51% - 60% | Other
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	121	74
61% - 75%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 2,815	$ 2,396
% of total	41.00%	35.00%
Weighted-average debt service coverage ratio	1.61	1.61
61% - 75% | Retail
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 1,310	$ 859
61% - 75% | Industrial
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	435	456
61% - 75% | Office
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	604	595
61% - 75% | Apartments
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	283	238
61% - 75% | Mixed Use
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	140	127
61% - 75% | Other
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	43	121
76% - 100%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 0	$ 103
% of total	0.00%	2.00%
Weighted-average debt service coverage ratio	0	1.49
76% - 100% | Retail
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 0	$ 29
76% - 100% | Industrial
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	0	33
76% - 100% | Office
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	0	18
76% - 100% | Apartments
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	0	6
76% - 100% | Mixed Use
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	0	0
76% - 100% | Other
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	0	17
Greater than 100%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 22	$ 2
% of total	0.00%	0.00%
Weighted-average debt service coverage ratio	0.68	0.64
Greater than 100% | Retail
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 0	$ 2
Greater than 100% | Industrial
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	0	0
Greater than 100% | Office
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	22	0
Greater than 100% | Apartments
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	0	0
Greater than 100% | Mixed Use
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	0	0
Greater than 100% | Other
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, amortized cost	$ 0	$ 0

Debt Service Coverage Ratio for

Debt Service Coverage Ratio for Fixed Rate Commercial Mortgage Loans by Property Type (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, recorded investment	$ 6,856	$ 6,774
% of total	100.00%	100.00%
Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, recorded investment	$ 6,856	$ 6,774
% of total	100.00%	100.00%
Weighted-average debt-to-value	55.00%	53.00%
Retail
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, recorded investment	$ 2,774	$ 2,442
% of total	40.00%	36.00%
Retail | Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, recorded investment	$ 2,774	$ 2,442
Industrial
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, recorded investment	$ 1,420	$ 1,638
% of total	21.00%	24.00%
Industrial | Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, recorded investment	$ 1,420	$ 1,638
Office
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, recorded investment	$ 1,526	$ 1,567
% of total	22.00%	23.00%
Office | Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, recorded investment	$ 1,526	$ 1,567
Apartments
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, recorded investment	$ 585	$ 529
% of total	9.00%	8.00%
Apartments | Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, recorded investment	$ 585	$ 529
Mixed Use
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, recorded investment	$ 330	$ 286
% of total	5.00%	4.00%
Mixed Use | Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, recorded investment	$ 330	$ 286
Other
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, recorded investment	$ 221	$ 312
% of total	3.00%	5.00%
Other | Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, recorded investment	$ 221	$ 312
Less than 1.00 | Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, recorded investment	$ 223	$ 216
% of total	3.00%	3.00%
Weighted-average debt-to-value	68.00%	57.00%
Less than 1.00 | Retail | Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, recorded investment	$ 102	$ 55
Less than 1.00 | Industrial | Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, recorded investment	9	21
Less than 1.00 | Office | Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, recorded investment	67	101
Less than 1.00 | Apartments | Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, recorded investment	17	9
Less than 1.00 | Mixed Use | Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, recorded investment	24	5
Less than 1.00 | Other | Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, recorded investment	4	25
1.00 - 1.25 | Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, recorded investment	$ 559	$ 526
% of total	8.00%	8.00%
Weighted-average debt-to-value	61.00%	62.00%
1.00 - 1.25 | Retail | Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, recorded investment	$ 166	$ 169
1.00 - 1.25 | Industrial | Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, recorded investment	64	85
1.00 - 1.25 | Office | Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, recorded investment	109	99
1.00 - 1.25 | Apartments | Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, recorded investment	62	24
1.00 - 1.25 | Mixed Use | Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, recorded investment	32	24
1.00 - 1.25 | Other | Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, recorded investment	126	125
1.26 - 1.50 | Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, recorded investment	$ 791	$ 992
% of total	12.00%	15.00%
Weighted-average debt-to-value	61.00%	62.00%
1.26 - 1.50 | Retail | Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, recorded investment	$ 405	$ 483
1.26 - 1.50 | Industrial | Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, recorded investment	82	143
1.26 - 1.50 | Office | Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, recorded investment	167	170
1.26 - 1.50 | Apartments | Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, recorded investment	84	126
1.26 - 1.50 | Mixed Use | Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, recorded investment	40	29
1.26 - 1.50 | Other | Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, recorded investment	13	41
1.51 - 2.00 | Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, recorded investment	$ 2,958	$ 2,590
% of total	43.00%	38.00%
Weighted-average debt-to-value	60.00%	57.00%
1.51 - 2.00 | Retail | Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, recorded investment	$ 1,375	$ 969
1.51 - 2.00 | Industrial | Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, recorded investment	599	616
1.51 - 2.00 | Office | Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, recorded investment	593	634
1.51 - 2.00 | Apartments | Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, recorded investment	225	228
1.51 - 2.00 | Mixed Use | Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, recorded investment	118	115
1.51 - 2.00 | Other | Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, recorded investment	48	28
Greater than 2.00 | Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, recorded investment	$ 2,325	$ 2,450
% of total	34.00%	36.00%
Weighted-average debt-to-value	43.00%	44.00%
Greater than 2.00 | Retail | Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, recorded investment	$ 726	$ 766
Greater than 2.00 | Industrial | Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, recorded investment	666	773
Greater than 2.00 | Office | Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, recorded investment	590	563
Greater than 2.00 | Apartments | Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, recorded investment	197	142
Greater than 2.00 | Mixed Use | Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, recorded investment	116	113
Greater than 2.00 | Other | Fixed Rate Commercial Mortgage Loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Commercial mortgage loans, recorded investment	$ 30	$ 93

Schedule of Positions in Deriva

Schedule of Positions in Derivative Instruments (Detail) - USD ($) $ in Millions		Dec. 31, 2021	Dec. 31, 2020
Derivative [Line Items]
Derivative assets, fair value		$ 433	$ 600
Derivative liabilities, fair value		616	830
Policyholder account balances
Derivative [Line Items]
Derivative liabilities, fair value		590	804
Other liabilities
Derivative [Line Items]
Derivative liabilities, fair value		26	26
Other invested assets
Derivative [Line Items]
Derivative assets, fair value		414	574
Interest rate swaps | Other liabilities
Derivative [Line Items]
Derivative liabilities, fair value		26	23
Interest rate swaps | Other invested assets
Derivative [Line Items]
Derivative assets, fair value		364	468
Foreign currency swaps | Other liabilities
Derivative [Line Items]
Derivative liabilities, fair value			2
Foreign currency swaps | Other invested assets
Derivative [Line Items]
Derivative assets, fair value		6	1
Equity index options | Other invested assets
Derivative [Line Items]
Derivative assets, fair value		42	63
Other foreign currency contracts | Other liabilities
Derivative [Line Items]
Derivative liabilities, fair value			1
Other foreign currency contracts | Other invested assets
Derivative [Line Items]
Derivative assets, fair value		2	42
GMWB embedded derivatives | Policyholder account balances
Derivative [Line Items]
Derivative liabilities, fair value		271	379
GMWB embedded derivatives | Reinsurance recoverable
Derivative [Line Items]
Derivative assets, fair value		19	26
Fixed index annuity embedded derivatives | Policyholder account balances
Derivative [Line Items]
Derivative liabilities, fair value		294	399
Indexed universal life embedded derivatives | Policyholder account balances
Derivative [Line Items]
Derivative liabilities, fair value		25	26
Designated As Hedging Instrument | Cash Flow Hedges
Derivative [Line Items]
Derivative assets, fair value		370	469
Derivative liabilities, fair value		26	25
Designated As Hedging Instrument | Cash Flow Hedges | Interest rate swaps | Other liabilities
Derivative [Line Items]
Derivative liabilities, fair value		26	23
Designated As Hedging Instrument | Cash Flow Hedges | Interest rate swaps | Other invested assets
Derivative [Line Items]
Derivative assets, fair value		364	468
Designated As Hedging Instrument | Cash Flow Hedges | Foreign currency swaps | Other liabilities
Derivative [Line Items]
Derivative liabilities, fair value		0	2
Designated As Hedging Instrument | Cash Flow Hedges | Foreign currency swaps | Other invested assets
Derivative [Line Items]
Derivative assets, fair value		6	1
Derivatives not designated as hedges
Derivative [Line Items]
Derivative assets, fair value		63	131
Derivative liabilities, fair value		590	805
Derivatives not designated as hedges | Equity index options | Other liabilities
Derivative [Line Items]
Derivative liabilities, fair value		0	0
Derivatives not designated as hedges | Equity index options | Other invested assets
Derivative [Line Items]
Derivative assets, fair value		42	63
Derivatives not designated as hedges | Financial futures | Other liabilities
Derivative [Line Items]
Derivative liabilities, fair value		0	0
Derivatives not designated as hedges | Financial futures | Other invested assets
Derivative [Line Items]
Derivative assets, fair value		0	0
Derivatives not designated as hedges | Other foreign currency contracts | Other liabilities
Derivative [Line Items]
Derivative liabilities, fair value		0	1
Derivatives not designated as hedges | Other foreign currency contracts | Other invested assets
Derivative [Line Items]
Derivative assets, fair value		2	42
Derivatives not designated as hedges | GMWB embedded derivatives | Policyholder account balances
Derivative [Line Items]
Derivative liabilities, fair value	[1]	271	379
Derivatives not designated as hedges | GMWB embedded derivatives | Reinsurance recoverable
Derivative [Line Items]
Derivative assets, fair value	[2]	19	26
Derivatives not designated as hedges | Fixed index annuity embedded derivatives | Policyholder account balances
Derivative [Line Items]
Derivative liabilities, fair value	[3]	294	399
Derivatives not designated as hedges | Fixed index annuity embedded derivatives | Other assets
Derivative [Line Items]
Derivative assets, fair value		0	0
Derivatives not designated as hedges | Indexed universal life embedded derivatives | Policyholder account balances
Derivative [Line Items]
Derivative liabilities, fair value	[4]	25	26
Derivatives not designated as hedges | Indexed universal life embedded derivatives | Reinsurance recoverable
Derivative [Line Items]
Derivative assets, fair value		$ 0	$ 0
[1]	Represents the embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance.
[2]	Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities.
[3]	Represents the embedded derivatives associated with our fixed index annuity liabilities.
[4]	Represents the embedded derivatives associated with our indexed universal life liabilities.

Activity Associated with Deriva

Activity Associated with Derivative Instruments (Detail) $ in Millions	12 Months Ended
	Dec. 31, 2021USD ($)Policies
Derivative [Line Items]
Notional amount, beginning balance	$ 17,269
Additions	5,350
Maturities/ terminations	(12,364)
Notional amount, ending balance	10,255
Designated As Hedging Instrument
Derivative [Line Items]
Notional amount, beginning balance	8,305
Additions	0
Maturities/ terminations	(525)
Notional amount, ending balance	7,780
Designated As Hedging Instrument | Cash Flow Hedges
Derivative [Line Items]
Notional amount, beginning balance	8,305
Additions	0
Maturities/ terminations	(525)
Notional amount, ending balance	7,780
Designated As Hedging Instrument | Cash Flow Hedges | Interest rate swaps
Derivative [Line Items]
Notional amount, beginning balance	8,178
Additions	0
Maturities/ terminations	(525)
Notional amount, ending balance	7,653
Designated As Hedging Instrument | Cash Flow Hedges | Foreign currency swaps
Derivative [Line Items]
Notional amount, beginning balance	127
Additions	0
Maturities/ terminations	0
Notional amount, ending balance	127
Derivatives not designated as hedges
Derivative [Line Items]
Notional amount, beginning balance	8,964
Additions	5,350
Maturities/ terminations	(11,839)
Notional amount, ending balance	2,475
Derivatives not designated as hedges | Interest rate swaps
Derivative [Line Items]
Notional amount, beginning balance	4,674
Additions	0
Maturities/ terminations	(4,674)
Notional amount, ending balance	0
Derivatives not designated as hedges | Equity index options
Derivative [Line Items]
Notional amount, beginning balance	2,000
Additions	1,438
Maturities/ terminations	(1,992)
Notional amount, ending balance	1,446
Derivatives not designated as hedges | Financial futures
Derivative [Line Items]
Notional amount, beginning balance	1,104
Additions	3,887
Maturities/ terminations	(4,045)
Notional amount, ending balance	946
Derivatives not designated as hedges | Other foreign currency contracts
Derivative [Line Items]
Notional amount, beginning balance	1,186
Additions	25
Maturities/ terminations	(1,128)
Notional amount, ending balance	$ 83
Derivatives not designated as hedges | GMWB embedded derivatives
Derivative [Line Items]
Notional amount, beginning balance | Policies	23,713
Additions | Policies	0
Maturities/ terminations | Policies	(1,909)
Notional amount, ending balance | Policies	21,804
Derivatives not designated as hedges | Fixed index annuity embedded derivatives
Derivative [Line Items]
Notional amount, beginning balance | Policies	12,778
Additions | Policies	0
Maturities/ terminations | Policies	(3,434)
Notional amount, ending balance | Policies	9,344
Derivatives not designated as hedges | Indexed universal life embedded derivatives
Derivative [Line Items]
Notional amount, beginning balance | Policies	842
Additions | Policies	0
Maturities/ terminations | Policies	(36)
Notional amount, ending balance | Policies	806

Schedule of Pre-Tax Income (Los

Schedule of Pre-Tax Income (Loss) Effects of Cash Flow Hedges (Detail) - Cash Flow Hedges - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gain (loss) recognized in OCI	$ (57)	$ 439	$ 418
Gain (loss) reclassified into net income from OCI	217	208	170
Gain (loss) recognized in net income (loss)	0	0	2
Interest Rate Swaps Hedging Assets | Net Investment Income
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gain (loss) recognized in OCI	(100)	482	456
Gain (loss) reclassified into net income from OCI	217	196	164
Interest Rate Swaps Hedging Assets | Net Investment Gains (Losses)
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gain (loss) recognized in OCI	0	0	0
Gain (loss) reclassified into net income from OCI	1	12	6
Gain (loss) recognized in net income (loss)	0	0	0
Interest Rate Swaps Hedging Liabilities | Interest Expense
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gain (loss) recognized in OCI	36	(38)	(36)
Gain (loss) reclassified into net income from OCI	(1)	0	0
Interest Rate Swaps Hedging Liabilities | Net Investment Gains (Losses)
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gain (loss) recognized in net income (loss)	0	0	0
Foreign currency swaps | Net Investment Income
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gain (loss) recognized in OCI	7	(5)	(2)
Gain (loss) reclassified into net income from OCI	0	0	0
Foreign currency swaps | Net Investment Gains (Losses)
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gain (loss) recognized in net income (loss)	$ 0	$ 0	0
Foreign currency swaps | Net Investment Gains (Losses)
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gain (loss) recognized in OCI			0
Gain (loss) reclassified into net income from OCI			0
Gain (loss) recognized in net income (loss)			$ 2

Reconciliation of Current Perio

Reconciliation of Current Period Changes, Net of Applicable Income Taxes, for Derivatives Qualifying as Hedges (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Derivative Instruments [Abstract]
Current period increases (decreases) in fair value, net of deferred taxes of $12, $(95) and $(87)	$ (45)	$ 344	$ 331
Derivatives qualifying as effective accounting hedges as of January 1	2,211	2,002	1,781
Reclassification to net (income), net of deferred taxes of $76, $73 and $60	(141)	(135)	(110)
Derivatives qualifying as effective accounting hedges as of December 31	$ 2,025	$ 2,211	$ 2,002

Reconciliation of Current Per_2

Reconciliation of Current Period Changes, Net of Applicable Income Taxes, for Derivatives Qualifying as Hedges (Parenthetical) (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Current period increases (decreases) in fair value, deferred taxes	$ 12	$ (95)	$ (87)
Reclassification to net (income), deferred taxes	$ 76	$ 73	$ 60

Derivative Instruments - Additi

Derivative Instruments - Additional Information (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Derivative [Line Items]
Derivatives designated as cash flow hedges gain (loss), amount expected to be reclassified to future net income (loss), net of tax	$ 2,025	$ 2,211	$ 2,002	$ 1,781
Year by which all forecasted transactions associated with qualifying cash flow hedges are expected to occur	2057
Derivatives designated as cash flow hedges gain (loss), amount expected to be reclassified to net income in the next 12 months, net of tax	$ 143
Amount reclassified to net income in connection with forecasted transactions that were no longer considered probable of occurring	$ 10	$ 15	$ 5

Schedule of Pre-Tax Gain (Loss)

Schedule of Pre-Tax Gain (Loss) Recognized in Net Income (Loss) for Effects of Derivatives not Designated as Hedges (Detail) - Derivatives not designated as hedges - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Derivative [Line Items]
Pre-tax gain (loss) recognized in net income	$ 13	$ (61)	$ (78)
Interest rate swaps | Net Investment Gains (Losses)
Derivative [Line Items]
Pre-tax gain (loss) recognized in net income	2	(11)	(3)
Equity index options | Net Investment Gains (Losses)
Derivative [Line Items]
Pre-tax gain (loss) recognized in net income	18	4	43
Financial futures | Net Investment Gains (Losses)
Derivative [Line Items]
Pre-tax gain (loss) recognized in net income	(123)	2	(64)
Other foreign currency contracts | Net Investment Gains (Losses)
Derivative [Line Items]
Pre-tax gain (loss) recognized in net income	0	6	(6)
GMWB embedded derivatives | Net Investment Gains (Losses)
Derivative [Line Items]
Pre-tax gain (loss) recognized in net income	124	(28)	38
Fixed index annuity embedded derivatives | Net Investment Gains (Losses)
Derivative [Line Items]
Pre-tax gain (loss) recognized in net income	(32)	(51)	(90)
Indexed universal life embedded derivatives | Net Investment Gains (Losses)
Derivative [Line Items]
Pre-tax gain (loss) recognized in net income	$ 24	$ 17	$ 4

Additional Information about De

Additional Information about Derivative Assets and Liabilities Subject to Enforceable Master Netting Arrangement (Detail) - USD ($) $ in Millions		Dec. 31, 2021	Dec. 31, 2020
Derivative [Line Items]
Gross amounts recognized, derivatives assets		$ 433	$ 600
Gross amounts recognized, derivatives liabilities		616	830
Subject to enforceable master netting arrangement
Derivative [Line Items]
Gross amounts recognized, net derivatives		388	548
Gross amounts offset in the balance sheet, net derivatives		0	0
Net amounts presented in the balance sheet, net derivatives		388	548
Gross amounts not offset in the balance sheet, financial instruments, net derivatives	[1]	0	0
Collateral received		(308)	(401)
Collateral pledged		536	505
Over collateralization, net derivatives		(528)	(497)
Net amount		88	155
Subject to enforceable master netting arrangement | Derivative assets
Derivative [Line Items]
Gross amounts recognized, derivatives assets	[2]	414	574
Gross amounts offset in the balance sheet, derivatives assets	[2]	0	0
Net amounts presented in the balance sheet, derivatives assets	[2]	414	574
Gross amounts not offset in the balance sheet, financial instruments, derivatives assets	[1]	(20)	(20)
Collateral received	[2]	(308)	(401)
Collateral pledged	[2]	0	0
Over collateralization, derivatives assets	[2]	2	2
Net amount, derivatives assets	[2]	88	155
Subject to enforceable master netting arrangement | Derivative liabilities
Derivative [Line Items]
Gross amounts recognized, derivatives liabilities	[2]	26	26
Gross amounts offset in the balance sheet, derivatives liabilities	[2]	0	0
Net amounts presented in the balance sheet, derivatives liabilities	[2]	26	26
Gross amounts not offset in the balance sheet, financial instruments, derivative liabilities	[1],[2]	(20)	(20)
Collateral received	[2]	0	0
Collateral pledged	[2]	(536)	(505)
Over collateralization, derivatives liabilities	[2]	530	499
Net amount, derivatives liabilities	[2]	$ 0	$ 0
[1]	Amounts represent derivative assets and/or liabilities that are presented gross within the balance sheet but are held with the same counterparty where we have a master netting arrangement. This adjustment results in presenting the net asset and net liability position for each counterparty.
[2]	Does not include amounts related to embedded derivatives as of December 31, 2021 and 2020.

Activity Impacting Deferred Acq

Activity Impacting Deferred Acquisition Costs (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Deferred Policy Acquisition Costs [Line Items]
Unamortized beginning balance	$ 2,809	$ 3,243	$ 3,591
Costs deferred	8	3	17
Amortization, net of interest accretion	(379)	(437)	(365)
Unamortized ending balance	2,438	2,809	3,243
Accumulated effect of net unrealized investment (gains) losses	(1,292)	(1,322)	(1,444)
Ending balance	$ 1,146	$ 1,487	$ 1,799

Deferred Acquisition Costs - Ad

Deferred Acquisition Costs - Additional Information (Detail) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Deferred Policy Acquisition Costs [Line Items]
Deferred policy acquisition costs, impairment loss	$ 41
Deferred Policy acquisition costs amortization		$ 379	$ 437	$ 365
Accumulated effect of net unrealized investment gains (losses)		1,292	1,322	1,444
Universal and term universal life insurance contracts | Unlocking
Deferred Policy Acquisition Costs [Line Items]
Deferred policy acquisition costs, impairment loss		117	63
Deferred Policy acquisition costs amortization			48	58
Shadow accounting adjustment
Deferred Policy Acquisition Costs [Line Items]
Accumulated effect of net unrealized investment gains (losses)		1,300	1,300	1,400
Shadow accounting adjustment | Long-term Care Insurance
Deferred Policy Acquisition Costs [Line Items]
Accumulated effect of net unrealized investment gains (losses)		$ 1,000	$ 1,000	$ 1,100

Intangible Assets (Detail)

Intangible Assets (Detail) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	$ 2,984	$ 2,963
Accumulated amortization	(2,841)	(2,806)
Present Value Of Future Profits
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	2,065	2,065
Accumulated amortization	(1,994)	(1,992)
Capitalized Software
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	465	457
Accumulated amortization	(403)	(385)
Deferred Sales Inducements To Contractholders
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	295	284
Accumulated amortization	(288)	(274)
Other Intangible Assets
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	159	157
Accumulated amortization	$ (156)	$ (155)

Intangible Assets - Additional

Intangible Assets - Additional Information (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Finite-Lived Intangible Assets [Line Items]
Amortization expense related to PVFP, capitalized software and other intangible assets	$ 30	$ 26	$ 44
Amortization expense related to deferred sales inducements	$ 14	$ 16	$ 15

Activity in Present Value of Fu

Activity in Present Value of Future Profits (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Finite-Lived Intangible Assets [Line Items]
Unamortized balance as of January 1	$ 154	$ 154	$ 170
Interest accreted at 5.23%, 5.19% and 5.56%	8	8	9
Amortization	(10)	(8)	(25)
Unamortized balance as of December 31	152	154	154
Accumulated effect of net unrealized investment (gains) losses	(81)	(81)	(80)
Balance as of December 31	$ 71	$ 73	$ 74

Activity in Present Value of _2

Activity in Present Value of Future Profits (Parenthetical) (Detail)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Finite-Lived Intangible Assets [Line Items]
Interest accreted percentage	5.23%	5.19%	5.56%

Percentage of PVFP Balance Net

Percentage of PVFP Balance Net of Interest Accretion, before Effect of Unrealized Investment Gains or Losses, Estimated to be Amortized Over Next Five years (Detail)	Dec. 31, 2021
Finite-Lived Intangible Assets [Line Items]
2022	4.20%
2023	4.20%
2024	4.20%
2025	4.00%
2026	5.00%

Reinsurance - Additional Inform

Reinsurance - Additional Information (Detail) - USD ($) $ in Millions	Jan. 27, 2022	Dec. 01, 2021	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Reinsurance Premiums for Insurance Companies, by Product Segment [Line Items]
Maximum amount of individual ordinary life insurance normally retained by us on any one individual life policy			$ 5
Reinsurance recoverable			16,813	$ 16,819
Reinsurance recoveries recognized as a reduction of benefits and other changes in reserves		$ 360	2,850	2,649	$ 2,751
Reinsurance Recoverable, Past Due			16,868	16,864
Gain or loss on reinsurance transaction	$ 294
U.S. Life Insurance Subsidiaries | Fixed maturity securities
Reinsurance Premiums for Insurance Companies, by Product Segment [Line Items]
Assets pledged as collateral			13,123	13,188
U.S. Life Insurance Subsidiaries | Commercial Mortgage Loan
Reinsurance Premiums for Insurance Companies, by Product Segment [Line Items]
Assets pledged as collateral			810	873
Scottish Re Group Limited [Member]
Reinsurance Premiums for Insurance Companies, by Product Segment [Line Items]
Reinsurance Recoverable, Past Due			40	19
Enact Holdings Inc [Member] | Mortgage Insurance Policy [Member]
Reinsurance Premiums for Insurance Companies, by Product Segment [Line Items]
Fully collaterised excess loss coverage			210
Reinsurance coverage in excess of retention			$ 1,170	350
Reinsurance treaty period			10 years
Union Fidelity Life Insurance Company
Reinsurance Premiums for Insurance Companies, by Product Segment [Line Items]
Minimum amount of risk-based capital General Electric Company agreed to maintain in UFLIC			150.00%
Union Fidelity Life Insurance Company | Ceded Credit Risk
Reinsurance Premiums for Insurance Companies, by Product Segment [Line Items]
Reinsurance recoverable			$ 13,095	$ 13,415

Net Domestic Life Insurance In-

Net Domestic Life Insurance In-Force (Detail) - USD ($) $ in Millions		Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Reinsurance [Abstract]
Direct life insurance in-force		$ 471,147	$ 509,670	$ 555,252
Amounts assumed from other companies		573	624	673
Amounts ceded to other companies	[1]	(427,464)	(458,999)	(500,965)
Net life insurance in-force		$ 44,256	$ 51,295	$ 54,960
Percentage of amount assumed to net		1.00%	1.00%	1.00%
[1]	Includes amounts accounted for under the deposit method.

Effects of Reinsurance on Premi

Effects of Reinsurance on Premiums Written and Earned (Detail) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Reinsurance [Abstract]
Direct, Written		$ 4,561	$ 4,578	$ 4,481
Assumed, Written		305	317	326
Ceded, Written		(1,526)	(1,157)	(1,147)
Net premiums, Written		3,340	3,738	3,660
Direct, Earned		4,659	4,678	4,548
Assumed, Earned		309	328	331
Ceded, Earned		(1,533)	(1,170)	(1,154)
Net premiums, Earned		$ 3,435	$ 3,836	$ 3,725
Percentage of amount assumed to net		9.00%	9.00%	9.00%
Life insurance
Reinsurance [Abstract]
Direct, Written		$ 774	$ 795	$ 845
Assumed, Written		2	1	1
Ceded, Written	[1]	(913)	(558)	(568)
Direct, Earned		775	795	845
Assumed, Earned		2	2	1
Ceded, Earned	[1]	(913)	(559)	(568)
Accident and Health Insurance Product Line
Reinsurance [Abstract]
Direct, Written	[2]	2,797	2,836	2,792
Assumed, Written	[2]	300	313	321
Ceded, Written	[2]	(541)	(550)	(557)
Direct, Earned	[2]	2,834	2,860	2,821
Assumed, Earned	[2]	304	322	326
Ceded, Earned	[2]	(548)	(562)	(564)
Mortgage insurance
Reinsurance [Abstract]
Direct, Written		990	947	844
Assumed, Written		3	3	4
Ceded, Written		(72)	(49)	(22)
Direct, Earned		1,050	1,023	882
Assumed, Earned		3	4	4
Ceded, Earned		$ (72)	$ (49)	$ (22)
[1]	Effective December 1, 2021 and included in the year ended December 31, 2021, we entered into a reinsurance agreement with SCOR Global Life USA Reinsurance Company, under which we ceded premiums of $360 million associated with certain term life insurance policies in connection with a life block transaction.
[2]	Accident and health insurance is comprised almost entirely of our long-term care insurance products.

Effects of Reinsurance on Pre_2

Effects of Reinsurance on Premiums Written and Earned (Parenthetical) (Detail) - USD ($) $ in Millions	Dec. 01, 2021	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Policyholders Account In Life Insurance Business [Abstract]
Reinsurance recoveries recognized as a reduction of benefits and other changes in reserves	$ 360	$ 2,850	$ 2,649	$ 2,751

Reinsurance - Schedule of Reins

Reinsurance - Schedule of Reinsurance Recoverable in Allowance for Credit Losses (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Beginning balance	$ 45	$ 0
Cumulative effect of change in accounting	0	40
Provision	10	5
Write-offs	0	0
Recoveries	0	0
Ending balance	$ 55	$ 45

Reinsurance - Schedule Of Credi

Reinsurance - Schedule Of Credit Ratings on Reinsurance Recoverable (Detail) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Reinsurance recoverable	$ 16,868	$ 16,864
A++
Reinsurance recoverable	543	519
A+
Reinsurance recoverable	3,091	2,780
A
Reinsurance recoverable	59	64
B+
Reinsurance recoverable		1
Non rated
Reinsurance recoverable	13,175	13,500
Collateralized
Reinsurance recoverable	14,698	14,875
Collateralized | A++
Reinsurance recoverable	0	0
Collateralized | A+
Reinsurance recoverable	1,581	1,437
Collateralized | A
Reinsurance recoverable	18	19
Collateralized | B+
Reinsurance recoverable		0
Collateralized | Non rated
Reinsurance recoverable	13,099	13,419
Non-collateralized
Reinsurance recoverable	2,170	1,989
Non-collateralized | A++
Reinsurance recoverable	543	519
Non-collateralized | A+
Reinsurance recoverable	1,510	1,343
Non-collateralized | A
Reinsurance recoverable	41	45
Non-collateralized | B+
Reinsurance recoverable		1
Non-collateralized | Non rated
Reinsurance recoverable	$ 76	$ 81

Recorded Liabilities and Major

Recorded Liabilities and Major Assumptions Underlying Future Policy Benefits (Detail) - USD ($) $ in Millions		Dec. 31, 2021	Dec. 31, 2020
Liability for Future Policy Benefit, by Product Segment [Line Items]
Future policy benefits		$ 41,528	$ 42,695
Long Term Care Insurance Contracts
Liability for Future Policy Benefit, by Product Segment [Line Items]
Future policy benefits	[1]	$ 28,232	28,770
Long Term Care Insurance Contracts | Minimum
Liability for Future Policy Benefit, by Product Segment [Line Items]
Future policy benefits, Interest rate assumption	[1]	3.75%
Long Term Care Insurance Contracts | Maximum
Liability for Future Policy Benefit, by Product Segment [Line Items]
Future policy benefits, Interest rate assumption	[1]	7.50%
Structured Settlements with Life Contingencies
Liability for Future Policy Benefit, by Product Segment [Line Items]
Future policy benefits	[2]	$ 8,075	8,240
Structured Settlements with Life Contingencies | Minimum
Liability for Future Policy Benefit, by Product Segment [Line Items]
Future policy benefits, Interest rate assumption	[2]	1.00%
Structured Settlements with Life Contingencies | Maximum
Liability for Future Policy Benefit, by Product Segment [Line Items]
Future policy benefits, Interest rate assumption	[2]	8.00%
Annuity Contracts with Life Contingencies
Liability for Future Policy Benefit, by Product Segment [Line Items]
Future policy benefits	[2]	$ 2,934	3,252
Annuity Contracts with Life Contingencies | Minimum
Liability for Future Policy Benefit, by Product Segment [Line Items]
Future policy benefits, Interest rate assumption	[2]	1.00%
Annuity Contracts with Life Contingencies | Maximum
Liability for Future Policy Benefit, by Product Segment [Line Items]
Future policy benefits, Interest rate assumption	[2]	8.00%
Traditional Life Insurance Contracts
Liability for Future Policy Benefit, by Product Segment [Line Items]
Future policy benefits	[3]	$ 1,956	2,101
Traditional Life Insurance Contracts | Minimum
Liability for Future Policy Benefit, by Product Segment [Line Items]
Future policy benefits, Interest rate assumption	[3]	3.00%
Traditional Life Insurance Contracts | Maximum
Liability for Future Policy Benefit, by Product Segment [Line Items]
Future policy benefits, Interest rate assumption	[3]	7.50%
Supplementary Contracts with Life Contingencies
Liability for Future Policy Benefit, by Product Segment [Line Items]
Future policy benefits	[2]	$ 331	$ 332
Supplementary Contracts with Life Contingencies | Minimum
Liability for Future Policy Benefit, by Product Segment [Line Items]
Future policy benefits, Interest rate assumption	[2]	1.00%
Supplementary Contracts with Life Contingencies | Maximum
Liability for Future Policy Benefit, by Product Segment [Line Items]
Future policy benefits, Interest rate assumption	[2]	8.00%
[1]	The 1983 Individual Annuitant Mortality Table or the 2000 U.S. Annuity Table, or the 1983 Group Annuitant Mortality Table or the 1994 Group Annuitant Mortality Table and company experience.
[2]	Assumptions for limited-payment contracts come from either the U.S. Population Table, the 1983 Group Annuitant Mortality Table, the 1983 Individual Annuitant Mortality Table, the Annuity 2000 Mortality Table or the 2012 Individual Annuity Reserving Table.
[3]	Principally modifications based on company experience of the Society of Actuaries 1965-70 or 1975-80 Select and the Ultimate Tables, the 1941, 1958, 1980 and 2001 Commissioner’s Standard Ordinary Tables, the 1980 Commissioner’s Extended Term table and (IA) Standard Table 1996 (modified).

Insurance Reserves - Additional

Insurance Reserves - Additional Information (Detail) - USD ($) $ in Millions	3 Months Ended		12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Insurance Reserves [Line Items]
Future policy benefit reserves	$ 41,528	$ 42,695	$ 41,528	$ 42,695
Policyholder account values	19,354	21,503	19,354	21,503
Shadow accounting adjustment
Insurance Reserves [Line Items]
Future policy benefit reserves	3,200	4,500	3,200	4,500
Immediate Fixed Annuity | Loss Recognition Testing
Insurance Reserves [Line Items]
Increase in future policy benefit reserves			0	0	$ 39
Universal and term universal life insurance contracts | Shadow accounting adjustment
Insurance Reserves [Line Items]
Policyholder account values	900	1,400	900	1,400
Long-term Care Insurance | Shadow accounting adjustment
Insurance Reserves [Line Items]
Future policy benefit reserves	2,600		2,600
Profits Followed By Losses | Long-term Care Insurance
Insurance Reserves [Line Items]
Future policy benefit reserves	1,274	625	1,274	625
Long-term care insurance future policy benefit reserves present value of expected losses	$ 2,500	$ 2,100	$ 2,500	$ 2,100
Percentage of profits to be accrued to reserves	76.00%	76.00%	76.00%	76.00%
Unlocking | Universal and term universal life insurance contracts
Insurance Reserves [Line Items]
Increase (decrease) in liability for policyholder account balances	$ (87)	$ 118
Federal Home Loan Bank
Insurance Reserves [Line Items]
Federal Home Loan Bank common stock held	28	42	$ 28	$ 42
Amount of funding agreements issued to the Federal Home Loan Bank	250	421	250	421
Pledged assets for Federal Home Loan Bank at fair value	907	1,309	907	1,309
Federal Home Loan Bank | Universal and term universal life insurance contracts
Insurance Reserves [Line Items]
Amount of funding agreements issued to the Federal Home Loan Bank		121		121
Variable Annuity | Nontraditional Long-Duration Contracts
Insurance Reserves [Line Items]
Nontraditional long-duration contracts liability	4,492	4,668	4,492	4,668
Guaranteed Minimum Death Benefit | Nontraditional Long-Duration Contracts | Annuity contracts
Insurance Reserves [Line Items]
Nontraditional long-duration contracts liability	135	128	135	128
Guaranteed Minimum Withdrawal And Guaranteed Annuitization Benefit Contracts
Insurance Reserves [Line Items]
Guaranteed annuitization benefit contracts	$ 602	$ 669	$ 602	$ 669

Recorded Liabilities for Policy

Recorded Liabilities for Policyholder Account Balances (Detail) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Insurance Reserves [Line Items]
Policyholder account balances	$ 19,354	$ 21,503
Investment contracts
Insurance Reserves [Line Items]
Policyholder account balances	8,657	10,276
Investment contracts | Annuity contracts
Insurance Reserves [Line Items]
Policyholder account balances	6,816	8,273
Investment contracts | Funding agreements
Insurance Reserves [Line Items]
Policyholder account balances	250	300
Investment contracts | Structured settlements without life contingencies
Insurance Reserves [Line Items]
Policyholder account balances	1,027	1,114
Investment contracts | Supplementary contracts without life contingencies
Insurance Reserves [Line Items]
Policyholder account balances	550	576
Investment contracts | Other
Insurance Reserves [Line Items]
Policyholder account balances	14	13
Universal and term universal life insurance contract
Insurance Reserves [Line Items]
Policyholder account balances	$ 10,697	$ 11,227

Information about Variable Annu

Information about Variable Annuity Products with Death and Living Benefit Guarantees (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Guaranteed minimum standard death benefit
Net Amount at Risk by Product and Guarantee [Line Items]
Death benefits account value	$ 2,547	$ 2,611
Net amount at risk	$ 1	$ 2
Average attained age of contractholders	76 years	76 years
Guaranteed minimum enhanced death benefit
Net Amount at Risk by Product and Guarantee [Line Items]
Death benefits account value	$ 1,326	$ 1,350
Net amount at risk	$ 94	$ 105
Average attained age of contractholders	76 years	76 years
Guaranteed minimum living benefit
Net Amount at Risk by Product and Guarantee [Line Items]
Death benefits account value	$ 1,893	$ 1,999
Guaranteed annuitization benefits
Net Amount at Risk by Product and Guarantee [Line Items]
Death benefits account value	$ 1,002	$ 998

Account Balances of Variable An

Account Balances of Variable Annuity Contract with Death or Living Benefit Guarantees Invested in Separate Account Investment Options (Detail) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items]
Separate account investment	$ 3,796	$ 3,879
Balanced funds
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items]
Separate account investment	2,397	2,343
Equity funds
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items]
Separate account investment	913	1,016
Bond funds
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items]
Separate account investment	297	304
Money market funds
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items]
Separate account investment	$ 189	$ 216

Liability for Policy and Cont_3

Liability for Policy and Contract Claims (Detail) - USD ($) $ in Millions		Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Liability for Claims and Claims Adjustment Expense [Line Items]
Total liability for policy and contract claims		$ 11,841	$ 11,486
Long-term Care Insurance
Liability for Claims and Claims Adjustment Expense [Line Items]
Total liability for policy and contract claims		10,861	10,518	$ 10,239	$ 9,516
Liability for policy and contract claims, net of reinsurance		8,601	8,258	$ 7,956	$ 7,254
Enact Segment
Liability for Claims and Claims Adjustment Expense [Line Items]
Total liability for policy and contract claims	[1]	641
Insurance lines other than short-duration contracts
Liability for Claims and Claims Adjustment Expense [Line Items]
Total liability for policy and contract claims		11,191	10,920
Insurance lines other than short-duration contracts | Long-term Care Insurance
Liability for Claims and Claims Adjustment Expense [Line Items]
Total liability for policy and contract claims		10,861	10,518
Insurance lines other than short-duration contracts | Life Insurance
Liability for Claims and Claims Adjustment Expense [Line Items]
Total liability for policy and contract claims		308	378
Insurance lines other than short-duration contracts | Fixed Annuities
Liability for Claims and Claims Adjustment Expense [Line Items]
Total liability for policy and contract claims		14	12
Insurance lines other than short-duration contracts | Runoff
Liability for Claims and Claims Adjustment Expense [Line Items]
Total liability for policy and contract claims		8	12
Short-duration contracts
Liability for Claims and Claims Adjustment Expense [Line Items]
Liability for policy and contract claims, net of reinsurance		650	566
Short-duration contracts | Enact Segment
Liability for Claims and Claims Adjustment Expense [Line Items]
Liability for policy and contract claims, net of reinsurance		641	555
Short-duration contracts | Other Countries Mortgage Insurance
Liability for Claims and Claims Adjustment Expense [Line Items]
Liability for policy and contract claims, net of reinsurance		$ 9	$ 11
[1]	Represents the year in which first monthly mortgage payments have been missed by the borrower.

Changes in Liability for Policy

Changes in Liability for Policy and Contract Claims (Detail) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]
Beginning balance		$ 11,486
Ending balance	$ 11,486	11,841	$ 11,486
Long-term Care Insurance
Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]
Beginning balance		10,518	10,239	$ 9,516
Less reinsurance recoverables		(2,260)	(2,283)	(2,262)
Net beginning balance		8,258	7,956	7,254
Current year	91	2,761	2,595	2,717
Prior years		(610)	(398)	(219)
Total incurred		2,151	2,197	2,498
Current year		(203)	(189)	(205)
Prior years		(2,011)	(2,118)	(1,975)
Total paid		(2,214)	(2,307)	(2,180)
Interest on liability for policy and contract claims		406	412	384
Net ending balance	8,258	8,601	8,258	7,956
Add reinsurance recoverables	2,260	2,260	2,260	2,283
Ending balance	$ 10,518	$ 10,861	$ 10,518	$ 10,239

Liability for Policy and Cont_4

Liability for Policy and Contract Claims - Additional Information (Detail) - USD ($) $ in Millions		3 Months Ended	12 Months Ended
		Dec. 31, 2020	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Liability for Claims and Claims Adjustment Expense [Line Items]
Liability for Claims and Claims Adjustment Expense		$ 11,486	$ 11,841	$ 11,486
Covid Nineteen
Liability for Claims and Claims Adjustment Expense [Line Items]
Liability for Claims and Claims Adjustment Expense		199	209	199
Long-term Care Insurance
Liability for Claims and Claims Adjustment Expense [Line Items]
Increase (Decrease) in claim reserves			343	279	$ 723
Incurred related to insured events of prior year			(610)	(398)	(219)
Increase (decrease) in reserves for liability for policy and contract claims		47		108
Additional increase (decrease) in reserves for liability for policy and contract claims				91
Liability for Claims and Claims Adjustment Expense		10,518	10,861	$ 10,518	$ 10,239	$ 9,516
Long-term Care Insurance | Changes in Assumptions and Methodologies
Liability for Claims and Claims Adjustment Expense [Line Items]
Increase (Decrease) in claim reserves		$ 38
Policy Contract
Liability for Claims and Claims Adjustment Expense [Line Items]
Additional increase (decrease) in reserves for liability for policy and contract claims			343
Enact Segment
Liability for Claims and Claims Adjustment Expense [Line Items]
Increase (decrease) in reserves for liability for policy and contract claims			86
Liability for Claims and Claims Adjustment Expense	[1]		$ 641
[1]	Represents the year in which first monthly mortgage payments have been missed by the borrower.

Incurred Claims, Net of Reinsur

Incurred Claims, Net of Reinsurance, Cumulative Number of Reported Delinquencies and Total of Incurred-But-Not-Reported Liabilities (Detail) - Enact Segment $ in Millions		Dec. 31, 2021USD ($)Claim	Dec. 31, 2020USD ($)	Dec. 31, 2019USD ($)	Dec. 31, 2018USD ($)	Dec. 31, 2017USD ($)	Dec. 31, 2016USD ($)	Dec. 31, 2015USD ($)	Dec. 31, 2014USD ($)	Dec. 31, 2013USD ($)	Dec. 31, 2012USD ($)
Claims Development [Line Items]
Incurred claims and allocated claim adjustment expenses, net of reinsurance	[1]	$ 2,405
Accident Year 2012
Claims Development [Line Items]
Incurred claims and allocated claim adjustment expenses, net of reinsurance	[1]	667	$ 666	$ 666	$ 667	$ 668	$ 671	$ 673	$ 671	$ 675	$ 718
Total of IBNR liabilities including expected development on reported claims		$ 0
Number of reported delinquencies | Claim	[2]	31,126
Accident Year 2013
Claims Development [Line Items]
Incurred claims and allocated claim adjustment expenses, net of reinsurance	[1]	$ 381	381	381	382	384	387	392	407	475	0
Total of IBNR liabilities including expected development on reported claims		$ 0
Number of reported delinquencies | Claim	[2]	22,502
Accident Year 2014
Claims Development [Line Items]
Incurred claims and allocated claim adjustment expenses, net of reinsurance	[1]	$ 259	259	258	259	261	269	288	328	0	0
Total of IBNR liabilities including expected development on reported claims		$ 0
Number of reported delinquencies | Claim	[2]	17,809
Accident Year 2015
Claims Development [Line Items]
Incurred claims and allocated claim adjustment expenses, net of reinsurance	[1]	$ 179	180	180	181	187	208	235	0	0	0
Total of IBNR liabilities including expected development on reported claims		$ 0
Number of reported delinquencies | Claim	[2]	15,400
Accident Year 2016
Claims Development [Line Items]
Incurred claims and allocated claim adjustment expenses, net of reinsurance	[1]	$ 136	137	136	138	160	198	0	0	0	0
Total of IBNR liabilities including expected development on reported claims		$ 0
Number of reported delinquencies | Claim	[2]	13,970
Accident Year 2017
Claims Development [Line Items]
Incurred claims and allocated claim adjustment expenses, net of reinsurance	[1]	$ 104	105	102	121	171	0	0	0	0	0
Total of IBNR liabilities including expected development on reported claims		$ 0
Number of reported delinquencies | Claim	[2]	15,097
Accident Year 2018
Claims Development [Line Items]
Incurred claims and allocated claim adjustment expenses, net of reinsurance	[1]	$ 78	84	84	117	0	0	0	0	0	0
Total of IBNR liabilities including expected development on reported claims		$ 1
Number of reported delinquencies | Claim	[2]	11,269
Accident Year 2019
Claims Development [Line Items]
Incurred claims and allocated claim adjustment expenses, net of reinsurance	[1]	$ 98	111	106	0	0	0	0	0	0	0
Total of IBNR liabilities including expected development on reported claims		$ 1
Number of reported delinquencies | Claim	[2]	11,883
Accident Year 2020
Claims Development [Line Items]
Incurred claims and allocated claim adjustment expenses, net of reinsurance	[1]	$ 362	365	0	0	0	0	0	0	0	0
Total of IBNR liabilities including expected development on reported claims		$ 1
Number of reported delinquencies | Claim	[2]	38,863
Accident Year 2021
Claims Development [Line Items]
Incurred claims and allocated claim adjustment expenses, net of reinsurance	[1]	$ 141	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0
Total of IBNR liabilities including expected development on reported claims		$ 15
Number of reported delinquencies | Claim	[2]	12,585
[1]	Represents the year in which first monthly mortgage payments have been missed by the borrower.
[2]	Represents reported and outstanding delinquencies less actual cures as of December 31 for each respective accident year.

Paid Claims Development, Net of

Paid Claims Development, Net of Reinsurance (Detail) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Claims Development [Line Items]
Liability for policy and contract claims		$ 11,841	$ 11,486
Enact Segment
Claims Development [Line Items]
Total incurred	[1]	2,405
Total paid	[1]	1,783
All outstanding liabilities before 2011	[1]	19
Liability for policy and contract claims	[1]	641
Enact Segment | Accident Year 2012
Claims Development [Line Items]
Total incurred	[1]	667	666	$ 666	$ 667	$ 668	$ 671	$ 673	$ 671	$ 675	$ 718
Other	[1]	663	663	662	658	650	634	602	532	391	92
Enact Segment | Accident Year 2013
Claims Development [Line Items]
Total incurred	[1]	381	381	381	382	384	387	392	407	475	0
Other	[1]	377	376	375	372	362	340	297	202	44	0
Enact Segment | Accident Year 2014
Claims Development [Line Items]
Total incurred	[1]	259	259	258	259	261	269	288	328	0	0
Other	[1]	255	254	253	247	233	195	127	22	0	0
Enact Segment | Accident Year 2015
Claims Development [Line Items]
Total incurred	[1]	179	180	180	181	187	208	235	0	0	0
Other	[1]	176	175	173	167	145	85	12	0	0	0
Enact Segment | Accident Year 2016
Claims Development [Line Items]
Total incurred	[1]	136	137	136	138	160	198	0	0	0	0
Other	[1]	128	127	124	110	64	10	0	0	0	0
Enact Segment | Accident Year 2017
Claims Development [Line Items]
Total incurred	[1]	104	105	102	121	171	0	0	0	0	0
Other	[1]	90	87	77	46	6	0	0	0	0	0
Enact Segment | Accident Year 2018
Claims Development [Line Items]
Total incurred	[1]	78	84	84	117	0	0	0	0	0	0
Other	[1]	55	48	32	3	0	0	0	0	0	0
Enact Segment | Accident Year 2019
Claims Development [Line Items]
Total incurred	[1]	98	111	106	0	0	0	0	0	0	0
Other	[1]	31	18	2	0	0	0	0	0	0	0
Enact Segment | Accident Year 2020
Claims Development [Line Items]
Total incurred	[1]	362	365	0	0	0	0	0	0	0	0
Other	[1]	8	1	0	0	0	0	0	0	0	0
Enact Segment | Accident Year 2021
Claims Development [Line Items]
Total incurred	[1]	141	0	0	0	0	0	0	0	0	0
Other	[1]	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0
[1]	Represents the year in which first monthly mortgage payments have been missed by the borrower.

Average Payout of Incurred Clai

Average Payout of Incurred Claims by Age (Detail) - Enact Segment	Dec. 31, 2021
Claims Development [Line Items]
Average annual percentage payout of incurred claims, net of reinsurance, by age, year one	6.00%
Average annual percentage payout of incurred claims, net of reinsurance, by age, year two	33.30%
Average annual percentage payout of incurred claims, net of reinsurance, by age, year three	25.70%
Average annual percentage payout of incurred claims, net of reinsurance, by age, year four	11.00%
Average annual percentage payout of incurred claims, net of reinsurance, by age, year five	4.00%
Average annual percentage payout of incurred claims, net of reinsurance, by age, year six	1.80%
Average annual percentage payout of incurred claims, net of reinsurance, by age, year seven	0.80%
Average annual percentage payout of incurred claims, net of reinsurance, by age, year eight	0.30%
Average annual percentage payout of incurred claims, net of reinsurance, by age, year nine	0.20%
Average annual percentage payout of incurred claims, net of reinsurance, by age, year ten	0.10%

Employee Benefit Plans - Additi

Employee Benefit Plans - Additional Information (Detail) - USD ($) $ in Millions	Jan. 01, 2017	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Savings Plan
Defined Benefit Plan Disclosure [Line Items]
Defined contribution plan required years of service to vest for employees hired on or after January 1, 2011		2 years
Deposits recorded by our life insurance subsidiaries		$ 1	$ 1
Costs associated with plan		$ 13	13	$ 13
Maximum contribution to employees savings plans	5.00%
Savings Plan | First 4% of pay deferred
Defined Benefit Plan Disclosure [Line Items]
Employer matching contribution, percent of match	100.00%
Maximum contribution to employees savings plans	4.00%
Savings Plan | Next 2% of pay deferred
Defined Benefit Plan Disclosure [Line Items]
Employer matching contribution, percent of match	50.00%
Maximum contribution to employees savings plans	2.00%
Defined Contribution Pension Plan
Defined Benefit Plan Disclosure [Line Items]
Percentage funding of plan by Genworth		100.00%
Defined contribution pension plan required years of service to vest		3 years
Liability related to benefit plan		$ 11	11
Pension and Retiree Health and Life Insurance Benefit Plans
Defined Benefit Plan Disclosure [Line Items]
Costs associated with plan		18	18	$ 19
Retiree Health and Life Insurance Benefit Plans
Defined Benefit Plan Disclosure [Line Items]
Liability related to benefit plan		71	77
Change in other comprehensive income, (increase) reduction		$ 11	6
Age for retirees receiving policy coverage		65 years
Number of years before retirement eligibility at which retiree medical benefits are available to employees		10 years
Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Liability related to benefit plan		$ 65	69
Change in other comprehensive income, (increase) reduction		$ 6	$ 8

Borrowings and Other Financin_3

Borrowings and Other Financings - Long Term Borrowings (Detail) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Debt Instrument [Line Items]
Total	$ 1,899	$ 3,403
Genworth Holdings
Debt Instrument [Line Items]
Long-term borrowings	1,178	2,693
Bond consent fees	(12)	(19)
Deferred borrowing charges	(7)	(9)
Total	1,159	2,665
Genworth Holdings | 7.20% Senior Notes, Due 2021
Debt Instrument [Line Items]
Long-term borrowings	0	338
Genworth Holdings | 7.625% Senior Notes, Due 2021
Debt Instrument [Line Items]
Long-term borrowings	0	660
Genworth Holdings | 4.90% Senior Notes, Due 2023
Debt Instrument [Line Items]
Long-term borrowings	0	400
Genworth Holdings | 4.80% Senior Notes, Due 2024
Debt Instrument [Line Items]
Long-term borrowings	282	400
Genworth Holdings | 6.50% Senior Notes, Due 2034
Debt Instrument [Line Items]
Long-term borrowings	298	297
Genworth Holdings | Floating Rate Junior Subordinated Notes, due 2066
Debt Instrument [Line Items]
Long-term borrowings	598	598
Enact Holdings
Debt Instrument [Line Items]
Deferred borrowing charges	(10)	(12)
Total	740	738
Enact Holdings | 6.50% Senior Notes, Due 2025
Debt Instrument [Line Items]
Long-term borrowings	$ 750	$ 750

Borrowings and Other Financin_4

Borrowings and Other Financings - Long Term Borrowings (Parenthetical) (Detail)	Feb. 18, 2022	Mar. 31, 2022	Dec. 31, 2021	Dec. 31, 2021	Jul. 21, 2021	Mar. 31, 2021	Aug. 21, 2020
7.20% Senior Notes, Due 2021 | Genworth Holdings
Debt Instrument [Line Items]
Interest rate			7.20%	7.20%
Debt instrument, maturity year				2021
7.625% Senior Notes, Due 2021 | Genworth Holdings
Debt Instrument [Line Items]
Interest rate			7.625%	7.625%	7.625%	7.625%
Debt instrument, maturity year				2021
4.90% Senior Notes, Due 2023 | Genworth Holdings
Debt Instrument [Line Items]
Interest rate			4.90%	4.90%
Debt instrument, maturity year			2023	2023
4.80% Senior Notes, Due 2024 | Genworth Holdings
Debt Instrument [Line Items]
Interest rate	4.80%	4.80%	4.80%	4.80%
Debt instrument, maturity year	2024	2024	2024	2024
6.50% Senior Notes, Due 2034 | Genworth Holdings
Debt Instrument [Line Items]
Interest rate			6.50%	6.50%
Debt instrument, maturity year				2034
Floating Rate Junior Subordinated Notes, due 2066 | Genworth Holdings
Debt Instrument [Line Items]
Debt instrument, maturity year				2066
6.50% Senior Notes, Due 2025 | Enact Holdings
Debt Instrument [Line Items]
Interest rate			6.50%	6.50%			6.50%
Debt instrument, maturity year				2025

Borrowings and Other Financin_5

Borrowings and Other Financings - Additional Information (Detail) - USD ($) $ in Millions	Feb. 18, 2022	Dec. 15, 2021	Jul. 21, 2021	Mar. 31, 2021	Feb. 16, 2021	Aug. 21, 2020	Jan. 31, 2020	Mar. 31, 2022	Dec. 31, 2021	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Debt Instrument [Line Items]
Pre-tax gain (loss) on early extinguishment of debt										$ (45)	$ (9)	$ 0
Debt instrument, interest rate terms										The United Kingdom Financial Conduct Authority announced its intention to eliminate the use of three-month LIBOR effective June 30, 2023. The Alternate Reference Rate Committee, convened by the Board of Governors of the Federal Reserve System and the New York Federal Reserve Bank, is expected to authorize the use of an alternative rate to replace the current contractual three-month LIBOR rate used for the 2066 Notes. As such, we currently have no intention of refinancing the 2066 Notes. Until the elimination of the published rate and transition to an alternate reference rate become effective, we will continue to calculate and record interest payable and expense using three-month LIBOR plus 2.0025%
Cash and government securities collateral, minimum amount of the fair value of the applicable securities loaned											102.00%
Securities lending activity, fair value of securities loaned											$ 66
Securities lending activity, fair value of collateral held											67
Securities lending activity, obligation to return collateral											67
Interest paid										$ 198	$ 188	$ 287
Genworth Holdings
Debt Instrument [Line Items]
Debt instrument, maturity month and year							2020-06
Pre-tax make-whole expense on redemption of senior notes							$ 9
Genworth Holdings | Fixed Rate Senior Notes | Minimum
Debt Instrument [Line Items]
Interest rate									4.80%	4.80%
Senior notes option to redeem										100.00%
Genworth Holdings | Fixed Rate Senior Notes | Maximum
Debt Instrument [Line Items]
Interest rate									6.50%	6.50%
Genworth Holdings | Junior Notes, due 2066
Debt Instrument [Line Items]
Issued notes, aggregate principal amount									$ 600	$ 600
Debt instrument, maturity month and year										2066-11
Debt instrument, interest rate terms										three-month LIBOR plus 2.0025%
Scheduled redemption date										Nov. 15, 2036
Right to defer the payment of interest on the 2066 Notes during period, years										10 years
Debt Instrument, Call Date, Latest										Nov. 15, 2046
Debt instrument unamortized discount									$ 2	$ 2
Genworth Holdings | 7.20% Senior Notes, Due 2021
Debt Instrument [Line Items]
Debt instrument, maturity date					Feb. 16, 2021
Interest rate					7.20%
Redemption of senior notes					$ 350
Aggregate principal amount of notes redeemed					$ 338
Genworth Holdings | 7.625% Senior Notes, Due 2021
Debt Instrument [Line Items]
Interest rate			7.625%	7.625%					7.625%	7.625%
Debt instrument, maturity month and year										2021-09
Early redemption of senior notes			$ 532
Pre-tax make-whole expense on redemption of senior notes			6
Pre-tax gain (loss) on early extinguishment of debt				$ 4
Debt instrument, maturity year										2021
Aggregate principal amount of notes repurchased				$ 146
Interest paid			13
Aggregate principal amount of notes redeemed			$ 513
Genworth Holdings | 4.90% Senior Notes, Due 2023
Debt Instrument [Line Items]
Interest rate									4.90%	4.90%
Debt instrument, maturity month and year		2023-08
Early redemption of senior notes		$ 334
Pre-tax make-whole expense on redemption of senior notes		20
Pre-tax gain (loss) on early extinguishment of debt									$ 9
Debt instrument, maturity year									2023	2023
Aggregate principal amount of notes repurchased									$ 91	$ 91
Interest paid		5
Aggregate principal amount of notes redeemed		$ 309
Genworth Holdings | 4.80% Senior Notes, Due to 2024
Debt Instrument [Line Items]
Interest rate	4.80%							4.80%	4.80%	4.80%
Pre-tax gain (loss) on early extinguishment of debt									$ 6
Debt instrument, maturity year	2024							2024	2024	2024
Aggregate principal amount of notes repurchased	$ 0							$ 33	$ 118	$ 118
Rivermont Life Insurance Company | Non-Recourse Funding Obligations Due 2050
Debt Instrument [Line Items]
Pre-tax gain (loss) on early extinguishment of debt							$ 4
Debt instrument, maturity year							2050
Redemption of secured debt							$ 315
Enact Holdings | 6.50% Senior Notes, due 2025
Debt Instrument [Line Items]
Interest rate						6.50%			6.50%	6.50%
Issued notes, aggregate principal amount						$ 750
Debt instrument, maturity year										2025
Long term debt terms of interest payment						Interest on the notes is payable semi-annually
Long-term debt maturity date						Aug. 15, 2025
Option to redeem, price percentage of principal						100.00%
Debt instrument, option to redeem date, prior to						Feb. 15, 2025
Debt instrument, option to redeem date, on or afte						Feb. 15, 2025

Principal Amounts of Long Term

Principal Amounts of Long Term Debt Including Senior Notes and Non-recourse Funding by Maturity (Detail) $ in Millions	Dec. 31, 2021USD ($)
Principal Amounts Of Long Term Debt Including Senior Notes And Non Recourse Funding By Maturity [Line Items]
2022	$ 0
2023	0
2024	282
2025	750
2026 and thereafter	900
Total	$ 1,932

Remaining Contractual Maturity

Remaining Contractual Maturity of Agreements (Detail) $ in Millions	Dec. 31, 2020USD ($)
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities lending	$ 67
Equity Securities
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities lending	7
Fixed maturity securities
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities lending	60
Fixed maturity securities | Non-U.S. government
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities lending	1
Fixed maturity securities | U.S. corporate
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities lending	40
Fixed maturity securities | Non-U.S. corporate
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities lending	19
Overnight and continuous
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities lending	67
Overnight and continuous | Equity Securities
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities lending	7
Overnight and continuous | Fixed maturity securities
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities lending	60
Overnight and continuous | Fixed maturity securities | Non-U.S. government
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities lending	1
Overnight and continuous | Fixed maturity securities | U.S. corporate
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities lending	40
Overnight and continuous | Fixed maturity securities | Non-U.S. corporate
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities lending	19
Up to 30 days
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities lending	0
Up to 30 days | Fixed maturity securities
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities lending	0
Up to 30 days | Fixed maturity securities | Non-U.S. government
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities lending	0
Up to 30 days | Fixed maturity securities | U.S. corporate
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities lending	0
Up to 30 days | Fixed maturity securities | Non-U.S. corporate
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities lending	0
31 - 90 days
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities lending	0
31 - 90 days | Fixed maturity securities
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities lending	0
31 - 90 days | Fixed maturity securities | Non-U.S. government
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities lending	0
31 - 90 days | Fixed maturity securities | U.S. corporate
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities lending	0
31 - 90 days | Fixed maturity securities | Non-U.S. corporate
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities lending	0
Greater than 90 days
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities lending	0
Greater than 90 days | Fixed maturity securities
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities lending	0
Greater than 90 days | Fixed maturity securities | Non-U.S. government
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities lending	0
Greater than 90 days | Fixed maturity securities | U.S. corporate
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities lending	0
Greater than 90 days | Fixed maturity securities | Non-U.S. corporate
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities lending	$ 0

Components of Income before Inc

Components of Income before Income Taxes (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Income Taxes [Abstract]
Domestic	$ 1,184	$ 931	$ 523
Foreign	(3)	(3)	(2)
Income from continuing operations before income taxes	$ 1,181	$ 928	$ 521

Components of Income Tax Provis

Components of Income Tax Provision (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Income Taxes [Abstract]
Current federal income taxes	$ (32)	$ 0	$ 6
Deferred federal income taxes	288	226	114
Total federal income taxes	256	226	120
Current state income taxes	5	3	2
Deferred state income taxes	2	2	5
Total state income taxes	7	5	7
Current foreign income taxes	0	0	12
Deferred foreign income taxes	0	(1)	0
Total foreign income taxes	0	(1)	12
Total provision for income taxes	$ 263	$ 230	$ 139

Income Taxes - Additional Infor

Income Taxes - Additional Information (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Income Taxes [Line Items]
Current income tax payable	$ 2	$ 32
Valuation allowances	382	396
NOL carryforwards	944
Foreign tax credit carryforwards	$ 174	136
Foreign tax credit carryforwards, expiration year	2025
Net deferred tax asset	$ 119	65
Unrecognized tax benefits	40	62	$ 64	$ 79
Unrecognized tax benefits, amount that if recognized would affect the effective rate on continuing operations	25
Unrecognized tax benefits, interest and penalties (expense)	2	1	1
Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities in 2020	25
Capital Loss Carryforward [Member]
Income Taxes [Line Items]
Tax credit carryforward, amount	$ 675
Tax credit carry forward expiration year	2026
Section 338 Election
Income Taxes [Line Items]
Maximum deferred tax assets related to Section 338 election deduction	$ 640
Percentage of tax savings associated with Section 338 deductions	80.00%
Tax Matters Agreement
Income Taxes [Line Items]
Interest expense related to tax matters agreement	$ 2	3	$ 4
Accretion rate for tax matters agreement	5.72%
Liability for estimated present value of tax payments to former parent	$ 29	$ 41

Reconciliation of Federal Statu

Reconciliation of Federal Statutory Tax Rate to Effective Income Tax Rate (Detail)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Income Tax Examination [Line Items]
Statutory U.S. federal income tax rate	21.00%	21.00%	21.00%
Swaps terminated prior to the TCJA	2.50%	3.00%	4.50%
Reduction in uncertain tax positions	(1.80%)	0.00%	0.00%
State income tax, net of federal income tax effect	0.50%	0.40%	1.10%
Other, net	0.10%	0.40%	0.10%
Effective rate	22.30%	24.80%	26.70%

Components Net Deferred Income

Components Net Deferred Income Tax Liability (Detail) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Income Taxes [Abstract]
Foreign tax credit carryforwards	$ 174	$ 136
Net operating loss carryforwards	202	56
Capital loss carryforwards	142	0
State income taxes	388	386
Insurance reserves	178	620
Accrued commission and general expenses	118	123
Liabilities associated with discontinued operations	122	126
Investments	0	10
Other	18	23
Gross deferred income tax assets	1,342	1,480
Valuation allowance	(382)	(396)
Total deferred income tax assets	960	1,084
Net unrealized gains on investment securities	506	590
Net unrealized gains on derivatives	73	70
DAC	98	181
PVFP and other intangibles	38	42
Insurance reserves transition adjustment	99	123
Investments	10	0
Other	17	13
Total deferred income tax liabilities	841	1,019
Net deferred income tax asset	$ 119	$ 65

Reconciliation of Unrecognized

Reconciliation of Unrecognized Tax Benefits (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Income Taxes [Abstract]
Balance as of January 1	$ 62	$ 64	$ 79
Gross additions, current period	0	0	0
Gross reductions, current period	(3)	(3)	(15)
Gross additions, prior years	0	1	0
Gross reductions, prior years	(19)	0	0
Balance as of December 31	$ 40	$ 62	$ 64

Supplemental Cash Flow Inform_2

Supplemental Cash Flow Information - Additional Information (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Supplemental Cash Flow Information [Abstract]
Net cash (paid) received for taxes	$ (7)	$ 3	$ 1
Cash paid for interest	$ 198	$ 188	$ 287

Stock-Based Compensation - Addi

Stock-Based Compensation - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Millions	Dec. 31, 2021	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2012	Dec. 31, 2011
Share Based Employee Compensation [Line Items]
Stock-based compensation expense		$ 40	$ 39	$ 26
Unrecognized stock-based compensation expense	$ 17	$ 17	15
Unrecognized stock-based compensation expense, expected weighted-average period of recognition (years)		2 years
Tax benefit realized from the exercise of share based awards		$ 4	$ 4
Enact Holdings Inc.
Share Based Employee Compensation [Line Items]
Equity awards, total amount of shares authorized to be outstanding	4,000,000	4,000,000
Unrecognized stock-based compensation expense	$ 11	$ 11
Unrecognized stock-based compensation expense, expected weighted-average period of recognition (years)	3 years
Stock-based compensation expense		$ 2
Cash Awards
Share Based Employee Compensation [Line Items]
Granted stock options, fair value		$ 1	$ 1	$ 1
Time Based Cash Awards
Share Based Employee Compensation [Line Items]
Average vesting period		3 years	3 years	3 years
Vested		15,000,000	11,000,000
Restricted Stock Units
Share Based Employee Compensation [Line Items]
Granted stock options, fair value		$ 3.31	$ 3.53	$ 3.36
Average vesting period		3 years	3 years	3 years
Vested		1,474,000	1,336,000
Performance Stock Units ("PSUs")
Share Based Employee Compensation [Line Items]
Stock-based compensation expense		$ 16	$ 18	$ 5
Granted stock options, fair value		$ 3.45	$ 3.03	$ 4.61
Average vesting period		3 years	3 years	3 years
Performance metric grant-date fair value, metric two		$ 3.31
Performance metric grant-date fair value	$ 4.18	$ 4.18
Restricted Stock Units | Enact Holdings Inc.
Share Based Employee Compensation [Line Items]
Vested	0
Omnibus Incentive Plan
Share Based Employee Compensation [Line Items]
Equity awards, total amount of shares authorized to be outstanding					16,000,000
Equity awards, amount of shares authorized to grant						25,000,000
Stock-based compensation expense		$ 38	$ 39	$ 26
2018 Omnibus Incentive Plan
Share Based Employee Compensation [Line Items]
Equity awards, total amount of shares authorized to be outstanding	25,000,000	25,000,000
Equity awards, amount of shares authorized to grant	20,000,000	20,000,000
2021 Omnibus Incentive Plan
Share Based Employee Compensation [Line Items]
Equity awards, total amount of shares authorized to be outstanding	25,000,000	25,000,000
Equity awards, amount of shares authorized to grant	20,000,000	20,000,000

Stock-Based Compensation - Summ

Stock-Based Compensation - Summary of Other Equity Awards Valuation Assumptions (Detail)	12 Months Ended
	Dec. 31, 2021$ / shares
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]
Valuation-date stock price	$ 3.31
Volatility	65.00%
Dividend yield	0.00%
Risk-free rate	0.30%
Valuation maximum	800% of grant-date stock price

Stock-Based Compensation - Su_2

Stock-Based Compensation - Summary of Cash Award Activity (Detail) - shares shares in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Performance Based Cash Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Balance as of January 1, number of awards	7	13
Granted, number of awards	0	0
Performance adjustment	6	1
Vested, number of awards	(13)	(5)
Forfeited, number of awards	0	(2)
Balance as of December 31, number of awards	0	7
Time Based Cash Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Balance as of January 1, number of awards	30	26
Granted, number of awards	15	17
Performance adjustment	0	0
Vested, number of awards	(15)	(11)
Forfeited, number of awards	(3)	(2)
Balance as of December 31, number of awards	27	30

Rollforward of Share-Based Comp

Rollforward of Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding (Detail) - $ / shares shares in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Stock-Based Compensation [Abstract]
Beginning balance, shares subject to option	1	801
Granted, shares subject to option	0	0
Exercised, shares subject to option	0	0
Expired and forfeited, shares subject to option	(1)	(800)
Ending balance, shares subject to option	0	1
Exercisable as of December 31, shares subject to option	0
Beginning balance, weighted-average exercise price	$ 12.75	$ 14.17
Granted, weighted-average exercise price	0	0
Exercised, weighted-average exercise price	0	0
Expired and forfeited, weighted-average exercise price	12.75	14.17
Ending balance, weighted-average exercise price	0	$ 12.75
Exercisable as of December 31, weighted-average exercise price	$ 0

Stock Option Activity and Other

Stock Option Activity and Other Equity-Based Awards (Detail) - $ / shares shares in Thousands		12 Months Ended
		Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Balance as of January 1, number of awards		2,534	2,675
Granted, number of awards		1,391	1,683
Performance adjustment	[1]	0	0
Exercised, number of awards		(1,474)	(1,336)
Terminated, number of awards		(134)	(488)
Balance as of December 31, number of awards		2,317	2,534	2,675
Balance as of January 1, weighted-average grant date fair value		$ 3.48	$ 3.51
Granted, weighted-average grant date fair value		3.31	3.53	$ 3.36
Performance adjustment, weighted-average grant date fair value	[1]	0	0
Exercised, weighted-average grant date fair value		3.47	3.62
Terminated, weighted-average grant date fair value		3.53	3.47
Balance as of December 31, weighted-average grant date fair value		$ 3.38	$ 3.48	$ 3.51
Performance Stock Units ("PSUs")
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Balance as of January 1, number of awards		5,734	5,142
Granted, number of awards		2,510	2,789
Performance adjustment	[1]	626	443
Exercised, number of awards		(1,365)	(1,994)
Terminated, number of awards		0	(646)
Balance as of December 31, number of awards		7,505	5,734	5,142
Balance as of January 1, weighted-average grant date fair value		$ 3.79	$ 4.28
Granted, weighted-average grant date fair value		3.45	3.03
Performance adjustment, weighted-average grant date fair value	[1]	3.58	4.01
Exercised, weighted-average grant date fair value		3.58	4.01
Terminated, weighted-average grant date fair value		0	3.86
Balance as of December 31, weighted-average grant date fair value		$ 3.70	$ 3.79	$ 4.28
Deferred Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Balance as of January 1, number of awards		1,537	1,515
Granted, number of awards		315	237
Performance adjustment	[1]	0	0
Exercised, number of awards		(15)	(215)
Terminated, number of awards		0	0
Balance as of December 31, number of awards		1,837	1,537	1,515
Balance as of January 1, weighted-average grant date fair value		$ 3.95	$ 4.37
Granted, weighted-average grant date fair value		2.52	2
Performance adjustment, weighted-average grant date fair value	[1]	0	0
Exercised, weighted-average grant date fair value		7.46	4.76
Terminated, weighted-average grant date fair value		0	0
Balance as of December 31, weighted-average grant date fair value		$ 3.42	$ 3.95	$ 4.37
Stock Appreciation Rights
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Balance as of January 1, number of awards		7,030	8,151
Granted, number of awards		0	0
Performance adjustment	[1]	0	0
Exercised, number of awards		0	0
Terminated, number of awards		(835)	(1,121)
Balance as of December 31, number of awards		6,195	7,030	8,151
Balance as of January 1, weighted-average grant date fair value		$ 3.32	$ 3.41
Granted, weighted-average grant date fair value		0	0
Performance adjustment, weighted-average grant date fair value	[1]	0	0
Exercised, weighted-average grant date fair value		0	0
Terminated, weighted-average grant date fair value		3.04	3.99
Balance as of December 31, weighted-average grant date fair value		$ 3.36	$ 3.32	$ 3.41
[1]	The performance adjustment relates to additional awards expected to be earned through the achievement of certain performance metrics.

Stock-Based Compensation - Su_3

Stock-Based Compensation - Summary of Enact Holdings' equity-based awards (Details) - $ / shares shares in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Restricted Stock Units | Enact Holdings Inc.
Number of awards
Balance as of January 1, number of awards	0
Granted	628
Dividend equivalents	36
Vested, number of awards	0
Terminated, number of awards	(10)
Balance as of December 31, number of awards	654	0
Weighted average grant date fair value
Balance as of January 1, weighted-average grant date fair value	$ 0
Granted, weighted-average grant date fair value	19.02
Dividend equivalents	21.25
Vested	0
Terminated, weighted-average grant date fair value	19
Balance as of December 31, weighted-average grant date fair value	$ 19.02	$ 0
Deferred Stock Units
Number of awards
Balance as of January 1, number of awards	1,537	1,515
Granted	315	237
Vested, number of awards	(15)	(215)
Terminated, number of awards	0	0
Balance as of December 31, number of awards	1,837	1,537
Weighted average grant date fair value
Balance as of January 1, weighted-average grant date fair value	$ 3.95	$ 4.37
Granted, weighted-average grant date fair value	2.52	2
Vested	7.46	4.76
Terminated, weighted-average grant date fair value	0	0
Balance as of December 31, weighted-average grant date fair value	$ 3.42	$ 3.95
Deferred Stock Units | Enact Holdings Inc.
Number of awards
Balance as of January 1, number of awards	0
Granted	17
Dividend equivalents	0
Vested, number of awards	0
Terminated, number of awards	0
Balance as of December 31, number of awards	17	0
Weighted average grant date fair value
Balance as of January 1, weighted-average grant date fair value	$ 0
Granted, weighted-average grant date fair value	20.87
Dividend equivalents	0
Vested	0
Terminated, weighted-average grant date fair value	0
Balance as of December 31, weighted-average grant date fair value	$ 20.87	$ 0

Fair Value of Financial Instr_3

Fair Value of Financial Instruments - Additional Information (Detail) $ in Millions	12 Months Ended
	Dec. 31, 2021USD ($)	Dec. 31, 2020USD ($)
Fair Value of Financial Instruments [Line Items]
Available-for-sale debt securities	$ 60,480	$ 63,495
GMWB non-performance risk impact	$ 49	66
Period end valuation	0
Fixed maturity securities
Fair Value of Financial Instruments [Line Items]
Available-for-sale debt securities	$ 60,480	63,495
Fixed maturity securities | U.S. corporate
Fair Value of Financial Instruments [Line Items]
Available-for-sale debt securities	34,924	35,857
Fixed maturity securities | Non-U.S. corporate
Fair Value of Financial Instruments [Line Items]
Available-for-sale debt securities	10,535	10,811
Level 2
Fair Value of Financial Instruments [Line Items]
Available-for-sale debt securities	56,672	59,406
Level 2 | Fixed maturity securities | U.S. corporate
Fair Value of Financial Instruments [Line Items]
Available-for-sale debt securities	32,543	33,585
Level 2 | Fixed maturity securities | Non-U.S. corporate
Fair Value of Financial Instruments [Line Items]
Available-for-sale debt securities	$ 9,373	9,203
Level 2 | Fixed maturity securities | Third-Party Pricing Services
Fair Value of Financial Instruments [Line Items]
Percentage of available for sale debt securities	89.00%
Level 2 | Fixed maturity securities | Third-Party Pricing Services | U.S. corporate
Fair Value of Financial Instruments [Line Items]
Available-for-sale debt securities	$ 30,774
Level 2 | Fixed maturity securities | Third-Party Pricing Services | Non-U.S. corporate
Fair Value of Financial Instruments [Line Items]
Available-for-sale debt securities	8,322
Level 2 | Fixed maturity securities | Internal models | U.S. corporate
Fair Value of Financial Instruments [Line Items]
Available-for-sale debt securities	1,769
Level 2 | Fixed maturity securities | Internal models | Non-U.S. corporate
Fair Value of Financial Instruments [Line Items]
Available-for-sale debt securities	1,051
Level 3
Fair Value of Financial Instruments [Line Items]
Available-for-sale debt securities	3,808	4,089
Level 3 | Fixed maturity securities | U.S. corporate
Fair Value of Financial Instruments [Line Items]
Available-for-sale debt securities	2,381	2,272
Level 3 | Fixed maturity securities | Non-U.S. corporate
Fair Value of Financial Instruments [Line Items]
Available-for-sale debt securities	1,162	$ 1,608
Level 3 | Fixed maturity securities | Internal models
Fair Value of Financial Instruments [Line Items]
Available-for-sale debt securities	3,496
Level 3 | Fixed maturity securities | Broker Quotes
Fair Value of Financial Instruments [Line Items]
Available-for-sale debt securities	$ 312
Fair Value Measured at Net Asset Value Per Share | Limited Partnerships | Maximum
Fair Value of Financial Instruments [Line Items]
Liquidation period	10 years
Contractual period	12 years
Fair Value Measured at Net Asset Value Per Share | Limited Partnerships | Minimum
Fair Value of Financial Instruments [Line Items]
Liquidation period	5 years
Contractual period	10 years

Fair Value of Financial Instr_4

Fair Value of Financial Instruments - Summary of Significant Inputs Used by Third-Party Pricing Services for Certain Fair Value Measurements of Fixed Maturity Securities that Classified as Level 2 (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	$ 60,480	$ 63,495
Fixed maturity securities
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	60,480	63,495
Fixed maturity securities | U.S. government, agencies and government-sponsored enterprises
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	4,552	4,805
Fixed maturity securities | State and Political Subdivisions
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	3,450	3,165
Fixed maturity securities | Non-U.S. government
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	835	854
Fixed maturity securities | U.S. corporate
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	34,924	35,857
Fixed maturity securities | Non-U.S. corporate
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	10,535	10,811
Fixed maturity securities | Residential mortgage-backed
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	1,440	1,909
Fixed maturity securities | Commercial mortgage-backed
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	2,584	2,974
Fixed maturity securities | Other asset-backed
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	2,160	3,120
Level 2
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	56,672	59,406
Level 2 | Fixed maturity securities | U.S. government, agencies and government-sponsored enterprises
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	4,552	4,805
Level 2 | Fixed maturity securities | State and Political Subdivisions
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	3,368	3,099
Level 2 | Fixed maturity securities | Non-U.S. government
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	833	854
Level 2 | Fixed maturity securities | U.S. corporate
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	32,543	33,585
Level 2 | Fixed maturity securities | Non-U.S. corporate
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	9,373	9,203
Level 2 | Fixed maturity securities | Residential mortgage-backed
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	1,413	1,895
Level 2 | Fixed maturity securities | Commercial mortgage-backed
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	2,568	2,954
Level 2 | Fixed maturity securities | Other asset-backed
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	2,022	$ 3,011
Level 2 | Third-Party Pricing Services | Fixed maturity securities | U.S. government, agencies and government-sponsored enterprises
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	$ 4,552
Primary methodologies	Price quotes from trading desk, broker feeds
Significant inputs	Bid side prices, trade prices, Option Adjusted Spread (“OAS”) to swap curve, Bond Market Association OAS, Treasury Curve, Agency Bullet Curve, maturity to issuer spread
Level 2 | Third-Party Pricing Services | Fixed maturity securities | State and Political Subdivisions
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	$ 3,368
Primary methodologies	Multi-dimensional attribute-based modeling systems, third-party pricing vendors
Significant inputs	Trade prices, material event notices, Municipal Market Data benchmark yields, broker quotes
Level 2 | Third-Party Pricing Services | Fixed maturity securities | Non-U.S. government
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	$ 833
Primary methodologies	Matrix pricing, spread priced to benchmark curves, price quotes from market makers
Significant inputs	Benchmark yields, trade prices, broker quotes, comparative transactions, issuer spreads, bid-offer spread, market research publications, third-party pricing sources
Level 2 | Third-Party Pricing Services | Fixed maturity securities | U.S. corporate
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	$ 30,774
Primary methodologies	Multi-dimensional attribute-based modeling systems, broker quotes, price quotes from market makers, OAS-based models
Significant inputs	Bid side prices to Treasury Curve, Issuer Curve, which includes sector, quality, duration, OAS percentage and change for spread matrix, trade prices, comparative transactions, Trade Reporting and Compliance Engine (“TRACE”) reports
Level 2 | Third-Party Pricing Services | Fixed maturity securities | Non-U.S. corporate
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	$ 8,322
Primary methodologies	Multi-dimensional attribute-based modeling systems, OAS-based models, price quotes from market makers
Significant inputs	Benchmark yields, trade prices, broker quotes, comparative transactions, issuer spreads, bid-offer spread, market research publications, third-party pricing sources
Level 2 | Third-Party Pricing Services | Fixed maturity securities | Residential mortgage-backed
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	$ 1,413
Primary methodologies	OAS-based models, single factor binomial models, internally priced
Significant inputs	Prepayment and default assumptions, aggregation of bonds with similar characteristics, including collateral type, vintage, tranche type, weighted-average life, weighted-average loan age, issuer program and delinquency ratio, pay up and pay down factors, TRACE reports
Level 2 | Third-Party Pricing Services | Fixed maturity securities | Commercial mortgage-backed
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	$ 2,568
Primary methodologies	Multi-dimensional attribute-based modeling systems, pricing matrix, spread matrix priced to swap curves, Trepp commercial mortgage-backed securities analytics model
Significant inputs	Credit risk, interest rate risk, prepayment speeds, new issue data, collateral performance, origination year, tranche type, original credit ratings, weighted-average life, cash flows, spreads derived from broker quotes, bid side prices, spreads to daily updated swap curves, TRACE reports
Level 2 | Third-Party Pricing Services | Fixed maturity securities | Other asset-backed
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	$ 2,022
Primary methodologies	Multi-dimensional attribute-based modeling systems, spread matrix priced to swap curves, price quotes from market makers
Significant inputs	Spreads to daily updated swap curves, spreads derived from trade prices and broker quotes, bid side prices, new issue data, collateral performance, analysis of prepayment speeds, cash flows, collateral loss analytics, historical issue analysis, trade data from market makers, TRACE reports

Assets by Class of Instrument t

Assets by Class of Instrument that are Measured at Fair Value on Recurring Basis (Detail) - USD ($) $ in Millions		Dec. 31, 2021		Dec. 31, 2020
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		$ 60,480		$ 63,495
Available-for-sale equity securities		198		386
Derivative assets, fair value		433		600
Limited partnerships		1,900		1,049
Total other invested assets		820		1,050
Separate account assets		6,066		6,081
Total assets		68,665		71,509
Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	[1]	0
Available-for-sale equity securities		0	[1]	0
Limited partnerships		1,462	[1]	835
Separate account assets		0		0
Total assets		1,462		835
Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		414		574
Securities lending collateral				67
Short-term investments		26		45
Total other invested assets		440		686
Other invested assets | Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		0	[1]	0
Securities lending collateral				0
Short-term investments		0	[1]	0
Total other invested assets		0	[1]	0
Interest rate swaps | Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		364		468
Interest rate swaps | Other invested assets | Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		0	[1]	0
Foreign currency swaps | Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		6		1
Foreign currency swaps | Other invested assets | Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		0	[1]	0
Equity index options | Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		42		63
Equity index options | Other invested assets | Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		0	[1]	0
Other foreign currency contracts | Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		2		42
Other foreign currency contracts | Other invested assets | Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		0	[1]	0
GMWB embedded derivatives | Reinsurance recoverable
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		19		26
GMWB embedded derivatives | Reinsurance recoverable | Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value	[2]	0	[1]	0
Fixed maturity securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		60,480		63,495
Fixed maturity securities | U.S. government, agencies and government-sponsored enterprises
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		4,552		4,805
Fixed maturity securities | U.S. government, agencies and government-sponsored enterprises | Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	[1]	0
Fixed maturity securities | State and Political Subdivisions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		3,450		3,165
Fixed maturity securities | State and Political Subdivisions | Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	[1]	0
Fixed maturity securities | Non-U.S. government
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		835		854
Fixed maturity securities | Non-U.S. government | Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	[1]	0
Fixed maturity securities | U.S. corporate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		34,924		35,857
Fixed maturity securities | U.S. corporate | Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	[1]	0
Fixed maturity securities | U.S. corporate | Utilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		5,104		5,194
Fixed maturity securities | U.S. corporate | Utilities | Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	[1]	0
Fixed maturity securities | U.S. corporate | Energy
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		2,934		2,883
Fixed maturity securities | U.S. corporate | Energy | Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	[1]	0
Fixed maturity securities | U.S. corporate | Finance and insurance
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		8,991		9,102
Fixed maturity securities | U.S. corporate | Finance and insurance | Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	[1]	0
Fixed maturity securities | U.S. corporate | Consumer-non-cyclical
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		6,159		6,437
Fixed maturity securities | U.S. corporate | Consumer-non-cyclical | Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	[1]	0
Fixed maturity securities | U.S. corporate | Technology and communications
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		3,808		3,761
Fixed maturity securities | U.S. corporate | Technology and communications | Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	[1]	0
Fixed maturity securities | U.S. corporate | Industrial
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		1,494		1,602
Fixed maturity securities | U.S. corporate | Industrial | Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	[1]	0
Fixed maturity securities | U.S. corporate | Capital goods
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		2,745		2,991
Fixed maturity securities | U.S. corporate | Capital goods | Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	[1]	0
Fixed maturity securities | U.S. corporate | Consumer-cyclical
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		1,899		1,947
Fixed maturity securities | U.S. corporate | Consumer-cyclical | Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	[1]	0
Fixed maturity securities | U.S. corporate | Transportation
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		1,371		1,500
Fixed maturity securities | U.S. corporate | Transportation | Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	[1]	0
Fixed maturity securities | U.S. corporate | Other
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		419		440
Fixed maturity securities | U.S. corporate | Other | Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	[1]	0
Fixed maturity securities | Non-U.S. corporate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		10,535		10,811
Fixed maturity securities | Non-U.S. corporate | Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	[1]	0
Fixed maturity securities | Non-U.S. corporate | Utilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		928		922
Fixed maturity securities | Non-U.S. corporate | Utilities | Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	[1]	0
Fixed maturity securities | Non-U.S. corporate | Energy
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		1,383		1,380
Fixed maturity securities | Non-U.S. corporate | Energy | Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	[1]	0
Fixed maturity securities | Non-U.S. corporate | Finance and insurance
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		2,432		2,476
Fixed maturity securities | Non-U.S. corporate | Finance and insurance | Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	[1]	0
Fixed maturity securities | Non-U.S. corporate | Consumer-non-cyclical
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		743		773
Fixed maturity securities | Non-U.S. corporate | Consumer-non-cyclical | Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	[1]	0
Fixed maturity securities | Non-U.S. corporate | Technology and communications
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		1,250		1,291
Fixed maturity securities | Non-U.S. corporate | Technology and communications | Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	[1]	0
Fixed maturity securities | Non-U.S. corporate | Industrial
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		1,047		1,128
Fixed maturity securities | Non-U.S. corporate | Industrial | Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	[1]	0
Fixed maturity securities | Non-U.S. corporate | Capital goods
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		705		576
Fixed maturity securities | Non-U.S. corporate | Capital goods | Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	[1]	0
Fixed maturity securities | Non-U.S. corporate | Consumer-cyclical
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		341		371
Fixed maturity securities | Non-U.S. corporate | Consumer-cyclical | Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	[1]	0
Fixed maturity securities | Non-U.S. corporate | Transportation
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		489		570
Fixed maturity securities | Non-U.S. corporate | Transportation | Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	[1]	0
Fixed maturity securities | Non-U.S. corporate | Other
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		1,217		1,324
Fixed maturity securities | Non-U.S. corporate | Other | Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	[1]	0
Fixed maturity securities | Residential mortgage-backed
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		1,440		1,909
Fixed maturity securities | Residential mortgage-backed | Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	[1]	0
Fixed maturity securities | Commercial mortgage-backed
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		2,584		2,974
Fixed maturity securities | Commercial mortgage-backed | Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	[1]	0
Fixed maturity securities | Other asset-backed
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		2,160		3,120
Fixed maturity securities | Other asset-backed | Net Asset Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	[1]	0
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0		0
Available-for-sale equity securities		101		276
Limited partnerships		0		0
Separate account assets		6,066		6,081
Total assets		6,167		6,382
Level 1 | Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		0		0
Securities lending collateral				0
Short-term investments		0		25
Total other invested assets		0		25
Level 1 | Interest rate swaps | Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		0		0
Level 1 | Foreign currency swaps | Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		0		0
Level 1 | Equity index options | Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		0		0
Level 1 | Other foreign currency contracts | Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		0		0
Level 1 | GMWB embedded derivatives | Reinsurance recoverable
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value	[2]	0		0
Level 1 | Fixed maturity securities | U.S. government, agencies and government-sponsored enterprises
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0		0
Level 1 | Fixed maturity securities | State and Political Subdivisions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0		0
Level 1 | Fixed maturity securities | Non-U.S. government
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0		0
Level 1 | Fixed maturity securities | U.S. corporate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0		0
Level 1 | Fixed maturity securities | U.S. corporate | Utilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0		0
Level 1 | Fixed maturity securities | U.S. corporate | Energy
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0		0
Level 1 | Fixed maturity securities | U.S. corporate | Finance and insurance
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0		0
Level 1 | Fixed maturity securities | U.S. corporate | Consumer-non-cyclical
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0		0
Level 1 | Fixed maturity securities | U.S. corporate | Technology and communications
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0		0
Level 1 | Fixed maturity securities | U.S. corporate | Industrial
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0		0
Level 1 | Fixed maturity securities | U.S. corporate | Capital goods
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0		0
Level 1 | Fixed maturity securities | U.S. corporate | Consumer-cyclical
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0		0
Level 1 | Fixed maturity securities | U.S. corporate | Transportation
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0		0
Level 1 | Fixed maturity securities | U.S. corporate | Other
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0		0
Level 1 | Fixed maturity securities | Non-U.S. corporate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0		0
Level 1 | Fixed maturity securities | Non-U.S. corporate | Utilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0		0
Level 1 | Fixed maturity securities | Non-U.S. corporate | Energy
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0		0
Level 1 | Fixed maturity securities | Non-U.S. corporate | Finance and insurance
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0		0
Level 1 | Fixed maturity securities | Non-U.S. corporate | Consumer-non-cyclical
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0		0
Level 1 | Fixed maturity securities | Non-U.S. corporate | Technology and communications
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0		0
Level 1 | Fixed maturity securities | Non-U.S. corporate | Industrial
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0		0
Level 1 | Fixed maturity securities | Non-U.S. corporate | Capital goods
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0		0
Level 1 | Fixed maturity securities | Non-U.S. corporate | Consumer-cyclical
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0		0
Level 1 | Fixed maturity securities | Non-U.S. corporate | Transportation
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0		0
Level 1 | Fixed maturity securities | Non-U.S. corporate | Other
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0		0
Level 1 | Fixed maturity securities | Residential mortgage-backed
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0		0
Level 1 | Fixed maturity securities | Commercial mortgage-backed
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0		0
Level 1 | Fixed maturity securities | Other asset-backed
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0		0
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		56,672		59,406
Available-for-sale equity securities		60		59
Limited partnerships		0		0
Separate account assets		0		0
Total assets		57,130		60,063
Level 2 | Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		372		511
Securities lending collateral				67
Short-term investments		26		20
Total other invested assets		398		598
Level 2 | Interest rate swaps | Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		364		468
Level 2 | Foreign currency swaps | Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		6		1
Level 2 | Equity index options | Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		0		0
Level 2 | Other foreign currency contracts | Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		2		42
Level 2 | GMWB embedded derivatives | Reinsurance recoverable
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		0		0
Level 2 | Fixed maturity securities | U.S. government, agencies and government-sponsored enterprises
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		4,552		4,805
Level 2 | Fixed maturity securities | State and Political Subdivisions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		3,368		3,099
Level 2 | Fixed maturity securities | Non-U.S. government
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		833		854
Level 2 | Fixed maturity securities | U.S. corporate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		32,543		33,585
Level 2 | Fixed maturity securities | U.S. corporate | Utilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		4,154		4,352
Level 2 | Fixed maturity securities | U.S. corporate | Energy
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		2,858		2,755
Level 2 | Fixed maturity securities | U.S. corporate | Finance and insurance
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		8,306		8,495
Level 2 | Fixed maturity securities | U.S. corporate | Consumer-non-cyclical
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		6,055		6,328
Level 2 | Fixed maturity securities | U.S. corporate | Technology and communications
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		3,779		3,714
Level 2 | Fixed maturity securities | U.S. corporate | Industrial
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		1,457		1,562
Level 2 | Fixed maturity securities | U.S. corporate | Capital goods
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		2,700		2,931
Level 2 | Fixed maturity securities | U.S. corporate | Consumer-cyclical
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		1,762		1,797
Level 2 | Fixed maturity securities | U.S. corporate | Transportation
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		1,307		1,430
Level 2 | Fixed maturity securities | U.S. corporate | Other
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		165		221
Level 2 | Fixed maturity securities | Non-U.S. corporate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		9,373		9,203
Level 2 | Fixed maturity securities | Non-U.S. corporate | Utilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		583		570
Level 2 | Fixed maturity securities | Non-U.S. corporate | Energy
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		1,238		1,135
Level 2 | Fixed maturity securities | Non-U.S. corporate | Finance and insurance
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		2,272		2,171
Level 2 | Fixed maturity securities | Non-U.S. corporate | Consumer-non-cyclical
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		680		706
Level 2 | Fixed maturity securities | Non-U.S. corporate | Technology and communications
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		1,222		1,263
Level 2 | Fixed maturity securities | Non-U.S. corporate | Industrial
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		954		1,033
Level 2 | Fixed maturity securities | Non-U.S. corporate | Capital goods
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		532		398
Level 2 | Fixed maturity securities | Non-U.S. corporate | Consumer-cyclical
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		265		225
Level 2 | Fixed maturity securities | Non-U.S. corporate | Transportation
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		436		461
Level 2 | Fixed maturity securities | Non-U.S. corporate | Other
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		1,191		1,241
Level 2 | Fixed maturity securities | Residential mortgage-backed
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		1,413		1,895
Level 2 | Fixed maturity securities | Commercial mortgage-backed
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		2,568		2,954
Level 2 | Fixed maturity securities | Other asset-backed
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		2,022		3,011
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		3,808		4,089
Available-for-sale equity securities		37		51
Limited partnerships		0		0
Separate account assets		0		0
Total assets		3,906		4,229
Level 3 | Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		42		63
Securities lending collateral				0
Short-term investments		0		0
Total other invested assets		42		63
Level 3 | Interest rate swaps | Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		0		0
Level 3 | Foreign currency swaps | Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		0		0
Level 3 | Equity index options | Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		42		63
Level 3 | Other foreign currency contracts | Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		0		0
Level 3 | GMWB embedded derivatives | Reinsurance recoverable
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		19		26
Level 3 | Fixed maturity securities | U.S. government, agencies and government-sponsored enterprises
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0		0
Level 3 | Fixed maturity securities | State and Political Subdivisions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		82		66
Level 3 | Fixed maturity securities | Non-U.S. government
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		2		0
Level 3 | Fixed maturity securities | U.S. corporate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		2,381		2,272
Level 3 | Fixed maturity securities | U.S. corporate | Utilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		950		842
Level 3 | Fixed maturity securities | U.S. corporate | Energy
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		76		128
Level 3 | Fixed maturity securities | U.S. corporate | Finance and insurance
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		685		607
Level 3 | Fixed maturity securities | U.S. corporate | Consumer-non-cyclical
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		104		109
Level 3 | Fixed maturity securities | U.S. corporate | Technology and communications
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		29		47
Level 3 | Fixed maturity securities | U.S. corporate | Industrial
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		37		40
Level 3 | Fixed maturity securities | U.S. corporate | Capital goods
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		45		60
Level 3 | Fixed maturity securities | U.S. corporate | Consumer-cyclical
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		137		150
Level 3 | Fixed maturity securities | U.S. corporate | Transportation
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		64		70
Level 3 | Fixed maturity securities | U.S. corporate | Other
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		254		219
Level 3 | Fixed maturity securities | Non-U.S. corporate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		1,162		1,608
Level 3 | Fixed maturity securities | Non-U.S. corporate | Utilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		345		352
Level 3 | Fixed maturity securities | Non-U.S. corporate | Energy
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		145		245
Level 3 | Fixed maturity securities | Non-U.S. corporate | Finance and insurance
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		160		305
Level 3 | Fixed maturity securities | Non-U.S. corporate | Consumer-non-cyclical
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		63		67
Level 3 | Fixed maturity securities | Non-U.S. corporate | Technology and communications
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		28		28
Level 3 | Fixed maturity securities | Non-U.S. corporate | Industrial
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		93		95
Level 3 | Fixed maturity securities | Non-U.S. corporate | Capital goods
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		173		178
Level 3 | Fixed maturity securities | Non-U.S. corporate | Consumer-cyclical
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		76		146
Level 3 | Fixed maturity securities | Non-U.S. corporate | Transportation
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		53		109
Level 3 | Fixed maturity securities | Non-U.S. corporate | Other
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		26		83
Level 3 | Fixed maturity securities | Residential mortgage-backed
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		27		14
Level 3 | Fixed maturity securities | Commercial mortgage-backed
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		16		20
Level 3 | Fixed maturity securities | Other asset-backed
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		$ 138		$ 109
[1]	Limited partnerships that are measured at fair value using the NAV per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy.
[2]	Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities.

Assets Measured at Fair Value o

Assets Measured at Fair Value on Recurring Basis and Utilized Significant Unobservable (Level 3) Inputs to Determine Fair Value (Detail) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		$ 4,229	$ 4,304	$ 3,909
Total realized and unrealized gains (losses), Included in net income		27	40	51
Total realized and unrealized gains (losses), Included in OCI		(16)	60	346
Purchases		633	701	716
Sales		(11)	(41)	(73)
Issuances		2	2	1
Settlements		(478)	(486)	(419)
Transfer into Level 3	[1]	186	529	249
Transfer out of Level 3	[1]	(666)	(880)	(476)
Ending balance		3,906	4,229	4,304
Total gains (losses) included in net income attributable to assets still held		10	16	23
Total gains (losses) included in OCI attributable to assets still held		(29)	76
Other invested assets
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		63	81	39
Total realized and unrealized gains (losses), Included in net income		18	4	43
Total realized and unrealized gains (losses), Included in OCI		0	0	0
Purchases		31	59	63
Sales		0	0	0
Issuances		0	0	0
Settlements		(70)	(81)	(64)
Transfer into Level 3	[1]	0	0	0
Transfer out of Level 3	[1]	0	0	0
Ending balance		42	63	81
Total gains (losses) included in net income attributable to assets still held		10	5	18
Total gains (losses) included in OCI attributable to assets still held		0	0
Other invested assets | Derivative assets
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		63	81	39
Total realized and unrealized gains (losses), Included in net income		18	4	43
Total realized and unrealized gains (losses), Included in OCI		0	0	0
Purchases		31	59	63
Sales		0	0	0
Issuances		0	0	0
Settlements		(70)	(81)	(64)
Transfer into Level 3	[1]	0	0	0
Transfer out of Level 3	[1]	0	0	0
Ending balance		42	63	81
Total gains (losses) included in net income attributable to assets still held		10	5	18
Total gains (losses) included in OCI attributable to assets still held		0	0
Other invested assets | Derivative assets | Equity index options
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		63	81	39
Total realized and unrealized gains (losses), Included in net income		18	4	43
Total realized and unrealized gains (losses), Included in OCI		0	0	0
Purchases		31	59	63
Sales		0	0	0
Issuances		0	0	0
Settlements		(70)	(81)	(64)
Transfer into Level 3	[1]	0	0	0
Transfer out of Level 3	[1]	0	0	0
Ending balance		42	63	81
Total gains (losses) included in net income attributable to assets still held		10	5	18
Total gains (losses) included in OCI attributable to assets still held		0	0
Reinsurance recoverable
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance	[2]	26	20	20
Total realized and unrealized gains (losses), Included in net income	[2]	(9)	4	(1)
Total realized and unrealized gains (losses), Included in OCI	[2]	0	0	0
Purchases	[2]	0	0	0
Sales	[2]	0	0	0
Issuances	[2]	2	2	1
Settlements	[2]	0	0	0
Transfer into Level 3	[1],[2]	0	0	0
Transfer out of Level 3	[1],[2]	0	0	0
Ending balance	[2]	19	26	20
Total gains (losses) included in net income attributable to assets still held	[2]	(9)	4	(1)
Total gains (losses) included in OCI attributable to assets still held	[2]	0	0
Fixed maturity securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		4,089	4,152	3,792
Total realized and unrealized gains (losses), Included in net income		18	32	9
Total realized and unrealized gains (losses), Included in OCI		(16)	60	346
Purchases		602	636	651
Sales		(2)	(34)	(64)
Issuances		0	0	0
Settlements		(403)	(405)	(355)
Transfer into Level 3	[1]	186	528	249
Transfer out of Level 3	[1]	(666)	(880)	(476)
Ending balance		3,808	4,089	4,152
Total gains (losses) included in net income attributable to assets still held		9	7	6
Total gains (losses) included in OCI attributable to assets still held		(29)	76
Fixed maturity securities | State and political subdivisions
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		66	102	51
Total realized and unrealized gains (losses), Included in net income		3	3	3
Total realized and unrealized gains (losses), Included in OCI		13	(11)	20
Purchases		0	0	0
Sales		0	0	0
Issuances		0	0	0
Settlements		0	(1)	0
Transfer into Level 3	[1]	0	0	28
Transfer out of Level 3	[1]	0	(27)	0
Ending balance		82	66	102
Total gains (losses) included in net income attributable to assets still held		3	3	3
Total gains (losses) included in OCI attributable to assets still held		13	(11)
Fixed maturity securities | U.S. corporate
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		2,272	2,239	1,998
Total realized and unrealized gains (losses), Included in net income		0	15	1
Total realized and unrealized gains (losses), Included in OCI		(17)	37	175
Purchases		430	403	308
Sales		0	(34)	(37)
Issuances		0	0	0
Settlements		(153)	(196)	(161)
Transfer into Level 3	[1]	138	274	129
Transfer out of Level 3	[1]	(289)	(466)	(174)
Ending balance		2,381	2,272	2,239
Total gains (losses) included in net income attributable to assets still held		0	0	(1)
Total gains (losses) included in OCI attributable to assets still held		(17)	50
Fixed maturity securities | U.S. corporate | Utilities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		842	865	643
Total realized and unrealized gains (losses), Included in net income		0	9	1
Total realized and unrealized gains (losses), Included in OCI		3	8	72
Purchases		118	76	156
Sales		0	(13)	(14)
Issuances		0	0	0
Settlements		(18)	(56)	(49)
Transfer into Level 3	[1]	18	42	72
Transfer out of Level 3	[1]	(13)	(89)	(16)
Ending balance		950	842	865
Total gains (losses) included in net income attributable to assets still held		0	0	0
Total gains (losses) included in OCI attributable to assets still held		4	14
Fixed maturity securities | U.S. corporate | Energy
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		128	129	121
Total realized and unrealized gains (losses), Included in net income		0	1	0
Total realized and unrealized gains (losses), Included in OCI		4	1	9
Purchases		50	30	17
Sales		0	(21)	(5)
Issuances		0	0	0
Settlements		(10)	(21)	(13)
Transfer into Level 3	[1]	8	22	0
Transfer out of Level 3	[1]	(104)	(13)	0
Ending balance		76	128	129
Total gains (losses) included in net income attributable to assets still held		0	0	0
Total gains (losses) included in OCI attributable to assets still held		1	(3)
Fixed maturity securities | U.S. corporate | Finance and insurance
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		607	572	534
Total realized and unrealized gains (losses), Included in net income		0	2	0
Total realized and unrealized gains (losses), Included in OCI		(18)	16	51
Purchases		233	167	50
Sales		0	0	0
Issuances		0	0	0
Settlements		(46)	(41)	(39)
Transfer into Level 3	[1]	17	0	35
Transfer out of Level 3	[1]	(108)	(109)	(59)
Ending balance		685	607	572
Total gains (losses) included in net income attributable to assets still held		0	0	0
Total gains (losses) included in OCI attributable to assets still held		(16)	19
Fixed maturity securities | U.S. corporate | Consumer-non-cyclical
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		109	94	73
Total realized and unrealized gains (losses), Included in net income		0	0	0
Total realized and unrealized gains (losses), Included in OCI		(2)	4	5
Purchases		0	8	23
Sales		0	0	(5)
Issuances		0	0	0
Settlements		(3)	(22)	(11)
Transfer into Level 3	[1]	3	25	9
Transfer out of Level 3	[1]	(3)	0	0
Ending balance		104	109	94
Total gains (losses) included in net income attributable to assets still held		0	0	0
Total gains (losses) included in OCI attributable to assets still held		(2)	4
Fixed maturity securities | U.S. corporate | Technology and communications
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		47	50	50
Total realized and unrealized gains (losses), Included in net income		0	0	0
Total realized and unrealized gains (losses), Included in OCI		(1)	3	7
Purchases		12	82	0
Sales		0	0	0
Issuances		0	0	0
Settlements		0	(1)	(1)
Transfer into Level 3	[1]	4	13	5
Transfer out of Level 3	[1]	(33)	(100)	(11)
Ending balance		29	47	50
Total gains (losses) included in net income attributable to assets still held		0	0	0
Total gains (losses) included in OCI attributable to assets still held		(1)	5
Fixed maturity securities | U.S. corporate | Industrial
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		40	40	39
Total realized and unrealized gains (losses), Included in net income		0	0	0
Total realized and unrealized gains (losses), Included in OCI		0	0	1
Purchases		17	0	0
Sales		0	0	0
Issuances		0	0	0
Settlements		(20)	0	0
Transfer into Level 3	[1]	0	0	0
Transfer out of Level 3	[1]	0	0	0
Ending balance		37	40	40
Total gains (losses) included in net income attributable to assets still held		0	0	0
Total gains (losses) included in OCI attributable to assets still held		(1)	0
Fixed maturity securities | U.S. corporate | Capital goods
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		60	102	92
Total realized and unrealized gains (losses), Included in net income		0	0	0
Total realized and unrealized gains (losses), Included in OCI		(1)	0	10
Purchases		0	0	0
Sales		0	0	0
Issuances		0	0	0
Settlements		(14)	(8)	0
Transfer into Level 3	[1]	0	11	0
Transfer out of Level 3	[1]	0	(45)	0
Ending balance		45	60	102
Total gains (losses) included in net income attributable to assets still held		0	0	0
Total gains (losses) included in OCI attributable to assets still held		(2)	1
Fixed maturity securities | U.S. corporate | Consumer-cyclical
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		150	173	211
Total realized and unrealized gains (losses), Included in net income		0	3	0
Total realized and unrealized gains (losses), Included in OCI		0	4	11
Purchases		0	15	0
Sales		0	0	(13)
Issuances		0	0	0
Settlements		(5)	(36)	(18)
Transfer into Level 3	[1]	0	47	0
Transfer out of Level 3	[1]	(8)	(56)	(18)
Ending balance		137	150	173
Total gains (losses) included in net income attributable to assets still held		0	0	(1)
Total gains (losses) included in OCI attributable to assets still held		0	6
Fixed maturity securities | U.S. corporate | Transportation
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		70	78	57
Total realized and unrealized gains (losses), Included in net income		0	0	0
Total realized and unrealized gains (losses), Included in OCI		(1)	(1)	3
Purchases		0	0	39
Sales		0	0	0
Issuances		0	0	0
Settlements		(5)	(4)	(10)
Transfer into Level 3	[1]	0	27	0
Transfer out of Level 3	[1]	0	(30)	(11)
Ending balance		64	70	78
Total gains (losses) included in net income attributable to assets still held		0	0	0
Total gains (losses) included in OCI attributable to assets still held		(1)	2
Fixed maturity securities | U.S. corporate | Other
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		219	136	178
Total realized and unrealized gains (losses), Included in net income		0	0	0
Total realized and unrealized gains (losses), Included in OCI		(1)	2	6
Purchases		0	25	23
Sales		0	0	0
Issuances		0	0	0
Settlements		(32)	(7)	(20)
Transfer into Level 3	[1]	88	87	8
Transfer out of Level 3	[1]	(20)	(24)	(59)
Ending balance		254	219	136
Total gains (losses) included in net income attributable to assets still held		0	0	0
Total gains (losses) included in OCI attributable to assets still held		1	2
Fixed maturity securities | Non-U.S. corporate
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		1,608	1,685	1,532
Total realized and unrealized gains (losses), Included in net income		15	14	5
Total realized and unrealized gains (losses), Included in OCI		(10)	33	130
Purchases		95	109	218
Sales		(2)	0	(25)
Issuances		0	0	0
Settlements		(220)	(190)	(175)
Transfer into Level 3	[1]	3	219	63
Transfer out of Level 3	[1]	(327)	(262)	(63)
Ending balance		1,162	1,608	1,685
Total gains (losses) included in net income attributable to assets still held		5	4	4
Total gains (losses) included in OCI attributable to assets still held		(23)	36
Fixed maturity securities | Non-U.S. corporate | Utilities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		352	374	404
Total realized and unrealized gains (losses), Included in net income		0	0	0
Total realized and unrealized gains (losses), Included in OCI		(5)	10	30
Purchases		30	13	30
Sales		0	0	(7)
Issuances		0	0	0
Settlements		(8)	0	(67)
Transfer into Level 3	[1]	0	28	0
Transfer out of Level 3	[1]	(24)	(73)	(16)
Ending balance		345	352	374
Total gains (losses) included in net income attributable to assets still held		0	0	0
Total gains (losses) included in OCI attributable to assets still held		(6)	9
Fixed maturity securities | Non-U.S. corporate | Energy
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		245	247	217
Total realized and unrealized gains (losses), Included in net income		0	0	(1)
Total realized and unrealized gains (losses), Included in OCI		7	(5)	19
Purchases		0	7	46
Sales		0	0	(18)
Issuances		0	0	0
Settlements		(28)	(28)	(16)
Transfer into Level 3	[1]	0	24	0
Transfer out of Level 3	[1]	(79)	0	0
Ending balance		145	245	247
Total gains (losses) included in net income attributable to assets still held		0	0	0
Total gains (losses) included in OCI attributable to assets still held		3	(5)
Fixed maturity securities | Non-U.S. corporate | Finance and insurance
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		305	234	171
Total realized and unrealized gains (losses), Included in net income		3	4	4
Total realized and unrealized gains (losses), Included in OCI		(1)	17	23
Purchases		1	15	7
Sales		(2)	0	0
Issuances		0	0	0
Settlements		(62)	(10)	(16)
Transfer into Level 3	[1]	0	77	54
Transfer out of Level 3	[1]	(84)	(32)	(9)
Ending balance		160	305	234
Total gains (losses) included in net income attributable to assets still held		5	4	4
Total gains (losses) included in OCI attributable to assets still held		(14)	17
Fixed maturity securities | Non-U.S. corporate | Consumer-non-cyclical
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		67	59	106
Total realized and unrealized gains (losses), Included in net income		1	0	2
Total realized and unrealized gains (losses), Included in OCI		(2)	3	5
Purchases		8	20	1
Sales		0	0	0
Issuances		0	0	0
Settlements		(14)	0	(55)
Transfer into Level 3	[1]	3	1	0
Transfer out of Level 3	[1]	0	(16)	0
Ending balance		63	67	59
Total gains (losses) included in net income attributable to assets still held		0	0	0
Total gains (losses) included in OCI attributable to assets still held		(2)	2
Fixed maturity securities | Non-U.S. corporate | Technology and communications
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		28	28	26
Total realized and unrealized gains (losses), Included in net income		0	0	0
Total realized and unrealized gains (losses), Included in OCI		0	0	2
Purchases		0	0	0
Sales		0	0	0
Issuances		0	0	0
Settlements		0	0	0
Transfer into Level 3	[1]	0	0	0
Transfer out of Level 3	[1]	0	0	0
Ending balance		28	28	28
Total gains (losses) included in net income attributable to assets still held		0	0	0
Total gains (losses) included in OCI attributable to assets still held		(1)	1
Fixed maturity securities | Non-U.S. corporate | Industrial
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		95	104	61
Total realized and unrealized gains (losses), Included in net income		2	0	0
Total realized and unrealized gains (losses), Included in OCI		(4)	4	5
Purchases		14	0	38
Sales		0	0	0
Issuances		0	0	0
Settlements		(14)	(5)	0
Transfer into Level 3	[1]	0	0	0
Transfer out of Level 3	[1]	0	(8)	0
Ending balance		93	95	104
Total gains (losses) included in net income attributable to assets still held		0	0	0
Total gains (losses) included in OCI attributable to assets still held		(2)	3
Fixed maturity securities | Non-U.S. corporate | Capital goods
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		178	161	173
Total realized and unrealized gains (losses), Included in net income		0	1	0
Total realized and unrealized gains (losses), Included in OCI		1	1	12
Purchases		25	20	10
Sales		0	0	0
Issuances		0	0	0
Settlements		0	(39)	(16)
Transfer into Level 3	[1]	0	34	3
Transfer out of Level 3	[1]	(31)	0	(21)
Ending balance		173	178	161
Total gains (losses) included in net income attributable to assets still held		0	0	0
Total gains (losses) included in OCI attributable to assets still held		0	1
Fixed maturity securities | Non-U.S. corporate | Consumer-cyclical
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		146	147	122
Total realized and unrealized gains (losses), Included in net income		0	0	0
Total realized and unrealized gains (losses), Included in OCI		0	3	12
Purchases		17	21	16
Sales		0	0	0
Issuances		0	0	0
Settlements		0	(26)	(3)
Transfer into Level 3	[1]	0	32	0
Transfer out of Level 3	[1]	(87)	(31)	0
Ending balance		76	146	147
Total gains (losses) included in net income attributable to assets still held		0	0	0
Total gains (losses) included in OCI attributable to assets still held		0	2
Fixed maturity securities | Non-U.S. corporate | Transportation
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		109	191	171
Total realized and unrealized gains (losses), Included in net income		3	0	0
Total realized and unrealized gains (losses), Included in OCI		(3)	1	10
Purchases		0	7	27
Sales		0	0	0
Issuances		0	0	0
Settlements		(49)	(10)	0
Transfer into Level 3	[1]	0	22	0
Transfer out of Level 3	[1]	(7)	(102)	(17)
Ending balance		53	109	191
Total gains (losses) included in net income attributable to assets still held		0	0	0
Total gains (losses) included in OCI attributable to assets still held		0	4
Fixed maturity securities | Non-U.S. corporate | Other
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		83	140	81
Total realized and unrealized gains (losses), Included in net income		6	9	0
Total realized and unrealized gains (losses), Included in OCI		(3)	(1)	12
Purchases		0	6	43
Sales		0	0	0
Issuances		0	0	0
Settlements		(45)	(72)	(2)
Transfer into Level 3	[1]	0	1	6
Transfer out of Level 3	[1]	(15)	0	0
Ending balance		26	83	140
Total gains (losses) included in net income attributable to assets still held		0	0	0
Total gains (losses) included in OCI attributable to assets still held		(1)	2
Fixed maturity securities | Residential mortgage-backed
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		14	27	35
Total realized and unrealized gains (losses), Included in net income		0	0	0
Total realized and unrealized gains (losses), Included in OCI		0	(1)	1
Purchases		5	0	0
Sales		0	0	(2)
Issuances		0	0	0
Settlements		(2)	(1)	(1)
Transfer into Level 3	[1]	10	4	0
Transfer out of Level 3	[1]	0	(15)	(6)
Ending balance		27	14	27
Total gains (losses) included in net income attributable to assets still held		0	0	0
Total gains (losses) included in OCI attributable to assets still held		0	0
Fixed maturity securities | Commercial mortgage-backed
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		20	6	95
Total realized and unrealized gains (losses), Included in net income		0	0	0
Total realized and unrealized gains (losses), Included in OCI		(2)	1	17
Purchases		1	0	3
Sales		0	0	0
Issuances		0	0	0
Settlements		(3)	0	0
Transfer into Level 3	[1]	0	20	1
Transfer out of Level 3	[1]	0	(7)	(110)
Ending balance		16	20	6
Total gains (losses) included in net income attributable to assets still held		1	0	0
Total gains (losses) included in OCI attributable to assets still held		(2)	1
Fixed maturity securities | Other asset-backed
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		109	93	81
Total realized and unrealized gains (losses), Included in net income		0	0	0
Total realized and unrealized gains (losses), Included in OCI		0	1	3
Purchases		69	124	122
Sales		0	0	0
Issuances		0	0	0
Settlements		(25)	(16)	(18)
Transfer into Level 3	[1]	35	10	28
Transfer out of Level 3	[1]	(50)	(103)	(123)
Ending balance		138	109	93
Total gains (losses) included in net income attributable to assets still held		0	0	0
Total gains (losses) included in OCI attributable to assets still held		0	0
Fixed maturity securities | Non-U.S. government
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		0	0
Total realized and unrealized gains (losses), Included in net income		0	0
Total realized and unrealized gains (losses), Included in OCI		0	0
Purchases		2	0
Sales		0	0
Issuances		0	0
Settlements		0	(1)
Transfer into Level 3	[1]	0	1
Transfer out of Level 3	[1]	0	0
Ending balance		2	0	0
Total gains (losses) included in net income attributable to assets still held		0	0
Total gains (losses) included in OCI attributable to assets still held		0	0
Equity Securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		51	51	58
Total realized and unrealized gains (losses), Included in net income		0	0	0
Total realized and unrealized gains (losses), Included in OCI		0	0	0
Purchases		0	6	2
Sales		(9)	(7)	(9)
Issuances		0	0	0
Settlements		(5)	0	0
Transfer into Level 3	[1]	0	1	0
Transfer out of Level 3	[1]	0	0	0
Ending balance		37	51	51
Total gains (losses) included in net income attributable to assets still held		0	0	$ 0
Total gains (losses) included in OCI attributable to assets still held		$ 0	$ 0
[1]	The transfers into and out of Level 3 for fixed maturity securities were related to changes in the primary pricing source and changes in the observability of external information used in determining the fair value, such as external ratings or credit spreads, as well as changes in the industry sectors assigned to specific securities.
[2]	Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities.

Gains and Losses Included in Ne

Gains and Losses Included in Net Income (Loss) from Assets Measured at Fair Value (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Fair value of financial instruments [Abstract]
Total realized and unrealized gains (losses) included in net income, assets	$ 27	$ 40	$ 51
Total gains (losses) included in net income attributable to assets still held, assets	10	16	23
Net Investment Income
Fair value of financial instruments [Abstract]
Total realized and unrealized gains (losses) included in net income, assets	19	32	10
Total gains (losses) included in net income attributable to assets still held, assets	9	7	6
Net investment gains (losses)
Fair value of financial instruments [Abstract]
Total realized and unrealized gains (losses) included in net income, assets	8	8	41
Total gains (losses) included in net income attributable to assets still held, assets	$ 1	$ 9	$ 17

Summary of Significant Unobserv

Summary of Significant Unobservable Inputs Used for Fair Value Measurements Classified As Level 3 (Detail) $ in Millions		12 Months Ended
		Dec. 31, 2021USD ($)bps		Dec. 31, 2020USD ($)
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Derivative liabilities, fair value | $		$ 616		$ 830
Fixed maturity securities available-for-sale, at fair value | $		60,480		63,495
Derivative assets, fair value | $		433		600
Policyholder account balances
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Derivative liabilities, fair value | $		590		804
Policyholder account balances | GMWB embedded derivatives
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Derivative liabilities, fair value | $		271		379
Policyholder account balances | Fixed index annuity embedded derivatives
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Derivative liabilities, fair value | $		294		399
Policyholder account balances | Indexed universal life embedded derivatives
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Derivative liabilities, fair value | $		25		26
Level 3
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fixed maturity securities available-for-sale, at fair value | $		$ 3,808		4,089
Level 3 | Other invested assets | Equity index options
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Discounted cash flows
Derivative assets, fair value | $		$ 42
Fair value input, equity index volatility, lower limit		6.00%
Fair value input, equity index volatility, upper limit		50.00%
Fair value input, equity index volatility, weighted-average	[1]	25.00%
Level 3 | Policyholder account balances
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Derivative liabilities, fair value | $		$ 590		804
Level 3 | Policyholder account balances | GMWB embedded derivatives
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique	[2]	Stochastic cash flow model
Derivative liabilities, fair value | $		$ 271	[2]	379
Fair value, withdrawal utilization rate, lower limit		60.00%
Fair value, withdrawal utilization rate, upper limit		89.00%
Fair value, lapse rate, lower limit		2.00%
Fair value, lapse rate, upper limit		9.00%
Fair value input, credit spreads, lower limit		20
Fair value input, credit spreads, upper limit		83
Fair value input, credit spreads, weighted-average	[3]	66
Fair value input, equity index volatility, lower limit	[2]	15.00%
Fair value input, equity index volatility, upper limit	[2]	27.00%
Fair value, withdrawal utilization rate, weighted-average	[3]	76.00%
Fair value, lapse rate, weighted-average	[3]	4.00%
Fair value input, equity index volatility, weighted-average	[2],[3]	22.00%
Level 3 | Policyholder account balances | Fixed index annuity embedded derivatives
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Option budget method
Derivative liabilities, fair value | $		$ 294		399
Fair value, expected future interest credited, lower limit		0.00%
Fair value, expected future interest credited, upper limit		3.00%
Fair value, expected future interest credited, weighted-average	[3]	1.00%
Level 3 | Policyholder account balances | Indexed universal life embedded derivatives
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Option budget method
Derivative liabilities, fair value | $		$ 25		$ 26
Fair value, expected future interest credited, lower limit		3.00%
Fair value, expected future interest credited, upper limit		11.00%
Fair value, expected future interest credited, weighted-average	[3]	5.00%
Internal Models | Level 3 | U.S. corporate
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Internal models
Fixed maturity securities available-for-sale, at fair value | $		$ 2,227
Fair value input, credit spreads, lower limit		47
Fair value input, credit spreads, upper limit		217
Fair value input, credit spreads, weighted-average	[1]	130
Internal Models | Level 3 | U.S. corporate | Utilities
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Internal models
Fixed maturity securities available-for-sale, at fair value | $		$ 916
Fair value input, credit spreads, lower limit		59
Fair value input, credit spreads, upper limit		202
Fair value input, credit spreads, weighted-average	[1]	138
Internal Models | Level 3 | U.S. corporate | Energy
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Internal models
Fixed maturity securities available-for-sale, at fair value | $		$ 61
Fair value input, credit spreads, lower limit		95
Fair value input, credit spreads, upper limit		217
Fair value input, credit spreads, weighted-average	[1]	149
Internal Models | Level 3 | U.S. corporate | Finance and insurance
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Internal models
Fixed maturity securities available-for-sale, at fair value | $		$ 679
Fair value input, credit spreads, lower limit		50
Fair value input, credit spreads, upper limit		184
Fair value input, credit spreads, weighted-average	[1]	131
Internal Models | Level 3 | U.S. corporate | Consumer-non-cyclical
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Internal models
Fixed maturity securities available-for-sale, at fair value | $		$ 104
Fair value input, credit spreads, lower limit		55
Fair value input, credit spreads, upper limit		217
Fair value input, credit spreads, weighted-average	[1]	121
Internal Models | Level 3 | U.S. corporate | Technology and communications
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Internal models
Fixed maturity securities available-for-sale, at fair value | $		$ 29
Fair value input, credit spreads, lower limit		80
Fair value input, credit spreads, upper limit		158
Fair value input, credit spreads, weighted-average	[1]	131
Internal Models | Level 3 | U.S. corporate | Industrial
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Internal models
Fixed maturity securities available-for-sale, at fair value | $		$ 37
Fair value input, credit spreads, lower limit		91
Fair value input, credit spreads, upper limit		171
Fair value input, credit spreads, weighted-average	[1]	123
Internal Models | Level 3 | U.S. corporate | Capital goods
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Internal models
Fixed maturity securities available-for-sale, at fair value | $		$ 45
Fair value input, credit spreads, lower limit		67
Fair value input, credit spreads, upper limit		175
Fair value input, credit spreads, weighted-average	[1]	133
Internal Models | Level 3 | U.S. corporate | Consumer-cyclical
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Internal models
Fixed maturity securities available-for-sale, at fair value | $		$ 137
Fair value input, credit spreads, lower limit		87
Fair value input, credit spreads, upper limit		165
Fair value input, credit spreads, weighted-average	[1]	125
Internal Models | Level 3 | U.S. corporate | Transportation
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Internal models
Fixed maturity securities available-for-sale, at fair value | $		$ 53
Fair value input, credit spreads, lower limit		47
Fair value input, credit spreads, upper limit		139
Fair value input, credit spreads, weighted-average	[1]	91
Internal Models | Level 3 | U.S. corporate | Other
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Internal models
Fixed maturity securities available-for-sale, at fair value | $		$ 166
Fair value input, credit spreads, lower limit		78
Fair value input, credit spreads, upper limit		163
Fair value input, credit spreads, weighted-average	[1]	95
Internal Models | Level 3 | Non-U.S. corporate
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Internal models
Fixed maturity securities available-for-sale, at fair value | $		$ 1,134
Fair value input, credit spreads, lower limit		55
Fair value input, credit spreads, upper limit		202
Fair value input, credit spreads, weighted-average	[1]	111
Internal Models | Level 3 | Non-U.S. corporate | Utilities
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Internal models
Fixed maturity securities available-for-sale, at fair value | $		$ 344
Fair value input, credit spreads, lower limit		70
Fair value input, credit spreads, upper limit		202
Fair value input, credit spreads, weighted-average	[1]	118
Internal Models | Level 3 | Non-U.S. corporate | Energy
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Internal models
Fixed maturity securities available-for-sale, at fair value | $		$ 135
Fair value input, credit spreads, lower limit		76
Fair value input, credit spreads, upper limit		171
Fair value input, credit spreads, weighted-average	[1]	120
Internal Models | Level 3 | Non-U.S. corporate | Finance and insurance
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Internal models
Fixed maturity securities available-for-sale, at fair value | $		$ 160
Fair value input, credit spreads, lower limit		71
Fair value input, credit spreads, upper limit		128
Fair value input, credit spreads, weighted-average	[1]	98
Internal Models | Level 3 | Non-U.S. corporate | Consumer-non-cyclical
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Internal models
Fixed maturity securities available-for-sale, at fair value | $		$ 61
Fair value input, credit spreads, lower limit		55
Fair value input, credit spreads, upper limit		140
Fair value input, credit spreads, weighted-average	[1]	94
Internal Models | Level 3 | Non-U.S. corporate | Technology and communications
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Internal models
Fixed maturity securities available-for-sale, at fair value | $		$ 28
Fair value input, credit spreads, lower limit		95
Fair value input, credit spreads, upper limit		114
Fair value input, credit spreads, weighted-average	[1]	108
Internal Models | Level 3 | Non-U.S. corporate | Industrial
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Internal models
Fixed maturity securities available-for-sale, at fair value | $		$ 93
Fair value input, credit spreads, lower limit		67
Fair value input, credit spreads, upper limit		161
Fair value input, credit spreads, weighted-average	[1]	113
Internal Models | Level 3 | Non-U.S. corporate | Capital goods
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Internal models
Fixed maturity securities available-for-sale, at fair value | $		$ 173
Fair value input, credit spreads, lower limit		55
Fair value input, credit spreads, upper limit		202
Fair value input, credit spreads, weighted-average	[1]	115
Internal Models | Level 3 | Non-U.S. corporate | Consumer-cyclical
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Internal models
Fixed maturity securities available-for-sale, at fair value | $		$ 61
Fair value input, credit spreads, lower limit		91
Fair value input, credit spreads, upper limit		171
Fair value input, credit spreads, weighted-average	[1]	121
Internal Models | Level 3 | Non-U.S. corporate | Transportation
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Internal models
Fixed maturity securities available-for-sale, at fair value | $		$ 53
Fair value input, credit spreads, lower limit		55
Fair value input, credit spreads, upper limit		171
Fair value input, credit spreads, weighted-average	[1]	84
Internal Models | Level 3 | Non-U.S. corporate | Other
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Internal models
Fixed maturity securities available-for-sale, at fair value | $		$ 26
Fair value input, credit spreads, lower limit		64
Fair value input, credit spreads, upper limit		120
Fair value input, credit spreads, weighted-average	[1]	102
[1]	Unobservable inputs weighted by the relative fair value of the associated instrument for fixed maturity securities and by notional for derivative assets.
[2]	Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. The unobservable inputs associated with GMWB embedded derivatives are not interrelated and therefore, a directional change in one input will not affect the other inputs.
[3]	Unobservable inputs weighted by the policyholder account balances associated with the instrument.

Liabilities by Class of Instrum

Liabilities by Class of Instrument that are Measured at Fair Value on Recurring Basis (Detail) - USD ($) $ in Millions	Dec. 31, 2021		Dec. 31, 2020
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value	$ 616		$ 830
Total liabilities	616		830
Other liabilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value	26		26
Other liabilities | Interest rate swaps
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value	26		23
Other liabilities | Foreign currency swaps
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value			2
Other liabilities | Other foreign currency contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value			1
Policyholder account balances
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value	590		804
Policyholder account balances | GMWB embedded derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value	271		379
Policyholder account balances | Fixed index annuity embedded derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value	294		399
Policyholder account balances | Indexed universal life embedded derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value	25		26
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities	0		0
Level 1 | Other liabilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value	0		0
Level 1 | Other liabilities | Interest rate swaps
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value	0		0
Level 1 | Other liabilities | Foreign currency swaps
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value			0
Level 1 | Other liabilities | Other foreign currency contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value			0
Level 1 | Policyholder account balances
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value	0		0
Level 1 | Policyholder account balances | GMWB embedded derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value	0		0
Level 1 | Policyholder account balances | Fixed index annuity embedded derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value	0		0
Level 1 | Policyholder account balances | Indexed universal life embedded derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value	0		0
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities	26		26
Level 2 | Other liabilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value	26		26
Level 2 | Other liabilities | Interest rate swaps
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value	26		23
Level 2 | Other liabilities | Foreign currency swaps
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value			2
Level 2 | Other liabilities | Other foreign currency contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value			1
Level 2 | Policyholder account balances
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value	0		0
Level 2 | Policyholder account balances | GMWB embedded derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value	0		0
Level 2 | Policyholder account balances | Fixed index annuity embedded derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value	0		0
Level 2 | Policyholder account balances | Indexed universal life embedded derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value	0		0
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities	590		804
Level 3 | Other liabilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value	0		0
Level 3 | Other liabilities | Interest rate swaps
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value	0		0
Level 3 | Other liabilities | Foreign currency swaps
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value			0
Level 3 | Other liabilities | Other foreign currency contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value			0
Level 3 | Policyholder account balances
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value	590		804
Level 3 | Policyholder account balances | GMWB embedded derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value	271	[1]	379
Level 3 | Policyholder account balances | Fixed index annuity embedded derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value	294		399
Level 3 | Policyholder account balances | Indexed universal life embedded derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value	$ 25		$ 26
[1]	Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. The unobservable inputs associated with GMWB embedded derivatives are not interrelated and therefore, a directional change in one input will not affect the other inputs.

Liabilities Measured at Fair Va

Liabilities Measured at Fair Value on Recurring Basis and Utilized Significant Unobservable (Level 3) Inputs to Determine Fair Value (Detail) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		$ 804	$ 794	$ 738
Total realized and unrealized (gains) losses included in net (income)		(125)	66	47
Total realized and unrealized (gains) losses included in OCI		0	0	0
Purchases		0	0	0
Sales		0	0	0
Issuances		48	48	36
Settlements		(136)	(104)	(27)
Transfer into Level 3		0	0	0
Transfer out of Level 3		(1)	0	0
Ending balance		590	804	794
Total (gains) losses included in net (income) attributable to liabilities still held		(119)	72	52
Total (gains) losses included in OCI attributable to liabilities still held		0	0
Policyholder account balances
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		804	794	738
Total realized and unrealized (gains) losses included in net (income)		(125)	66	47
Total realized and unrealized (gains) losses included in OCI		0	0	0
Purchases		0	0	0
Sales		0	0	0
Issuances		48	48	36
Settlements		(136)	(104)	(27)
Transfer into Level 3		0	0	0
Transfer out of Level 3		(1)	0	0
Ending balance		590	804	794
Total (gains) losses included in net (income) attributable to liabilities still held		(119)	72	52
Total (gains) losses included in OCI attributable to liabilities still held		0	0
Policyholder account balances | GMWB embedded derivatives
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance	[1]	379	323	337
Total realized and unrealized (gains) losses included in net (income)	[1]	(133)	32	(39)
Total realized and unrealized (gains) losses included in OCI	[1]	0	0	0
Purchases	[1]	0	0	0
Sales	[1]	0	0	0
Issuances	[1]	25	24	25
Settlements	[1]	0	0	0
Transfer into Level 3	[1]	0	0	0
Transfer out of Level 3	[1]	0	0	0
Ending balance	[1]	271	379	323
Total (gains) losses included in net (income) attributable to liabilities still held	[1]	(127)	38	(34)
Total (gains) losses included in OCI attributable to liabilities still held	[1]	0	0
Policyholder account balances | Fixed index annuity embedded derivatives
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		399	452	389
Total realized and unrealized (gains) losses included in net (income)		32	51	90
Total realized and unrealized (gains) losses included in OCI		0	0	0
Purchases		0	0	0
Sales		0	0	0
Issuances		0	0	0
Settlements		(136)	(104)	(27)
Transfer into Level 3		0	0	0
Transfer out of Level 3		(1)	0	0
Ending balance		294	399	452
Total (gains) losses included in net (income) attributable to liabilities still held		32	51	90
Total (gains) losses included in OCI attributable to liabilities still held		0	0
Policyholder account balances | Indexed universal life embedded derivatives
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		26	19	12
Total realized and unrealized (gains) losses included in net (income)		(24)	(17)	(4)
Total realized and unrealized (gains) losses included in OCI		0	0	0
Purchases		0	0	0
Sales		0	0	0
Issuances		23	24	11
Settlements		0	0	0
Transfer into Level 3		0	0	0
Transfer out of Level 3		0	0	0
Ending balance		25	26	19
Total (gains) losses included in net (income) attributable to liabilities still held		(24)	(17)	$ (4)
Total (gains) losses included in OCI attributable to liabilities still held		$ 0	$ 0
[1]	Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. The unobservable inputs associated with GMWB embedded derivatives are not interrelated and therefore, a directional change in one input will not affect the other inputs.

Gains and Losses Included in _2

Gains and Losses Included in Net (Income) from Liabilities Measured at Fair Value (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Total realized and unrealized (gains) losses included in net (income), liabilities	$ (125)	$ 66	$ 47
Total (gains) losses included in net (income) attributable to liabilities still held, liabilities	(119)	72	52
Net Investment Income
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Total realized and unrealized (gains) losses included in net (income), liabilities	0	0	0
Total (gains) losses included in net (income) attributable to liabilities still held, liabilities	0	0	0
Net investment (gains) losses
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Total realized and unrealized (gains) losses included in net (income), liabilities	(125)	66	47
Total (gains) losses included in net (income) attributable to liabilities still held, liabilities	$ (119)	$ 72	$ 52

Fair Value Financial Instrument

Fair Value Financial Instruments Not Required to Be Carried at Fair Value (Detail) - USD ($) $ in Millions		Dec. 31, 2021	Dec. 31, 2020
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Commercial mortgage loans		$ 6,830	$ 6,743
Liabilities:
Long-term borrowings		1,899	3,403
Off-balance sheet risk		1,185	1,090
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Commercial mortgage loans		0	0
Bank loan investments		0	0
Liabilities:
Long-term borrowings	[1]	0	0
Investment contracts		0	0
Level 1 | Commitments to fund limited partnerships
Liabilities:
Off-balance sheet risk		0	0
Level 1 | Commitments to fund bank loan investments
Liabilities:
Off-balance sheet risk		0	0
Level 1 | Ordinary course of business lending commitments
Liabilities:
Off-balance sheet risk		0	0
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Commercial mortgage loans		0	0
Bank loan investments		0	0
Liabilities:
Long-term borrowings	[1]	1,767	3,090
Investment contracts		0	0
Level 2 | Commitments to fund limited partnerships
Liabilities:
Off-balance sheet risk		0	0
Level 2 | Commitments to fund bank loan investments
Liabilities:
Off-balance sheet risk		0	0
Level 2 | Ordinary course of business lending commitments
Liabilities:
Off-balance sheet risk		0	0
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Commercial mortgage loans		7,224	7,145
Bank loan investments		370	354
Liabilities:
Long-term borrowings	[1]	0	0
Investment contracts		9,352	11,353
Level 3 | Commitments to fund limited partnerships
Liabilities:
Off-balance sheet risk		0	0
Level 3 | Commitments to fund bank loan investments
Liabilities:
Off-balance sheet risk		0	0
Level 3 | Ordinary course of business lending commitments
Liabilities:
Off-balance sheet risk		0	0
Carrying value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Commercial mortgage loans		6,830	6,743
Bank loan investments		363	344
Liabilities:
Long-term borrowings	[1]	1,899	3,403
Investment contracts		8,657	10,276
Carrying value | Commitments to fund limited partnerships
Liabilities:
Off-balance sheet risk		0	0
Carrying value | Commitments to fund bank loan investments
Liabilities:
Off-balance sheet risk		0	0
Carrying value | Ordinary course of business lending commitments
Liabilities:
Off-balance sheet risk		0	0
Fair value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Commercial mortgage loans		7,224	7,145
Bank loan investments		370	354
Liabilities:
Long-term borrowings	[1]	1,767	3,090
Investment contracts		9,352	11,353
Fair value | Commitments to fund limited partnerships
Liabilities:
Off-balance sheet risk		0	0
Fair value | Commitments to fund bank loan investments
Liabilities:
Off-balance sheet risk		0	0
Fair value | Ordinary course of business lending commitments
Liabilities:
Off-balance sheet risk		0	0
Notional amount | Commitments to fund limited partnerships
Liabilities:
Off-balance sheet risk		1,185	1,090
Notional amount | Commitments to fund bank loan investments
Liabilities:
Off-balance sheet risk		141	32
Notional amount | Ordinary course of business lending commitments
Liabilities:
Off-balance sheet risk		$ 125	$ 117
[1]	See note 12 for additional information related to borrowings.

Summary of carrying value of li

Summary of carrying value of limited partnerships and commitments to fund (Detail) - USD ($) $ in Millions		Dec. 31, 2021	Dec. 31, 2020
Schedule of Carrying Value of Limited Partnerships and Commitments To Fund [Line Items]
Limited partnerships, carrying value		$ 1,900	$ 1,049
Off-balance sheet risk		1,185	1,090
Assets Measured Using Net Asset Value | Limited Partnerships Private Equity Funds
Schedule of Carrying Value of Limited Partnerships and Commitments To Fund [Line Items]
Limited partnerships, carrying value	[1]	1,338	749
Off-balance sheet risk	[1]	951	859
Assets Measured Using Net Asset Value | Limited Partnerships Real Estate Funds
Schedule of Carrying Value of Limited Partnerships and Commitments To Fund [Line Items]
Limited partnerships, carrying value	[2]	67	39
Off-balance sheet risk	[2]	101	66
Assets Measured Using Net Asset Value | Limited Partnerships Infrastructure Funds
Schedule of Carrying Value of Limited Partnerships and Commitments To Fund [Line Items]
Limited partnerships, carrying value	[3]	57	47
Off-balance sheet risk	[3]	13	22
Assets Measured Using Net Asset Value | Limited Partnerships
Schedule of Carrying Value of Limited Partnerships and Commitments To Fund [Line Items]
Limited partnerships, carrying value		1,462	835
Off-balance sheet risk		1,065	947
Accounted For Under Equity method of Accounting | Limited Partnerships
Schedule of Carrying Value of Limited Partnerships and Commitments To Fund [Line Items]
Limited partnerships, carrying value		437	213
Off-balance sheet risk		120	143
Low-Income Housing Tax Credits | Limited Partnerships
Schedule of Carrying Value of Limited Partnerships and Commitments To Fund [Line Items]
Limited partnerships, carrying value	[4]	1	1
Off-balance sheet risk	[4]	$ 0	$ 0
[1]	This class employs various investment strategies such as leveraged buyout, growth equity, venture capital and mezzanine financing, generally investing in debt or equity positions directly in companies or assets of various sizes across diverse industries globally, primarily concentrated in North America.
[2]	This class invests in real estate in North America, Europe and Asia via direct property ownership, joint ventures, mortgages and investments in debt and equity instruments.
[3]	This class invests in the debt or equity of cash flow generating assets diversified across a variety of industries, including transportation, energy infrastructure, renewable power, social infrastructure, power generation, water, telecommunications and other regulated entities globally.
[4]	Relates to limited partnership investments that invest in affordable housing projects that qualify for the Low-Income Housing Tax Credit and are accounted for using the proportional amortization method.

Insurance Subsidiary Financia_3

Insurance Subsidiary Financial Information and Regulatory Matters - Additional Information (Detail) € in Millions, $ in Millions	Dec. 31, 2021USD ($)	Dec. 31, 2020USD ($)	Feb. 01, 2020USD ($)	Dec. 31, 2019USD ($)	Dec. 31, 2021USD ($)	Sep. 30, 2021	Jun. 30, 2021USD ($)	Jun. 30, 2021EUR (€)	Mar. 31, 2021USD ($)	Dec. 31, 2020USD ($)	Dec. 31, 2021USD ($)Ratio	Dec. 31, 2020USD ($)	Dec. 31, 2019USD ($)
Statutory Accounting Practices [Line Items]
Amount of dividends our subsidiaries could pay in 2021 without obtaining regulatory approval	$ 70				$ 70						$ 70
Statutory contingency reserve, annual additions, percentage of earned premiums, minimum	50.00%				50.00%						50.00%
Minimum loss ratio requirement to hold statutory contingency reserve	35.00%				35.00%						35.00%
Period of time when statutory contingency reserve has to be held, in years											10 years
Statutory contingency reserve	$ 3,000	$ 2,500			$ 3,000					$ 2,500	$ 3,000	$ 2,500
Moody's, Baa1 Rating
Statutory Accounting Practices [Line Items]
Credit rating												Baa1
PMIERs Amended Stipulation For Non Performing Loans Relating To Government Sponsored Enterprises | Fitch, BBB+ Rating
Statutory Accounting Practices [Line Items]
Credit rating										BBB+
Settlement Of Amounts In Relation To Underwriting Losses On A Products Sold By A Distributor | Genworth Financial International Holdings | Gurantee Agreement
Statutory Accounting Practices [Line Items]
Loss Contingency Accrual, Payments							$ 18	€ 15
Forbearance Plan | Payment Not Made On After Thirty First Of March Two Thousand And Twenty And On Or Before Thirty First Of January First Two Thousand And Twenty One | PMIERs Amended Stipulation For Non Performing Loans Relating To Government Sponsored Enterprises
Statutory Accounting Practices [Line Items]
Multiplier used for assessing risk based factor for non performing loans	0.30
Forbearance Plan | Regulation Applicable For Not More Than Three Months | PMIERs Amended Stipulation For Non Performing Loans Relating To Government Sponsored Enterprises
Statutory Accounting Practices [Line Items]
Multiplier used for assessing risk based factor for non performing loans	0.30
U.S. Mortgage Insurance
Statutory Accounting Practices [Line Items]
Maximum risk-to-capital ratio | Ratio											25
Percentage of available assets to PMIERs required assets	165.00%	137.00%
Net assets required	$ 3,074	$ 3,359			3,074					$ 3,359	$ 3,074	$ 3,359
Net assets in excess of the statutory requirement	2,003	1,229			2,003					1,229	2,003	1,229
Cumulative benefit in respect of asset required base	390	1,046			390					1,046	390	1,046
Net assets actually available	5,077	4,588			5,077					4,588	5,077	4,588
Guarantees provided to third parties
Statutory Accounting Practices [Line Items]
Maximum potential amount of future obligation	10	4			10					4	10	4
Mexico Guarantee
Statutory Accounting Practices [Line Items]
Maximum potential amount of future obligation	175				175						175
Long-term Care Insurance
Statutory Accounting Practices [Line Items]
Statutory Reserve including additional reserve	572	504			572					504	572	504
Genworth European Mortgage Insurance Business
Statutory Accounting Practices [Line Items]
Maximum potential amount of future obligation	1,100				1,100						1,100
Variable Annuity
Statutory Accounting Practices [Line Items]
Statutory Reserve including additional reserve	35	35			35					35	35	35
Domestic subsidiaries
Statutory Accounting Practices [Line Items]
Amount of dividends our subsidiaries could pay in 2021 without obtaining regulatory approval	70				70						70
Combined statutory capital and surplus	7,384	6,204			7,384					6,204	7,384	6,204
Reinsurance returned capital value											104
Domestic subsidiaries | Captive life reinsurance subsidiaries
Statutory Accounting Practices [Line Items]
Combined statutory capital and surplus	$ 98	$ 106			$ 98					$ 106	98	106
Domestic subsidiaries | Life insurance
Statutory Accounting Practices [Line Items]
Statutory Accounting Practices, Permitted Practice, Amount											$ 0	$ 0
Consolidated RBC ratio	289.00%	229.00%			289.00%					229.00%	289.00%	229.00%
Statutory Reserve including additional reserve	$ 1,000				$ 1,000						$ 1,000
Domestic subsidiaries | River Lake VIII
Statutory Accounting Practices [Line Items]
Contributed surplus	29			$ 20
Domestic subsidiaries | River Lake VII
Statutory Accounting Practices [Line Items]
Contributed surplus	37
Domestic subsidiaries | Rivermont I
Statutory Accounting Practices [Line Items]
Contributed surplus			$ 198
Domestic insurance subsidiaries | Extraordinary Dividend
Statutory Accounting Practices [Line Items]
Dividends from subsidiaries											0
Insurance Subsidiaries | Universal and term universal life insurance contracts | Virginia and Delaware
Statutory Accounting Practices [Line Items]
Additional statutory reserves	231	$ 232		$ 54	231					$ 232	231	$ 232	$ 54
Insurance Subsidiary | Long-term Care Insurance | NEW YORK
Statutory Accounting Practices [Line Items]
Additional statutory reserve	68	100			68					100	68	100
Statutory Reserve including additional reserve	$ 607	$ 539			$ 607					$ 539	$ 607	$ 539
Genworth Mortgage Insurance Corporation (GMICO) | PMIERs Amended Stipulation For Non Performing Loans Relating To Government Sponsored Enterprises
Statutory Accounting Practices [Line Items]
Percentage of minimum required assets buffers					115.00%	150.00%
Genworth Mortgage Insurance Corporation (GMICO) | PMIERs Amended Stipulation For Non Performing Loans Relating To Government Sponsored Enterprises | Twelve Months Ended Thirty First December Two Thousand And Twenty One
Statutory Accounting Practices [Line Items]
Percentage of minimum required assets to be maintained as per statutory need		115.00%								115.00%		115.00%
Genworth Mortgage Insurance Corporation (GMICO) | PMIERs Amended Stipulation For Non Performing Loans Relating To Government Sponsored Enterprises | Twelve Months Ended Thirty First December Two Thousand And Twenty Two
Statutory Accounting Practices [Line Items]
Percentage of minimum required assets to be maintained as per statutory need		120.00%								120.00%		120.00%
Genworth Mortgage Insurance Corporation (GMICO) | PMIERs Amended Stipulation For Non Performing Loans Relating To Government Sponsored Enterprises | Twelve Months Ended Thirty First December Two Thousand And Twenty Three
Statutory Accounting Practices [Line Items]
Percentage of minimum required assets to be maintained as per statutory need		125.00%								125.00%		125.00%
Genworth Mortgage Insurance Corporation (GMICO) | U.S. Mortgage Insurance subsidiaries
Statutory Accounting Practices [Line Items]
Risk-to-capital ratio	12.3				12.3						12.3
Genworth Mortgage Holdings, Inc. | PMIERs Amended Stipulation For Non Performing Loans Relating To Government Sponsored Enterprises
Statutory Accounting Practices [Line Items]
Restricted Cash	$ 300				$ 300						$ 300
Genworth Life Insurance Company of New York (GLICNY) | Long-term Care Insurance
Statutory Accounting Practices [Line Items]
Asset adequacy deficiency reserves	66				66						66
Genworth Life Insurance Company of New York (GLICNY) | Variable Annuity
Statutory Accounting Practices [Line Items]
Asset adequacy deficiency reserves	35				35						35
Genworth Life Insurance Company of New York (GLICNY) | Structured Settlements
Statutory Accounting Practices [Line Items]
Statutory Reserves Established For Asset Adequacy Deficiencies	31				31						31
Enact Holdings Inc
Statutory Accounting Practices [Line Items]
Debt instrument covenant minimum cash required	$ 252				$ 252						$ 252
Enact Holdings Inc | Minimum
Statutory Accounting Practices [Line Items]
Liquidity as a percentage of outstanding debt to be maintained	13.50%				13.50%						13.50%
Enact Holdings Inc | Domestic insurance subsidiaries
Statutory Accounting Practices [Line Items]
Dividends from subsidiaries											$ 200	$ 437	$ 250
Enact Holdings Inc | Domestic insurance subsidiaries | Noncontrolling interests
Statutory Accounting Practices [Line Items]
Dividends from subsidiaries											37
Enact Holdings Inc | Domestic insurance subsidiaries | Genworth Holdings
Statutory Accounting Practices [Line Items]
Dividend paid during the period											$ 163
Enact Holdings Inc | International Subsidiaries
Statutory Accounting Practices [Line Items]
Dividends from subsidiaries									$ 370

Schedule of Statutory Accountin

Schedule of Statutory Accounting Practices (Detail) - Domestic subsidiaries - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Statutory Accounting Practices [Line Items]
Combined statutory net income (loss)	$ (104)	$ 610	$ 1,237
Combined statutory capital and surplus	7,384	6,204
Life insurance subsidiaries, excluding captive life reinsurance subsidiaries
Statutory Accounting Practices [Line Items]
Combined statutory net income (loss)	654	197	740
Combined statutory capital and surplus	2,945	2,131
Mortgage insurance subsidiaries
Statutory Accounting Practices [Line Items]
Combined statutory net income (loss)	593	404	847
Combined statutory capital and surplus	4,439	4,073
Combined statutory net income, excluding captive reinsurance subsidiaries
Statutory Accounting Practices [Line Items]
Combined statutory net income (loss)	1,247	601	1,587
Captive life reinsurance subsidiaries
Statutory Accounting Practices [Line Items]
Combined statutory net income (loss)	(1,351)	9	$ (350)
Combined statutory capital and surplus	$ 98	$ 106

Segment Information - Additiona

Segment Information - Additional Information (Detail) $ in Millions	1 Months Ended	3 Months Ended	12 Months Ended
	Jan. 31, 2020USD ($)	Dec. 31, 2021USD ($)	Dec. 31, 2021USD ($)Segment	Dec. 31, 2020USD ($)	Dec. 31, 2019USD ($)
Segment Reporting Information [Line Items]
Number of operating segments | Segment			3
Assumed tax rate on adjustments to adjusted operating income			21.00%	21.00%
Expenses related to restructuring			$ 34	$ 3	$ 4
Pre-tax gain (loss) on early extinguishment of debt			(45)	(9)	0
Initial loss from life block transaction		$ 92	92	0	$ 0
Floating Rate Subordinated Notes Due in 2050 | Non-Recourse Funding Obligations
Segment Reporting Information [Line Items]
Pre-tax gain (loss) on early extinguishment of debt	$ 4
Redemption of secured debt	$ 315
Debt instrument, maturity year	2050
Genworth Holdings
Segment Reporting Information [Line Items]
Pre-tax make-whole expense	$ 9
Debt instrument, maturity month and year	2020-06
Genworth Holdings | Senior Notes 2023 and 2024
Segment Reporting Information [Line Items]
Pre-tax gain (loss) on early extinguishment of debt		15
Genworth Holdings | Senior Notes 2021
Segment Reporting Information [Line Items]
Pre-tax gain (loss) on early extinguishment of debt			4	4
Pre-tax make-whole expense			6
Aggregate principal amount of notes repurchased		146	$ 146	$ 84
Debt instrument, maturity year			2021	2021
Debt instrument, maturity month and year			2021-09
Genworth Holdings | Senior Notes 2023
Segment Reporting Information [Line Items]
Pre-tax make-whole expense			$ 20
Aggregate principal amount of notes repurchased		91	$ 91
Debt instrument, maturity year			2023
Debt instrument, maturity month and year			2023-08
Genworth Holdings | Senior Notes 2024
Segment Reporting Information [Line Items]
Aggregate principal amount of notes repurchased		$ 118	$ 118
Debt instrument, maturity year			2024

Summary of Segments and Corpora

Summary of Segments and Corporate and Other Activities (Detail) - USD ($) $ in Millions	3 Months Ended																12 Months Ended
	Dec. 31, 2021		Sep. 30, 2021		Jun. 30, 2021		Mar. 31, 2021		Dec. 31, 2020		Sep. 30, 2020		Jun. 30, 2020		Mar. 31, 2020		Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Segment Reporting Information [Line Items]
Premiums																	$ 3,435	$ 3,836	$ 3,725
Net investment income																	3,370	3,227	3,164
Net investment gains (losses)																	323	492	27
Policy fees and other income																	704	729	789
Total revenues	$ 1,736	[1]	$ 2,070	[1]	$ 2,041	[1]	$ 1,985	[1]	$ 2,154	[2]	$ 2,318	[2]	$ 2,003	[2]	$ 1,809	[2]	7,832	8,284	7,705
Benefits and other changes in policy reserves																	4,383	5,214	5,059
Interest credited																	508	549	577
Acquisition and operating expenses, net of deferrals																	1,223	935	909
Amortization of deferred acquisition costs and intangibles																	377	463	408
Interest expense																	160	195	231
Total benefits and expenses	1,481	[3]	1,697	[3]	1,721	[3]	1,752	[3]	1,771	[4]	1,786	[4]	1,925	[4]	1,874	[4]	6,651	7,356	7,184
Income (loss) from continuing operations before income taxes																	1,181	928	521
Provision (benefit) for income taxes																	263	230	139
Income from continuing operations	193	[1],[3],[5]	306	[1],[3],[5]	245	[1],[3],[5]	174	[1],[3],[5]	301	[2],[4],[6]	402	[2],[4],[6]	55	[2],[4],[6]	(60)	[2],[4],[6]	918	698	382
Net income (loss)	192	[1],[3],[5]	318	[1],[3],[5]	240	[1],[3],[5]	195	[1],[3],[5]	266	[2],[4],[6],[7]	436	[2],[4],[6],[7]	(418)	[2],[4],[6],[7]	(72)	[2],[4],[6],[7]	945	212	530
Less: net income from continuing operations attributable to noncontrolling interests	29	[8]	4	[8]	0	[8]	0	[8]	0		0		0		0		33	0	0
Less: net income from discontinued operations attributable to noncontrolling interests	0		0		0		8		(1)		18		23		(6)		8	34	187
Net income (loss) available to Genworth Financial, Inc.'s common stockholders	163	[8]	314	[8]	240	[8]	187	[8]	267		418		(441)		(66)		904	178	343
Assets held for sale related to discontinued operations	0								2,817								0	2,817
Income (loss) from continuing operations available to Genworth Financial, Inc.'s common stockholders	164		302		245		174		301		402		55		(60)		885	698	382
Income (loss) from discontinued operations available to Genworth Financial, Inc.'s common stockholders	(1)		$ 12		$ (5)		$ 13		(34)		$ 16		$ (496)		$ (6)		19	(520)	(39)
Total assets	99,171								105,747								99,171	105,747
Segment, Continuing Operations
Segment Reporting Information [Line Items]
Premiums																	3,435	3,836	3,725
Net investment income																	3,370	3,227	3,164
Net investment gains (losses)																	323	492	27
Policy fees and other income																	704	729	789
Total revenues																	7,832	8,284	7,705
Benefits and other changes in policy reserves																	4,383	5,214	5,059
Interest credited																	508	549	577
Acquisition and operating expenses, net of deferrals																	1,223	935	909
Amortization of deferred acquisition costs and intangibles																	377	463	408
Interest expense																	160	195	231
Total benefits and expenses																	6,651	7,356	7,184
Income (loss) from continuing operations before income taxes																	1,181	928	521
Provision (benefit) for income taxes																	263	230	139
Income from continuing operations																	918	698	382
Net income (loss)																	945	212	530
Less: net income from continuing operations attributable to noncontrolling interests																	33	0	0
Net income (loss) available to Genworth Financial, Inc.'s common stockholders																	904	178	343
Income (loss) from continuing operations available to Genworth Financial, Inc.'s common stockholders																	885	698	382
Total assets	99,171								102,930								99,171	102,930
Discontinued Operations
Segment Reporting Information [Line Items]
Income from discontinued operations, net of taxes																	27	(486)	148
Less: net income from discontinued operations attributable to noncontrolling interests																	8	34	187
Assets held for sale related to discontinued operations	0								2,817								0	2,817
Income (loss) from discontinued operations available to Genworth Financial, Inc.'s common stockholders																	19	(520)	(39)
Enact
Segment Reporting Information [Line Items]
Total assets	5,850								5,627								5,850	5,627
Enact | Segment, Continuing Operations
Segment Reporting Information [Line Items]
Premiums																	975	971	856
Net investment income																	141	133	117
Net investment gains (losses)																	(2)	(4)	1
Policy fees and other income																	4	6	4
Total revenues																	1,118	1,106	978
Benefits and other changes in policy reserves																	125	381	50
Interest credited																	0	0	0
Acquisition and operating expenses, net of deferrals																	230	206	191
Amortization of deferred acquisition costs and intangibles																	15	21	15
Interest expense																	51	18	0
Total benefits and expenses																	421	626	256
Income (loss) from continuing operations before income taxes																	697	480	722
Provision (benefit) for income taxes																	148	102	153
Income from continuing operations																	549	378	569
Net income (loss)																	549	378	569
Less: net income from continuing operations attributable to noncontrolling interests																	33	0	0
Net income (loss) available to Genworth Financial, Inc.'s common stockholders																	516	378	569
Income (loss) from continuing operations available to Genworth Financial, Inc.'s common stockholders																	516	378	569
Total assets	5,850								5,627								5,850	5,627
Enact | Discontinued Operations
Segment Reporting Information [Line Items]
Income from discontinued operations, net of taxes																	0	0	0
Less: net income from discontinued operations attributable to noncontrolling interests																	0	0	0
Assets held for sale related to discontinued operations	0								0								0	0
Income (loss) from discontinued operations available to Genworth Financial, Inc.'s common stockholders																	0	0	0
U.S. Life Insurance
Segment Reporting Information [Line Items]
Total assets	81,210								84,671								81,210	84,671
U.S. Life Insurance | Segment, Continuing Operations
Segment Reporting Information [Line Items]
Premiums																	2,454	2,858	2,861
Net investment income																	3,029	2,878	2,852
Net investment gains (losses)																	329	517	82
Policy fees and other income																	565	595	643
Total revenues																	6,377	6,848	6,438
Benefits and other changes in policy reserves																	4,230	4,781	4,979
Interest credited																	346	383	419
Acquisition and operating expenses, net of deferrals																	865	620	604
Amortization of deferred acquisition costs and intangibles																	340	418	372
Interest expense																	0	5	17
Total benefits and expenses																	5,781	6,207	6,391
Income (loss) from continuing operations before income taxes																	596	641	47
Provision (benefit) for income taxes																	155	163	34
Income from continuing operations																	441	478	13
Net income (loss)																	441	478	13
Less: net income from continuing operations attributable to noncontrolling interests																	0	0	0
Net income (loss) available to Genworth Financial, Inc.'s common stockholders																	441	478	13
Income (loss) from continuing operations available to Genworth Financial, Inc.'s common stockholders																	441	478	13
Total assets	81,210								84,671								81,210	84,671
U.S. Life Insurance | Discontinued Operations
Segment Reporting Information [Line Items]
Income from discontinued operations, net of taxes																	0	0	0
Less: net income from discontinued operations attributable to noncontrolling interests																	0	0	0
Assets held for sale related to discontinued operations	0								0								0	0
Income (loss) from discontinued operations available to Genworth Financial, Inc.'s common stockholders																	0	0	0
Runoff
Segment Reporting Information [Line Items]
Total assets	9,460								9,735								9,460	9,735
Runoff | Segment, Continuing Operations
Segment Reporting Information [Line Items]
Premiums																	0	0	0
Net investment income																	194	210	187
Net investment gains (losses)																	3	(26)	(25)
Policy fees and other income																	134	130	140
Total revenues																	331	314	302
Benefits and other changes in policy reserves																	27	48	27
Interest credited																	162	166	158
Acquisition and operating expenses, net of deferrals																	53	48	52
Amortization of deferred acquisition costs and intangibles																	20	23	18
Interest expense																	0	0	0
Total benefits and expenses																	262	285	255
Income (loss) from continuing operations before income taxes																	69	29	47
Provision (benefit) for income taxes																	13	4	8
Income from continuing operations																	56	25	39
Net income (loss)																	56	25	39
Less: net income from continuing operations attributable to noncontrolling interests																	0	0	0
Net income (loss) available to Genworth Financial, Inc.'s common stockholders																	56	25	39
Income (loss) from continuing operations available to Genworth Financial, Inc.'s common stockholders																	56	25	39
Total assets	9,460								9,735								9,460	9,735
Runoff | Discontinued Operations
Segment Reporting Information [Line Items]
Income from discontinued operations, net of taxes																	0	0	0
Less: net income from discontinued operations attributable to noncontrolling interests																	0	0	0
Assets held for sale related to discontinued operations	0								0								0	0
Income (loss) from discontinued operations available to Genworth Financial, Inc.'s common stockholders																	0	0	0
Corporate and Other
Segment Reporting Information [Line Items]
Total assets	2,651								5,714								2,651	5,714
Corporate and Other | Segment, Continuing Operations
Segment Reporting Information [Line Items]
Premiums																	6	7	8
Net investment income																	6	6	8
Net investment gains (losses)																	(7)	5	(31)
Policy fees and other income																	1	(2)	2
Total revenues																	6	16	(13)
Benefits and other changes in policy reserves																	1	4	3
Interest credited																	0	0	0
Acquisition and operating expenses, net of deferrals																	75	61	62
Amortization of deferred acquisition costs and intangibles																	2	1	3
Interest expense																	109	172	214
Total benefits and expenses																	187	238	282
Income (loss) from continuing operations before income taxes																	(181)	(222)	(295)
Provision (benefit) for income taxes																	(53)	(39)	(56)
Income from continuing operations																	(128)	(183)	(239)
Net income (loss)																	(101)	(669)	(91)
Less: net income from continuing operations attributable to noncontrolling interests																	0	0	0
Net income (loss) available to Genworth Financial, Inc.'s common stockholders																	(109)	(703)	(278)
Income (loss) from continuing operations available to Genworth Financial, Inc.'s common stockholders																	(128)	(183)	(239)
Total assets	2,651								2,897								2,651	2,897
Corporate and Other | Discontinued Operations
Segment Reporting Information [Line Items]
Income from discontinued operations, net of taxes																	27	(486)	148
Less: net income from discontinued operations attributable to noncontrolling interests																	8	34	187
Assets held for sale related to discontinued operations	$ 0								$ 2,817								0	2,817
Income (loss) from discontinued operations available to Genworth Financial, Inc.'s common stockholders																	$ 19	$ (520)	$ (39)
[1]	In the fourth quarter of 2021, our life insurance business initially ceded $360 million of premiums associated with certain term life insurance policies under a new reinsurance treaty as part of a life block transaction.
[2]	In the fourth quarter of 2020, we recorded lower net investment gains as compared to the third quarter of 2020. The higher net investment gains recorded in the third quarter of 2020 related to the sale of available-for-sale fixed maturity securities of $330 million driven primarily from the sale of U.S. government securities due to portfolio rebalancing and asset exposure management as a result of the prolonged low interest rate environment. This decrease to total revenues was partially offset by higher net investment income recorded in the fourth quarter of 2020 largely driven by bond calls and mortgage loan repayments of $40 million and limited partnerships of $38 million.
[3]	In the fourth quarter of 2021, our life insurance business initially ceded $268 million of certain term life insurance reserves under a new reinsurance treaty as part of a life block transaction. Our life insurance business also completed its annual review of assumptions in the fourth quarter of 2021. This review resulted in higher total benefits and expenses of $87 million from an unfavorable unlocking in our term universal and universal life insurance products largely attributable to higher pre-COVID-19 mortality. In our term universal life insurance products, we also recorded a DAC impairment of $41 million in the fourth quarter of 2021 principally due to lower future estimated gross profits.
[4]	Given our assumption that COVID-19 has temporarily decreased the number of new claims submitted, our long-term care insurance business strengthened IBNR reserves in the fourth quarter of 2020 by $47 million. Additionally, our long-term care insurance business recorded a $91 million increase to claim reserves reflecting our assumption that COVID-19 accelerated mortality experience on the most vulnerable claimants, leaving the remaining claim population less likely to terminate compared to the pre-pandemic average population. Our Enact segment recorded an unfavorable reserve adjustment of $37 million primarily due to slowing cure emergence patterns impacting the frequency of claim. Our life insurance business completed its annual review of assumptions in the fourth quarter of 2020. This review resulted in lower total benefits and expenses of $82 million from a net favorable unlocking in our term universal and universal life insurance products largely attributable to a model refinement in our term universal life insurance product related to persistency and grace period timing and lower projected cost of insurance assessments on our universal life insurance products. In addition, we recorded a DAC impairment of $63 million in our universal life insurance products due principally to lower future estimated gross profits.
[5]	In the fourth quarter of 2021, our life insurance business recorded a net loss of $131 million predominantly driven by an initial loss of $73 million as a result of ceding certain term life insurance policies as part of a life block transaction, an unfavorable unlocking of $70 million associated with its annual review of assumptions and a DAC impairment of $32 million as a result of recoverability testing.
[6]	In the fourth quarter of 2020, our long-term care insurance business strengthened its reserves by $109 million after-tax. Our Enact segment strengthened loss reserves by $29 million after-tax. Our life insurance business recorded a $60 million net favorable unlocking, net of taxes, related to its annual review of assumptions. This favorable unlocking in our life insurance business was partially offset by a DAC impairment of $50 million, net of taxes, as a result of recoverability testing. For all of the aforementioned transactions, see above under superscript (2) for additional details.
[7]	In the fourth quarter of 2020, we recorded a loss from discontinued operations, net of taxes, of $35 million principally attributed to expenses associated with the promissory note owed to AXA and from a $5 million net loss in Genworth Australia. The expenses associated with the promissory note mostly consisted of foreign currency remeasurement losses of $26 million, unfavorable tax charges of $17 million and other expenses of $8 million. These expenses were partially offset by derivative hedge gains of $21 million associated with foreign currency forward contracts entered into to mitigate our exposure to the installment payments to be made in British Pounds in 2022. See note 23 for additional details on discontinued operations.
[8]	On September 20, 2021, we completed the minority IPO of Enact Holdings, which reduced our ownership percentage to 81.6%, and lowered our available net income by $29 million in the fourth quarter of 2021.

Summary of Revenues for Segment

Summary of Revenues for Segments and Corporate and Other Activities (Detail) - USD ($) $ in Millions	3 Months Ended																12 Months Ended
	Dec. 31, 2021	[1]	Sep. 30, 2021	[1]	Jun. 30, 2021	[1]	Mar. 31, 2021	[1]	Dec. 31, 2020	[2]	Sep. 30, 2020	[2]	Jun. 30, 2020	[2]	Mar. 31, 2020	[2]	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Segment Reporting Information [Line Items]
Revenues	$ 1,736		$ 2,070		$ 2,041		$ 1,985		$ 2,154		$ 2,318		$ 2,003		$ 1,809		$ 7,832	$ 8,284	$ 7,705
Segment, Continuing Operations
Segment Reporting Information [Line Items]
Revenues																	7,832	8,284	7,705
Segment, Continuing Operations | Enact [Member]
Segment Reporting Information [Line Items]
Revenues																	1,118	1,106	978
Segment, Continuing Operations | Long-term Care Insurance
Segment Reporting Information [Line Items]
Revenues																	4,875	4,960	4,385
Segment, Continuing Operations | Life Insurance
Segment Reporting Information [Line Items]
Revenues																	996	1,357	1,444
Segment, Continuing Operations | Fixed Annuities
Segment Reporting Information [Line Items]
Revenues																	506	531	609
Segment, Continuing Operations | U.S. Life Insurance
Segment Reporting Information [Line Items]
Revenues																	6,377	6,848	6,438
Segment, Continuing Operations | Runoff
Segment Reporting Information [Line Items]
Revenues																	331	314	302
Segment, Continuing Operations | Corporate and Other
Segment Reporting Information [Line Items]
Revenues																	$ 6	$ 16	$ (13)
[1]	In the fourth quarter of 2021, our life insurance business initially ceded $360 million of premiums associated with certain term life insurance policies under a new reinsurance treaty as part of a life block transaction.
[2]	In the fourth quarter of 2020, we recorded lower net investment gains as compared to the third quarter of 2020. The higher net investment gains recorded in the third quarter of 2020 related to the sale of available-for-sale fixed maturity securities of $330 million driven primarily from the sale of U.S. government securities due to portfolio rebalancing and asset exposure management as a result of the prolonged low interest rate environment. This decrease to total revenues was partially offset by higher net investment income recorded in the fourth quarter of 2020 largely driven by bond calls and mortgage loan repayments of $40 million and limited partnerships of $38 million.

Summary of Net Operating Income

Summary of Net Operating Income (Loss) for Segments and Corporate and Other Activities (Detail) - USD ($) $ in Millions		3 Months Ended																12 Months Ended
		Dec. 31, 2021		Sep. 30, 2021		Jun. 30, 2021		Mar. 31, 2021		Dec. 31, 2020		Sep. 30, 2020		Jun. 30, 2020		Mar. 31, 2020		Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Segment Reporting Information [Line Items]
Net income available to Genworth Financial, Inc.'s common stockholders		$ 163	[1]	$ 314	[1]	$ 240	[1]	$ 187	[1]	$ 267		$ 418		$ (441)		$ (66)		$ 904	$ 178	$ 343
Add: net income (loss) from continuing operations attributable to noncontrolling interests		29	[1]	4	[1]	0	[1]	0	[1]	0		0		0		0		33	0	0
Add: net income from discontinued operations attributable to noncontrolling interests		0		0		0		8		(1)		18		23		(6)		8	34	187
Net income		192	[2],[3],[4]	318	[2],[3],[4]	240	[2],[3],[4]	195	[2],[3],[4]	266	[5],[6],[7],[8]	436	[5],[6],[7],[8]	(418)	[5],[6],[7],[8]	(72)	[5],[6],[7],[8]	945	212	530
Income (loss) from discontinued operations, net of taxes		(1)		12		(5)		21		(35)	[7]	34	[7]	(473)	[7]	(12)	[7]	27	(486)	148
Income from continuing operations		193	[2],[3],[4]	306	[2],[3],[4]	245	[2],[3],[4]	174	[2],[3],[4]	301	[5],[6],[8]	402	[5],[6],[8]	55	[5],[6],[8]	(60)	[5],[6],[8]	918	698	382
Less: net income from continuing operations attributable to noncontrolling interests		29	[1]	4	[1]	0	[1]	0	[1]	0		0		0		0		33	0	0
Income from continuing operations available to Genworth Financial, Inc.'s common stockholders		164		$ 302		$ 245		$ 174		$ 301		$ 402		$ 55		$ (60)		885	698	382
Net investment (gains) losses, net	[9]																	(324)	(503)	(38)
(Gains) losses on early extinguishment of debt																		45	9	0
Initial loss from life block transaction		$ 92																92	0	0
Expenses related to restructuring																		34	3	4
Taxes on adjustments																		33	103	7
Adjusted operating income (loss) available to Genworth Financial, Inc.'s common stockholders																		765	310	355
Segment, Continuing Operations
Segment Reporting Information [Line Items]
Net income available to Genworth Financial, Inc.'s common stockholders																		904	178	343
Add: net income (loss) from continuing operations attributable to noncontrolling interests																		33	0	0
Net income																		945	212	530
Income from continuing operations																		918	698	382
Less: net income from continuing operations attributable to noncontrolling interests																		33	0	0
Income from continuing operations available to Genworth Financial, Inc.'s common stockholders																		885	698	382
Segment, Continuing Operations | Long-term Care Insurance
Segment Reporting Information [Line Items]
Adjusted operating income (loss) available to Genworth Financial, Inc.'s common stockholders																		445	237	57
Segment, Continuing Operations | Life Insurance
Segment Reporting Information [Line Items]
Adjusted operating income (loss) available to Genworth Financial, Inc.'s common stockholders																		(269)	(247)	(181)
Segment, Continuing Operations | Fixed Annuities
Segment Reporting Information [Line Items]
Adjusted operating income (loss) available to Genworth Financial, Inc.'s common stockholders																		91	78	69
Segment, Continuing Operations | U.S. Life Insurance
Segment Reporting Information [Line Items]
Net income available to Genworth Financial, Inc.'s common stockholders																		441	478	13
Add: net income (loss) from continuing operations attributable to noncontrolling interests																		0	0	0
Net income																		441	478	13
Income from continuing operations																		441	478	13
Less: net income from continuing operations attributable to noncontrolling interests																		0	0	0
Income from continuing operations available to Genworth Financial, Inc.'s common stockholders																		441	478	13
Adjusted operating income (loss) available to Genworth Financial, Inc.'s common stockholders																		267	68	(55)
Segment, Continuing Operations | Runoff
Segment Reporting Information [Line Items]
Net income available to Genworth Financial, Inc.'s common stockholders																		56	25	39
Add: net income (loss) from continuing operations attributable to noncontrolling interests																		0	0	0
Net income																		56	25	39
Income from continuing operations																		56	25	39
Less: net income from continuing operations attributable to noncontrolling interests																		0	0	0
Income from continuing operations available to Genworth Financial, Inc.'s common stockholders																		56	25	39
Adjusted operating income (loss) available to Genworth Financial, Inc.'s common stockholders																		54	43	56
Segment, Continuing Operations | Corporate and Other
Segment Reporting Information [Line Items]
Net income available to Genworth Financial, Inc.'s common stockholders																		(109)	(703)	(278)
Add: net income (loss) from continuing operations attributable to noncontrolling interests																		0	0	0
Net income																		(101)	(669)	(91)
Income from continuing operations																		(128)	(183)	(239)
Less: net income from continuing operations attributable to noncontrolling interests																		0	0	0
Income from continuing operations available to Genworth Financial, Inc.'s common stockholders																		(128)	(183)	(239)
Adjusted operating income (loss) available to Genworth Financial, Inc.'s common stockholders																		(76)	(182)	(214)
Segment, Continuing Operations | Enact [Member]
Segment Reporting Information [Line Items]
Net income available to Genworth Financial, Inc.'s common stockholders																		516	378	569
Add: net income (loss) from continuing operations attributable to noncontrolling interests																		33	0	0
Net income																		549	378	569
Income from continuing operations																		549	378	569
Less: net income from continuing operations attributable to noncontrolling interests																		33	0	0
Income from continuing operations available to Genworth Financial, Inc.'s common stockholders																		516	378	569
Adjusted operating income (loss) available to Genworth Financial, Inc.'s common stockholders																		$ 520	$ 381	$ 568
[1]	On September 20, 2021, we completed the minority IPO of Enact Holdings, which reduced our ownership percentage to 81.6%, and lowered our available net income by $29 million in the fourth quarter of 2021.
[2]	In the fourth quarter of 2021, our life insurance business initially ceded $268 million of certain term life insurance reserves under a new reinsurance treaty as part of a life block transaction. Our life insurance business also completed its annual review of assumptions in the fourth quarter of 2021. This review resulted in higher total benefits and expenses of $87 million from an unfavorable unlocking in our term universal and universal life insurance products largely attributable to higher pre-COVID-19 mortality. In our term universal life insurance products, we also recorded a DAC impairment of $41 million in the fourth quarter of 2021 principally due to lower future estimated gross profits.
[3]	In the fourth quarter of 2021, our life insurance business initially ceded $360 million of premiums associated with certain term life insurance policies under a new reinsurance treaty as part of a life block transaction.
[4]	In the fourth quarter of 2021, our life insurance business recorded a net loss of $131 million predominantly driven by an initial loss of $73 million as a result of ceding certain term life insurance policies as part of a life block transaction, an unfavorable unlocking of $70 million associated with its annual review of assumptions and a DAC impairment of $32 million as a result of recoverability testing.
[5]	Given our assumption that COVID-19 has temporarily decreased the number of new claims submitted, our long-term care insurance business strengthened IBNR reserves in the fourth quarter of 2020 by $47 million. Additionally, our long-term care insurance business recorded a $91 million increase to claim reserves reflecting our assumption that COVID-19 accelerated mortality experience on the most vulnerable claimants, leaving the remaining claim population less likely to terminate compared to the pre-pandemic average population. Our Enact segment recorded an unfavorable reserve adjustment of $37 million primarily due to slowing cure emergence patterns impacting the frequency of claim. Our life insurance business completed its annual review of assumptions in the fourth quarter of 2020. This review resulted in lower total benefits and expenses of $82 million from a net favorable unlocking in our term universal and universal life insurance products largely attributable to a model refinement in our term universal life insurance product related to persistency and grace period timing and lower projected cost of insurance assessments on our universal life insurance products. In addition, we recorded a DAC impairment of $63 million in our universal life insurance products due principally to lower future estimated gross profits.
[6]	In the fourth quarter of 2020, our long-term care insurance business strengthened its reserves by $109 million after-tax. Our Enact segment strengthened loss reserves by $29 million after-tax. Our life insurance business recorded a $60 million net favorable unlocking, net of taxes, related to its annual review of assumptions. This favorable unlocking in our life insurance business was partially offset by a DAC impairment of $50 million, net of taxes, as a result of recoverability testing. For all of the aforementioned transactions, see above under superscript (2) for additional details.
[7]	In the fourth quarter of 2020, we recorded a loss from discontinued operations, net of taxes, of $35 million principally attributed to expenses associated with the promissory note owed to AXA and from a $5 million net loss in Genworth Australia. The expenses associated with the promissory note mostly consisted of foreign currency remeasurement losses of $26 million, unfavorable tax charges of $17 million and other expenses of $8 million. These expenses were partially offset by derivative hedge gains of $21 million associated with foreign currency forward contracts entered into to mitigate our exposure to the installment payments to be made in British Pounds in 2022. See note 23 for additional details on discontinued operations.
[8]	In the fourth quarter of 2020, we recorded lower net investment gains as compared to the third quarter of 2020. The higher net investment gains recorded in the third quarter of 2020 related to the sale of available-for-sale fixed maturity securities of $330 million driven primarily from the sale of U.S. government securities due to portfolio rebalancing and asset exposure management as a result of the prolonged low interest rate environment. This decrease to total revenues was partially offset by higher net investment income recorded in the fourth quarter of 2020 largely driven by bond calls and mortgage loan repayments of $40 million and limited partnerships of $38 million.
[9]	For the years ended December 31, 2021, 2020 and 2019, net investment (gains) losses were adjusted for DAC and other intangible amortization and certain benefit reserves of $(1) million, $(11) million and $(11) million, respectively.

Summary of Net Operating Inco_2

Summary of Net Operating Income (Loss) for Segments and Corporate and Other Activities (Parenthetical) (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Net Investment (Gains) Losses
Segment Reporting Information [Line Items]
Adjustment for DAC and other intangibles and certain benefit reserves	$ (1)	$ (11)	$ (11)

Schedule of Revenue, Net Income

Schedule of Revenue, Net Income and Assets by Geographic Location (Detail) - USD ($) $ in Millions	3 Months Ended																12 Months Ended
	Dec. 31, 2021		Sep. 30, 2021	[1]	Jun. 30, 2021	[1]	Mar. 31, 2021	[1]	Dec. 31, 2020		Sep. 30, 2020	[2]	Jun. 30, 2020	[2]	Mar. 31, 2020	[2]	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Segment Reporting Information [Line Items]
Total revenues	$ 1,736	[1]	$ 2,070		$ 2,041		$ 1,985		$ 2,154	[2]	$ 2,318		$ 2,003		$ 1,809		$ 7,832	$ 8,284	$ 7,705
Income (loss) from continuing operations	193	[1],[3],[4]	306	[3],[4]	245	[3],[4]	174	[3],[4]	301	[2],[5],[6]	402	[5],[6]	55	[5],[6]	(60)	[5],[6]	918	698	382
Net income (loss)	192	[1],[3],[4]	$ 318	[3],[4]	$ 240	[3],[4]	$ 195	[3],[4]	266	[2],[5],[6],[7]	$ 436	[5],[6],[7]	$ (418)	[5],[6],[7]	$ (72)	[5],[6],[7]	945	212	530
Total assets	99,171								105,747								99,171	105,747
Assets held for sale related to discontinued operations	0								2,817								0	2,817
Continuing Operations [Member]
Segment Reporting Information [Line Items]
Total revenues																	7,832	8,284	7,705
Income (loss) from continuing operations																	918	698	382
Net income (loss)																	945	212	530
Total assets	99,171								102,930								99,171	102,930
Discontinued Operations [Member]
Segment Reporting Information [Line Items]
Assets held for sale related to discontinued operations	0								2,817								0	2,817
Geographic Distribution, Domestic | United States
Segment Reporting Information [Line Items]
Total assets	99,117								102,871								99,117	102,871
Geographic Distribution, Domestic | United States | Continuing Operations [Member]
Segment Reporting Information [Line Items]
Total revenues																	7,825	8,275	7,696
Income (loss) from continuing operations																	921	700	384
Net income (loss)																	948	214	532
Total assets	99,117								102,871								99,117	102,871
Geographic Distribution, Domestic | United States | Discontinued Operations [Member]
Segment Reporting Information [Line Items]
Assets held for sale related to discontinued operations	0								0								0	0
Geographic Distribution, Foreign
Segment Reporting Information [Line Items]
Total assets	54								2,876								54	2,876
Geographic Distribution, Foreign | Continuing Operations [Member]
Segment Reporting Information [Line Items]
Total revenues																	7	9	9
Income (loss) from continuing operations																	(3)	(2)	(2)
Net income (loss)																	(3)	(2)	$ (2)
Total assets	54								59								54	59
Geographic Distribution, Foreign | Discontinued Operations [Member]
Segment Reporting Information [Line Items]
Assets held for sale related to discontinued operations	$ 0								$ 2,817								$ 0	$ 2,817
[1]	In the fourth quarter of 2021, our life insurance business initially ceded $360 million of premiums associated with certain term life insurance policies under a new reinsurance treaty as part of a life block transaction.
[2]	In the fourth quarter of 2020, we recorded lower net investment gains as compared to the third quarter of 2020. The higher net investment gains recorded in the third quarter of 2020 related to the sale of available-for-sale fixed maturity securities of $330 million driven primarily from the sale of U.S. government securities due to portfolio rebalancing and asset exposure management as a result of the prolonged low interest rate environment. This decrease to total revenues was partially offset by higher net investment income recorded in the fourth quarter of 2020 largely driven by bond calls and mortgage loan repayments of $40 million and limited partnerships of $38 million.
[3]	In the fourth quarter of 2021, our life insurance business initially ceded $268 million of certain term life insurance reserves under a new reinsurance treaty as part of a life block transaction. Our life insurance business also completed its annual review of assumptions in the fourth quarter of 2021. This review resulted in higher total benefits and expenses of $87 million from an unfavorable unlocking in our term universal and universal life insurance products largely attributable to higher pre-COVID-19 mortality. In our term universal life insurance products, we also recorded a DAC impairment of $41 million in the fourth quarter of 2021 principally due to lower future estimated gross profits.
[4]	In the fourth quarter of 2021, our life insurance business recorded a net loss of $131 million predominantly driven by an initial loss of $73 million as a result of ceding certain term life insurance policies as part of a life block transaction, an unfavorable unlocking of $70 million associated with its annual review of assumptions and a DAC impairment of $32 million as a result of recoverability testing.
[5]	Given our assumption that COVID-19 has temporarily decreased the number of new claims submitted, our long-term care insurance business strengthened IBNR reserves in the fourth quarter of 2020 by $47 million. Additionally, our long-term care insurance business recorded a $91 million increase to claim reserves reflecting our assumption that COVID-19 accelerated mortality experience on the most vulnerable claimants, leaving the remaining claim population less likely to terminate compared to the pre-pandemic average population. Our Enact segment recorded an unfavorable reserve adjustment of $37 million primarily due to slowing cure emergence patterns impacting the frequency of claim. Our life insurance business completed its annual review of assumptions in the fourth quarter of 2020. This review resulted in lower total benefits and expenses of $82 million from a net favorable unlocking in our term universal and universal life insurance products largely attributable to a model refinement in our term universal life insurance product related to persistency and grace period timing and lower projected cost of insurance assessments on our universal life insurance products. In addition, we recorded a DAC impairment of $63 million in our universal life insurance products due principally to lower future estimated gross profits.
[6]	In the fourth quarter of 2020, our long-term care insurance business strengthened its reserves by $109 million after-tax. Our Enact segment strengthened loss reserves by $29 million after-tax. Our life insurance business recorded a $60 million net favorable unlocking, net of taxes, related to its annual review of assumptions. This favorable unlocking in our life insurance business was partially offset by a DAC impairment of $50 million, net of taxes, as a result of recoverability testing. For all of the aforementioned transactions, see above under superscript (2) for additional details.
[7]	In the fourth quarter of 2020, we recorded a loss from discontinued operations, net of taxes, of $35 million principally attributed to expenses associated with the promissory note owed to AXA and from a $5 million net loss in Genworth Australia. The expenses associated with the promissory note mostly consisted of foreign currency remeasurement losses of $26 million, unfavorable tax charges of $17 million and other expenses of $8 million. These expenses were partially offset by derivative hedge gains of $21 million associated with foreign currency forward contracts entered into to mitigate our exposure to the installment payments to be made in British Pounds in 2022. See note 23 for additional details on discontinued operations.

Quarterly Results of Operatio_3

Quarterly Results of Operations (Detail) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended																12 Months Ended
	Dec. 31, 2021		Sep. 30, 2021		Jun. 30, 2021		Mar. 31, 2021		Dec. 31, 2020		Sep. 30, 2020		Jun. 30, 2020		Mar. 31, 2020		Dec. 31, 2021		Dec. 31, 2020		Dec. 31, 2019
Quarterly Results Of Operations [Abstract]
Total revenues	$ 1,736	[1]	$ 2,070	[1]	$ 2,041	[1]	$ 1,985	[1]	$ 2,154	[2]	$ 2,318	[2]	$ 2,003	[2]	$ 1,809	[2]	$ 7,832		$ 8,284		$ 7,705
Total benefits and expenses	1,481	[3]	1,697	[3]	1,721	[3]	1,752	[3]	1,771	[4]	1,786	[4]	1,925	[4]	1,874	[4]	6,651		7,356		7,184
Income (loss) from continuing operations	193	[1],[3],[5]	306	[1],[3],[5]	245	[1],[3],[5]	174	[1],[3],[5]	301	[2],[4],[6]	402	[2],[4],[6]	55	[2],[4],[6]	(60)	[2],[4],[6]	918		698		382
Income (loss) from discontinued operations, net of taxes	(1)		12		(5)		21		(35)	[7]	34	[7]	(473)	[7]	(12)	[7]	27		(486)		148
Net income (loss)	192	[1],[3],[5]	318	[1],[3],[5]	240	[1],[3],[5]	195	[1],[3],[5]	266	[2],[4],[6],[7]	436	[2],[4],[6],[7]	(418)	[2],[4],[6],[7]	(72)	[2],[4],[6],[7]	945		212		530
Net income from continuing operations attributable to noncontrolling interests	29	[8]	4	[8]	0	[8]	0	[8]	0		0		0		0		33		0		0
Net income (loss) from discontinued operations attributable to noncontrolling interests	0		0		0		8		(1)		18		23		(6)		8		34		187
Net income (loss) available to Genworth Financial, Inc.'s common stockholders	163	[8]	314	[8]	240	[8]	187	[8]	267		418		(441)		(66)		904		178		343
Net income (loss) available to Genworth Financial, Inc.'s common stockholders:
Income (loss) from continuing operations available to Genworth Financial, Inc.'s common stockholders	164		302		245		174		301		402		55		(60)		885		698		382
Income (loss) from discontinued operations available to Genworth Financial, Inc.'s common stockholders	(1)		12		(5)		13		(34)		16		(496)		(6)		19		(520)		(39)
Net income (loss) available to Genworth Financial, Inc.'s common stockholders	$ 163	[8]	$ 314	[8]	$ 240	[8]	$ 187	[8]	$ 267		$ 418		$ (441)		$ (66)		$ 904		$ 178		$ 343
Income (loss) from continuing operations available to Genworth Financial, Inc.'s common stockholders per share:
Basic	$ 0.32		$ 0.59		$ 0.48		$ 0.35		$ 0.60		$ 0.79		$ 0.11		$ (0.12)		$ 1.75		$ 1.38		$ 0.76
Diluted	0.32		0.59		0.47		0.34		0.59		0.79		0.11		(0.12)		1.72		1.36		0.75
Net income (loss) available to Genworth Financial, Inc.'s common stockholders per share:
Basic	0.32		0.62		0.47		0.37		0.53		0.83		(0.87)		(0.13)		1.78	[9]	0.35	[9]	0.68	[9]
Diluted	$ 0.32		$ 0.61		$ 0.47		$ 0.37		$ 0.52		$ 0.82		$ (0.86)		$ (0.13)		$ 1.76	[9]	$ 0.35	[9]	$ 0.67	[9]
Weighted-average common shares outstanding:
Basic	507.4		507.4		507		506		505.6		505.6		505.4		504.3		506.9		505.2		502.9
Diluted	515.6		514.2		515		513.8		512.5	[10]	511.5	[10]	512.5	[10]	504.3	[10]	514.7		511.6		509.7
[1]	In the fourth quarter of 2021, our life insurance business initially ceded $360 million of premiums associated with certain term life insurance policies under a new reinsurance treaty as part of a life block transaction.
[2]	In the fourth quarter of 2020, we recorded lower net investment gains as compared to the third quarter of 2020. The higher net investment gains recorded in the third quarter of 2020 related to the sale of available-for-sale fixed maturity securities of $330 million driven primarily from the sale of U.S. government securities due to portfolio rebalancing and asset exposure management as a result of the prolonged low interest rate environment. This decrease to total revenues was partially offset by higher net investment income recorded in the fourth quarter of 2020 largely driven by bond calls and mortgage loan repayments of $40 million and limited partnerships of $38 million.
[3]	In the fourth quarter of 2021, our life insurance business initially ceded $268 million of certain term life insurance reserves under a new reinsurance treaty as part of a life block transaction. Our life insurance business also completed its annual review of assumptions in the fourth quarter of 2021. This review resulted in higher total benefits and expenses of $87 million from an unfavorable unlocking in our term universal and universal life insurance products largely attributable to higher pre-COVID-19 mortality. In our term universal life insurance products, we also recorded a DAC impairment of $41 million in the fourth quarter of 2021 principally due to lower future estimated gross profits.
[4]	Given our assumption that COVID-19 has temporarily decreased the number of new claims submitted, our long-term care insurance business strengthened IBNR reserves in the fourth quarter of 2020 by $47 million. Additionally, our long-term care insurance business recorded a $91 million increase to claim reserves reflecting our assumption that COVID-19 accelerated mortality experience on the most vulnerable claimants, leaving the remaining claim population less likely to terminate compared to the pre-pandemic average population. Our Enact segment recorded an unfavorable reserve adjustment of $37 million primarily due to slowing cure emergence patterns impacting the frequency of claim. Our life insurance business completed its annual review of assumptions in the fourth quarter of 2020. This review resulted in lower total benefits and expenses of $82 million from a net favorable unlocking in our term universal and universal life insurance products largely attributable to a model refinement in our term universal life insurance product related to persistency and grace period timing and lower projected cost of insurance assessments on our universal life insurance products. In addition, we recorded a DAC impairment of $63 million in our universal life insurance products due principally to lower future estimated gross profits.
[5]	In the fourth quarter of 2021, our life insurance business recorded a net loss of $131 million predominantly driven by an initial loss of $73 million as a result of ceding certain term life insurance policies as part of a life block transaction, an unfavorable unlocking of $70 million associated with its annual review of assumptions and a DAC impairment of $32 million as a result of recoverability testing.
[6]	In the fourth quarter of 2020, our long-term care insurance business strengthened its reserves by $109 million after-tax. Our Enact segment strengthened loss reserves by $29 million after-tax. Our life insurance business recorded a $60 million net favorable unlocking, net of taxes, related to its annual review of assumptions. This favorable unlocking in our life insurance business was partially offset by a DAC impairment of $50 million, net of taxes, as a result of recoverability testing. For all of the aforementioned transactions, see above under superscript (2) for additional details.
[7]	In the fourth quarter of 2020, we recorded a loss from discontinued operations, net of taxes, of $35 million principally attributed to expenses associated with the promissory note owed to AXA and from a $5 million net loss in Genworth Australia. The expenses associated with the promissory note mostly consisted of foreign currency remeasurement losses of $26 million, unfavorable tax charges of $17 million and other expenses of $8 million. These expenses were partially offset by derivative hedge gains of $21 million associated with foreign currency forward contracts entered into to mitigate our exposure to the installment payments to be made in British Pounds in 2022. See note 23 for additional details on discontinued operations.
[8]	On September 20, 2021, we completed the minority IPO of Enact Holdings, which reduced our ownership percentage to 81.6%, and lowered our available net income by $29 million in the fourth quarter of 2021.
[9]	May not total due to whole number calculation.
[10]	Under applicable accounting guidance, companies in a loss position are required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share. Therefore, as a result of our loss from continuing operations available to Genworth Financial, Inc.’s common stockholders for the three months ended March 31, 2020, we were required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share for the three months ended March 31, 2020, as the inclusion of shares for stock options, RSUs and SARs of 5.4 million would have been antidilutive to the calculation. If we had not incurred a loss from continuing operations available to Genworth Financial, Inc.’s common stockholders for the three months ended March 31, 2020, dilutive potential weighted-average common shares outstanding would have been 509.7 million.

Quarterly Results of Operatio_4

Quarterly Results of Operations (Parenthetical) (Detail) - USD ($) shares in Millions, $ in Millions		Sep. 20, 2021	Dec. 31, 2021		Sep. 30, 2021		Jun. 30, 2021		Mar. 31, 2021		Dec. 31, 2020		Sep. 30, 2020		Jun. 30, 2020		Mar. 31, 2020		Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Quarterly Financial Information [Line Items]
Total benefits and expenses			$ 1,481	[1]	$ 1,697	[1]	$ 1,721	[1]	$ 1,752	[1]	$ 1,771	[2]	$ 1,786	[2]	$ 1,925	[2]	$ 1,874	[2]	$ 6,651	$ 7,356	$ 7,184
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount									5.4
Weighted-average number of diluted shares if not in a loss position																	509.7
Net income loss			163	[3]	314	[3]	240	[3]	$ 187	[3]	267		418		(441)		$ (66)		904	178	343
Income (loss) from discontinued operations, net of taxes			(1)		12		(5)		21		(35)	[4]	34	[4]	(473)	[4]	(12)	[4]	27	(486)	148
Impairment of deferred acquisition costs			41
Sale of available for sale debt securities													330
Proceeds from sale and collection of mortgage loan repayments and bond calls											40
Proceeds from limited partnership investments on account of redemptions											38
Life insurance reserves ceded	[5]		427,464								458,999								427,464	458,999	500,965
Income attributable to noncontrolling interests associated with minority IPO			29	[3]	$ 4	[3]	$ 0	[3]	$ 0	[3]	0		$ 0		$ 0		$ 0		33	0	0
Term Life Insurance | Life Block Transaction
Quarterly Financial Information [Line Items]
Gains (losses) from life block transactions			73
Life insurance premiums ceded			360
Life insurance reserves ceded			268																268
Enact Holdings Inc.
Quarterly Financial Information [Line Items]
Sale of stock percentage of ownership after transaction		81.60%
Discontinued Operations [Member]
Quarterly Financial Information [Line Items]
Disposal group discontinued operations unfavourable tax charges											17
Discontinued Operations [Member] | Promissory Note
Quarterly Financial Information [Line Items]
Income (loss) from discontinued operations, net of taxes											5
Discontinued Operations [Member] | Foreign Exchange Forward
Quarterly Financial Information [Line Items]
Derivative gains losses foreign exchange contracts											21
Discontinued Operations [Member] | AXA Settlement Agreement
Quarterly Financial Information [Line Items]
Income (loss) from discontinued operations, net of taxes											35
Foreign currency remeasurement loss											26
Discontinued Operations [Member] | AXA Settlement Agreement | Promissory Note
Quarterly Financial Information [Line Items]
Interest expense											8
Universal Life
Quarterly Financial Information [Line Items]
Net income loss			131
Impairment of deferred acquisition costs											63
Minority IPO | Income Attributable To Noncontrolling Interests
Quarterly Financial Information [Line Items]
Income attributable to noncontrolling interests associated with minority IPO			29
Unlocking | Universal Life
Quarterly Financial Information [Line Items]
Total benefits and expenses											82
Favorable (unfavorable) adjustment, net of taxes											60
Impairment of deferred acquisition costs											50
Annual Review of Assumptions | Universal Life
Quarterly Financial Information [Line Items]
Unfavorable adjustment, net of taxes			70
Lower Future Gross Profits Estimated in the Future | Universal Life
Quarterly Financial Information [Line Items]
Deferred Policy Acquisition Costs Impairment Loss After Tax			32
Life Insurance | Unfavorable Unlocking
Quarterly Financial Information [Line Items]
Total benefits and expenses			$ 87
Long-term Care Insurance
Quarterly Financial Information [Line Items]
Increase (decrease) in incurred but not reported reserves											47									108
Increase in reserves related to accelarated claims termination											91								$ 2,761	2,595	$ 2,717
Increase in reserves related to accelerated claims terminations											109
U.S. Mortgage Insurance
Quarterly Financial Information [Line Items]
Favorable (unfavorable) adjustment, net of taxes											29
Unfavorable adjustment											$ 37									$ 37
[1]	In the fourth quarter of 2021, our life insurance business initially ceded $268 million of certain term life insurance reserves under a new reinsurance treaty as part of a life block transaction. Our life insurance business also completed its annual review of assumptions in the fourth quarter of 2021. This review resulted in higher total benefits and expenses of $87 million from an unfavorable unlocking in our term universal and universal life insurance products largely attributable to higher pre-COVID-19 mortality. In our term universal life insurance products, we also recorded a DAC impairment of $41 million in the fourth quarter of 2021 principally due to lower future estimated gross profits.
[2]	Given our assumption that COVID-19 has temporarily decreased the number of new claims submitted, our long-term care insurance business strengthened IBNR reserves in the fourth quarter of 2020 by $47 million. Additionally, our long-term care insurance business recorded a $91 million increase to claim reserves reflecting our assumption that COVID-19 accelerated mortality experience on the most vulnerable claimants, leaving the remaining claim population less likely to terminate compared to the pre-pandemic average population. Our Enact segment recorded an unfavorable reserve adjustment of $37 million primarily due to slowing cure emergence patterns impacting the frequency of claim. Our life insurance business completed its annual review of assumptions in the fourth quarter of 2020. This review resulted in lower total benefits and expenses of $82 million from a net favorable unlocking in our term universal and universal life insurance products largely attributable to a model refinement in our term universal life insurance product related to persistency and grace period timing and lower projected cost of insurance assessments on our universal life insurance products. In addition, we recorded a DAC impairment of $63 million in our universal life insurance products due principally to lower future estimated gross profits.
[3]	On September 20, 2021, we completed the minority IPO of Enact Holdings, which reduced our ownership percentage to 81.6%, and lowered our available net income by $29 million in the fourth quarter of 2021.
[4]	In the fourth quarter of 2020, we recorded a loss from discontinued operations, net of taxes, of $35 million principally attributed to expenses associated with the promissory note owed to AXA and from a $5 million net loss in Genworth Australia. The expenses associated with the promissory note mostly consisted of foreign currency remeasurement losses of $26 million, unfavorable tax charges of $17 million and other expenses of $8 million. These expenses were partially offset by derivative hedge gains of $21 million associated with foreign currency forward contracts entered into to mitigate our exposure to the installment payments to be made in British Pounds in 2022. See note 23 for additional details on discontinued operations.
[5]	Includes amounts accounted for under the deposit method.

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Detail) - USD ($) $ in Millions	Aug. 11, 2021	Jul. 17, 2020	Jan. 31, 2020	Jan. 31, 2021	Jan. 31, 2020	Dec. 31, 2019	Dec. 31, 2021	Dec. 31, 2020	Sep. 11, 2019
Commitments and Contingencies Disclosure [Line Items]
Off-balance sheet risk							$ 1,185	$ 1,090
Commitments to Fund Limited Partnerships
Commitments and Contingencies Disclosure [Line Items]
Off-balance sheet risk							1,185
Commitments to fund U.S. commercial mortgage loan investments
Commitments and Contingencies Disclosure [Line Items]
Off-balance sheet risk							28
Commitments to Fund Private Placement Investments
Commitments and Contingencies Disclosure [Line Items]
Off-balance sheet risk							97
Commitments to Fund Bank Loan Investments
Commitments and Contingencies Disclosure [Line Items]
Off-balance sheet risk							$ 141
Other Litigation
Commitments and Contingencies Disclosure [Line Items]
Plaintiff's Motion Dismissed					$ 395
Loss Contingency, Damages Sought	$ 5	$ 5		$ 5
Plaintiffs' motion			$ 15			$ 410
Restricted cash proceeds on sale per litigation									$ 450

Component of Changes in Accumul

Component of Changes in Accumulated Other Comprehensive Income (Loss) (Detail) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance		$ 4,425	$ 3,433	$ 2,044
OCI before reclassifications		(210)	1,531	1,728
Amounts reclassified from (to) OCI		(192)	(509)	(172)
Total other comprehensive income (loss)		(402)	1,022	1,556
Balances before nonnontrolling interests		4,023	4,455	3,600
Less: change in OCI attributable to noncontrolling interests		162	30	167
Ending balance		3,861	4,425	3,433
Net unrealized investment gains (losses)
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance	[1]	2,214	1,456	595
OCI before reclassifications	[1]	(313)	1,132	910
Amounts reclassified from (to) OCI	[1]	(51)	(374)	(62)
Total other comprehensive income (loss)	[1]	(364)	758	848
Balances before nonnontrolling interests	[1]	1,850	2,214	1,443
Less: change in OCI attributable to noncontrolling interests	[1]	(10)	0	(13)
Ending balance	[1]	1,860	2,214	1,456
Derivatives qualifying as hedges
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance	[2]	2,211	2,002	1,781
OCI before reclassifications	[2]	(45)	344	331
Amounts reclassified from (to) OCI	[2]	(141)	(135)	(110)
Total other comprehensive income (loss)	[2]	(186)	209	221
Balances before nonnontrolling interests	[2]	2,025	2,211	2,002
Less: change in OCI attributable to noncontrolling interests	[2]	0	0	0
Ending balance	[2]	2,025	2,211	2,002
Foreign currency translation and other adjustments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance		0	(25)	(332)
OCI before reclassifications		148	55	487
Amounts reclassified from (to) OCI		0	0	0
Total other comprehensive income (loss)		148	55	487
Balances before nonnontrolling interests		148	30	155
Less: change in OCI attributable to noncontrolling interests		172	30	180
Ending balance		$ (24)	$ 0	$ (25)
[1]	Net of adjustments to DAC, PVFP, sales inducements and benefit reserves. See note 4 for additional information.
[2]	See note 5 for additional information.

Changes In Accumulated Other _3

Changes In Accumulated Other Comprehensive Income (Loss) - Additional Information (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Accumulated Other Comprehensive Income (Loss) [Line Items]
Unrecognized postretirement benefit obligation, current period OCI	$ (1)	$ (15)	$ (4)
Unrecognized postretirement benefit obligation, current period OCI, tax	$ 1	4	1
Foreign currency translation and other adjustments, current period OCI, tax		$ 21	$ 22

Reclassifications In (Out) of A

Reclassifications In (Out) of Accumulated Other Comprehensive Income (Loss), Net of Taxes (Detail) - USD ($) $ in Millions		3 Months Ended																12 Months Ended
		Dec. 31, 2021	[1],[2],[3]	Sep. 30, 2021	[1],[2],[3]	Jun. 30, 2021	[1],[2],[3]	Mar. 31, 2021	[1],[2],[3]	Dec. 31, 2020	[4],[5],[6]	Sep. 30, 2020	[4],[5],[6]	Jun. 30, 2020	[4],[5],[6]	Mar. 31, 2020	[4],[5],[6]	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Net investment income																		$ (3,370)	$ (3,227)	$ (3,164)
Net investment (gains) losses																		(323)	(492)	(27)
Income taxes																		263	230	139
(Income) loss from continuing operations		$ (193)		$ (306)		$ (245)		$ (174)		$ (301)		$ (402)		$ (55)		$ 60		(918)	(698)	(382)
Interest expense																		160	195	231
Amount reclassified from accumulated other comprehensive income (loss) | Net unrealized investment (gains) losses
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Net investment (gains) losses	[7]																	(65)	(474)	(79)
Income taxes																		14	100	17
(Income) loss from continuing operations																		(51)	(374)	(62)
Amount reclassified from accumulated other comprehensive income (loss) | Derivatives qualifying as hedges
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Income taxes																		76	73	60
(Income) loss from continuing operations																		(141)	(135)	(110)
Amount reclassified from accumulated other comprehensive income (loss) | Derivatives qualifying as hedges | Interest rate swaps | Derivative liabilities
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Interest expense																		1	0	0
Amount reclassified from accumulated other comprehensive income (loss) | Derivatives qualifying as hedges | Interest rate swaps | Derivative assets
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Net investment income																		(217)	(196)	(164)
Net investment (gains) losses																		$ (1)	$ (12)	$ (6)
[1]	In the fourth quarter of 2021, our life insurance business initially ceded $268 million of certain term life insurance reserves under a new reinsurance treaty as part of a life block transaction. Our life insurance business also completed its annual review of assumptions in the fourth quarter of 2021. This review resulted in higher total benefits and expenses of $87 million from an unfavorable unlocking in our term universal and universal life insurance products largely attributable to higher pre-COVID-19 mortality. In our term universal life insurance products, we also recorded a DAC impairment of $41 million in the fourth quarter of 2021 principally due to lower future estimated gross profits.
[2]	In the fourth quarter of 2021, our life insurance business initially ceded $360 million of premiums associated with certain term life insurance policies under a new reinsurance treaty as part of a life block transaction.
[3]	In the fourth quarter of 2021, our life insurance business recorded a net loss of $131 million predominantly driven by an initial loss of $73 million as a result of ceding certain term life insurance policies as part of a life block transaction, an unfavorable unlocking of $70 million associated with its annual review of assumptions and a DAC impairment of $32 million as a result of recoverability testing.
[4]	Given our assumption that COVID-19 has temporarily decreased the number of new claims submitted, our long-term care insurance business strengthened IBNR reserves in the fourth quarter of 2020 by $47 million. Additionally, our long-term care insurance business recorded a $91 million increase to claim reserves reflecting our assumption that COVID-19 accelerated mortality experience on the most vulnerable claimants, leaving the remaining claim population less likely to terminate compared to the pre-pandemic average population. Our Enact segment recorded an unfavorable reserve adjustment of $37 million primarily due to slowing cure emergence patterns impacting the frequency of claim. Our life insurance business completed its annual review of assumptions in the fourth quarter of 2020. This review resulted in lower total benefits and expenses of $82 million from a net favorable unlocking in our term universal and universal life insurance products largely attributable to a model refinement in our term universal life insurance product related to persistency and grace period timing and lower projected cost of insurance assessments on our universal life insurance products. In addition, we recorded a DAC impairment of $63 million in our universal life insurance products due principally to lower future estimated gross profits.
[5]	In the fourth quarter of 2020, our long-term care insurance business strengthened its reserves by $109 million after-tax. Our Enact segment strengthened loss reserves by $29 million after-tax. Our life insurance business recorded a $60 million net favorable unlocking, net of taxes, related to its annual review of assumptions. This favorable unlocking in our life insurance business was partially offset by a DAC impairment of $50 million, net of taxes, as a result of recoverability testing. For all of the aforementioned transactions, see above under superscript (2) for additional details.
[6]	In the fourth quarter of 2020, we recorded lower net investment gains as compared to the third quarter of 2020. The higher net investment gains recorded in the third quarter of 2020 related to the sale of available-for-sale fixed maturity securities of $330 million driven primarily from the sale of U.S. government securities due to portfolio rebalancing and asset exposure management as a result of the prolonged low interest rate environment. This decrease to total revenues was partially offset by higher net investment income recorded in the fourth quarter of 2020 largely driven by bond calls and mortgage loan repayments of $40 million and limited partnerships of $38 million.
[7]	Amounts exclude adjustments to DAC, PVFP, sales inducements and benefit reserves.

Noncontrolling Interests - Summ

Noncontrolling Interests - Summary of Changes in Ownership Interests (Details) - USD ($) $ in Millions

3 Months Ended

12 Months Ended

Dec. 31, 2021

[1]

Sep. 30, 2021

[1]

Jun. 30, 2021

[1]

Mar. 31, 2021

[1]

Dec. 31, 2020

Sep. 30, 2020

Jun. 30, 2020

Mar. 31, 2020

Dec. 31, 2021

Dec. 31, 2020

Dec. 31, 2019

Noncontrolling Interest [Abstract]

Net income available to Genworth Financial, Inc.'s common stockholders

$ 163

$ 314

$ 240

$ 187

$ 267

$ 418

$ (441)

$ (66)

$ 904

$ 178

$ 343

Transfers to noncontrolling interests:

Decrease in Genworth Financial, Inc.'s additional paid-in capital for initial sale of Enact Holdings shares to noncontrolling interests

(167)

Net transfers to noncontrolling interests

(167)

Change from net income available to Genworth Financial, Inc.'s common stockholders and transfers to noncontrolling interests

$ 737

[1]

On September 20, 2021, we completed the minority IPO of Enact Holdings, which reduced our ownership percentage to 81.6%, and lowered our available net income by $29 million in the fourth quarter of 2021.

Noncontrolling Interests - Addi

Noncontrolling Interests - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Millions	Sep. 16, 2021	Sep. 15, 2021	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Mar. 03, 2021
Noncontrolling Interest [Line Items]
Payment of dividends minority interest			$ 37	$ 0	$ 0
Stockholders' Equity Attributable to Noncontrolling Interests			$ 756	$ 502
Genworth Australia
Noncontrolling Interest [Line Items]
Beneficial ownership percentage of ordinary shares						52.00%
Stockholders' Equity Attributable to Noncontrolling Interests						$ 500
Enact Holdings Inc.
Noncontrolling Interest [Line Items]
Beneficial ownership percentage of ordinary shares			81.60%
Payment of dividends minority interest			$ 37
Costs directly related to the Offering	$ 24
Proceeds from the sale of subsidiary shares gross	$ 553
Enact Holdings Inc. | IPO
Noncontrolling Interest [Line Items]
Shares sold	13,310,400
Price per ordinary share	$ 19
Enact Holdings Inc. | Private Placement
Noncontrolling Interest [Line Items]
Shares sold	14,655,600
Price per ordinary share	$ 17.86
Enact Holdings Inc. | Over-Allotment Option
Noncontrolling Interest [Line Items]
Shares sold	1,996,560	1,996,560

Schedule Of Income Loss On Sale

Schedule Of Income Loss On Sale Recorded In Our Disposition Group (Detail) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2021	Dec. 31, 2019
Genworth Canada
Net cash proceeds			$ 1,736
Add: carrying value of noncontrolling interests			1,417
Total adjusted consideration			3,153
Carrying value of the disposal group before accumulated other comprehensive loss			3,022
Add: total accumulated other comprehensive loss of disposal group			325
Total adjusted carrying value of the disposal group			3,347
Pre-tax loss on sale			(194)
Tax benefit on sale			73
After-tax loss on sale			$ (121)
Genworth Australia
Net cash proceeds		$ 370
Add: carrying value of noncontrolling interests	[1]	657
Total adjusted consideration	[2]	1,027
Carrying value of the disposal group before accumulated other comprehensive loss		1,040
Add: total accumulated other comprehensive loss of disposal group	[3]	109
Total adjusted carrying value of the disposal group		1,149
Pre-tax loss on sale		(122)
Tax benefit on sale		122
After-tax loss on sale		$ 0
[1]	In accordance with accounting guidance on the deconsolidation of a subsidiary or group of assets, the carrying amount of any noncontrolling interests in the subsidiary sold (adjusted to reflect amounts in accumulated other comprehensive income (loss) recognized upon final disposition) is added to the total fair value of the consideration received.
[2]	Represents the aggregate of the net cash proceeds received upon sale closing plus the adjusted carrying amount of noncontrolling interests in the subsidiary sold.
[3]	Amount consists of $160 million of cumulative losses on foreign currency translation adjustments, partially offset by cumulative unrealized investment gains of $29 million and deferred tax gains of $22 million.

Schedule Of Income Loss On Sa_2

Schedule Of Income Loss On Sale Recorded In Our Disposition Group (Parenthetical) (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Net unrealized investment gains (losses)	$ 1,860	$ 2,214	$ 1,456	$ 595
Genworth Canada
Foreign currency translation and other adjustments	369
Deferred tax losses on accumulated other comprehensive income	71
Net unrealized investment gains (losses)	115
Genworth Australia
Foreign currency translation and other adjustments	160
Deferred tax losses on accumulated other comprehensive income	29
Net unrealized investment gains (losses)	22
Favorable adjustment relating to refinement of tax matters agreement	$ 10

Assets and Liabilities Held for

Assets and Liabilities Held for Sale Related to Australia Mortgage Insurance Business (Detail) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Investments:
Fixed maturity securities available-for-sale, at fair value	$ 60,480	$ 63,495
Equity securities, at fair value	198	386
Other invested assets	820	1,050
Total investments	72,278	74,701
Cash, cash equivalents and restricted cash	1,571	2,561	$ 3,262
Accrued investment income	647	655
Deferred acquisition costs	1,146	1,487	$ 1,799
Other assets	388	404
Deferred tax asset	119	65
Assets related to discontinued operations	0	2,817
Liabilities
Liability for policy and contract claims	11,841	11,486
Unearned premiums	672	775
Other liabilities	1,511	1,614
Long-term borrowings	1,899	3,403
Liabilities related to discontinued operations	34	2,370
Genworth Australia
Investments:
Fixed maturity securities available-for-sale, at fair value	0	2,295
Equity securities, at fair value	0	90
Other invested assets	0	154
Total investments	0	2,539
Cash, cash equivalents and restricted cash	0	95
Accrued investment income	0	16
Deferred acquisition costs	0	42
Intangible assets and goodwill	0	43
Other assets	0	40
Deferred tax asset	0	42
Assets related to discontinued operations	0	2,817
Liabilities
Liability for policy and contract claims	0	331
Unearned premiums	0	1,193
Other liabilities	0	104
Long-term borrowings	0	145
Liabilities related to discontinued operations	$ 0	$ 1,773

Discontinued Operations - Addit

Discontinued Operations - Additional Information (Detail) $ / shares in Units, € in Millions, £ in Millions, $ in Millions, $ in Millions

Sep. 21, 2021USD ($)

Sep. 21, 2021GBP (£)

Mar. 31, 2021USD ($)

Mar. 31, 2021GBP (£)

Mar. 03, 2021USD ($)

Mar. 03, 2021AUD ($)

Dec. 31, 2021USD ($)

Dec. 31, 2021EUR (€)

Dec. 31, 2020USD ($)

Dec. 31, 2019USD ($)

Feb. 28, 2022USD ($)

Dec. 31, 2021GBP (£)

Dec. 31, 2019$ / shares

Income Statement, Balance Sheet and Additional Disclosures by Planned Disposal Groups [Line Items]

Unrelated liability

$ 4

$ 16

Underwriting Liability [Member] | AXA [Member]

Income Statement, Balance Sheet and Additional Disclosures by Planned Disposal Groups [Line Items]

Adjustments to underwriting loss

(4)

23

$ 0

Cash settlement payment, underwriting losses

18

€ 15

Genworth Mortgage Insurance Australia Limited

Income Statement, Balance Sheet and Additional Disclosures by Planned Disposal Groups [Line Items]

Proceeds from sale of disposal group including discontinuing operations

$ 370

$ 483

AXA Settlement Agreement

Income Statement, Balance Sheet and Additional Disclosures by Planned Disposal Groups [Line Items]

Income loss from discontinued operations after tax

$ 4

$ (572)

(110)

AXA Settlement Agreement | Discontinued Operations | Promissory Note

Income Statement, Balance Sheet and Additional Disclosures by Planned Disposal Groups [Line Items]

Percent of security interest pledged

19.90%

19.90%

AXA Settlement Agreement Promissory Note | Discontinued Operations | Future Claims

Income Statement, Balance Sheet and Additional Disclosures by Planned Disposal Groups [Line Items]

Loss Contingency, Estimate of Possible Loss

$ 30

$ 30

£ 22

AXA Settlement Agreement Promissory Note | Discontinued Operations | Promissory Note | Mandatory Payment

Income Statement, Balance Sheet and Additional Disclosures by Planned Disposal Groups [Line Items]

Repayment of mandatory principal payment

$ 296

£ 215

$ 245

£ 176

Genworth Canada MI

Income Statement, Balance Sheet and Additional Disclosures by Planned Disposal Groups [Line Items]

Proceeds from sale of disposal group including discontinuing operations

1,700

Payments of dividends to holding company

54

Special dividend reducing the purchase price per share | $ / shares

$ 1.45

Gain (loss) on sale of business after tax

$ 121

Summary of Operating Results Re

Summary of Operating Results Related to Discontinued Operations (Detail) - USD ($) $ in Millions		3 Months Ended																12 Months Ended
		Dec. 31, 2021		Sep. 30, 2021		Jun. 30, 2021		Mar. 31, 2021		Dec. 31, 2020		Sep. 30, 2020		Jun. 30, 2020		Mar. 31, 2020		Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Revenues:
Premiums																		$ 3,435	$ 3,836	$ 3,725
Net investment income																		3,370	3,227	3,164
Net investment gains (losses)																		323	492	27
Policy fees and other income																		704	729	789
Benefits and expenses:
Benefits and other changes in policy reserves																		4,383	5,214	5,059
Acquisition and operating expenses, net of deferrals																		1,223	935	909
Amortization of deferred acquisition costs and intangibles																		377	463	408
Total benefits and expenses		$ 1,481	[1]	$ 1,697	[1]	$ 1,721	[1]	$ 1,752	[1]	$ 1,771	[2]	$ 1,786	[2]	$ 1,925	[2]	$ 1,874	[2]	6,651	7,356	7,184
Income from discontinued operations, net of taxes		(1)		12		(5)		21		(35)	[3]	34	[3]	(473)	[3]	(12)	[3]	27	(486)	148
Less: net income from discontinued operations attributable to noncontrolling interests		0		0		0		8		(1)		18		23		(6)		8	34	187
Income (loss) from discontinued operations available to Genworth Financial, Inc.'s common stockholders		$ (1)		$ 12		$ (5)		$ 13		$ (34)		$ 16		$ (496)		$ (6)		19	(520)	(39)
Assets Held For Sale Related To Discontinued Operations | Canada Mortgage Insurance
Revenues:
Premiums																				466
Net investment income																				132
Net investment gains (losses)																				(13)
Total revenues																				585
Benefits and expenses:
Benefits and other changes in policy reserves																				79
Acquisition and operating expenses, net of deferrals																				64
Amortization of deferred acquisition costs and intangibles																				39
Interest expense																				50
Total benefits and expenses																				232
Income before income taxes and gain (loss) on sale																				353
Provision for income taxes																				111
Income before gain (loss) on sale																				242
Gain (loss) on sale, net of taxes																				(121)
Income from discontinued operations, net of taxes																				121
Less: net income from discontinued operations attributable to noncontrolling interests																				123
Income (loss) from discontinued operations available to Genworth Financial, Inc.'s common stockholders																				(2)
Assets Held For Sale Related To Discontinued Operations | Genworth Australia
Revenues:
Premiums																		51	274	312
Net investment income																		4	33	56
Net investment gains (losses)																		(5)	66	23
Policy fees and other income																		0	1	0
Total revenues																		50	374	391
Benefits and expenses:
Benefits and other changes in policy reserves																		11	177	104
Acquisition and operating expenses, net of deferrals																		7	53	53
Amortization of deferred acquisition costs and intangibles																		6	29	33
Interest expense																		1	7	8
Goodwill impairment																		0	5	0
Total benefits and expenses																		25	271	198
Income before income taxes and gain (loss) on sale	[4]																	25	103	193
Provision for income taxes																		8	40	56
Income before gain (loss) on sale																		17	63	137
Gain (loss) on sale, net of taxes																		0	0	0
Income from discontinued operations, net of taxes																		17	63	137
Less: net income from discontinued operations attributable to noncontrolling interests																		8	34	64
Income (loss) from discontinued operations available to Genworth Financial, Inc.'s common stockholders																		$ 9	$ 29	$ 73
[1]	In the fourth quarter of 2021, our life insurance business initially ceded $268 million of certain term life insurance reserves under a new reinsurance treaty as part of a life block transaction. Our life insurance business also completed its annual review of assumptions in the fourth quarter of 2021. This review resulted in higher total benefits and expenses of $87 million from an unfavorable unlocking in our term universal and universal life insurance products largely attributable to higher pre-COVID-19 mortality. In our term universal life insurance products, we also recorded a DAC impairment of $41 million in the fourth quarter of 2021 principally due to lower future estimated gross profits.
[2]	Given our assumption that COVID-19 has temporarily decreased the number of new claims submitted, our long-term care insurance business strengthened IBNR reserves in the fourth quarter of 2020 by $47 million. Additionally, our long-term care insurance business recorded a $91 million increase to claim reserves reflecting our assumption that COVID-19 accelerated mortality experience on the most vulnerable claimants, leaving the remaining claim population less likely to terminate compared to the pre-pandemic average population. Our Enact segment recorded an unfavorable reserve adjustment of $37 million primarily due to slowing cure emergence patterns impacting the frequency of claim. Our life insurance business completed its annual review of assumptions in the fourth quarter of 2020. This review resulted in lower total benefits and expenses of $82 million from a net favorable unlocking in our term universal and universal life insurance products largely attributable to a model refinement in our term universal life insurance product related to persistency and grace period timing and lower projected cost of insurance assessments on our universal life insurance products. In addition, we recorded a DAC impairment of $63 million in our universal life insurance products due principally to lower future estimated gross profits.
[3]	In the fourth quarter of 2020, we recorded a loss from discontinued operations, net of taxes, of $35 million principally attributed to expenses associated with the promissory note owed to AXA and from a $5 million net loss in Genworth Australia. The expenses associated with the promissory note mostly consisted of foreign currency remeasurement losses of $26 million, unfavorable tax charges of $17 million and other expenses of $8 million. These expenses were partially offset by derivative hedge gains of $21 million associated with foreign currency forward contracts entered into to mitigate our exposure to the installment payments to be made in British Pounds in 2022. See note 23 for additional details on discontinued operations.
[4]	The years ended December 31, 2021, 2020 and 2019 include pre-tax income from discontinued operations available to Genworth Financial, Inc.’s common stockholders of $13 million, $54 million and $100 million, respectively.

Summary of Operating Results _2

Summary of Operating Results Related to Discontinued Operations (Parenthetical) (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Parent Company [Member]
Discontinued operation pretax income attributable to parent			$ 186
Genworth Canada Mortgage Insurance
Interest expense-term loan			34
Genworth Australia | Parent Company [Member]
Discontinued operation pretax income attributable to parent	$ 13	$ 54	$ 100

Discontinued Operations - Summa

Discontinued Operations - Summary of Liabilities Related to Discontinued Operations (Detail) - AXA Settlement Agreement £ in Millions, $ in Millions		12 Months Ended
		Dec. 31, 2021USD ($)	Dec. 31, 2021GBP (£)	Dec. 31, 2020USD ($)	Dec. 31, 2020GBP (£)	Dec. 31, 2021GBP (£)	Dec. 31, 2020GBP (£)
Installment Payments Due To AXA [Abstract]
Amounts billed as future losses		$ 3	£ 2	$ 0	£ 0
Total amounts due under the promissory note		0		473		£ 0	£ 346
Future claims:
Estimated beginning balance		108	79	146	107
Change in estimated future claims		(14)	(10)	1	1
Less: Amounts billed and included as mandatory prepayments		(61)	(45)	(39)	(29)
Less: Amounts paid		(3)	(2)	0	0
Estimated future billings		30	22	108	79
Total amounts due to AXA under the settlement agreement		30		581		£ 22	£ 425
June 2022
Installment Payments Due To AXA [Abstract]
Beginning balance		217	159	217	159
Prepayments	[1]	(217)	(159)	0	0
Ending balance		0	0	217	159
September 2022
Installment Payments Due To AXA [Abstract]
Beginning balance		256	187	217	158
Prepayments	[1]	(324)	(232)	0	0
Amounts billed as future losses		61	45	39	29
Foreign exchange and other		7	0	0	0
Ending balance		0	0	256	187
Future claims:
Less: Amounts paid		$ (61)	£ (45)	$ (39)	£ (29)
[1]	On March 3, 2021, we completed the sale of Genworth Australia and received net proceeds of approximately AUD483 million ($370 million). The sale of Genworth Australia resulted in a mandatory principal payment of approximately £176 million ($245 million) related to our outstanding secured promissory note issued to AXA, dated as of July 20, 2020, as amended by the parties in connection with the Genworth Australia sale. On September 21, 2021, Genworth Holdings used a portion of the net proceeds from the minority IPO of Enact Holdings to repay the remaining outstanding balance of the secured promissory note of approximately £215 million ($296 million).

Discontinued Operations - Sum_2

Discontinued Operations - Summary of Liabilities Related to Discontinued Operations (Parenthetical) (Detail) - Mar. 03, 2021 - Genworth Mortgage Insurance Australia Limited [Member] £ in Millions, $ in Millions, $ in Millions	USD ($)	AUD ($)	GBP (£)
Income Statement, Balance Sheet and Additional Disclosures by Planned Disposal Groups [Line Items]
Proceeds from sale of disposal group including discontinuing operations	$ 370	$ 483
Mandatory Payment [Member] | Promissory Note [Member] | Discontinued Operations [Member]
Income Statement, Balance Sheet and Additional Disclosures by Planned Disposal Groups [Line Items]
Promissory Note repayment	296		£ 215
AXA Settlement Agreement Promissory Note [Member] | Mandatory Payment [Member] | Promissory Note [Member] | Discontinued Operations [Member]
Income Statement, Balance Sheet and Additional Disclosures by Planned Disposal Groups [Line Items]
Promissory Note repayment	$ 245		£ 176

Schedule I Genworth Financial_2

Schedule I Genworth Financial, Inc. Summary of Investments-Other than Investments in Related Parties (Detail) $ in Millions	Dec. 31, 2021USD ($)
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized cost or cost	$ 63,431
Carrying value	72,278
Commercial mortgage loans
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized cost or cost	6,830
Carrying value	6,830
Policy Loans
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized cost or cost	2,050
Carrying value	2,050
Limited Partnerships
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized cost or cost	1,314
Carrying value	1,900
Other invested assets
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized cost or cost	440	[1]
Carrying value	820	[1]
Fixed maturity securities | Bonds
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized cost or cost	52,611
Fair value	60,480
Carrying value	60,480
Fixed maturity securities | Bonds | U.S. government, agencies and authorities
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized cost or cost	3,368
Fair value	4,552
Carrying value	4,552
Fixed maturity securities | Bonds | State and Political Subdivisions
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized cost or cost	2,982
Fair value	3,450
Carrying value	3,450
Fixed maturity securities | Bonds | Non-U.S. government
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized cost or cost	762
Fair value	835
Carrying value	835
Fixed maturity securities | Bonds | Public Utilities
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized cost or cost	5,197
Fair value	6,032
Carrying value	6,032
Fixed maturity securities | Bonds | All Other Corporate Bonds
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized cost or cost	40,302
Fair value	45,611
Carrying value	45,611
Equity Securities
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized cost or cost	186
Fair value	198
Carrying value	$ 198
[1]	The amount shown in the consolidated balance sheet for other invested assets differs from amortized cost or cost presented, as other invested assets include certain assets with a carrying amount that differs from amortized cost or cost.

Schedule II Genworth Financia_2

Schedule II Genworth Financial, Inc. (Parent Company Only) (Balance Sheets) (Detail) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Assets
Deferred tax asset	$ 960	$ 1,084
Other assets	388	404
Total assets	99,171	105,747
Liabilities and stockholders' equity
Other liabilities	1,511	1,614
Total liabilities	82,905	89,927
Commitments and contingencies
Stockholders' equity:
Common stock	1	1
Additional paid-in capital	11,858	12,008
Net unrealized investment gains (losses)
Accumulated other comprehensive income (loss)	3,861	4,425	$ 3,433	$ 2,044
Retained earnings	2,490	1,584
Treasury stock, at cost	(2,700)	(2,700)
Total Genworth Financial, Inc.'s stockholders' equity	15,510	15,318
Total liabilities and equity	99,171	105,747
Parent Company
Assets
Investments in subsidiaries	15,517	15,358
Deferred tax asset	4	13
Other assets	5	2
Total assets	15,526	15,373
Liabilities and stockholders' equity
Other liabilities	4	55
Intercompany notes payable	12	0
Total liabilities	16	55
Commitments and contingencies
Stockholders' equity:
Common stock	1	1
Additional paid-in capital	11,858	12,008
Net unrealized investment gains (losses)
Accumulated other comprehensive income (loss)	3,861	4,425
Retained earnings	2,490	1,584
Treasury stock, at cost	(2,700)	(2,700)
Total Genworth Financial, Inc.'s stockholders' equity	15,510	15,318
Total liabilities and equity	$ 15,526	$ 15,373

Schedule II Genworth Financia_3

Schedule II Genworth Financial, Inc. (Parent Company Only) (Statements of Income) (Detail) - USD ($) $ in Millions	3 Months Ended																12 Months Ended
	Dec. 31, 2021		Sep. 30, 2021		Jun. 30, 2021		Mar. 31, 2021		Dec. 31, 2020		Sep. 30, 2020		Jun. 30, 2020		Mar. 31, 2020		Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Revenues:
Net investment income																	$ 3,370	$ 3,227	$ 3,164
Total revenues	$ 1,736	[1]	$ 2,070	[1]	$ 2,041	[1]	$ 1,985	[1]	$ 2,154	[2]	$ 2,318	[2]	$ 2,003	[2]	$ 1,809	[2]	7,832	8,284	7,705
Expenses:
Acquisition and operating expenses, net of deferrals																	1,223	935	909
Interest expense																	160	195	231
Loss before income taxes and equity in income of subsidiaries																	1,181	928	521
Benefit from income taxes																	263	230	139
Income from continuing operations	164		302		245		174		301		402		55		(60)		885	698	382
Income from discontinued operations, net of taxes	(1)		12		(5)		21		(35)	[3]	34	[3]	(473)	[3]	(12)	[3]	27	(486)	148
Net income available to Genworth Financial, Inc.'s common stockholders	$ 163	[4]	$ 314	[4]	$ 240	[4]	$ 187	[4]	$ 267		$ 418		$ (441)		$ (66)		904	178	343
Parent Company
Revenues:
Net investment income																	(3)	(3)	(3)
Total revenues																	(3)	(3)	(3)
Expenses:
Acquisition and operating expenses, net of deferrals																	25	31	20
Interest expense																	(1)	1	3
Total expenses																	24	32	23
Loss before income taxes and equity in income of subsidiaries																	(27)	(35)	(26)
Benefit from income taxes																	(1)	(2)	(3)
Equity in income of subsidiaries																	930	210	366
Income from continuing operations																	904	177	343
Income from discontinued operations, net of taxes																	0	1	0
Net income available to Genworth Financial, Inc.'s common stockholders																	$ 904	$ 178	$ 343
[1]	In the fourth quarter of 2021, our life insurance business initially ceded $360 million of premiums associated with certain term life insurance policies under a new reinsurance treaty as part of a life block transaction.
[2]	In the fourth quarter of 2020, we recorded lower net investment gains as compared to the third quarter of 2020. The higher net investment gains recorded in the third quarter of 2020 related to the sale of available-for-sale fixed maturity securities of $330 million driven primarily from the sale of U.S. government securities due to portfolio rebalancing and asset exposure management as a result of the prolonged low interest rate environment. This decrease to total revenues was partially offset by higher net investment income recorded in the fourth quarter of 2020 largely driven by bond calls and mortgage loan repayments of $40 million and limited partnerships of $38 million.
[3]	In the fourth quarter of 2020, we recorded a loss from discontinued operations, net of taxes, of $35 million principally attributed to expenses associated with the promissory note owed to AXA and from a $5 million net loss in Genworth Australia. The expenses associated with the promissory note mostly consisted of foreign currency remeasurement losses of $26 million, unfavorable tax charges of $17 million and other expenses of $8 million. These expenses were partially offset by derivative hedge gains of $21 million associated with foreign currency forward contracts entered into to mitigate our exposure to the installment payments to be made in British Pounds in 2022. See note 23 for additional details on discontinued operations.
[4]	On September 20, 2021, we completed the minority IPO of Enact Holdings, which reduced our ownership percentage to 81.6%, and lowered our available net income by $29 million in the fourth quarter of 2021.

Schedule II Genworth Financia_4

Schedule II Genworth Financial, Inc. (Parent Company Only) (Statements of Comprehensive Income) (Detail) - USD ($) $ in Millions	3 Months Ended																12 Months Ended
	Dec. 31, 2021	[1],[2],[3]	Sep. 30, 2021	[1],[2],[3]	Jun. 30, 2021	[1],[2],[3]	Mar. 31, 2021	[1],[2],[3]	Dec. 31, 2020	[4],[5],[6],[7]	Sep. 30, 2020	[4],[5],[6],[7]	Jun. 30, 2020	[4],[5],[6],[7]	Mar. 31, 2020	[4],[5],[6],[7]	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Net income available to Genworth Financial, Inc.'s common stockholders	$ 192		$ 318		$ 240		$ 195		$ 266		$ 436		$ (418)		$ (72)		$ 945	$ 212	$ 530
Other comprehensive income (loss), net of taxes:
Net unrealized gains (losses) on securities without an allowance for credit losses																	(370)	764	0
Net unrealized gains (losses) on securities with an allowance for credit losses																	6	(6)	0
Net unrealized gains (losses) on securities not other-than-temporarily impaired																	0	0	846
Derivatives qualifying as hedges																	(186)	209	221
Foreign currency translation and other adjustments																	148	55	487
Total other comprehensive income (loss)																	(402)	1,022	1,556
Total comprehensive income available to Genworth Financial, Inc.'s common stockholders																	366	1,170	1,732
Parent Company [Member]
Net income available to Genworth Financial, Inc.'s common stockholders																	904	178	343
Other comprehensive income (loss), net of taxes:
Net unrealized gains (losses) on securities without an allowance for credit losses																	(334)	764	0
Net unrealized gains (losses) on securities with an allowance for credit losses																	6	(6)	0
Net unrealized gains (losses) on securities not other-than-temporarily impaired																	0	0	859
Net unrealized gains (losses) on other-than-temporarily impaired securities																	0	0	2
Derivatives qualifying as hedges																	(186)	209	221
Foreign currency translation and other adjustments																	(24)	25	307
Total other comprehensive income (loss)																	(538)	992	1,389
Total comprehensive income available to Genworth Financial, Inc.'s common stockholders																	$ 366	$ 1,170	$ 1,732
[1]	In the fourth quarter of 2021, our life insurance business initially ceded $268 million of certain term life insurance reserves under a new reinsurance treaty as part of a life block transaction. Our life insurance business also completed its annual review of assumptions in the fourth quarter of 2021. This review resulted in higher total benefits and expenses of $87 million from an unfavorable unlocking in our term universal and universal life insurance products largely attributable to higher pre-COVID-19 mortality. In our term universal life insurance products, we also recorded a DAC impairment of $41 million in the fourth quarter of 2021 principally due to lower future estimated gross profits.
[2]	In the fourth quarter of 2021, our life insurance business initially ceded $360 million of premiums associated with certain term life insurance policies under a new reinsurance treaty as part of a life block transaction.
[3]	In the fourth quarter of 2021, our life insurance business recorded a net loss of $131 million predominantly driven by an initial loss of $73 million as a result of ceding certain term life insurance policies as part of a life block transaction, an unfavorable unlocking of $70 million associated with its annual review of assumptions and a DAC impairment of $32 million as a result of recoverability testing.
[4]	Given our assumption that COVID-19 has temporarily decreased the number of new claims submitted, our long-term care insurance business strengthened IBNR reserves in the fourth quarter of 2020 by $47 million. Additionally, our long-term care insurance business recorded a $91 million increase to claim reserves reflecting our assumption that COVID-19 accelerated mortality experience on the most vulnerable claimants, leaving the remaining claim population less likely to terminate compared to the pre-pandemic average population. Our Enact segment recorded an unfavorable reserve adjustment of $37 million primarily due to slowing cure emergence patterns impacting the frequency of claim. Our life insurance business completed its annual review of assumptions in the fourth quarter of 2020. This review resulted in lower total benefits and expenses of $82 million from a net favorable unlocking in our term universal and universal life insurance products largely attributable to a model refinement in our term universal life insurance product related to persistency and grace period timing and lower projected cost of insurance assessments on our universal life insurance products. In addition, we recorded a DAC impairment of $63 million in our universal life insurance products due principally to lower future estimated gross profits.
[5]	In the fourth quarter of 2020, our long-term care insurance business strengthened its reserves by $109 million after-tax. Our Enact segment strengthened loss reserves by $29 million after-tax. Our life insurance business recorded a $60 million net favorable unlocking, net of taxes, related to its annual review of assumptions. This favorable unlocking in our life insurance business was partially offset by a DAC impairment of $50 million, net of taxes, as a result of recoverability testing. For all of the aforementioned transactions, see above under superscript (2) for additional details.
[6]	In the fourth quarter of 2020, we recorded a loss from discontinued operations, net of taxes, of $35 million principally attributed to expenses associated with the promissory note owed to AXA and from a $5 million net loss in Genworth Australia. The expenses associated with the promissory note mostly consisted of foreign currency remeasurement losses of $26 million, unfavorable tax charges of $17 million and other expenses of $8 million. These expenses were partially offset by derivative hedge gains of $21 million associated with foreign currency forward contracts entered into to mitigate our exposure to the installment payments to be made in British Pounds in 2022. See note 23 for additional details on discontinued operations.
[7]	In the fourth quarter of 2020, we recorded lower net investment gains as compared to the third quarter of 2020. The higher net investment gains recorded in the third quarter of 2020 related to the sale of available-for-sale fixed maturity securities of $330 million driven primarily from the sale of U.S. government securities due to portfolio rebalancing and asset exposure management as a result of the prolonged low interest rate environment. This decrease to total revenues was partially offset by higher net investment income recorded in the fourth quarter of 2020 largely driven by bond calls and mortgage loan repayments of $40 million and limited partnerships of $38 million.

Schedule II Genworth Financia_5

Schedule II Genworth Financial, Inc. (Parent Company Only) (Statements of Cash Flows) (Detail) - USD ($) $ in Millions	3 Months Ended																12 Months Ended
	Dec. 31, 2021		Sep. 30, 2021		Jun. 30, 2021		Mar. 31, 2021		Dec. 31, 2020		Sep. 30, 2020	[6]	Jun. 30, 2020	[6]	Mar. 31, 2020		Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Cash flows from (used by) operating activities:
Net income available to Genworth Financial, Inc.'s common stockholders	$ 192	[1],[2],[3]	$ 318	[1],[2],[3]	$ 240	[1],[2],[3]	$ 195	[1],[2],[3]	$ 266	[4],[5],[6],[7]	$ 436	[4],[5],[7]	$ (418)	[4],[5],[7]	$ (72)	[4],[5],[6],[7]	$ 945	$ 212	$ 530
Less (income) loss from discontinued operations, net of taxes	1		$ (12)		$ 5		(21)		35	[6]	$ (34)		$ 473		12	[6]	(27)	486	(148)
Adjustments to reconcile net income available to Genworth Financial, Inc.'s common stockholders to net cash from (used by) operating activities:
Deferred income taxes																	290	228	119
Stock-based compensation expense																	40	39	26
Change in certain assets and liabilities:
Accrued investment income and other assets																	(129)	(92)	(359)
Current tax liabilities																	(34)	6	21
Other liabilities and other policy-related balances																	310	830	636
Net cash from operating activities																	437	1,960	2,079
Cash flows used by investing activities:
Net cash from (used by) investing activities																	896	(1,153)	1,301
Cash flows from (used by) financing activities:
Other, net																	32	(2)	(35)
Net cash used by financing activities																	(2,419)	(1,507)	(2,217)
Cash, cash equivalents and restricted cash at beginning of year							2,561								3,262		2,561	3,262
Cash, cash equivalents and restricted cash at end of year	1,571								2,561								1,571	2,561	3,262
Parent Company
Cash flows from (used by) operating activities:
Net income available to Genworth Financial, Inc.'s common stockholders																	904	178	343
Less (income) loss from discontinued operations, net of taxes																	0	(1)	0
Adjustments to reconcile net income available to Genworth Financial, Inc.'s common stockholders to net cash from (used by) operating activities:
Equity in income from subsidiaries																	(930)	(210)	(366)
Dividends from subsidiaries																	0	0	250
Deferred income taxes																	0	(1)	1
Stock-based compensation expense																	40	39	26
Change in certain assets and liabilities:
Accrued investment income and other assets																	(1)	2	0
Current tax liabilities																	(5)	(1)	16
Other liabilities and other policy-related balances																	(13)	11	(17)
Net cash from operating activities																	(5)	17	253
Cash flows used by investing activities:
Intercompany notes receivable, net																	0	(10)	(119)
Capital contributions paid to subsidiaries																	(2)	(2)	(5)
Net cash from (used by) investing activities																	(2)	(12)	(124)
Cash flows from (used by) financing activities:
Other, net																	(5)	(5)	(7)
Intercompany notes payable, net																	12	0	(122)
Net cash used by financing activities																	7	(5)	(129)
Effect of exchange rate changes on cash, cash equivalents and restricted cash																	0	0	0
Cash, cash equivalents and restricted cash at beginning of year							$ 0								$ 0		0	0	0
Cash, cash equivalents and restricted cash at end of year	$ 0								$ 0								$ 0	$ 0	$ 0
[1]	In the fourth quarter of 2021, our life insurance business initially ceded $268 million of certain term life insurance reserves under a new reinsurance treaty as part of a life block transaction. Our life insurance business also completed its annual review of assumptions in the fourth quarter of 2021. This review resulted in higher total benefits and expenses of $87 million from an unfavorable unlocking in our term universal and universal life insurance products largely attributable to higher pre-COVID-19 mortality. In our term universal life insurance products, we also recorded a DAC impairment of $41 million in the fourth quarter of 2021 principally due to lower future estimated gross profits.
[2]	In the fourth quarter of 2021, our life insurance business initially ceded $360 million of premiums associated with certain term life insurance policies under a new reinsurance treaty as part of a life block transaction.
[3]	In the fourth quarter of 2021, our life insurance business recorded a net loss of $131 million predominantly driven by an initial loss of $73 million as a result of ceding certain term life insurance policies as part of a life block transaction, an unfavorable unlocking of $70 million associated with its annual review of assumptions and a DAC impairment of $32 million as a result of recoverability testing.
[4]	Given our assumption that COVID-19 has temporarily decreased the number of new claims submitted, our long-term care insurance business strengthened IBNR reserves in the fourth quarter of 2020 by $47 million. Additionally, our long-term care insurance business recorded a $91 million increase to claim reserves reflecting our assumption that COVID-19 accelerated mortality experience on the most vulnerable claimants, leaving the remaining claim population less likely to terminate compared to the pre-pandemic average population. Our Enact segment recorded an unfavorable reserve adjustment of $37 million primarily due to slowing cure emergence patterns impacting the frequency of claim. Our life insurance business completed its annual review of assumptions in the fourth quarter of 2020. This review resulted in lower total benefits and expenses of $82 million from a net favorable unlocking in our term universal and universal life insurance products largely attributable to a model refinement in our term universal life insurance product related to persistency and grace period timing and lower projected cost of insurance assessments on our universal life insurance products. In addition, we recorded a DAC impairment of $63 million in our universal life insurance products due principally to lower future estimated gross profits.
[5]	In the fourth quarter of 2020, our long-term care insurance business strengthened its reserves by $109 million after-tax. Our Enact segment strengthened loss reserves by $29 million after-tax. Our life insurance business recorded a $60 million net favorable unlocking, net of taxes, related to its annual review of assumptions. This favorable unlocking in our life insurance business was partially offset by a DAC impairment of $50 million, net of taxes, as a result of recoverability testing. For all of the aforementioned transactions, see above under superscript (2) for additional details.
[6]	In the fourth quarter of 2020, we recorded a loss from discontinued operations, net of taxes, of $35 million principally attributed to expenses associated with the promissory note owed to AXA and from a $5 million net loss in Genworth Australia. The expenses associated with the promissory note mostly consisted of foreign currency remeasurement losses of $26 million, unfavorable tax charges of $17 million and other expenses of $8 million. These expenses were partially offset by derivative hedge gains of $21 million associated with foreign currency forward contracts entered into to mitigate our exposure to the installment payments to be made in British Pounds in 2022. See note 23 for additional details on discontinued operations.
[7]	In the fourth quarter of 2020, we recorded lower net investment gains as compared to the third quarter of 2020. The higher net investment gains recorded in the third quarter of 2020 related to the sale of available-for-sale fixed maturity securities of $330 million driven primarily from the sale of U.S. government securities due to portfolio rebalancing and asset exposure management as a result of the prolonged low interest rate environment. This decrease to total revenues was partially offset by higher net investment income recorded in the fourth quarter of 2020 largely driven by bond calls and mortgage loan repayments of $40 million and limited partnerships of $38 million.

Schedule II Genworth Financia_6

Schedule II Genworth Financial, Inc. (Parent Company Only) - Additional Information (Detail) - USD ($) $ in Millions	3 Months Ended												12 Months Ended
	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2020		Sep. 30, 2020	[1]	Jun. 30, 2020	[1]	Mar. 31, 2020	[1]	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Apr. 01, 2013
Condensed Financial Statements, Captions [Line Items]
Deferred tax asset	$ 960				$ 1,084								$ 960	$ 1,084
Current income tax payable	2				32								2	32
Net cash received (paid) for taxes													7	(3)	$ (1)
Loss from discontinued operations, net of taxes	(1)	$ 12	$ (5)	$ 21	(35)	[1]	$ 34		$ (473)		$ (12)		27	(486)	148
Parent Company
Condensed Financial Statements, Captions [Line Items]
Deferred tax asset	4				13								4	13
Current income tax receivable	$ 2												2
Current income tax payable					$ 3									3
Net cash received (paid) for taxes													(4)	0	21
Loss from discontinued operations, net of taxes													$ 0	1	$ 0
Genworth Holdings
Condensed Financial Statements, Captions [Line Items]
Percentage of subsidiary equity ownership																100.00%
Loans to related party forgiven														129
Loss from discontinued operations, net of taxes														$ 549
[1]	In the fourth quarter of 2020, we recorded a loss from discontinued operations, net of taxes, of $35 million principally attributed to expenses associated with the promissory note owed to AXA and from a $5 million net loss in Genworth Australia. The expenses associated with the promissory note mostly consisted of foreign currency remeasurement losses of $26 million, unfavorable tax charges of $17 million and other expenses of $8 million. These expenses were partially offset by derivative hedge gains of $21 million associated with foreign currency forward contracts entered into to mitigate our exposure to the installment payments to be made in British Pounds in 2022. See note 23 for additional details on discontinued operations.

Schedule III Genworth Financial

Schedule III Genworth Financial, Inc. Supplemental Insurance Information (Schedule of Supplemental Insurance Information) (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Supplementary Insurance Information, by Segment [Line Items]
Deferred Acquisition Costs	$ 1,146	$ 1,487
Future Policy Benefits	41,528	42,695
Policyholder Account Balances	19,354	21,503
Liability for Policy and Contract Claims	11,841	11,486
Unearned Premiums	672	775
Premium Revenue	3,435	3,836	$ 3,725
Net Investment Income	3,370	3,227	3,164
Interest Credited and Benefits and Other Changes in Policy Reserves	4,891	5,763	5,636
Amortization of Deferred Acquisition Costs	346	437	365
Other Operating Expenses	1,414	1,156	1,183
Premiums Written	3,340	3,738	3,660
Enact
Supplementary Insurance Information, by Segment [Line Items]
Deferred Acquisition Costs	27	29
Future Policy Benefits	0	0
Policyholder Account Balances	0	0
Liability for Policy and Contract Claims	641	555
Unearned Premiums	246	307
Premium Revenue	975	971	856
Net Investment Income	141	133	117
Interest Credited and Benefits and Other Changes in Policy Reserves	125	381	50
Amortization of Deferred Acquisition Costs	9	14	9
Other Operating Expenses	287	231	197
Premiums Written	914	894	818
U.S. Life Insurance
Supplementary Insurance Information, by Segment [Line Items]
Deferred Acquisition Costs	1,008	1,319
Future Policy Benefits	41,526	42,693
Policyholder Account Balances	16,343	18,385
Liability for Policy and Contract Claims	11,183	10,908
Unearned Premiums	423	465
Premium Revenue	2,454	2,858	2,861
Net Investment Income	3,029	2,878	2,852
Interest Credited and Benefits and Other Changes in Policy Reserves	4,576	5,164	5,398
Amortization of Deferred Acquisition Costs	318	400	340
Other Operating Expenses	887	643	653
Premiums Written	2,419	2,837	2,834
Runoff
Supplementary Insurance Information, by Segment [Line Items]
Deferred Acquisition Costs	111	139
Future Policy Benefits	2	2
Policyholder Account Balances	3,011	3,118
Liability for Policy and Contract Claims	8	12
Unearned Premiums	3	3
Premium Revenue	0	0	0
Net Investment Income	194	210	187
Interest Credited and Benefits and Other Changes in Policy Reserves	189	214	185
Amortization of Deferred Acquisition Costs	19	23	16
Other Operating Expenses	54	48	54
Premiums Written	0	0	0
Corporate and Other
Supplementary Insurance Information, by Segment [Line Items]
Deferred Acquisition Costs	0	0
Future Policy Benefits	0	0
Policyholder Account Balances	0	0
Liability for Policy and Contract Claims	9	11
Unearned Premiums	0	0
Premium Revenue	6	7	8
Net Investment Income	6	6	8
Interest Credited and Benefits and Other Changes in Policy Reserves	1	4	3
Amortization of Deferred Acquisition Costs	0	0	0
Other Operating Expenses	186	234	279
Premiums Written	$ 7	$ 7	$ 8